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ý 77  5 ý-w  aI SUMMARY 
Two  methionine  y-lyase  gene  homologues,  mgII  and  mgI2  have  been  isolated  from 
Trichomonas  vaginalis  using  a  degenerate  oligonucleotide/PCR  approach.  Degenerate 
oligonucleotides  designed  against  cystathionine  y-lyase  from  yeast,  rat  and  human  were 
used  in  the  PCR  experiments.  mgII  and  mgI2  are  present  at  single  copy  in  the  T 
vaginalis  genome  and  are  expressed  to  give  1.3kb  mRNAs.  The  two  genes  have 
extremely  short  5'  untranslated  regions.  The  predicted  molecular  mass  of  MGL1  and 
MGL2  are  42.9  and  43.1  kDa,  respectively.  High  homology  exists  at  the  amino  acid 
level  between  the  two  T  vaginalis  methionine  y-lyase  gene  homologues  and  methionine 
, y-lyase  from  Pseudomonas  putida  and  cystathionine  y  -lyase  from  a  range  of  organisms 
and  other  related  sulphur  amino  acid-metabolising  enzymes. 
The  two  methionine  y-lyase  homologues  were  cloned  into  expression  vectors  and 
recombinant  proteins  purified  and  subsequently  characterised.  Biochemical 
characterisation  of  rMGL1  and  rMGL2  revealed  that  both  recombinant  proteins  were 
able  to  break  down  methionine,  catabolise  homocysteine  at  high  rate  and  also  able  to 
metabolise  cysteine  and  0-acetyl  L-serine.  Interestingly,  the  recombinant  proteins  were 
not  able  to  break  down  cystathionine.  The  two  proteins  were  expressed  in  T  vaginalis, 
as  judged  by  -43  kDa  proteins  being  detected  in  T  vaginalis  lysates  and  soluble 
extracts  by  Western  blot  analysis. 
Tritrichomonasfoetus  and  Tritrichomonas  augusta  do  not  possess  the  ability  to 
breakdown  homocysteine  and  are  thought  not  to  contain  methionine  y-lyase. 
Interestingly,  however,  antibodies  raised  against  rMGLI  and  rMGL2  recognised proteins  of  various  molecular  weights  and  upon  immunostaining  with  intact  parasites,  it 
is  probable  that  the  Golgi  apparatus  of  these  parasites  were  recognised  by  the  anti 
rMGL  I  and  rMGL2  sera.  For  T  vaginalis,  immunostaining  using  the  anti  rMGL  I  and 
rMGL2  sera  revealed  a  staining  of  the  nucleus  and  a  more  general  staining  of  the 
cytoplasm  of  these  parasites. 
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xvii CHAPTER  1.  INTRODUCTION. 
1.1  General  biology  of  Trichomonads. 
Species  of  the  genus  Trichomonas  identified  by  Donne  in  1896  are  protists,  that  occur  in 
the  intestines  of  mammals  including  man,  birds,  reptiles,  amphibia,  molluscs  (slugs)  and 
termites;  in  the  mouth  of  man  and  monkeys;  and  the  urinogenital  tract  of  man  and  cattle. 
No  cyst  is  produced,  and  no  sexual  process  is  known.  Reproduction  is  solely  by  binary 
fission.  There  are  three  species  of  trichomonads  that  infect  human  beings,  and  they  are 
extremely  site  specific  (Honigberg,  1989).  Trichomonas  tenax  lives  only  in  the  oral 
cavity,  Pentatrichomonas  hominis  only  in  the  intestinal  tract  and  Trichomonas  vaginalis 
only  in  the  lower  genitourinary  tract.  Only  T  vaginalis  is  considered  pathogenic 
(Thomason  et  al.,  1984,  Honigberg,  1989,  Graves  and  Gardner,  1993). 
Tritrichomonasfoetus  is  the  bovine  equivalent  to  T  vaginalis.  T  foetus  lives  in  the 
vagina  and  uterus  of  the  cow  and  in  the  prepucial  sheath  of  the  bull.  As  with  the  human 
equivalent  the  disease  is  sexually  transmitted.  Trichomoniasis  in  cows  could  be 
considered  to  be  more  serious  than  the  human  condition  because  if  T  foetus  is  present  in 
a  pregnant  uterus  the  organism  invades  the  foetus  and  an  early  abortion  often  results. 
This  aspect  of  the  biology  of  T  foetus  is  obviously  important  from  an  economic 
perspective.  In  cows  the  infection  is  self  limiting  with  all  trophozoites  being  expelled 
with  the  foetus  and  placenta,  this  is  fortunate  since  no  reliable  treatment  is  known. 
Trichomonas  gallinae  is  a  species  of  trichomonad  that  infects  birds,  primarily  the 
domestic  pigeon  Columba  livia.  The  trophozoites  inhabit  the  mouth,  pharynx, oesophagus  and  crop.  T  gallinae  produces  a  severe  disease  in  some  young  pigeons, 
which  may  be  fatal.  The  disease  is  variously  known  as  canker,  frounce,  roup  or  more 
scientifically,  avian  trichomoniasis.  Finally,  Trichomitus  augusta  is  a  species  of 
trichomonad  that  infects  the  intestine  of  the  leopard  frog  Rana  pipiens! 
T  vaginalis  is  the  organism  of  choice  for  the  area  of  research  covered  by  this  thesis,  but 
there  will  also  be  some  mention  of  T  foetus  and  T  augusta. 
1.2  Biology  of  Trichomonas  vaginalis. 
Trichomonas  vaginalis  is  a  motile,  ovoid,  10  to  20pm  in  length,  flagellated,  anaerobic 
protozoon.  The  organism  has  four  anterior  flagella  and  a  fifth  recurrent  flagellum  which 
is  attached  to  thin  fin-like  extension  of  the  body  to  form  an  undulating  membrane.  The 
undulating  membrane  covers  the  upper  two  thirds  of  its  body,  beneath  which  is  located  a 
cytoplasmic  costa.  All  five  flagella  are  involved  in  locomotion.  Although  capable  of 
rapid  motility  T  vaginalis  also  shows  amoeboid  movement.  An  axostyle,  a  skeletal 
organelle  of  longitudinally  arranged  parallel  microtubules,  runs  the  entire  length  of  the 
organism  and  protrudes  posteriorly. 
Internally,  T  vaginalis  has  a  large  nucleus  characteristic  of  eukaryotic  cells  as  well  as  a 
highly  developed  golgi  complex  (Diaz  et  al.,  1996)  The  cytoplasm  is  rich  in  glycogen 
granules  and  ribosomes  but  contains  no  mitochondria,  peroxisomes  or  glycosomes. 
Electron  dense  chromatic  granules,  called  hydrogenosomes  (Muller,  1980,1993),  which 
occur  in  other  anaerobic  protozoa  and  fungi  (Brul  et  al.,  1994)  are  found  within  the 
cytoplasm  and  play  an  important  role  in  metabolism. 
2 1.2.1  Nutrition. 
T.  vaginalis  is  an  aerotolerant  anaerobe,  optimal  growth  and  reproduction  occurs  in 
anaerobic  conditions.  An  extremely  fastidious  organism,  in  vitro  cultivation  requires  a 
large  number  of  essential  nutrients,  including  carbohydrates  (Read,  1957),  amino  acids 
(Rowe  and  Lowe,  1986),  purines  (Heyworth  et  al.,  1982)  and  pyrimidines  (Wang  and 
Cleng,  1984),  fatty  acids  (Roitman  et  al.,  1978),  vitamins  (Hollander  and  Leggett,  1985) 
and  iron  (Gorrell,  1985).  In  vivo,  the  vagina  and  its  secretions  contain  all  of  the 
nutrients  required  for  growth  (Huggins  and  Petri,  198  1).  T  vaginalis,  also  engulfs  and 
digests  bacteria,  possibly  helping  to  fulfil  nutritional  requirements  (Francioli  et  al., 
1983). 
T  vaginalis  is  known  to  attach  to  mucous  membranes  via  specific  adhesins. 
This  action  is  mediated  by  surface  proteinases  (Arroyo  and  Alderete,  1989)  and  is  iron 
regulated,  as  lactoferrin  (the  major  iron  source  at  mucosal  surfaces)  upregulates  adhesin 
protein  expression  (Lehker  et  al,  199  1).  For  a  review  of  the  mechanisms  and  molecules 
involved  in  cytoadherence  and  pathogenesis  of  T  vaginalis  see  Alderete  et  al.,  (1995). 
1.2.2  Immunity  to  T.  vaginalis. 
Protective  immunity  does  not  occur  with  trichomoniasis.  Specific  anti-T  vaginalis 
serum  antibody  (Coyne  el  al,  1975),  usually  at  low  titres,  has  been  identified  in  both 
men  and  women,  but  local  mucosal  antibody  has  been  isolated  in  women  only  (Ackers 
et  al.,  1975).  No  convincing  evidence  supports  a  major  role  for  antibodies  preventing  or 
clearing  trichomonal  infection  (Ackers,  1985).  Absence  of  an  effective  antibody 
response  highlights  the  roles  of  non  specific  host  immune  responses.  These  include 
activation  of  the  alternative  pathway  of  complement  (Demes  et  al.,  1988),  neutrophil 
3 chernotaxis  and  activation  induced  by  the  organism  itself  (Mason  and  Forman,  1982),  -  -- 
and,  possibly,  locally  increased  zinc  levels  (Krieger  and  Rein,  1982).  These  non- 
specific  defences  may  not  be  completely  effective  in  the  treatment,  both  asymptornatic 
and  symptomatic  infections  can  persist  for  prolonged  periods. 
1.2.3  Trichomoniasis  occurrence. 
Trichomoniasis  is  the  most  prevalent  non-viral  sexually  transmitted  disease  (McLellan 
et  al.,  1982).  World-wide,  there  are  approximately  180  million  cases  with  2.5  to  3 
million  infections  occurring  in  the  United  States  annually  (Thomason  and  Gelbart, 
1989).  The  prevalence  of  disease  varies  widely  in  different  populations.  In 
asymptornatic  patients  attending  family  planning  clinics,  5%  of  women  had  disease, 
whereas  50%  to  75%  of  prostitutes  were  infected  (Rein  and  Muller,  1989).  In  sexually 
transmitted  disease  clinics,  the  prevalence  of  trichomoniasis  ranges  from  0.9%  to  39.6% 
(Lossick,  1989).  Multiple  sexual  partners,  black  race,  previous  history  of  sexually 
transmitted  diseases,  coexistent  infection  with  Neiserria  gonorrohoeae,  and  non  use  of 
either  barrier  or  hormonal  contraceptives  are  known  risk  factors  for  acquisition  of 
Trichomonas  (Lossick,  1989).  Previously  thought  risk  factors  such  as  age,  coexistent 
infection  with  chlamydia  and  seasonality  are  thought  to  play  much  less  important  roles 
in  T  vaginalh  acquisition  (Lossick,  1989). 
1.2.4  Transmission. 
Trichomoniasis  is  a  sexually  transmitted  disease.  This  was  demonstrated  by  Hasseltine 
in  1942  when  he  inoculated  the  vagina  of  pregnant  women  with  viable  trichomonads 
and  created  a  symptomatic  disease  (Hasseltine,  1942).  Transmission  rates  appear  higher 
from  men  to  women,  as  70%  of  men  have  the  disease  within  48  hours  of  exposure 
4 (Weston,  1963),  compared  to  85%  of  exposed  women  (Honigberg,  1989).  Interestingly, 
the  percentage  of  infected  men  decreases  to  33%  after  exposure,  suggesting  that  the 
disease  is  more  apt  to  be  spontaneously  cleared  in  men  (Weston,  1963).  The  organism 
lives  only  the  genitourinary  tract  on  the  squamous  epithelial  cells  lining  the  anterior 
fornix  of  the  vagina,  Skene  glands  and  urethra  in  women,  and  in  the  urethra  and  prostate 
gland  in  men.  It  can  also  live  under  the  foreskin  in  uncircumcised  males  (Weston, 
1963).  It  is  transferred  during  penile-vaginal  sexual  intercourse.  Although  T  vaginalis 
will  survive  for  short  periods  on  moist  objects,  for  example  toilet  seats,  damp  towels, 
(Whittington,  1957,  Burch  et  aL,  1959)  or  in  exposed  bodily  fluids  (Whittington,  1951 
Gallai  and  Sylvester,  1966),  no  cases  of  transmission  by  indirect  or  formite  exposure 
have  been  documented. 
1.2.5  Symptoms. 
Persons  infected  with  T  vaginalis  may  not  show  any  signs  of  infection.  Up  to  50%  of 
women  and  over  90%  of  men  who  harbour  the  organism  will  have  no  noticeable 
discomfort.  However,  30%  of  infected  women  have  the  acute  onset  of  profuse  vaginal 
discharge,  vulvar  pruritis,  cystitis,  dysuria,  or  mild  dyspareunia.  Symptoms  may  worsen 
after  menses.  The  most  common  symptom,  increased  vaginal  discharge,  is  found  in 
more  than  half  of  symptomatic  cases.  The  nature  of  the  discharge  depends  on  the 
presence  of  associated  bacteria.  Trichomoniasis  is  strongly  associated  with  bacterial 
vaginosis  because  T  vaginalis  creates  an  anaerobic  enviromnent,  thereby  changing  the 
vaginal  flora  (Thomason  el  al.,  1988).  The  classically  described  green,  frothy,  foul 
smelling  discharge  is  found  in  fewer  than  10%  of  symptomatic  infected  women,  and 
punctate  heamorrhagic  lesions  (strawberry  spots)  are  found  in  only  about  2%  of  cases 
(Wolner-Hanssen  el  al.,  1989).  Some  patients  may  have  lower  abdominal  discomfort, 
5 but  T  vaginalis  has  not  been  shown  to  cause  pelvic  inflammatory  disease.  Phagocytosis 
or  attaclunent  of  cervicovaginal  bacteria,  including,  N.  gonorrhoeae,  may  be  a  cause  of 
upper  reproductive  tract  infection  associated  with  T  vaginalis.  Increased  vaginal 
concentrations  of  iron  salts  (abundant  in  menstrual  blood  )  may  facilitate  overgrowth 
and  clinical  worsening  of  symptoms  associated  with  menses  (Rein  and  Chepel,  1975). 
In  these  circumstances  other  sexually  transmitted  disease  should  be  suspected. 
In  symptomatic  men,  common  complaints  include  scanty,  clear  to  mucopurulent  urethral 
discharge,  dysuria,  mild  pruritis  or  burning  immediately  after  intercourse.  The  prostate 
gland  is  infected  iLi  40%  of  symptomatic  males  (Kreiger,  1981).  Zinc,  which  has  anti- 
trichomonal  activity  in  vitro,  is  found  in  high  concentrations  in  nonnal  prostatic  fluid 
and  may  inhibit  multiplication  of  T  vaginalis  (Krieger  and  Rein,  1982).  This  may 
account  for  the  lower  number  of  organisms  found  in  males.  Men  with  non-specific 
urethritis  unresponsive  to  usual  antimicrobial  therapy  should  be  treated  for  T  vaginalis 
because  15-20%  will  harbour  this  organism  (Kreiger,  198  1). 
1.2.6  Diagnosis. 
Clinic-based  laboratory  evaluation  of  T  vaginalis  remains  unsatisfactory.  The  vaginal 
pH  is  elevated  above  4.5  in  as  many  as  90%  of  cases  (Rein,  1990).  This  finding, 
however,  is  non  specific  as  90%of  women  with  bacterial  vaginosis  also  have  an  elevated 
pH  (Pheifer  et  al,  1978).  The  presence  of  a  fishy  odour  after  application  of  10% 
potassium  hydroxide  (whiff  test)  is  present  in  50%  patients  (Chen  et  aL,  1982),  but  this 
test  is  non-specific  for  Trichomonas.  A  helpful  test  in  differentiating  trichornoniasis 
from  bacterial  vaginosis  is  evaluation  of  the  wet  smear  for  polymorphonuclear  cells 
(PNWs)  and  "clue  cells".  The  ratio  of  PMNs  to  vaginal  epithelial  cells  is  greater  than  I 
6 in  75%  of  trichomonal  infections,  whereas  in  bacterial  vaginosis  this  ratio  is  less  than  I 
in  90%  of  patients  (Rein,  1990). 
The  time  honoured  approach  for  the  diagnosis  of  trichomonal  infections  has  been 
microscopic  ("wet  prep")  evaluation.  A  sample  of  vaginal  fluid  is  placed  in  normal 
saline  and  viewed  under  phase-contrast  microscopy.  The  diagnosis  of  trichomoniasis  is 
made  by  directly  observing  the  motile  parasite.  This  procedure  detects  60%  to  80%  of 
cases  and  is  more  sensitive  if  symptoms  are  present. 
Newer  methods  of  identification  based  on  the  nucleic  acid  of  T  vaginalis  are  being 
rapidly  developed.  For  example  the  detection  of  variable  DNA  repeats  in  T  vaginalis 
by  a  single  set  of  polymerase  chain  reaction  primers  holds  promise  in  for  the 
development  of  a  typing  scheme  for  T  vaginalis  (Riley  et  al.,  199  1).  A  method  for  the 
identification  of  T  vaginalis  by  fluorescent  in  situ  hybridisation  (FISH)  has  also  been 
developed  (Muresu  et  al.,  1994).  Also  rapid  nucleic  acid  hybridisation  test  have  been 
developed  for  the  diagnosis  of  T  vaginalis  and  other  causative  agents  of  vaginitis  such 
as  Gardnerella  vaginalis  and  Candida  sp  (Ferris  et  al.,  1995).  A  detection  method  for 
T  vaginalis  in  pregnant  women  based  on  PCR  has  also  been  developed  recently  (Witkin 
et  al.,  1996). 
1.2.7  Treatment. 
Trichomoniasis  should  not  be  ignored  even  if  the  patient  has  no  symptoms.  Treatment 
is  necessary  to  prevent  transmission  to  sexual  partners  and  to  avoid  later  problems.  The 
only  drugs  proved  to  be  effective  are  the  5-nitroimidazoles.  These  include 
7 metronidazole,  omidazole  and  tinidazole.  If  both  partners  are  treated,  cure  rates 
approach  100%  (Lossick,  1982). 
Alternative  treatments  are  considered  palliative  because  the  5-nitroimidazoles  are  the 
only  drugs  with  documented  efficacy.  Clotrimazole  (an  anti-fungal  cream)  given 
intravaginally  for  6  days  cures  48%  to  66%  of  patients  (Schell,  1974).  Some  authors, 
however,  report  cure  rates  of  25%  or  less  (Rein  and  Muller,  1989,  Lossick,  1990). 
Nonoxynol-9  (a  spermicidal  agent)  was  anecdotally  effective  in  a  refractory  case 
(Livengood  and  Lossick,  1991).  Other  potential  treatments  requiring  further 
invcstigation  includc  mcbendozole  and  taxol  (Juliano  et  al.,  1987). 
It  has  been  shown  that  MDL  63  604,  a  semi  synthetic  derivative  of  purpuromycin,  had 
an  in  vitro  activity  similar  to  that  of  metronidazole  against  T  vaginalis  (Goldstein  et  al., 
1995).  It  has  also  been  shown  that  furazolidone,  a  nitrofuran  presently  used  to  treat 
giardiasis  and  infections  with  some  anaerobic  resistant  enteric  bacteria,  may  be  a  good 
candidate  for  treating  metronidazole  resistant  trichomoniasis  (Narcisi  and  Secor,  1996). 
Neo-Penotran@  pessaries,  500mg  metronidazole  and  I  00mg  miconazole  nitrate  have 
been  shown  to  be  a  novel  and  effective  formulation  for  the  treatment  of  common  types 
of  vaginitis  and  the  pessary  may  be  of  particular  value  in  the  treatment  of  resistant  or 
recurrent  vaginitis  (Kukner  et  al.,  1996).  Finally,  it  has  been  shown  that  geneticin 
(G418),  an  arninoglycoside  was  effective  at  killing  T  vaginalis  cells  at  doses 
inteffnediate  between  those  previously  effective  against  prokaryotes  and  eukaryotes 
(Riley  and  Kreiger,  1996). 
8 Concerns  continue  regarding  use  of  relatively  high  oral  doses  of  metronidazole  during 
pregnancy.  The  toxic  metronidazole  intermediate,  which  is  cidal  to  T  vaginalis, 
interacts  with  bacterial  and  mammalian  DNA  (Lossick,  1982).  Despite  this,  no  human 
data  demonstrate  increased  risks  or  teratogenesis  or  carcinogenesis  associated  with 
metronidazole  use  (Beard  et  al.,  1979,  Rosa  et  aL,  1987).  Most  practitioners,  however, 
prefer  to  delay  treatment  until  after  embryogenesis  is  complete.  Use  of  topical 
clotrimazole  may  be  effective  in  treating  patients  in  the  first  trimester. 
1.2.8  Phylogenetic  position  of  T.  vaginalis. 
Phylogenetic  trees  based  on  small  subunit  ribosomal  RNA  (SSU  rDNA)  (Sogin,  1991), 
reveals  three  protist  lineages  which  consistently  branch  most  deeply;  the  Parabasala, 
Metomonada  and  Microspora  (see  Corliss,  1994  for  nomenclature),  all  lack 
mitochondria.  One  possible  evolutionary  inference  is  that  all  three  of  these  protist 
groups  are  primitively  amitochondriate,  having  diverged  from  the  main  eukaryotic  trunk 
before  the  endosymbiotic  event  that  led  to  mitochondria  took  place  (Patterson  and 
Sogin,  1993).  In  addition,  trichomonads  and  microspora  possess  70S  rather  than  80S 
ribosomes,  which  has  been  interpreted  as  the  retention  of  ancestral  state  present  in 
prokaryote  outgroups,  providing  additional  support  for  their  divergence  early  in 
eukaryotes  history  (Champney  et  al.,  1992  and  Cavalier-Smith,  1993).  The  relative 
order  of  these  taxa  has  not  been  clearly  resolved,  as  it  varies  with  the  taxon  composition 
or  method  of  analysis,  and  all  three  groups  are  plausible  candidates  for  the  deepest 
branch  in  the  SSU  rDNA  tree  (Liepe  et  al.,  1993  and  Gunderson  et  al.,  1995). 
Trichomonads  (Parabasala)  are  unique  among  the  three  basal  taxa  in  that  they  do 
possess  another  double  membraned  organelle,  the  hydrogenosome. 
9 While  many  authors  suggest  that  the  deep  phylogenetic  position  of  trichomonads 
indicates  that  they  primitively  lack  mitochondria  (Patterson  and  Sogin,  1992  and  Muller, 
1993),  others  have  argues  that  they  may  have  secondarily  lost  mitochondrial  functions 
(Cavalier-Smith,  1987).  The  precise  question  of  hydrogenosome  evolution  in 
trichomonads,  in  particular  T  vaginalis,  is  addressed  in  section  1.3.1.1  of  this 
introduction. 
1.3  Biochemistry  of  T.  vaginalis. 
13.1  Energy  metabolism  of  T.  vaginalis. 
T  vaginalis  and  other  anaerobic  protozoa  eg.  Giardia  lamblia  and  Entamoeba 
histolytica  have  been  shown  to  be  fermentative  and  produce  a  mixture  of  acids  (eg. 
lactate,  acetate,  succinate,  butyrate  and  propionate),  alcohols  (eg.  ethanol  and  hydrogen) 
as  major  end  products  (Muller,  1988).  For  all  of  the  anaerobic  protozoa  investigated, 
including  T  vaginalis,  energy  production  is  based  upon  glycolysis  with  the  mixture  of 
end  products  providing  a  means  of  maintaining  redox  balance  at  the  same  time  as 
generating  energy,  which  is  additional  to  energy  resulting  from  glycolysis  (for  reviews 
see  Muller,  1988,1991  and  Coombs  and  Muller,  1995).  A  common  feature  is  the 
excretion  of  both  acetate  and  carbon  dioxide.  These  result  from  the  catabolism  of 
pyruvate,  catalysed  by  pyruvate:  ferredoxin  oxido-reductase,  to  give  acetyl  CoA,  reduced 
ferredoxin  and  carbon  dioxide.  In  T  vaginalis  the  reduced  ferredoxin  is  reoxidised  by 
hydrogenase  to  yield  hydrogen.  The  production  of  hydrogen  by  T  vaginalis  and  other 
anaerobic  protozoa,  such  as  rumen  protozoa,  is  strictly  correlated  with  the  presence,  in 
the  organism,  of  a  peculiar  microbody-like  organelle;  and  it  has  subsequently  been 
established  that  hydrogen  production  does  occur  in  these  organelles  which  have 
consequently  been  given  the  name  hydrogenosomes  (Muller,  1980,1993). 
10 1.3.1.1  Metabolism  and  Evolutionary  Origins  of  Hydrogenosomes  of  T.  vaginalis. 
The  hydrogenosomes  of  trichomonads  have  been  studied  in  most  detail.  This  organelle 
is  surrounded  by  two  membranes  and  appears  to  contain  no  genetic  material  (Muller, 
1993).  Metabolic  studies  on  cell  fractions  enriched  for  hydrogenosomes  have  shown 
that  the  organelle  is  involved  in  the  oxidation  of  pyruvate  to  acetate,  carbon  dioxide  and 
hydrogen.  This  process  is  accompanied  by  ATP  formation  via  substrate  level 
phosphorylation  (Muller,  1980,1993). 
Metabolically,  hydrogenosomes  could  be  said  to  be  the  anaerobic  equivalent  of 
mitochondria.  This,  as  well  as  the  fact  that  cells  which  contain  hydrogenosomes  lack 
mitochondria  (Muller,  1988),  has  lead  to  the  proposals  that  hydrogenosomes  are 
degenerate  mitochondria  (Cavalier  Smith,  1987)  or  that  these  two  organelles  are  derived 
from  a  common  progenitor  organelle  (Johnson  et  aL,  1990).  Analysis  of  T  vaginalis 
ribosomal  RNA  (rRNA)  (Sogin,  1989)  indicates  that  the  evolutionary  line  leading  to 
trichomonads  diverged  from  the  main  line  of  eukaryotic  evolution  prior  to  the 
appearance  of  mitochondria.  This  is  consistent  with  the  theory  of  a  common  progenitor 
organelle  that  ultimately  gave  rise  to  mitochondria,  in  aerobic  organisms  and 
hydrogenosomes  in  certain  anaerobic  organisms.  Alternatively,  hydrogenosomes  may 
have  arisen  completely  independently  of  mitochondria,  via  an  endosymbiotic 
relationship  with  an  anaerobic  bacterium  (Whately  et  al,  198  1).  The  presence  of 
hydrogenase  in  hydrogenosome,  as  well  as  other  proteins  which  are  typically  found  in 
anaerobic  bacteria  (Muller,  1980,1993),  supports  this  latter  hypothesis. 
11 Very  recently,  there  have  been  a  number  of  publications  that  have  addressed  the 
question  of  hydrogenosome  evolution.  Genes  have  been  isolated  from  T  vaginalis  that 
encode  chaperone  proteins,  HSP70,  HSP60,  HSP  10  (Gennot  et  al.,  1996  and  Bui  et  al., 
1996)  and  CPN60  (Roger  et  al.,  1996  and  Homer  et  al.,  1996),  proteins  that  in  other 
lineages  are  present  in  the  mitochondrial  compartment.  It  is  suggested  by  all  of  the 
above  authors  that  the  presence  of  the  genes  for  the  above  proteins  in  T  vaginalis 
provide  evidence  that  the  ancestors  of  trichomonads  perhaps  harboured  the 
endosymbiotic  progenitors  of  mitochondria,  but  these  evolved  into  hydrogenosomes 
early  in  trichomonad  evolution. 
1.3.2  Amino  acid  metabolism  of  T.  vaginalis. 
T  vaginalis  requires  amino  acids  for  protein  synthesis  but  they  may  also  be  involved  in 
other  aspects  of  cell  metabolism.  Amino  acid  metabolism  in  T.  vaginalis  has  been 
relatively  well  studied.  This  introduction  concentrates  on  the  aspects  of  amino  acid 
metabolism  of  T  vaginalis  that  are  most  relevant  to  this  study. 
1.3.2.1  Proteinases  of  T.  vaginalis. 
It  has  been  shown  that  T  vaginalis  contains  high  levels  of  proteinase  activity.  For  an 
extensive  review  of  proteinases  of  T  vaginalis  see  North,  1991.  The  especially  high 
levels  of  proteinase  activity  in  T  vaginalis  and  the  continuous  release  from  cells 
suggests  that  proteolysis  is  likely  to  be  important  for  the  organism.  Possible  roles 
include  the  utilisation  of  host  proteins  for  nutrition,  the  destruction  of  components  of  the 
host  immune  system,  the  release  of  amino  acids  for  amine  production  to  counter  the  low 
pH  of  the  vagina,  and  direct  effects  on  host  cells  to  assist  cytoadherence. 
12 1.3.2.2  Glutamate  Dehydrogenase  and  Aminotransferases. 
Glutamate  dehydrogenase  (GDH)  and  aminotransferases  have  a  central  role  in  the 
catabolism  and  biosynthesis  of  amino  acids.  Aminotransferases  redistribute  nitrogen 
from  amino  acids  to  keto  acids.  When  amino  acids  are  catabolized,  the  first  step  is 
frequently  catalysed  by  an  aminotransferase  which  transfers  the  amino  group  to 
ketoglutarate  to  form  glutamate  which  can  be  deaminated  by  GDH  to  give  cc- 
ketoglutarate  and  ammonia.  For  the  biosynthesis  of  amino  acids,  these  steps  are 
reversed.  Glutamate  dehydrogenase  was  isolated  from  T  vaginalis  and  characterised  by 
Turner  and  Lushbaugh  (1988).  The  enzyme  is  NADP-linked  and  is  able  to  catalyse  the 
amination  of  a-ketoglutarate  and  the  deamination  of  glutamate. 
A  number  of  different  amino  transferases  have  been  identified  in  T  vaginalis. 
The  aspartate  aminotransferase  of  T  vaginalis,  although  the  name  implies  a  high  level 
of  specificity,  is  able  to  use  a  broader  range  of  amino  acids  as  amino  acid  donors. 
Indeed  the  enzyme  will  also  catalyse  the  transamination  of  the  aromatic  amino  acids, 
phenylalanine,  tryptophan  and  tyrosine  (Lowe  and  Rowe  1985,1986  and  1987).  In 
contrast  the  mammalian  enzyme  will  only  catalyse  the  transamination  of  aspartate  or 
glutamate  with  oxaloacetate  or  cc-oxoglutarate. 
Lowe  and  Rowe  (I  986b)  published  a  survey  of  aminotransferase  activities  in  T 
vaginalis.  They  found  (x-ketoglutarate,  oxaloacetate  or  phenylpyruvate  acted  as 
effective  amino  acceptors  with  ten  amino  acids.  Activities  of  aspartate,  aromatic  amino 
acid,  branched  chain  amino  acid  and  o)-amino  acid  aminotransferases  were 
13 demonstrated.  The  high  levels  of  activity  with  branched  chain  and  aromatic  amino  acids 
and  aspartate  confirtned  the  earlier  findings  of  Jaroszewicz  and  May Iszko  (1965). 
1.3.2.3  Alanine  Metabolism. 
Alanine  is  an  end  product  of  glucose  catabolism  in  T  vaginalis  (Zuo  el  aL,  1995).  Its 
formation  is  linked  to  redox  balance,  alanine  aminotransferase  and  glucose  catabolism. 
When  alanine  is  a  major  end  product  of  glucose  catabolism,  substantial  amounts  of 
nitrogenous  compounds  must  be  available  to  contribute  the  amino  group.  In  T 
vaginalis  arginine  catabolism  is  a  likely  provider  of  nitrogen  for  alanine  synthesis 
(Linstead  and  Cranshaw,  1983).  It  has  also  been  shown  that  alanine  is  a  major  end 
product  of  metabolism  by  Giardia  lamblia.  Edwards  et  al.,  1988  have  shown  by  proton 
nuclear  magnetic  resonance  that  alanine  is  the  major  end  product  formed  during  log 
phase  growth  of  these  anaerobic  parasites.  Ethanol  is  also  produced  by  G.  lamblia  but 
its  fonnation  lags  behind  that  of  alanine  until  the  parasites  enter  stationary  phase. 
Acetate  is  also  produced  by  these  parasites  but  at  a  constant  rate  throughout  growth. 
13.2.4  Amino  acids  as  energy  sources  in  T.  vaginalis. 
T  vaginalis  relies  heavily  on  glycolysis  for  energy  production  (For  reviews  see,  Muller 
1988,1991;  Coombs  and  Muller  1995).  However,  it  has  also  been  suggested  that  amino 
acids  can  be  used  as  a  source  of  energy  in  T  vaginalis.  The  initial  step  of  amino  acid 
catabolism  frequently  involves  the  loss  of  the  amino  nitrogen  to  yield  a  carbon  skeleton 
in  the  form  of  cc  keto  acid,  either  as  a  result  of  transamination  or  by  deamination.  In 
general,  energy  is  derived  from  amino  acids  by  the  oxidation  of  the  carbon  skeletons 
after  entry  into  the  intermediary  metabolic  pathways. 
14 1.3.2.5  Arginine  and  Ornithine  Metabolism. 
Arginine  is  broken  down  by  T  vaginalis  to  ornithine,  ammonia,  and  C02.  The 
dihydrolase  pathway  is  involved  in  the  breakdown  of  arginine  which  consists  of  the 
three  enzymes:  arginine  deiminase,  catabolic  omithine  transcarbarmoylase  and 
carbarnate  kinase  (Linstead  and  Cranshaw,  1983)  Arginine,  is  present  at  relatively  high 
levels  in  the  extracellular  fluid  of  mammals  and  it  may  represent  a  major  energy  source 
for  T  vaginalis  in  vivo.  The  dihydrolase  pathway  is  unusual  in  eukaryotes.  The 
pathway  includes  a  substrate-level  phosphorylation  catalysed  by  carbarnate  kinase,  and 
production  of  ATP  means  that  arginine  can  act  as  an  energy  source  under  anaerobic 
conditions.  It  is  thought  that  the  major  role  of  the  dihydrolase  pathway  in  T  vaginalis 
would  be  to  produce  omithine  for  biosynthesis  of  polyarnines. 
The  arginine  dihydrolase  pathway  also  exists  in  G.  lamblia  (Edwards  et  aL,  1992).  Due 
to  the  high  activity  of  the  enzymes  of  this  pathway  in  G.  lamblia  it  is  thought  that 
arginine  catabolism  could  contribute  significantly  to  giardial  energy  production,  by 
substrate  level  phosphorylation  at  the  terminal  step  catalysed  by  carbarnate  kinase. 
13.2.6  Leucine  and  Threonine  Catabolism. 
Threonine  dehydratase,  which  converts  threonine  into  a-ketobutyrate  and  ammonia  has 
been  detected  in  T  vaginalis.  The  enzyme  is  involved  in  threonine  catabolism,  rather 
than  isoleucine  biosynthesis  (Lockwood  and  Coombs,  1989).  Addition  of  leucine  and 
threonine  to  culture  of  T  vaginalis  growing  in  vitro  results  in  the  production  and  release 
of  a-hydroxyisocaproate  and  cc-hydroxybutyrate;  respectively.  They  are  synthesised  via 
the  corresponding  cc-keto  acid. 
is The  functional  significance  of  the  catabolism  of  these  amino  acids  is  not  clear,  but  it  is 
likely  that  hydroxy  acid  secretion  is  simply  a  reflection  of  the  high  concentrations  of 
keto  acids  produced  and  the  broad  specificity  of  lactate  dehydrogenase.  Isoenzymes  of 
lactate  dehydrogenase  in  T  vaginalis  have  been  shown  to  be  active  towards  both  cc- 
ketobutyrate  and  a-ketoisocaproate  (Lockwood  and  Coombs,  1989). 
13.2.7  Sulphur  amino  acid  metabolism  in  T.  vaginalis. 
Sulphur  amino  acid  metabolism  in  T  vaginalis  forms  the  major  area  of  interest  and 
research  in  this  thesis.  The  pathways  of  sulphur  amino  acid  metabolism  in  T  vaginalis 
differ  significantly  from  those  of  the  host.  It  is  the  differences  in  some  of  the  pathways 
that  have  initiated  a  long  term  study  of  the  sulphur  amino  acid  metabolism  of  this 
parasite,  with  a  view  to  evaluating  some  of  the  peculiar  pathways  as  potential  targets  for 
chemotherapeutic  attack. 
Sulphur  amino  acid  metabolism  in  T  vaginalis  may  be  considered  to  be  made  up  of  two 
separate  parts,  the  methionine  cycle  and  the  reverse  transulphuration  pathway,  the  two 
pathways  are  linked  by  the  sulphur  containing  amino  acid  homocysteine  (see  Figure 
1.1). 
1.3.2.7.1  The  methionine  cycle  in  T.  vaginatis. 
L-methionine  is  required  by  T  vaginalis  for  the  biosynthesis  of  S-adenosylmethionine 
(SAM)  (Lawrence  and  Robert-Gero,  199  1).  This  compound  is  involved  in  a  number  of 
synthetic  processes  such  as  transmethylations  and  polyamine  biosynthesis.  Living 
trichomonads  havc  bccn  shown  to  incorporatc  exogenous  labclled  methioninc  into 
16 intracellular  S-adenosylmethionine  (SAM)  (Thong  et  aL,  1986  and  1987).  The  labelled 
methyl  carbon  was  also  detected  in  nucleic  acids  and  lipids  presumably  owing  to  the 
subsequent  role  of  SAM  as  a  one  carbon  donor  in  transmethylation  reactions  (Lawrence 
and  Robert-Gero,  199  1).  These  results  suggest  that  trichomonads  contain  SAM 
synthelase  and  SAM  dependent  methyltransferases,  and  both  of  these  enzymes  have 
been  detected  in  T  vaginalis  (Yarlett,  1988  and  Thong  et  al.,  1987),  respectively.  S- 
adenosyl  hornocysteine  hydrolase  activity  has  been  detected  in  T  vaginalis  (Thong  et 
al.,  1985)  and  recently  the  gene  for  this  enzyme  from  T  vaginalis  has  been  characterised 
(Bagnara  et  aL,  1996). 
1.3.2.7.2  Methionine  y-lyase  of  T.  vaginalis. 
In  T  vaginalis  methionine  is  rapidly  broken  down  to  cc-ketobutyrate,  methanethiol.  and 
ammonia  by  the  activity  of  methionine  y-lyase  (Thong  and  Coombs  1987a,  Lockwood 
and  Coombs,  199  1).  Methionine  7-lyase  of  T  vaginalis  catalyses  a  simultaneous 
dearnination  and  dethiomethylation  of  methionine,  whereas  mammals  and  aerobic 
organisms  catabolize  methionine  by  a  two  step  reaction  (i.  e.  transamination  and  then 
dethiomethylation  ).  The  enzyme  is  also  responsible  for  the  breakdown  of 
homocysteine  to  a-ketobutyrate,  hydrogen  sulphide  and  ammonia,  (Thong  and  Coombs, 
1985,1987).  A  reaction  catalysed  by  homocysteine  desulphurase,  (a  synonym  for 
methionine  7-1yase).  The  formation  of  cc-ketobutyrate  from  methionine  may  generate  an 
additional  source  of  energy.  It  is  probable  that  pyruvate:  ferredoxin  oxidoreductase 
catalyses  the  conversion  of  cc-ketobutyrate  to  propionyl  CoA  which  could  be  used  for 
substrate  level  phosphorylation.  Methionine  y-lyase  is  absent  from  mammalian  cells 
and,  although  homocysteine  desulphurase  activity  has  been  detected,  it  was  shown  to  be 
17 due  to  cystathionine  y-lyase  and  thought  to  be  of  little  or  no  significance  in  mammals 
(Cooper,  1983).  Thus  it  appears  that  methionine  y-lyase  of  T  vaginalis  performs  a 
function  peculiar  to  this  parasite,  and  clearly  the  presence  of  the  enzyme  offers 
opportunities  for  chemotherapeutic  exploitation. 
1.3.2.7.3  Reverse  transulphuration  pathways  in  T.  vaginalis. 
In  T  vaginalis  mcthioninc  sulphur  metabolism  occurs  by  the  methionine  cycle  coupled 
to  the  transulphuration  pathway,  as  well  as  by  the  direct  breakdown  by  methionine  y- 
lyase.  The  transulphuration  pathway  results  in  the  transfer  of  the  sulphur  of  methionine 
via  the  thioether  cystathionine  to  produce  cysteine.  The  pathways  of  methionine  and 
cysteine  metabolism  and  transulphuration  pathways  are  summarised  in  Figure  1.1. 
Points  of  interest  in  the  sulphur  amino  acid  metabolism  of  T  vaginalis  that  arise  from 
Figure  1.1  are  as  follows. 
Cystathionine  P-synthase  from  several  organisms  (mammals,  nematodes,  yeast  and 
fungi)  catalyses  the  synthesis  of  cystathionine,  from  hornocysteine  and  serine,  the 
penultimate  step  in  the  cysteine  biosynthetic  pathway  from  methionine.  The  enzyme 
also  catalyses  the  reversible  replacement  of  the  P-SH  group  of  cysteine  with  water  to 
form  serine  and  hydrogen  sulphicle.  The  enzyme  of  T  vaginalis  and  a  similar  enzyme 
found  in  nematodes  displays  'activated'  serine  sulphydrase  activity  in  which  the 
production  of  hydrogen  sulphide  from  cysteine  is  stimulated  by  a  second  thiol  substrate, 
a  property  which  distinguishes  them  from  their  mammalian  counterpart  (Thong  and 
Coombs  1985b,  Walker  and  Barrett,  1992).  Cystathionine  P-synthase  activity  in  T 
18 vaginalis  has  not  been  looked  at,  but  it  probably  exists  due  to  the  presence  of  activated 
serine  sulphydrase  activity  in  parasite  lysates. 
Cystathionine  y-lyase  (y-cystathionase)  catalyses  the  final  step  in  the  transulphuration 
pathway,  (which  serves  to  transfer  sulphur  from  dietary  methionine  to  cysteine).  The 
enzyme  has  been  identified  in  mammals,  yeast,  fungi,  nematodes  and  T  vaginalis.  For 
T  vaginalis  there  has  only  been  one  report  of  the  presence  of  cystathionine  -y-lyase  in 
parasite  lysates,  which  was  reported  to  have  a  very  low  specific  activity  (Thong,  1985), 
and  since  then  very  little  attention  has  been  given  to  this  enzyme. 
In  order  to  compare  the  metabolism  of  sulphur  amino  acids  in  T  vaginalis  with  other 
organisms,  I  find  that  Figures  1.2,1.3  and  1.4  illustrate  the  fundamental  differences 
between  this  parasite  and  other  general  classes  of  organism. 
1.3.2.8  Sulphur  amino  acid  metabolism  in  bacteria  and  plants. 
Soda,  1987  and  Giovanelli,  1987  have  presented  reviews  of  microbial  and  plant  sulphur 
amino  acid  metabolism,  also  Flavin,  1975  has  presented  a  detailed  review  of  methionine 
biosynthesis  in  micro-organisms.  Figure  1.2  summarises  the  metabolism  of  sulphur 
containing  amino  acids  in  plants  and  bacteria  based  on  the  information  provided  in  these 
reviews  and  more  recent  publications.  Various  interesting  points  arise  from  this 
pathway  which  have  relevance  to  this  thesis. 
In  bacteria  and  plants,  homoserine  0-phosphate  is  the  last  intermediate  of  the  aspartate 
pathway  that  is  common  to  both  methionine  and  threonine  biosynthesis.  It  can  either  be 
methylated  to  threonine  by  threonine  synthetase,  or  undergo  displacement  of  the 
19 phosphate  by  an  acyl  group  as  the  first  step  of  methionine  biosynthesis.  Homoserine  0- 
phosphate  is  esterified  by  acyl  transfer  from  acyl  CoA,  displacing  the  phosphate.  In 
Escherichia  coli  and  Salmonella  typhimurium  a  succinyl  ester  is  formed,  while  in  non- 
enteric  bacteria  it  is  an  acetyl  group  that  is  transferred  from  acetyl  CoA.  In  higher  plants 
a  variety  of  acyl  groups,  including  acetyl  and  oxalyl,  may  be  used  depending  on  species. 
As  can  be  seen  from  Figure  1.2  the  acyl  of  0-acylhomoserine  is  displaced  by  cysteine 
forming  cystathionine,  a  reaction  catalysed  by  cystathionine  y-synthase,  the  first  step  in 
the  transulphuration  pathway  of  bacteria  and  plants.  Cystathionine  7-synthase  has  been 
purified  and  characterised  for  a  number  of  plants.  Cystathionine  y-synthase  from  wheat 
(Triticum  aestivum)  was  found  to  have  a  native  molecular  mass  of  155  kDa  and  be 
composed  of  four  identical  subunits  of  -34.5  kDa  (Kreft  et  al.,  1994)  The  same  enzyme 
from  spinach  (Spinacea  oleracea)  has  also  been  characterised  and  was  shown  to  catalyse 
the  formation  of  cystathionine  or  homocysteine  depending  on  the  sulphur  containing 
substrate,  cysteine  or  sulphide  (Ravanel  et  al.,  1995).  The  gene  for  cystathionine  y- 
synthase  from  A.  thaliana  has  been  cloned  (Ravanel  et  al.,  1995)  and  has  subsequently 
been  purified  and  characterised  by  overexpression  in  K  coli  (Ravanel  et  al.,  1996). 
The  second  step  of  the  transulphuration  pathway  in  bacteria  and  plants  is  the  P-cleavage 
of  cystathionine  which  results  in  the  formation  of  homocysteine,  pyruvate  and  ammonia. 
In  recent  years,  there  has  been  considerable  research  activity  into  cystathionine  P-lyase 
from  a  variety  of  plant  and  bacterial  sources,  that  has  lead  to  the  detailed 
characterisation  of  this  enzyme.  Interest  in  cystathionine  P-lyase  of  spinach  was 
initiated  in  the  early  70's  by  Giovanelli  and  Mudd,  1971  and  the  enzyme  was  reported  to 
20 have  been  purified  from  this  plant  some  sixteen  years  later  (Giovanelli,  1987).  Further, 
more  detailed  characterisation  of  the  enzyme  from  spinach  was  reported  a  couple  of 
years  ago  (Droux  et  al.,  1995).  Around  the  same  time  of  reports  on  the  characterisation 
of  the  spinach  enzyme,  there  were  several  reports  of  the  enzyme  being  purified  and 
characterised  from  garlic  (Nock  and  Mazelis,  1986),  onion  (Nock  and  Mazelis,  1987) 
and  leek  (Won  and  Mazelis,  1989).  Analogous  enzymes  have  also  been  purified  from  - 
cabbage  (Hall  and  Smith,  1983)  and  broccoli  (Hamamoto  and  Mazelis  (1986).  More 
recently  the  gene  for  cystathionine  P-lyase  has  been  isolated  from  Arabidopsis  thaliana 
(Kim  and  Leustek,  1996)  and  this  will  probably  lead  onto  the  biochemical 
characterisation  of  this  protein  from  this  particular  organism. 
As  for  cystathionine  P-lyasc  in  bacteria.  The  enzyme  from  E.  coli  was  purified  and 
characterised  in  the  early  80's  (Dwivedi  et  al.,  1982).  The  pyridoxal  5'-phosphate 
binding  region  of  this  enzyme  was  characterised  by  Martel  et  al.,  (1987).  In  1996  the 
enzyme  was  overexpressed  in  E.  coli,  purified  and  crystallised  (Laber  et  al.,  1996).  The 
crystal  structure  of  cystathioninc  P-lyasc  from  Exo1i  has  now  been  resolved  to  1.83A 
(Clausen  et  al.,  1996).  The  enzyme  has  also  been  characterised  from  Bordetella  avium 
(Gentry-Weeks  el  al.,  1995),  the  aetiological  agent  of  an  upper  respiratory  disease  in 
birds  which,  symptomatically  and  pathologically,  resembles  bordetellosis  in  humans. 
Hornocysteine,  synthesis  in  bacteria  occurs  by  a  y-replacement  reaction  in  which  the 
substrate  O-succinylhornoserine  reacts  with  cysteine  to  fonn  homocysteine  and 
succinate,  the  same  reaction  in  plants  uses  0  acetyl  homoserine  in  combination  with 
sulphide  to  produce  homocysteine.  Bacteria  are  also  able  to  use  O-acetyl  homoserine  as 
21 a  substrate  in  the  synthesis  of  cystathionine.  Several  species  of  bacteria  use  the  O-acetyl 
form  of  homoserine  for  the  synthesis  of  cystathionine  and  homocysteine,  for  example 
Bacillus  subtilus  (Brush  and  Paulus,  1971)  A  polymyxa  (Wyman  and  Paulus,  1975), 
Corynebacterium  acetophilum  (Murooka  et  al.,  1970),  Brevibacteriumflavum  (Brush 
and  Paulus,  1973)  and  Arthrobacterparaffineus  (Nakayama  et  al.,  1969). 
Hornocysteine  is  then  methylated  to  methionine  in  a  methyl  tetrahydrofolate  dependent 
reaction. 
In  bacteria  and  plants,  cysteine  is  synthesised  by  a  two  step  reaction.  Serine  is  0- 
acetylated  by  a  reaction  with  acetyl  CoA,  catalysed  by  the  pyridoxal  phosphate 
dependent  serine  acetyltransferase.  The  acetyl  group  is  then  displaced  by  a  reaction  with 
inorganic  sulphide,  either  free  in  solution  or  bound  to  a  protein  such  as  thioredoxin  to 
produce  cysteine.  This  reaction  is  catalysed  by  O-acetyl  serine  sulphydrylase.  The 
pyridoxal  5'-phosphate  binding  region  for  this  enzymes  has  been  resolved  as  has  the 
reaction  mechanism  for  the  enzyme  (Schnackerz  and  Cook,  1995,  Cook  et  al.,  1996). 
The  pyridoxal.  5'-phosphate  binding  region  of  the  spinach  enzyme  has  also  been 
characterised  (Roland  et  al.,  1996). 
The  synthesis  of  cystathionine  in  bacteria  may  represent  a  means  of  storing  organic 
sulphur  in  a  readily  usable  and  relatively  non  toxic  form.  Sulphide  ions  are  rare  in  the 
environment  and  the  reduction  of  sulphate  to  sulphide  is  closely  linked  to  cysteine 
synthesis. 
1.3.2.8.1  Methionine  y-lyase  of  anaerobic  bacteria. 
22 Methionine  y-lyase  has  only  been  found  in  anaerobes,  namely  Clostridium  sp, 
(Wiesendanger  and  Nisman  1953)  Pseudomonas  (Miwatani  et  aL,  1954;  Kallio  and 
Larson,  1955;  Ito  et  al.,  1975;  Tanaka  et  al.,  1977),  Aeromonas  (Nakayama,  1984), 
some  rumen  bacteria  (Merricks  and  Salsbury,  1974)  and  Entamoeba  histolytica 
(Lockwood  and  Coombs,  1989).  As  in  T  vaginalis,  methionine  breakdown  in  these 
organisms  occurs  by  a  simultaneous  deamination  and  dethiomethylation.  Recently  the 
gene  for  methionine  y-lyase  from  P.  putida  has  been  isolated  and  characterised  (Inoue  et 
al.,  1995  and  Hori  et  al.,  1996) 
1.3.2.9  Sulphur  amino  acid  metabolism  in  yeast  and  fungi. 
Figure  1.3  gives  a  summary  of  the  metabolism  of  sulphur  containing  amino,  acids  in 
yeast  and  fungi.  There  are  a  number  of  points  of  interest  that  arise  from  the  metabolism 
of  sulphur  amino  acids  in  yeast  and  fungi  that  are  relevant  to  the  area  of  study  of  this 
thesis. 
A  characteristic  feature  of  sulphur  metabolism  of  yeast  and  fungi,  as  can  be  seen  from 
Figure  1.3,  is  the  existence  of  alternative  pathways  for  cysteine  and  homocysteine 
synthesis.  Cysteine  can  be  synthesised  from  O-acetylserine  (OAS)  by  O-acetylserine 
sulphydrylase  and  then  be  used  for  the  synthesis  of  homocysteine  in  two  reactions 
catalysed  by  cystathionine  y-synthase  and  cystathionine  P-lyase,  respectively. 
Altematively,  homocysteine  is  synthesised  directly  from  O-acetyl  homoserine  (OAS) 
and  sulphide  by  0-acetylhomoserine  sulphydrylase  and  serves  as  a  precursor  of  both 
cysteine  and  methionine.  The  physiological  role  of  these  pathways  may  differ 
considerably  in  various  yeast  and  fungi  (for  a  review  see  Yamagata,  1989).  The  OAS- 
OAH  sulphydrylase  of  S.  cerevisiae  was  shown  to  be  a  bifunctional  sulphydrylase,  it 
23 was  able  to  synthesise  both  cysteine  and  homocysteine  (Yamagata  et  al.,  1975).  The 
enzyme  is  also  able  to  catalyse  the  synthesis  of  methionine  and  ethionine  with  OAH 
when  the  sulphide  was  replaced  with  methylmercaptan  and  ethylmercaptan,  respectively 
(Yamagata,  1971).  It  has  been  shown  that  the  fission  yeast  Schizosaccharomycespombe 
catalyses  OAH  sulphydrylation  but  not  cystathionine  synthesis  (Yarnagata,  1984). 
Sacharomycopsis  Upolytica  also  has  a  OAS-OAH  sulphydrylase  which  is  very  similar  to 
that  described  for  S.  cerevisiae  (Paszewski  and  Grabski,  1976). 
OAH  sulphydrylase,  which  functions  in  hornocysteine  synthesis  in  fungi  has  been 
characterised  in  Neurospora  crassa  and  Aspergillus  nidulans.  (Piotrowska  et  al.,  1980 
and  Paszewski  et  al.,  1984).  Figure  1.3  shows  that  the  reverse  transulphuration 
pathway,  which  consists  of  cystathionine  P-synthase  and  cystathionine  -f-lyase,  also 
exists  in  yeast  and  fungi.  Cystathionine  P-synthase  from  S.  cerevisiae  has  been  purified 
and  characterised  (Ono  et  al.,  1994).  The  gene  for  cystathionine  y-lyase  from  S. 
cerevisiae  has  been  cloned,  expressed  in  E.  coli  purified  and  subsequently  characterised 
(Yamagataetal.,  1993).  The  enzyme  has  also  been  purified  and  characterised  from 
Neurospora  (Flavin  and  Slaughter,  1964  and  Flavin  and  Segal,  1964). 
1.3.2.10  Sulphur  amino  acid  metabolism  in  mammals. 
Figure  14.3  surnmarises  the  pathways  of  sulphur  amino  acid  metabolism  that  are  known 
to  exist  in  mammals.  The  metabolism  of  sulphur  amino  acids  in  mammals  can  be 
considered  in  two  parts.  Firstly,  the  methionine  cycle  in  which  S-adenosyl  methionine, 
as  in  T  vaginalis,  transfers  its  methyl  group  to  a  variety  of  acceptors  and  the  resultant  S- 
adenosylhomocysteine  is  deadenylated  by  S-adenosylhomocysteinase.  The  resultant 
homocysteine  may  be  either  remethylated  to  methionine  or  metabolised  by  way  of 
24 cysteine,  which  forms  the  second  part  of  sulphur  amino  acid  metabolism  in  mammals, 
the  reverse  transulphuration  pathway.  The  first  step  of  reverse  transulPhuration  in 
mammals  is  catalysed  by  cystathionine  P-synthase.  Cystathionine  P-synthase  has  been 
purified  and  characterised  from  rat  and  human  (Nakagawa  and  Kimura,  1968  and  Kraus 
and  Rosenberg,  1983).  The  final  step  of  mammalian  reverse  transulPhuration  is 
catalysed  by  cystathionine  y-lyase.  Cystathionine  y-lyase  from  rat  has  also  been  purified 
and  extensively  characterised.  (Matsuo  and  Greenberg  I  959a/b).  The  gene  sequences 
for  cystathionine  y-lyase  from  rat  and  human  have  also  been  isolated  and  characterised 
(Erickson  et  al.,  1990  and  Lu  et  al.,  1992). 
1.4  Molecular  biology  of  T.  vaginalis. 
The  molecular  biology  of  T  vaginalis  is  an  area  of  study  which  has  received  very  little 
attention.  Since  1990  there  have  been  several  publications  on  different  aspects  of  the 
molecular  biology  of  T  vaginalis.  However,  this  is  an  area  which  has  the  potential  to 
yield  more  information  on  the  molecular  aspects  of  this  ancient  eukaryote.  In  this 
introduction  my  aim,  simply,  is  to  give  an  overview  of  what  is  currently  known  about 
the  molecular  biology  of  T  vaginalis. 
1.4.1  T.  vagina&  DNA. 
The  DNA  from  T  vaginalis  and  has  been  thoroughly  characterised  by  Wang  and  Wang, 
1985.  The  unique  sequences  of  the  T  vaginalis  genome  constitute  2.5  X107  bp,  the 
value  comparable  with  the  complexity  of  Trypanosoma  brucei  (Borst  el  al.,  1980)  and 
Plasmodium  berghei  (Dore  et  al.,  1980).  Although  the  genome  of  trichomonads  is 
relatively  small,  it  contains  a  high  proportion  of  repetitive  sequences,  representing 
approximately  53.3%  of  T  vaginalis  DNA.  (Wang  and  Wang,  1985).  The  T  vaginalis 
25 genome  contains  an  additional  highly  repeated  DNA  fraction  comprising  13.3%  (Wang 
and  Wang,  1985).  Due  to  the  presence  of  repetitive  sequences,  distinct  banding  patterns 
can  be  seen  after  digestion  of  trichomonad  DNA  with  restriction  endonucleases  and 
separation  of  restriction  fragments  by  agarose  gel  electrophoresis. 
Further  characterisation  of  a  repetitive  sequence  specific  for  T  vaginalis  was  carried  out 
by  Paces  et  al.,  1992.  A  family  of  650bp  long  repeats  from  the  T  vaginalis  genome, 
designated  the  T  vaginalis-E650  family,  were  cloned  and  sequenced.  The  repetitive 
DNA  sequence  is  A+T-  rich  (73.3%  A+T).  The  T  vaginalis  E650  repeats  were 
conserved  in  all  T  vaginalis  strains  examined,  regardless  of  their  diverse  geographical 
origin.  Hybridisation  of  the  E650  repeats  showed  they  are  highly  conserved  between 
different  isolates.  A  dot  blot  hybridisation  protocol  was  developed  which  does  not 
required  the  isolation  of  DNA.  Use  of  the  protocol  allowed  the  detection  of  DNA 
released  from  approximately  103  T  vaginalis  cells  per  dot.  These  observations  suggest 
that  the  T  vaginalis  E650  probe  is  potentially  applicable  to  the  identification  and 
detection  of  T  vaginalis. 
1.4.2  T.  vaginalis  genes. 
To  date,  April  1997,  a  number  of  genes  have  been  characterised  from  T  vaginalis.  The 
genes  that  have  been  isolated  and  characterised  are  as  follows:  - 
Firstly,  ferredoxin  (Johnson  et  al.,  1990),  secondly,  P  Succinyl  Coenzyme  A  (Lahti,  et 
al.,  1992),  thirdly  P  tubulin  encoding  genes  (Katiyar  and  Edlind,  1994),  fourthly,  (x 
subunit  of  succinyl  CoA  synthetase  (Lahti  et  al,  1994),  fifthly,  cysteine  proteinase  genes 
26 (Mallinson  et  aL,  1994),  and  finally  P-glycoprotein,  a  70kDa  cytosolic  heat  shock 
protein  (HSP  70)  and  a  tubulin  encoding  genes  (Quon  et  al.,  1994). 
A  number  of  different  strategies  have  led  to  the  isolation  of  the  above  T  vaginalis 
genes,  in  the  case  of  feffedoxin  and  the  P  subunit  of  succinyl  CoA  synthetase  genes, 
antibodies  raised  against  purified  protein  and  an  enriched  bydrogenosomal  fraction, 
respectively  were  used  to  isolate  clones  from  T  vaginalis  cDNA  expression  libraries 
(Johnson  et  al.,  1990,  Lahti  et  al.,  1992). 
Use  of  a  Giardia  lamblia  P  tubulin  cDNA  as  a  heterologous  probe,  along  with 
degenerate  primers  designed  to  conserved  regions  of  0  tubulin  amino  acid  sequence, 
was  the  approach  used  to  isolate  the  0  tubulin  genes  from  T  vaginalis  (Katiyar  and 
Edlind,  1994).  An  a  tubulin  cDNA  probe  from  T  brucei  was  used  as  heterologous 
probe  to  isolate  cc  tubulin  genes  from  T  vaginalis  (Quon  et  al,  1994).  Glycoprotein, 
70kDa  cytosolic  heat  shock  protein  and  the  (x  subunit  of  succinyl  CoA  synthetase 
(Johnson  et  al.,  1994),  plus  the  cysteine  proteinase  genes  of  T  vaginalis  were  isolated 
using  PCR,  in  which  the  degenerate  primers  for  amplification  were  based  on  the 
relevant  genes  which  had  already  been  characterised  from  a  variety  of  sources  (Quon  et 
al.,  1994)  (Mallinson  et  al,  1994).  Seventeen  ubiquitin  genes  from  T  vaginalis, 
including  an  eleven  repeat  fragment  were  isolated  using  a  degenerate  primer/  PCR 
approach  (Keeling  and  Doolittle,  1995). 
The  degenerate  oligonucleotide/PCR  technique  has  been  the  approach  most  widely  used 
for  the  isolation  and  subsequent  molecular  characterisation  of  several  T  vaginalis  genes, 
27 in  the  past  year.  Bui  and  Johnson,  1996  used  the  technique  to  isolate  two  genes 
encoding  [Fe]  hydrogenases  from  T  vaginalis.  Five  superoxide  dismutase  genes  were 
also  isolated  from  T  vaginalis  using  the  same  approach  (Viscogliosi  et  aL,  1996). 
Interestingly,  the  first  gene  encoding  a  sulphur  amino  acid  metabolising  enzymefrom  T 
vaginalis  has  been  isolated  and  characterised  at  the  molecular  level.  Bagnara  et  al., 
1996  have  cloned  the  gene  encoding  S-adenosyl  hornocysteine  hydrolase  (sahh),  an 
enzyme  involved  in  the  methionine  cycle  of  sulphur  amino  acid  metabolism  in  T 
vaginalis,  the  authors  also  used  a  degenerate  oligo/PCR  approach. 
Genes  have  been  isolated  from  T  vaginalis  that  have  helped  address  the  question  of 
hydrogenosome  evolution.  The  genes  were  all  isolated  by  a  degenerate  oligo/PCR 
approach,  they  were  HSP70,  HSP60  and  HSP  10  (Germot  et  al.,  1996  and  Bui  et  al,. 
1996)  and  chaperonin  60  (cpn60)  (Homer  et  al.,  1996  and  Roger  et  al.,  1996).  The  gene 
for  the  largest  subunit  of  RNA  polymemse  11  in  T  vaginalis  has  been  isolated  (Quon  et 
al.,  1996)  as  have  genes  for  histone  H3  and  H4  (Marinets  et  al.,  1996),  the  approach 
used  for  the  isolation  of  these  genes  was  the  same  as  outlined  above.  Finally  a  gene  for 
acety1neuraminate  lyase  was  isolated  from  T  vaginalis  using  a  polyclonal  antisera 
that  had  been  raised  against  T  vaginalis  extracellular  proteases  (Meysick  et  al.,  1996) 
A  survey  of  the  T  vaginalis  genes  isolated  and  characterised  to  date  indicates  that  they 
appear  not  to  contain  introns,  and  they  have  unusually  short  5'  and  3'  untranslated 
regions  (Quon  et  al,  1994).  The  hydrogenosomal  genes  characterised  from  T  vaginalis 
have  been  found  to  encode,  a  8-9  amino  acid  sequence,  which  is  absent  from  the 
purified  proteins.  The  short  leader  sequence  is  thought  to  play  a  role  in  targeting  the 
protein  of  the  hydrogenosome,  as  these  amino  terminal  sequences  are  characterised  by 
properties  typical  of  mitochondrial  presequences. 
28 1.4.3  Transcriptional  control  of  T.  vaginalis  genes. 
An  attempt  has  been  made  to  identify  regulatory  elements  that  play  a  role  in 
transcription  initiation  of  T  vaginalis.  Characterisation  of  seven  protein  coding  genes 
from  this  protist  invariably  revealed  the  presence  of  a  highly  conserved  DNA  sequence 
motif  immediately  upstream  of  the  coding  region  (Quon  et  al.,  1994).  This  13 
nucleotide  motif  was  shown  to  surround  and  contain  precise  sites  for  transcription 
initiation.  No  typical  TATA  boxes,  positioned  at  25-30nt  upsteam  of  the  transcription 
start  sites  of  these  genes,  were  found  (Quon  et  al.,  1994). 
This  start  site  regions  from  a  seven  T  vaginalis  genes  impart  strong  specific  initiation  of 
transcription  in  a  mammal  in  vitro  transcription  assay.  The  consensus  promoter  element 
found  in  T  vaginalis  is  structurally  and  functionally  similar  to  elements  found  in 
promoters  of  higher  eukaryotes  (Smale  and  Baltimore,  1989). 
Recently,  transcription  in  T  vaginalis  was  examined  by  analysing  the  effect  of  the 
fungus  derived  toxin  a-amanitin  on  the  transcription  of  protein  coding  genes  in  this 
ancient  eukaryote.  It  was  found  that  the  RNA  polymerase  that  transcribes  the  protein- 
coding  genes  was  relatively  resistant  to  cc-arnanitin  and  molecular  characterisation  of  the 
gene  encoding  the  large  subunit  of  the  RNA  polymerase  11  shows  that  it  lacks  many  of 
the  conserved  residues  present  in  the  putative  a-amanitin  binding  site  of  other  RNA 
polymerase  II  genes,  including  the  typical  heptapeptide  repeat  carboxy-terminal  domain 
(CTD)  that  is  a  hallmark  of  higher  eukaryotic  RNA  polymerase  Us  (Quon  et  al.,  1996). 
29 1.5  Aims  of  the  project 
There  were  three  main  project  aims  at  the  onset  of  this  study: 
1.  To  isolate  and  characterise  the  gene  encoding  methionine  y-lyase  from  T  vaginalis. 
2.  To  clone  the  methionine  y-lyase  gene  of  T  vaginalis  into  a  protein  expression  vector, 
so  that  recombinant  protein  could  be  produced  and  be  biochemically  characterised. 
3.  To  gain  more  insight  into  the  function  of  methionine  y-lyase  and  other  sulphur  amino 
acid  metabolising  enzymes  of  T  vaginalis. 
30 methanethiol  + 
NH4+ 
(x-ketobutyrate  S-adenosylmethionine 
ATP 
(9) 
L-methionine 
(b) 
betaine  --'  (a) 
(SAM) 
transmethylation 
S-adenosylhomocysteine 
(SAH) 
(6) 
mTHF 
(2) 
(x-ketobutyrate 
+H,  S  +  NH4' 
homocysteine  adenosine 
(5)  senne 
if 
cystathionine 
-ff 
(4) 
serine  +  WS 
,  -»- 
(3) 
cysteine 
ct-ketobutyrate  + 
N"4f 
Enzymes:  (1)  S-adenosylhomocysteine  hydrolase-,  (2)  homocysteine  desulphurase; 
(3)  cystathionine  y-lyase,  (4)  serine  sulphydrase;  (5)  cystathionine  P-synthetase; 
(6a)  methy  Itetrahydrofo  late:  homocysteine  methy  Itrans  fe  rase;  (6b)  betaine: 
homocysteine  methyltransferase-,  (7)  S-adenosylmethionme  synthetase, 
(8)  S-adenosy  I  meth  ion  i  ne-dependent  methyltransferases;  (9)  methionine  y-lyase 
Figure  1.1  Metabolism  of  sulphur-containing  amino  acids 
in  T.  vaginalis 
31 um 
10 
%w 
cd 
F)  (ý-) 
ei 
rm 
*  ri 
, *w 
x 
05 
-?:, 
4) 
cl) 
1.  ) 
V) 
cli 
0 
1< 
riD 
0 
)  - 
- 
0 
0 
0 
(6 
o 
"- 
E 
0 
0 
- 
Cl, 
0 
E 
0 
32 
0 
g  -Z:  Q 
c 
,  wo *  ri  ,  wä 
:i 
CD 
I) 
DC 
t)  C 
) 
E 
>,  I 
ci  = 
C-) 
C) 
C) 
C- 
"- 
l) 
C-) 
rA 
-r 
C 
.?  ý  Q  , 4- 
C 
-0 
C) L 
ýid 
0 
(V 
0 
rA 
10 
= z 
C 
(X  , 
7  "m 
en  = 
44 
33 polyarnines 
t 
S-adenosylmethionine 
ATP 
S-adenos.  v  i  niethiom  ne 
synthetase 
methionine 
belalllcý  hoillocysi 
methyltransferase 
betaine  homocysteine 
mTHF  serine 
"I  Mll'!  It 
"-4to  ýI 
(SAM) 
transmethylation 
S-adenosylmethionine 
dependent  transferases 
S-adenosylhomocysteine 
(SAH) 
S-adenosy  I  lioniocý  ste  I  nase 
-49ý 
adenosine 
cvstathionme  fl-svnthase 
honloo"Stclile 
cystathionine 
C\  statillollifle  -/-1vase 
cysteine 
oc-ketobutyrate  + 
NH4+ 
Figure  1.4  Metabolism  of  sulphur-containing  amino  acids 
in  mammals 
34 CHAPTER  2.  MATERIALS  AND  METHODS. 
2.1  General  materials  and  methods. 
2.1.1  Parasites,  cultivation,  harvesting  and  subcellular  fractionations. 
2.1.1.1  Parasite  line. 
One  line  of  T  vaginalis  was  used  in  this  study.  Clone  G3  has  been  cultivated  in  vitro 
for  many  years  in  our  laboratory,  this  metronidazole  sensitive  line  was  used  for  all 
experiments.  T  foetus,  clone  F2,  and  T  augusta  were  the  other  trichomonads  used  in 
experiments  described  in  this  thesis. 
2.1.1.2  Cultivation  of  T.  vaginalis  in  vitro 
T  vaginalis  was  cultured  axenically  in  Modified  Diamonds  Medium  (MDM) 
(Diamond,  1957),  supplemented  with  10%  (v/v)  heat  inactivated  horse  serum  (Life 
Technologies)  (Complete  MDM),  at  37*C.  Cultures  of  T  vaginalis  were  subpassaged 
every  two  days.  As  routine  two  drops  of  late  log  phase  culture  (1  -2  X106  cells  /ml)  were 
aseptically  transferred  to  a  universal  tube  containing  fresh  complete  MDM,  via  a  l9g 
needle  attached  to  aI  ml  syringe.  At  each  subpassage  parasites  were  checked  for 
microbial  contamination  by  microscopical  examination.  In  order  that  cultures  were 
maintained  in  good  condition  over  the  weekend  newly  subpassaged  tubes  were  placed  at 
32'C  instead  of  37'C. 
Bulk  cultures  of  T  vaginalis  would  be  set  up  from  the  most  recent  tube  of  subpassaged. 
cells.  Parasites  would  be  set  up  at  an  initial  density  of  IX  104  cells/ml  and  grown  for 
-40-42  hours  at  37'C  and  harvested  at  late  log  phase.  Altematively  the  parasites  would 
35 be  initiated  at  Ix  105cells/ml  and  grown  for  24  hours  at  370C,  prior  to  harvesting  at  late 
log  phase  of  growth. 
2.1.1.3  Cell  counts. 
All  cell  counts  were  made  using  an  improved  Neubauer  hemocytometer  at  x40  objective 
magnification  under  phase  contrast  (  x400  overall  ). 
2.1.1.4  Harvesting  T.  vaginalis. 
Cells  at  late  log  phase  of  growth  (1-2  X106  cells  /ml)  were  harvested  by  centifugation  at 
2300  xg  for  15  minutes  at  4"C,  washed  twice  with  0.25  M  sucrose  and  used 
immediately  or  stored  as  pellets  at  -70"C  until  required. 
2.1.1.5  Production  of  crude  lysates,  cell  free  homogenates  and  soluble  fractions. 
Crude  lysates  of  T  vaginalis  in  0.25M  sucrose  were  produced  using  0.25%  (v/v)  Triton 
X-100.  Lysates  were  centrifuged  at  13,000  xg  in  a  bench  top  microcentrifiage  for  5 
minutes  to  pellet  cellular  debris.  The  supernatant  fraction  was  the  crude  soluble  fraction 
that  was  frequently  used  in  enzyme  assays  and  Western  blots. 
Soluble  fractions  for  native  enzyme  purifications  were  produced  by  resuspending  -109 
parasites  in  5  ml  of  0.25  M  sucrose  and  disrupting  them  by  30  strokes  of  a  Potter  tissue 
homogeniser  fitted  with  a  serrated  Teflon  plunger  type  A  (A.  H.  Thomas  Co., 
Philadelphia,  USA)  operating  at  2500  rpm.  This  caused  disruption  of  more  than  95%  of 
the  parasites  but  functioned  to  keep  organelles  such  as  hydrogenosomes  and  lysosomes 
intact.  The  parasite  homogenate,  was  centrifuged  at  100  000  xg  for  I  hour  at  40C  in 
order  to  obtain  soluble  and  particulate  fractions,  the  former  was  used  as  the  starting 
36 material  for  native  methionine  y-lyase  purifications.  The  proteinase  inhibitors  E64  (10 
gM),  1,10  phenanthroline  (2  mM),  pepstatin  A  (4  gM)  and  PMSF  (I  mM)  were  added 
to  all  types  of  T  vaginalis  lysates  and  homogenates  produced,  at  the  final  concentrations 
indicated. 
2.1.1.6  Cryopreservation  of  T.  vaginalis. 
T  vaginalis  was  cryopreserved  using  a  procedure  which  involved  adding  10%  (v/v) 
sterile  dimethylsulphoxide  (DMSO)  in  complete  MDM  to  late  log  cultures  (ie.  500  ýd 
10%  (v/v)  DMSO  in  MDM  +  500  [tl  late  log.  T  vaginalis)  I  ml  samples  were 
transferred  to  screw  capped  cryopreservation  tubes  (Nunc)  and  the  lids  tightened.  The 
tubes  were  wrapped  in  cottonwool  and  transferred  to  a  polystyrene  box  and  placed  at  - 
70'C  for  18-24  hours.  The  tubes  were  immersed  in  liquid  nitrogen  for  long  term 
storage.  T  vaginalis  was  removed  from  long  term  storage  by  thawing  the  contents  of  a 
single  tube  as  quickly  as  possible  using  warm  water  and  transferring  the  contents  (I  MI) 
aseptically  to  25  ml  of  MDM  in  a  sterile  universal  tube. 
2.2  Molecular  Materials  and  Methods. 
2.2.1  Bacterial  maintenance,  cultivation  and  harvesting. 
The  strains  of  Escherichia  coll  used  in  this  study  were:  XLI  -Blue  (Stratagene), 
MI  5pREP4  (Qiagen)  and  TOP  10  (Ingenius).  The  plasmids  used  in  this  study  were 
pBluescript  (SK-)  (Ampicillin  R)  (Stratagene).  pQE30  and  pQE60  (AmpicillinR) 
(Qiagen)  and  pTAg  (Ampicillin  R,  Kanamycin  R)  (Ingenius). 
37 2.2.1.1  Long-term  maintenance  of  bacterial  strains. 
Bacterial  strains  containing  plasmids  of  interest  were  maintained  as  a  glycerol  stabilate 
at  -70*C.  An  overnight  culture  of  bacteria  was  diluted  1:  1  with  40%  glycerol  and 
peptone  and  stored  in  screw  cap  vials  at  -70"C. 
2.2.1.2  Short-term  maintenance  of  bacterial  strains. 
Bacteria  were  made  available  for  inoculation  into  liquid  cultures  by  streaking  out  from  a 
glycerol  stabilate  onto  solid  L-agar  media  containing  the  appropriate  antibiotic  for 
plasmid  selection.  Discrete  colonies  were  produced  by  the  streaking  out  procedure. 
Bacteria  maintained  on  solid  L-agar  plates  remained  viable  for  a  period  of  4-6  weeks 
when  kept  sealed  at  4"C. 
2.2.1.3  Bacterial  cultivation. 
Bacterial  cultures  to  be  used  for  small  scale  preparations  of  plasmid  DNA  were 
cultivated  as  follows.  Between  3  and  10ml  of  LB  liquid  media  plus  appropriate 
antibiotic  (ampicillin  was  used  at  a  final  concentration  of  100  pg/ml,  kanamycin  was 
used  at  a  final  concentration  of  25  [tg/mI  and  tetracycline  was  used  at  a  final 
concentration  of  12.5  pg/ml),  were  transferred  aseptically  to  sterile  glass  tubes  with 
caps.  The  liquid  media  were  inoculated  with  a  single  bacterial  colony  taken  from  an 
agar  plate  via  a  long  wooden  sterile  stick.  Inoculated  cultures  were  incubated  in  a  rotary 
shaker  operating  at  200rpm  at  37'C  overnight.  - 
Larger  cultures  for  plasmid  preparation  or  recombinant  protein  expression  work  were 
prepared  in  the  same  manner  as  outlined  above  except  50mls  of  LB  broth  plus 
38 appropriate  antibiotic  were  placed  in  a  250  ml  sterile  conical  flask  plugged  with 
cottonwool  and  inoculated  with  a  single  bacterial  colony  taken  from  an  L-agar  plate. 
2.2.1.4  Bacterial  harvesting. 
Bacterial  cultures  for  small  scale  preparations  of  plasmid  DNA  were  transferred  to 
1.5ml  Eppendorfs  and  centrifuged  at  13  000  xg  in  a  microfuge  for  3  minutes  to  pellet 
cells.  Large  volumes  of  bacterial  cultures  were  decanted  into  sterile  centrifuge  pots  and 
centrifuged  at  6000  xg  for  10  minutes  in  a  Beckman  J2  centrifuge  using  a  JAI  4  rotor. 
2.2.2  Isolation  of  plasmid  DNA  from  E.  colL 
2.2.2.1  Small  scale  plasmid  preparations-'  mini-preps'. 
Plasmid  DNA  was  routinely  isolated  from  3  ml  of  the  appropriate  overnight  bacterial 
culture  using  Wizard  mini-preps  (Promega),  according  to  manufacturer's  instructions. 
Briefly,  the  bacterial  cells  were  resuspended,  lysed  and  neutralised.  The  bacterial 
chromosomal  DNA  was  centrifuged  out  and  the  cleared  supernatant  containing  the 
plasmid  DNA  was  loaded  on  to  a  column  containing  a  DNA  binding  resin,  the  column 
was  washed  prior  to  elution  of  the  DNA  in  sterile  water  or  TE  buffer  pH  8.0. 
2.2.2.2  Medium  scale  plasmid  preparations. 
'Midi-preps'  of  plasmid  DNA  were  prepared  using  Qiagen  tip  100  according  to 
manufacturer's  instructions.  The  procedure  was  essentially  the  same  as  for  Wizard 
Gmini-preps'  as  outlined  above.  Yield  was  approximately  100  pg  DNA.  The  principle 
of  Qiagen  Tip  100  is  basically  the  same  as  outlined  above  for  the  Wizard  mini-preps. 
39 2.2.3  Polymerase  Chain  Reaction  (PCRs)  Amplification  of  cystathionine  y-lyase 
homologues. 
Degenerate  primers  were  used  in  PCR  reactions  with  T  vaginalis  first  strand  cDNA. 
The  sequences  of  the  primers  used  in  the  degenerate  PCRs  and  for  gene  sequencing  are 
shown  in  Table  2.1.  The  50  pl  reaction  contained  5  ng  T  vaginalis  cDNA,  each  of  the 
primers  at  a  final  concentration  of  5  ng,  nucleotides  at  a  final  concentration  of  250  [tM 
and  5U  Taq  polymerase  (Promega).  The  following  amplification  protocol  was 
employed:  An  initial  denaturation  step  of  4  minutes  at  95'C  was  followed  by  30  cycles 
at  94*C  for  I  minute,  42"C  forl  minute  and  720C  forl  minute.  A  final  step  of  5  minutes 
at  72*C  was  used  to  complete  the  extension. 
PCRs  for  experiments  other  than  degenerate  PCR,  for  example  the  engineering  of 
restriction  sites  onto  the  ends  of  DNA  fragments  for  cloning  experiments,  contained  the 
same  PCR  constituents  as  outlined  above,  with  template  and  primers  at  approximately 
the  same  concentration.  If  amplified  DNA  was  required  in  which  base  changes 
introduced  by  Taq  polymerase  were  minimised,  then  Pfu  polymerase  (Stratagene), 
which  has  proof  reading  activity  was  used  (for  example,  when  mgII  was  cloned  into 
pQE60).  The  amplification  protocol  was  basically  the  same  but  with  higher  annealing 
temperatures  for  oligonucleotides  of  known  sequence.  Less  amplification  cycles  were 
used  if  the  DNA  template  had  been  previously  amplified. 
2.2.4  5'  RT  PCR-RACE. 
The  5'  ends  of  the  mRNA  transcribed  from  mgll  and  mgI2  were  determined  using  a  5' 
RACE  system  kit  (Life  Technologies).  For  RACE-PCR  (Loh  et  al.,  1989)  total  cellular 
40 RNA  from  T  vaginalis  (I  gg)  was  reverse  transcribed  into  single  stranded  cDNA 
(ssDNA)  using  the  components  of  the  S'  RACE  system  kit,  with  20ng  of  oligo  dT  as 
primer  for  the  cDNA  synthesis.  Excess  dNTPs  and  primer  were  removed  from  the 
ssDNA  using  a  Glassmax  cartridge  and  associated  reagents  (Life  Technologies)  and  a 
hornopolymeric  tail  of  dCs  were  added  to  the  3'  end  of  the  sscDNA.  5[d  of  tailed 
cDNA  was  added  to  50  pl  PCR  reactions  containing  the  components  of  the  5'  RACE 
System  Kit,  2U  Taq  (Promega),  anchor  primer  (which  included  a  sequence 
complementary  to  the  poly  dC  tail)  and  a  gene  specific  primer.  See  Table  2.1  for  details 
of  the  gene  specific  primers  used  in  the  5'RACE-PCR  experiments. 
2.2.5  T.  vaginalis  XZAPII  cDNA  library  screening. 
Screening  of  the  T  vaginalis  XZAPII  cDNA  library  (Mallinson  et  al.,  1994)  with 
oligonucleotide  probes  or  polyclonal  antisera  was  carried  out  in  accordance  to  the 
Stratagene  protocol,  the  suppliers  of  the  cDNA  library  components.  Information  on 
screening  procedures  and  the  subsequent  lambda  purification  procedures  were  from 
Sambrook  et  al.,  (1989).  Briefly,  100,000  XZAP  phage  particles  and  XLI-Blue  in  BBL 
top  agarose  were  plated  on  to  BBL  agar  in  18  cm  square  petri  dishes.  The  plates  were 
incubated  at  37  'C  until  the  lambda  plaques  just  touched  one  another.  TheDNAfrorn 
the  lambda  clones  was  transferred  to  Hybond  N  (Amersham)  and  the  lambda  DNA 
denatured,  neutralised  and  washed  using  the  same  procedure  as  for  Southern 
hybridisations.  Hybridisation  of  radioactive  gene  specific  probes  was  carried  out  as  for 
Southem  hybridisations. 
41 Once  pure  lamba  clones  containing  the  DNA  insert  of  interest  were  obtained,  the  inserts 
were  rescued  directly  into  the  pBluescript  phagemid  using  helper  phage  R408 
(Stratagene)  (Short  et  aL,  1987  and  Stratagene  protocol). 
2.2.6  Isolation  of  genomic  DNA  from  T.  vaginalis. 
Genomic  DNA  from  T  vaginalis  was  isolated  using  the  Nucleon  II  protocol  (Scotlab) 
according  to  manufacturer's  instructions.  Briefly,  the  parasites  were  resuspended  and 
then  lysed  using  an  SDS  based  solution,  the  RNA  was  degraded  using  RNase  and  the 
lysed  cells  deproteinised.  using  sodium  perchlorate.  The  genomic  DNA  was  extracted 
using  chloroform  and  a  silica  based  resin  and  finally  precipitated  using  ethanol. 
Approximately  0.5mg  of  genomic  DNA  was  obtained  from  3x  108  T  vaginalis. 
2.2.7  General  manipulation  of  nucleic  acids. 
2.2.7.1  Concentration  of  nucleic  acids. 
DNA  and  RNA  was  routinely  precipitated  by  the  addition  of  x  2.5  volumes  of  100% 
ethanol  and  /loth  volume  3M  NaAc  pH  5.2,  when  the  volume  of  the  nucleic  acid 
solution  to  be  precipitated  was  taken  into  consideration.  The  precipitation  process  was 
aided  by  a  minimum  incubation  of  15  minutes  at  -70'C.  The  nucleic  acid  precipitant 
was  then  centrifuged  at  13  000  xg  for  15  min  at  40C  in  a  microfage.  The  supernatant 
was  discarded,  the  precipitated  nucleic  acid  washed  with  70%  ethanol  and  resuspended 
in  a  suitable  volume  of  TE  buffer  pH  8  or  sterile  distilled  water. 
2.2.7.2  Restriction  endonuclease  digestion  of  plasmid  DNA. 
Plasmid  DNA  was  routinely  digested  using  an  excess  of  restriction  endonuclease.  For 
digestion  of  I  pg  of  plasmid  DNA  in  a  final  volume  of  I  Opl,  IOU  of  restriction  enzyme 
42 was  used.  The  restriction  cocktail  consisted  of.  -1  pg  plasmid  DNA,  I  pI  10  x  React 
buffer  (Life  Technologies),  IW  restriction  enzyme,  10  U  (Life  Technologies)  and  sterile 
distilled  water  made  up  to  a  final  volume  of  10  gl.  The  restriction  was  incubated  for  1-2 
hours  at  37T  and  the  reaction  stopped  by  adding  1/5th  volume  agarose  gel  loading 
buffer  (40%  sucrose  (w/v),  0.5%  (w/v)  SDS,  0.1  M  EDTA  pH8,0.05%  bromophenol 
blue  (w/v)).  If  higher  concentrations  of  plasmid  DNA  were  required  to  be  restricted,  the 
restriction  cocktail  was  simply  scaled  up. 
2.2.8  T.  vaginalis  genomic  DNA  restriction  digests. 
T  vaginalis  genomic  DNA  restriction  cocktails  routinely  consisted  of  the  following:  2 
ýtg  T  vaginalis  genomic  DNA,  2  pI  I  Ox  React  buffer  (Life  Technologies),  2  pI 
restriction  enzyme,  20  U  (Life  Technologies),  and  made  up  to  a  final  volume  of  20  pI 
with  sterile  distilled  water.  Genomic  DNA  restrictions  were  incubated  at  37C  for  5 
hours.  Restrictions  were  terminated  using  1/5th  restriction  volume  agarose  gel  loading 
buffer. 
2.2.9  Calf  Intestinal  Alkaline  Phosphatase  treatment  (CIP  treatment). 
For  plasmids  digested  with  only  one  restriction  enzyme,  religation  was  prevented  by  the 
removal  of  the  Yterminal  phosphates  through  CIP  treatment.  5U  of  CIP(Boehringer) 
was  added  directly  to  restriction  enzyme  cocktail  mixes  and  incubated  for  15  minutes  at 
37T.  Phosphatase  treatment  was  completed  by  the  addition  of  a  further  5U  of  CIP  and 
incubation  for  15  minutes  at  37"C,  prior  to  the  addition  of  gel  loading  buffer. 
2.2.10  Ligations. 
43 Ligation  of  plasmid  DNA  and  DNA  inserts  (50ng  of  each)  was  performed  using  the 
Amersharn  ligation  kit  according  to  the  manufacturer's  instructions,  The  kit  contained  a 
ligase  buffer  and  ligase.  Ligations  were  for  30  minutes  at  16*C. 
2.2.11  Bacterial  transformations  with  plasmid  DNA. 
Supercompetent  and  competent  XL  I  -Blue  were  purchased  from  Stratagene  for 
important  cloning  experiments.  Competent  strains  of  bacteria  used  for  routine  cloning 
experiments  were  also  made  in  the  laboratory  following  the  calcium  chloride  method  as 
outlined  in  Sambrook  et  al.,  (1989).  The  transformation  protocol  used  for  all 
experiments,  regardless  of  whether  the  cells  had  been  bought  from  Stratagene  or  made 
in  the  laboratory,  was  as  exactly  as  outlined  in  the  Stratagene  Supercompetent  and 
Competent  cell  protocol.  Briefly,  ligated  plasmid  and  insert  were  added  to  the 
competent  cells  in  a  Falcon  15  ml  polypropylene  tube  and  left  on  ice  for  30  minutes. 
The  cooled  cells  were  heat  shocked  for  421C,  left  on  ice  for  a  further  2  minutes  and  500 
gl  SOC  medium  added  to  the  cells  which  were  the  incubated  at  37*C  for  I  hour  with 
shaking  at  200  rpm.  200  pl  of  the  transformed  cells  were  aseptically  spread  on  to  plate 
containing  the  appropriate  antibiotic  for  plasmid  selection  and  in  the  case  of  XLI  -Blue, 
also  IPTG  (6.5pl  0.5M  stock  per  plate)  and  X-gal  (40ýd  20mg/ml  stock  per  plate). 
2.2.12  Agarose  Gel  electrophoresis. 
Two  types  of  buffer  system  were  used  for  agarose  gel  electrophoresis: 
1.  TBE  agarose  gel  electrophoresis  was  used  for  the  routine  visualisation  of  DNA  after 
restriction  endonuclease  digestion. 
2.  TAE  agarose  gel  electrophoresis  was  used  when  DNA  was  subsequently  excised 
from  the  agarose  gel  and  used  for  subsequent  DNA  manipulations  such  as  ligations. 
44 2.2.12.1  Mini  gels 
Two  sizes  of  agarose  gel  were  used  for  DNA  electrophoresis:  For  mini  gels,  50ml  of  the 
desired  percentage  agarose  gel  would  be  prepared  by  dispensing  the  appropriate  amount 
of  agarose  powder  (BRL-Ultrapure  (Life  Technologies)  for  routine  work,  Seakern  GTG 
(FMC  Bioproducts)  when  gel  purification  was  required)  and  buffer  into  a  250ml  conical 
flask.  The  agarose  would  be  melted  by  microwaving  at  medium  power  for 
approximately  3  minutes.  The  boiled  agarose  solution  was  cooled  to  hand  hot 
temperature  and  ethidiurn  bromide  (EtBr)  solution  added  to  a  final  concentration  of  0.5 
gg/ml.  The  cooled,  molten  agarose  was  poured  into  the  gel  tray  with  the  gel  formers 
and  comb  in  position  of  a  mini  gel  kit  (Life  Technologies).  Approximately  35mls  of 
molten  agarose  solution  was  sufficient  to  fill  the  gel  tray.  Gels  were  run  at  constant  80V 
until  the  bromophenol  blue  dye  front  had  migrated  two  thirds  of  the  way  down  the  gel. 
2.2.12.2  Midi  gels. 
For  midi  gels,  150mls  of  agarose  gel  solution  were  used  with  a  midi  gel  kit  (Life 
Technologies),  from  which  ethidium  bromide  would  be  omitted.  Gels  were  run  at  a 
constant  26  V  overnight  or  at  constant  120  V  for  4  to  5  hours. 
2.2.123  DNA  size  markers. 
DNA  size  standards  would  be  run  alongside  DNA  samples  under  investigation  during 
agarose  gel  electrophoresis.  I  kb  ladder  and  %HindIll  markers  (%  DNA  digested  with 
HindIll  (Life  Technologies)  were  routinely  used. 
2.2.13  Visualisation  of  DNA  and  photography. 
45 Agarose  mini  gels  in  which  EtBr  had  been  incorporated  could  be  examined  immediately 
over  a  source  of  UV  light.  However,  midi  gels  and  mini  gels  containing  DNA 
fragments  less  than  300  base  pairs  in  size  were  stained  for  30  minutes  in  a  0.5ýtg/ml 
EtBr  solution  in  electrophoresis  buffer  or  water  and  destained  under  running  tap  water 
prior  to  exposure  to  UV  light.  Short  wave  UV  light  (254nm)  was  used  to  visualise  DNA 
in  agarose  gels  and  the  results  recorded  using  a  Polaroid  camera  with  a  Wratten  2A  and 
gelatin  filter,  plus  667  film  or  by  using  an  Appligene  Imager  (Appligene  Oncor)  in 
which  the  captured  image  could  be  stored  to  disk  or  reproduced  on  paper.  Long  wave 
UV  light  (365mu)  was  used  to  visualise  gels  from  which  DNA  was  to  be  extracted  and 
used  for  subsequent  DNA  manipulations.  This  was  to  minimise  UV  light  induced 
damage  of  the  DNA. 
2.2.14  Extraction  of  DNA  from  agarose  gels. 
DNA  to  be  used  in  further  DNA  manipulations  (eg.  ligations,  random  priming)  was 
extracted  from  the  gel  using  a  clean  scapel  blade  and  the  DNA  removed  from  the  gel 
plug  using  one  of  two  procedures. 
1.  If  the  DNA  to  be  extracted  from  the  gel  plug  was  of  a  fairly  high  concentration  ie. 
greater  thanI  gg,  Spin  X  columns  (Costar)  were  used  according  to  the  manufacturer's 
instructions.  Spin  X  columns  contain  a  membrane  which  allows  the  passage  of  DNA 
whilst  the  components  of  the  agarose  gel  are  retained 
2.  If  the  DNA  to  be  extracted  from  the  gel  plug  was  less  than  I  gg,  the  Qiaex  gel 
extraction  kit  (Qiagen)  was  used  according  to  the  manufacturer's  instructions.  Briefly, 
the  agarose  gel  containing  the  DNA  to  be  extracted  is  solubilised,  the  solubilised 
material  is  applied  to  a  column  that  has  DNA  binding  capacity  and  after  column 
washing  the  DNA  is  eluted  in  sterile  water  or  TE  buffer  pH  8.0. 
46 2.2.15  Manual  DNA  sequencing. 
Manual  DNA  sequencing  was  carried  out  using  the  Sequenase  Quick  Denature  Plasmid 
Sequencing  Kit  (Amersham).  This  DNA  chain  terminating  kit  utilises  Sequenase" 
Version  2.0  DNA  polymerase  and  35S  methionine  (NEN  DupontO.  DNA  fragments 
were  resolved  on  6%  acrylamidelurea  gels  using  the  buffer  system  appropriate  to  the 
conditions  in  which  the  DNA  was  originally  denatured.  A  sequencing  gel  kit  (Life 
Technologics)  or  Basc  Acc  gcl  kit  (Stratagcnc)  was  uscd  to  run  wcdgcd  spaccd 
sequencing  gels.  Short  run  gels  were  run  at  a  constant  60W  for  -2  hours  or  until  the 
bromophenol  blue  dye  front  was  at  the  bottom  of  the  gel.  This  allowed  the  first  200 
base  pairs  of  sequence  from  the  primer  to  be  read.  Long  run  gels  were  run  at  a  constant 
60W  for  -5  hours  or  until  the  xylene  cyanol  dye  was  at  the  bottom  of  the  gel.  This 
allowed  200-500bp  of  sequence  from  the  primer  to  be  read.  After  electrophoresis  the 
gels  were  fixed  in  10%  (v/v)  methanol,  10%  (v/v)  acetic  acid  for  30  minutes  prior  to 
transfer  to  Whatman  3MM  chromatography  paper  which  was  overlaid  with  Saran  wrap 
and  dried  for  1.5  hours.  Dried  gels  with  the  Saran  wrap  removed,  were  exposed  to  Fuji 
RX  film  at  room  temperature,  ovemight  to  36  hours. 
2.2.16  DNA  sequence  analysis. 
The  University  of  Wisconsin  Genetic  Computer  Group  (GCG)  Version  7.0  and 
associated  programs  were  used  for  all  nucleic  and  amino  acid  analyses. 
2.2.17  Primers  for  DNA  sequencing  and  PCRs 
For  subclones  made  in  pBluescript,  T3,  T7  and  -20  reverse  primers  (Stratagene)  were 
used,  for  pTAg,  the  M  13  reverse  primer  was  used  (Applied  Biosystems).  Gene  specific 
primers  for  sequencing  and  PCRs  were  designed  by  taking  into  consideration  the 
47 nucleotide  sequence  already  obtained.  Gene  specific  primers/oligonucleotides  were 
commercially  synthesised  by  the  Molecular  Biology  Laboratory,  University  of 
Strathclyde,  Glasgow.  The  sequence  of  gene  specific  primers  and  degenerate  primers 
used  in  this  study  are  shown  in  Table  2.1. 
2.2.18  Radioactive  probes. 
Radioactive  DNA  probes  (ie.  20  ng  of  restriction  fragments  from  p4  1  oo  and  p5  1  oo)  used 
in  Southern  and  Northern  blot  hybridisations  were  synthesised  using  the  Prime  It  kit 
(Stratagene)  according  to  the  manufacturer's  protocol.  The  kit  uses  random  hexamers 
and  Exo  (-)  Klenow  DNA  polymerase  to  incorporate  a  radioactive  nucleotide  (dCTP, 
30OOmCi/mmol,  NEN  Dupont)  along  with  other  non  radioactive  nucleotides  into  a 
newly  synthesised  strand  of  DNA.  The  radioactive  probes  were  purified  using 
NucTrap@  probe  purification  columns  and  the  push  column  beta  shield  device 
(Stratagene)  prior  to  use  in  hybridisation  experiments.  Before  addition  to  hybridisation 
experiments,  the  radioactive  probes  were  boiled  for  10  minutes  to  make  them  single 
stranded. 
2.2.19  Southern  blotting  and  hybridisations. 
Prior  to  transfer  to  Hybond  N  membrane  (Amersham)  agarose  gels  containing  T 
vaginalis  genomic  DNA  were  depurinated  by  immersing  the  gel  in  0.25  M  HCI  for  30 
minutes  with  shaking  at  room  temperature,  this  was  followed  by  denaturation  of  the 
genomic  DNA  in  denaturation  solution  for  30  minutes  with  shaking,  followed  by  a  final 
neutralisation  step  for  30'minutes  in  neutralisation  solution,  prior  to  the  Southern  blot 
being  set  up.  Restricted  T  vaginalis  genomic  DNA  was  transferred  to  Hybond  N 
membrane  (Amersham)  as  described  by  Sambrook  et  aL,  (1989).  High  stringency 
48 hybridisations  of  immobilised  T  vaginalis  genomic  DNA  with  radioactive  fragments  of 
the  DNA  of  interest  were  carried  out  at  65'C.  Hybond  N  membranes  were 
prehybridised  in  glass  tubes  with  screw  capped  lids  (Hybaid)  with  15mls  of 
hybridisation  solution  (6x  SSC,  lOx  Denhardt's,  0.1%  (w/v)  SDS,  'O.  I%  (w/v)  sodium 
pyrophosphate  and  I  00[tg/ml  herring  sperm  denatured  and  sheared  DNA)  for  1.5  to  2 
hours  at  65"C.  The  prehybridisation  solution  was  then  discarded  and  10mls  of  fresh 
hybridisation  solution  was  added  to  the  tubes  and  the  single  stranded  radioactive 
fragment  of  DNA  added  directly.  The  filters  were  hybridised  for  approximately  18 
hours  (overnight)  at  650C  with  rotation  of  the  glass  tubes.  After  hybridisation  the 
radioactive  probe  was  decanted  off  and  the  filter  removed  for  washing.  The  filters  were 
washed  in  a  total  of  two  litres  of  0.1  x  SSC  and  0.1  %  SDS  (wash  solution)  for  I  hour  at 
65'C  with  shaking,  one  litre  of  wash  solution  was  replaced  after  30  minutes  with 
another  litre  of  pre-warmed  wash  solution. 
After  washing  the  filters  were  sealed  in  a  polythene  bag  and  exposed  to 
autoradiographic  film  (Fuji  RX)  with  intensifying  screen  at  -70'C  for  18  to  36  hours. 
Exposed  autoradiographic  films  were  automatically  developed  using  a  Kodak  Xomat 
film  processor. 
2.2.20  RNA  isolation  from  T.  vaginalis. 
Total  RNA  was  isolated  from  T  vaginalis  using  the  commercially  available  reagent 
TRIzolTM  (Gibco),  which  is  a  mono-phasic  solution  of  phenol  and  guanidine 
isothiocyanate,  according  to  manufacturers  instructions.  Poly  [A]+  RNA  was  isolated 
from  the  total  RNA  of  T  vaginalis  using  Poly  [A]'Quik  columns  (Stratagene), 
49 according  to  manufacturers  protocol.  The  concentration  of  the  Poly  [A]+  RNA  was 
spectrophotometrically  detennined  at  A  280/260  mn. 
2.2.21  First  strand  cDNA  synthesis  from  T.  vaginalis  poly  [A]+  RNA. 
I  gg  of  poly  [A]+  RNA  isolated  from  T  vaginalis  was  primed  with  oligo  dT  (22ng)  and 
made  up  to  a  final  volume  of  22.5  gl  with  diethylpyrocarbonate  (DEPQ  treated  water. 
The  tube  was  heated  at  65'C  for  10  minutes  to  make  the  RNA  single  stranded.  The  tube 
was  chilled  on  ice  and  spun  for  5  seconds  in  a  microfuge  to  collect  the  contents  at  the 
bottom  of  the  tube.  Reverse  transcriptase  buffer  was  added  to  a  final  Ix  concentration, 
also  DTT  (6  mM),  dNTPs  (0.3  mM)  and  RNase-in  were  added  The  tube  was  incubated 
at  42"C  for  2  minutes.  I  gl  (10  U)  Superscript  reverse  transcriptase  (Moloney,  Murine 
Leukaemia  Virus  (MMLV),  Life  Technologies)  was  added  and  the  tube  incubated  for  a 
further  30  minutes  at  42'C  to  allow  cDNA  synthesis  to  occur.  After  first  strand  cDNA 
synthesis  had  taken  place  480  gl  of  TE  pH  8.0  was  added  and  the  cDNA  heated  to  65"C 
for  10  minutes  to  denature  the  reverse  transcriptase. 
2.2.22  RNA  gels. 
1.4%  fonnaldehyde  agarose  gels  were  used  to  analyse  T  vaginalis  total  and  poly  [A]' 
RNA.  A  MOPS/  formaldehyde  buffer  system  was  used  to  run  the  RNA  samples  through 
the  gel  after  they  had  been  combined  with  formaldehyde  and  formamide  according  to 
Sambrook  et  al.,  (1989).  RNA  markers  (9.5  kb-0.24  kb,  Life  Technologies)  were  run  on 
the  gel  so  as  to  provide  an  estimation  of  the  size  of  the  T  vaginalis  RNA. 
2.2.23  Northern  blots  and  hybridisations. 
50 T  vaginalis  total  RNA  was  transferred  directly  to  Hybond  N  membrane  (Amersham), 
using  20x  SSC  as  the  transferrant  as  outlined  in  Sambrook  et  al.,  (1989).  RNA  transfer 
was  allowed  to  proceed  overnight.  Transfer  of  RNA  was  checked  by  staining  the  filter 
in  5%  methylene  blue  for  20  minutes  at  room  temperature  with  shaking  and  then 
destaining  with  20%  ethanol  until  the  background  of  the  filter  became  almost  white 
once  more,  destaining  was  completed  by  washing  with  2%  SDS.  If  ribosomal  RNA 
subunits  were  visible  upon  destaining,  as  well  as  the  RNA  size  markers,  then  this  was  an 
indication  that  successful  transfer  of  RNA  had  taken  place. 
2.2.24  Commonly  used  buffers,  reagents  and  media  in  molecular  biology. 
Buffers,  autoclavable  solutions  and  media  were  sterilised  using  the  following 
conditions:  120'C,  l5lbs  in-2  for  15  minutes. 
2.2.24.1  Commonly  used  buffers. 
SM  Buffer:  50  mM  Tris-HCI  (pH  7.5),  0.1  M  NaCl,  8  MM  MgS04,0-01%  (v/v)  gelatin 
in  distilled  water.  Autoclaved  and  stored  at  room  temperature. 
STE  buffer:  100  mM  NaCl,  20  mM  Tris-HCI  pH  7.5,10  mM  EDTA.  Stored  at  room 
temperature. 
TAE  (50x):  40  mM  Tris-acetate,  I  mM  EDTA  in  distilled  water.  Stored  at  room 
temperature. 
51 TBE  (10x):  0.9  M  Tris-HCI,  0.9  M  Boric  acid,  25  mM  EDTA  in  distilled  water.  Stored 
at  room  temperature. 
TE  buffer:  10  mM  Tris  pH  7.6  or  pH  8.0,1  mM  EDTA  in  distilled  water.  Autoclaved 
and  stored  at  room  temperature. 
2.2.24.2  Commonly  used  reagents. 
Agarose  gel  loading  buffer:  40%  (w/v)  sucrose,  0.1  M  EDTA,  0.5%  (w/v)  SDS,  0.5% 
bromophenol  blue.  Stored  at  room  temperature. 
Ampicillin:  100mg/ml  in  distilled  water,  filter  sterilised.  through  0.22  ýM  membrane 
(Millipore).  Stored  at  -201C. 
Denaturation  buffer:  1.5  M  NaCl,  0.5  M  NaOH  in  distilled  water.  Stored  at  room 
temperature. 
Denhardt's  solution  (50x):  1%  (w/v)  BSA,  1%  (w/v)  ficoll,  1%  (w/v)  polyvinyl 
pyrolidine  in  sterile  distilled  water. 
Ethidium  Bromide:  10  mg/ml  stock  in  distilled  water.  Final  working  concentration 
0.5  gg/ml.  Stored  at  room  temperature. 
IPTG:  0.5  M  stock  in  sterile  distilled  water.  Stored  at  -20T. 
52 Herring  sperm  DNA:  10  mg/ml  stock  in  sterile  distilled  water,  sheared  with  a 
hypodermic  needle  and  syringe  (19  gauge),  boiled  and  snap  frozen  at  -20'C. 
Kanamycin:  25  mg/ml  stock  in  distilled  water,  filter  sterilised  through  0.22  gM 
membrane  (Millipore).  Stored  at  -20'C. 
Magnesium  sulphate:  IM  and  10  mM  Magnesium  sulphate  in  distilled  water. 
Autoclaved  and  stored  at  room  temperature. 
Neutralisation  buffer:  1.5  M  NaCl,  0.5  M  Tris-HCI  pH  8.0  in  distilled  water.  Stored 
at  room  temperature. 
SDS:  10%  (w/v)  stock  solution  in  distilled  water.  Stored  at  room  temperature. 
SSC  (20x):  3M  NaCl,  0.3M  tri-sodium  citrate  pH  7.0  (using  NaOH)  in  distilled  water. 
Stored  at  room  temperature. 
Tetracycline:  12.5  mg/mI  in  100%  ethanol.  Stored  at  -20"C. 
2.2.24.3  Commonly  used  media. 
BBL  agar:  1%  (w/v)  trypticase  peptone,  0.5%  (w/v)  NaCl,  pH  7.2,1%  (w/v)  agar. 
Autoclaved  and  stored  at  room  temperature. 
53 BBLagarose:  1%(w/v)trypticasepeptone,  0.5`/ý(w/v)NaCl,  pH7.2,0.25ý/ýMgSO4 
7H209  0.65%  (w/v)  agarose  (Sigma  Type  I). 
Luria-Bertani  agar  (LB  agar):  As  LB  broth  with  0.8%  (w/v)  agar  (Difco). 
Autoclaved  and  stored  at  room  temperature. 
Luria-Bertani  broth  (LB  broth):  1%  (w/v)  bactotryptone  (Difco),  0.5%  (w/v)  yeast 
extract,  0.5%  (w/v)  NaCI  in  distilled  water.  The  broth  was  sterilised  by  autoclaving  and 
stored  at  room  temperature. 
SOB  medium:  2%  (w/v)  tryptone,  0.5%  (w/v)  yeast  extract,  0.05%  (w/v)  NaCl. 
Autoclaved  and  stored  at  room  temperature.  When  required  add 
MgS04  and 
M902  to  a 
final  concentration  of  10  mM  and  filter  sterilised  prior  to  use. 
SOC  medium:  As  SOB  medium,  plus  0.4%  (w/v)  final  concentration  glucose.  Filter 
sterilised  prior  to  use. 
YT  broth:  0.8%  (w/v)  bactotryptone,  0.5%  NaCl,  0.5%  yeast  extract.  Autoclaved  and 
stored  at  room  temperature. 
Suppliers  of  the  components  of  the  reagents,  buffers  and  media  used  in  this  study  were 
Sigma,  BDH,  ICN  Flow  and  Difco. 
54 2.3  Biochemical  Materials  and  Methods. 
23.1  Sodium  Dodecyl  Sulphate-PolyAcrylamide  Gel  Electrophoresis  (SDS-PAGE). 
T  vaginalis  native  and  recombinant  proteins  were  evaluated  using  discontinuous  SDS- 
PAGE  as  described  by  Laemmli,  1971.  Mini  (0.75  mm  thickness)  12%  (w/v) 
acrylamide  resolving  gels,  unless  indicated  otherwise,  were  cast,  loaded  and  run  using 
Bio-Rad  Mini-Protean  II  dual  slab  cell  (see  manufacturer's  protocol  for  instruction  on 
how  to  assemble,  cast  and  run  polyacrylamide  gels).  SDS  7  (Sigma),  Rainbow  markers 
(Amersham)  and  Biorad  PAGE  molecular  weight  markers  were  routinely  run  on 
polyacrylamide  gels  so  that  estimates  of  protein  molecular  weights  could  be  made. 
After  electrophoresis  was  complete,  gels  were  stained  for  20  minutes  to  2  hours  in 
Coomassie  Blue  stain  (0.1%  (w/v)  Coomassie  Blue  R250,7%  (v/v)  acetic  acid,  40% 
(v/v)  mcthanol)  and  thcn  dcstaincd  with  7%  (v/v)  acctic  acid  and  40%(v/v)  mcthanol 
until  the  background  of  the  gel  was  clear. 
2.3.2  Native  gel  clectrophoresis. 
Native  gels  were  cast,  loaded  and  run  as  for  SDS-PAGE  gels  except  that  SDS  was 
omitted  from  all  gel  buffers.  Also  reducing  agents,  such  as  P-mercaptoethanol,  were 
omitted  from  the  sample  buffer.  After  electrophoresis  the  gels  were  submerged  in  the 
relevant  enzyme  activity  stain.  Simply,  native  gels  containing  T  vaginalis  proteins  were 
placed  in  an  enzyme  assay  mixture  and  the  enzymatic  reaction  allowed  to  take  place  in 
situ. 
55 The  hornocysteine  catabolising  capabilities  of  T  vaginalis  was  investigated  using  native 
PAGE,  the  native  gel  was  placed  in  30  ml  of  enzyme  assay  mixture  containing:  3.3  mM 
homocysteine,  0.33  mM  lead  acetate,  28.4  mM  P-mercaptoethanol  in  0.1  M  sodium 
phosphate  buffer  pH  7.5  at  37C.  The  breakdown  of  homocysteine  by  T  vaginalis 
methionine  y-lyase  in  this  system  allows  the  detection  of  enzymatic  activities  by  a 
deposit  of  lead  sulphide  at  the  position  of  the  protein  responsible  for  the  homocysteine 
catabolism.  Hydrogen  sulphide,  one  of  the  products  of  the  breakdown  of  homocysteine, 
combines  with  the  lead  acetate  in  the  assay  to  fomi  lead  sulphide,  which  is  a  brown 
precipitate,  that  is  deposited  at  the  site  of  homocysteine  breakdown.  The  reaction  was 
stopped  by  replacing  the  assay  components  with  water. 
23.3  Western  blotting. 
2.3.3.1  Transfer  of  proteins  from  SDS-PAGE  gels  to  solid  supports. 
Proteins  from  SDS-PAGE  gels  were  transferred  to  a  solid  support  such  as  Hybond-ECL 
membrane  (Amersham)  essentially  as  described  by  Towbin  et  al.,  1979.  The  Bio-Rad 
mini  transblot  cell  was  used  for  the  transfer  of  proteins  to  solid  supports  in  accordance 
with  the  manufacturer's  instruction  booklet. 
After  transfer  of  proteins  to  the  solid  support,  the  membranes  to  which  the  protein  had 
been  blotted  would  sometimes  be  stained  in  Ponceau  S  stain  (2%  (w/v)  Ponceau  S,  30% 
(w/v)  trichloroacetic  acid  and  30%  (w/v)  sulphosalicyclic  acid,  10%  stock  diluted  to  ) 
which  enabled  one  to  establish  if  the  blotting  process  had  been  successful  and  localise 
tracks  of  protein  should  the  membrane  have  to  be  cut  prior  to  incubation  with  primary 
antibody.  Membranes  were  simply  placed  in  -20  ml  of  Ponceau  S  stain  for  15  minutes 
with  shaking  and  then  destained  with  5%  acetic  acid  until  the  background  of  the 
56 membrane  was  clear  once  more.  On  some  occasions  it  was  not  necessary  to  Ponceau 
stain  the  membrane  as  the  Rainbow  molecular  weight  markers  (Amersham)  were  clearly 
visible  if  the  blotting  process  has  been  successful. 
2.3.3.2  Blocking  binding  sites  for  immunoglobulins  in  the  solid  support. 
Once  the  blotting  process  had  taken  place,  the  sites  not  occupied  by  T  vaginalis  proteins 
or  other  proteins  in  question  are  blocked  so  as  to  prevent  non-specific  binding  of  the 
immunological  reagents  used  in  the  subsequent  steps  of  the  Western  blotting  process. 
The  blocking  reagent  used  in  all  Western  blots  described  in  this  study  was  5%  non-fat 
dried  milk  (Boots  own  brand),  10%  (v/v)  heat  inactivated  horse  serum  (Life 
Technologies)  in  Ix  Tris  Buffered  Saline  (TBS)  (20  mM  Tris,  137  mM  NaCl  pH  7.6). 
Membranes  were  placed  in  -20ml  of  blocker  and  incubated  at  4"C  overnight,  with 
shaking. 
23.3.3  Binding  of  the  primary  antibody  to  the  target  protein. 
After  the  membranes  were  incubated  overnight  in  blocker,  they  were  incubated  with  the 
primary  antibody  in  question.  Most  of  the  Western  blots  described  in  this  thesis 
involved  the  use  of  the  polyclonal  antisera  raised  against  recombinant  MGL  I  and 
MGL2,  there  were  also  some  results  of  Western  blots  in  which  antiserum  raised  to 
native  methionine  y-lyase  from  T  vaginalis  was  used.  The  incubation  of  the  membranes 
and  the  primary  antibodies  were  routinely  carried  out  small  heat  sealed  bags  that 
contained  5  ml  of  blocker  and  primary  antibody.  For  anti  rMGL  I  and  rMGL2  serum  a 
dilution  of  I  in  500  was  used  for  the  primary  antibody  incubation.  For  antiserum  raised 
against  native  methionine  y-lyase  from  T.  vaginalis  aI  in  50  dilution  was  used.  The 
57 membranes  and  primary  antibody  were  incubated  for  2  hours  at  4"C  with  shaking.  After 
incubation  with  primary  antibody,  the  membranes  were  washed  four  times  with  -200  ml 
of  TBST  (TB  S+0.1%  Tween  20)  for  IS  minutes  with  shaking. 
2.3.3.4  Binding  of  the  secondary  antibody  to  the  primary  antibody. 
Primary  antibody  incubations  involving  anti  rMGLI  and  rMGL2  sera,  used  horseradish 
pcroxidasc-conjugatcd  goat  anti-rabbit  IgG  secondary  antibody  (Scottish  Antibody 
Production  Unit,  SAPU)  at  a  dilution  of  I  in  2500  in  blocker.  Incubations  with  antisera 
to  native  methionine  y-lyase  from  T  vaginalis  used  alkaline  phosphatase  conjugated 
goat  anti  rabbit  antibody  (Stratagene)  at  a  dilution  of  1  in  3000.  Secondary  antibody 
incubations  were  carried  out  in  20  ml  of  blocker  for  I  hour  at  room  temperature  with 
shaking.  After  incubation  with  the  relevant  secondary  antibody,  the  filters  were  washed 
four  times  with  -200  ml  of  TBST  at  room  temperature  with  shaking. 
2.3.3.5  Development  of  Western  blots. 
For  blots  in  which  the  horseradish-peroxidase  conjugated  secondary  antibody  was  used 
(i.  e.,  those  blots  that  were  incubated  with  anti  rMGL  I  and  rMGL2  sera),  detection  of  the 
target  protein  and  primary  antibody  interactions  was  by  a  procedure  known  as  enhanced 
chemiluminescense  (ECL).  The  washed  membranes  were  incubated  in  the  components 
of  the  ECL  kit  (Amersham).  The  ECL  kit  consists  of  luminol  solutions  that  are  cleaved 
by  the  horseradish  peroxidase  which  emits  light,  at  the  location  of  the  antigen,  primary 
and  secondary  antibody  interactions,  which  is  detected  by  a  fogging  of  autoradiographic 
film.  Various  exposures  to  autoradiographic  film  in  a  cassette  holder  were  carried  out, 
and  the  exposed  film  was  automatically  developed  using  a  Kodak  Xomat  film  processor. 
58 For  blots  that  were  incubated  with  the  antisera,  raised  against  native  methionine  y-lyase 
and  the  alkaline  phosphatase-conjugated  secondary  antibody,  the  components  of  the 
picoBlue  immunoscreening  kit  (Stratagene)  were  used  to  detect  target  protein  and 
primary  antibody  interactions,  according  to  the  manufacturer's  instructions. 
23.4  Metabolic  labelling  of  T.  vaginalis  proteins. 
Two  cultures  of  T  vaginalis  were  set  up  as  in  2.1.1.2,  however  one  culture  was  grown 
in  the  presence  of  10  tiM  DL-propargylglycine.  Two  cell  pellets  of  Ix  10  7 
cells  were 
harvested  and  resuspended  in  I  ml  minimal  Eagles  medium  (MEM)  with  Earles  salts 
without  methionine  (Life  Technologies),  supplemented  with  10%(v/v)  heat  inactivated 
dialysed  foetal  bovine  serum  (glutamine  was  added  back  to  the  minimal  Eagles  medium 
to  a  final  concentration  of  lx  glutamine,  as  the  original  medium  does  not  contain 
glutamine).  The  resuspended  cells  were  then  placed  in  20  ml  of  the  above  medium 
which  contained  125  IiCi  Expre  35  S  35  S  protein  labelling  mix  (the  composition  of  which 
was  72%  L-[  35  S]  mcthioninc  and  18%  L-[  35  S]  cystcinc)  (NEN,  Dupont).  The  viability 
of  the  cells  was  checked  by  microscopic  observation  as  soon  as  they  were  placed  in  the 
radioactive  culture  medium.  Incubation  of  the  cells  was  for  six  hours  at  37  0  C.  Checks 
on  viability  of  the  cells  were  made  every  two  hours. 
After  incubation  the  cells  were  pelleted  by  centrifugation  at  2300  xg  and  washed  twice 
with  0.25  M  sucrose.  Resuspended  aliquots  of  cells  were  centrifuged  at  2300  x  g,  the 
supernatants  removed  and  the  radioactive  cell  pellets  stored  at  70*C  until  required. 
59 2.3.5  Preparation  of  radioactive  T.  vaginalis  cell  extracts. 
Radioactive  T  vaginalis  cell  pellets  were  resuspended  in  50mM  MOPS  (3-[N- 
Morpholino]propane  sulphonic  acid)  pH  7.2,100  mM  NaCl,  0.25%  (v/v)  Triton  XIOO, 
100  pg/ml  leupeptin,  50  pg/ml  PMSF  and  I  mM  1,10,  phenanthroline  (Lysis  solution 
with  inhibitors,  LSI)  and  incubated  on  ice  for  10  minutes.  The  lysed  cells  were 
centrifuged  at  13  000  xg  for  15  minutes  at  40C.  The  resulting  supernatants  were 
transferred  to  fresh  tubes  and  the  pellets  resuspended  in  0.5ml  LSI. 
Incorporation  of  35S  methionine  into  the  newly  synthesised  proteins  of  T  vaginalis  was 
evaluated  using  SDS-PAGE  as  described  in  section  2.2.1.  After  electrophoresis  one 
gel  was  stained  with  Coomassie  R250  as  described  in  section  2.2.1.  and  the  other  gel 
was  fixed  with  10%  acetic  acid  for  30  minutes,  submerged  in  Entensify  Part  A, 
precipitating  reagent  (NEN-Dupont)  for  30  minutes  and  finally  submerged  in  Entensify 
Part  B,  aqueous  fluor  solution  (NEN-Dupont)  for  30  minutes.  Both  gels  were  placed 
onto  Whatman  3M  chromatography  paper,  covered  in  clingfilm  and  dried  for 
approximately  30  minutes  (Bio-Rad  gel  drier).  Gels  were  then  placed  in  an 
autoradiography  cassette,  overlaid  with  film  and  exposed  for  approximately  17  hours  at 
room  temperature.  The  fluorograph  was  developed  automatically  by  a  Kodak  Xomat 
film  processor. 
2.3.6  Immunoprecipitation  of  T.  vaginalis  proteins  with  various  antisera. 
Protein-A  sepharose  beads  were  washed  extensively  with  50m  M  MOPS  pH  7.2,100 
mM  NaCl,  0.25%  (v/v)Triton  XIOO  (lysis  solution,  LS).  Immunoprecipitations  were 
carried  out  using  2  ml  select  columns  (CP  Labs)  as  the  protein-A  beads  could  be 
retained  in  the  column  as  they  were  being  washed. 
60 Polyclonal  antisera  (I.  pre-immune  anti-methionine  y-lyase,  2.  immune  anti-methionine 
y-lyase  and  3.  anti  VSG  of  Trypanosoma  brucei)  were  added  to  protein-A  sepharose 
beads  and  incubated  at  40C  with  rocking  for  I  hour.  The  beads  were  washed  with  two 
column  volumes  of  LS.  Bovine  serum  albumin  and  LSI  was  added  to  the  beads  and 
incubated  at  4"C  for  2  hours  with  rocking. 
35  S  labelled  cell  extract  supematants  of  T  vaginalis  were  added  directly  to  the  beads  and 
incubated  overnight  at  40C  on  a  roller.  After  overnight  incubation  the  beads  were 
washed  extensively  with  five  column  volumes  of  LS. 
The  beads  from  each  immunoprecipitation  were  boiled  with  2x  reducing  sample  buffer 
(0.5  M  Tris-HCI,  pH  6.8,10%  (v/v)  glycerol,  10%  (w/v)  SDS,  5%  (v/v)  0- 
mercaptoethanol  and  0.05%  bromophenol  blue)  to  release  immunoprecipitated  proteins. 
Analysis  of  immunoprecipitated  proteins  was  made  by  SDS-PAGE  and  fluorography  as 
outlined  in  section  2.3.1  and  2.3.5. 
2.3.7  Enzyme  assays. 
All  assays  were  carried  out  at  37C  in  a  final  volume  of  I  ml.  To  confirm  the  specificity 
of  the  reaction  control  assays  were  carried  out  lacking  one  or  more  of  the  assay 
components.  Experiments  were  also  conducted  to  ensure  a  linear  relationship  between 
reaction  rate  and  sample  size  over  the  normal  working  range. 
61 2.3.7.1  Methionine  y-lyase  assays  and  other  assays  which  determined  a-keto  acid 
production. 
(x-keto  acid  production  from  a  variety  of  substrates,  including  methionine  was 
determined  for  rMGLI  and  rMGL2.  The  production  of  a-ketobutyrate  was  determined 
as  described  by  Soda,  (1968),  but  with  the  following  exceptions.  Methionine 
breakdown  by  the  two  recombinant  proteins  was  investigated  by  using  saturating 
amounts  of  substrate  at  a  concentration  of  25  mM.  Homocysteine  breakdown  was  also 
measured  by  using  saturating  levels  of  homocysteine  (30  mM  for  rMGLI  and  40  mM 
for  rMGL2).  Cystathionine  breakdown  by  the  two  recombinant  proteins  used  a 
substrate  concentration  of  5  mM.  Also,  the  colour  development  part  of  the  assay  with 
methylbenzoylthiolhydrazone  (MBTH)  used  half  the  volume  of  reagents,  compared  to 
Soda,  (1968).  The  prmciple  of  the  assay  is  that  the  a-keto  acids  combine  with  the 
MBTH  reagent  to  form  azines  that  absorb  maximally  at  320nm 
Specific  activities  for  the  breakdown  of  methionine  and  other  substrates  by  rMGL  I  and 
rMGL2  were  determined  from  a  standard  curve  of  (x-ketobutyrate.  The  standard  curve 
for  cc-ketobutyrate  that  was  detennined  using  the  MBTH  reagent  is  shown  in  Figure 
2.3.1. 
The  breakdown  of  cysteine  and  O-acetyl  L-serine  by  the  two  recombinant  proteins  was 
determined  by  assaying  for  the  production  of  pyruvate,  using  LDH  as  a  coupling  enzyme 
with  NADH,  as  described  (Bergmeyer,  1965)  with  substrate  concentrations  at  10  mM 
for  cysteine  and  O-acetyl  L-serine.  All  assays  were  carried  out  using  0.1  M  imidazole 
buffer  pH  6.5  and  were  conducted  at  37T. 
62 2.3.7.2  Homocysteine  desulphurase  assays. 
The  breakdown  of  hornocysteine  by  T  vaginalis  crude  homogenates,  soluble  fraction 
and  rMGLI  and  rMGL2  was  determined  as  described  by  Thong  and  Coombs,  (1985). 
The  assay  works  on  the  principle  that  the  hydrogen  sulphide  produced  from  the 
breakdown  of  homocysteine  combines  with  the  lead  acetate  in  the  assay  to  produce  lead 
sulphide,  which  is  a  brown  precipitate,  the  production  of  which  can  be  monitored  at  360 
run.  -  For  rMGLI  and  rMGL2  hornocysteine  concentrations  were  30  mM  and  40  mM. 
2.3.7.2.1  Microtitre  plate  homocysteine  desulphurase  assays. 
As  a  matter  of  convenience  a  microtitre  plate  assay  for  the  catabolism  of  homocysteine 
was  used  for  assaying  column  fractions  that  were  produced  during  native  methionine 
Iyase  purifications  from  T  vaginalis  (Lockwood  and  Coombs,  1991).  The  reaction 
mixture  contained  a  final  concentration  of  2  mM  homocysteine,  I  mM  lead  acetate,  0.1 
M  potassium  phosphate  buffer  pH  7.5  and  50  VI  of  fraction  in  a  final  volume  of  150  [d. 
Incubation  was  at  3  70C,  and  the  A34o  nm.  after  10  minutes  was  measured  with  a  Titertek 
Multistage  MCC  plate  reader 
23.7.3  Activated  serine  sulphydrase  assays. 
The  activity  of  activated  serine  sulphydrase  in  T  vaginalis  crude  homogenates  and 
soluble  fractions  were  determined  as  described  by  Thong  and  Coombs,  1985b. 
2.3.8  Kinetic  calculations. 
63 Kinetic  calculations,  including  the  detennination.  of  Michaelis  constants  (Km)  were 
performed  using  the  computer  program  'Grafit'  (Leatherbarrow,  1992). 
2.3.9  Protein  estimations. 
Protein  concentrations  were  determined  using  the  Pierce  BCA  protein  assay  kit 
(microtitre  protocol)  with  bovine  serum  albumin  as  standard. 
23.10  Native  methionine  y-lyase  purification  from  T.  vaginalis. 
The  purification  of  methionine  y-lyase  from  T  vaginalis  was  carried  out  as  described  by 
Lockwood  and  Coombs,  199  1.  The  purification  protocol  is  briefly  sunimarised  below. 
23.10.1  Anion  exchange  chromatography 
The  non-sedimentable  fraction  of  aT  vaginalis  homogenate  as  produced  in  2.1.5  was 
clarified  through  a  0.22  pm  pore  GS  membrane  (Millipore).  Samples  (0.5ml)  were 
injected  onto  a  Mono  Q  HR5/5  (Pharmacia)  anion  exchange  column,  pre-equilibrated 
with  20  mM  potassium  phosphate  buffer  pH7.5,  containing  15  pM  P-mercaptoethanol, 
I  mM  ethylenediaminetetra  acetic  acid  (EDTA)  and  20  pM  pyridoxal  Y-phosphate 
(PLP).  Protein  was  eluted  with  a  0-350  mM  NaCl  gradient  in  the  same  buffer. 
Fractions  containing  the  major  peak  of  methionine  y-lyase  activity  were  pooled  and 
concentrated  using  centricon  microconcentrators  (Amicon)  with  a  molecular  weight 
cut-off  of  30  kDa. 
2.3.10.3  Hydrophobic  interaction  chromatography. 
64 Solid  ammonium  sulphate  was  added  to  the  concentrated  fractions  to  give  a  final  - 
concentration  of  2.4  M,  the  sample  was  filtered  to  remove  any  precipitated  proteins. 
Filtered  sarnple  (I  ml)  was  injected  onto  an  Alkyl  Superose  HR5/5  (Phartnacia) 
hydrophobic  interaction  chromatography  column,  equilibrated  with  the  same  buffer  as 
used  for  anion  exchange  chromatography.  Bound  protein  was  eluted  by  linearly 
decreasing  the  ammonium  sulphate  concentration. 
2.3.10.4  Gel  filtration  chromatography. 
Fractions  containing  methionine  y-lyase  eluted  from  the  Alkyl  Superose  column  were 
pooled  and  injected  onto  a  Superose  12  FIR  10/30  gel  filtration  column  (Pharmacia), 
equilibrated  with  0.2  M  potassium  phosphate  buffer  pH  7.5  with  the  same  additions  as 
in  previous  steps.  Protein  was  eluted  with  the  same  buffer. 
2.3.11  Production  of  rMGLI  and  rMGL2. 
Briefly,  50ml  of  an  overnight  culture  of  E  coli  containing  pQMGLI  or  pQMGL2  were 
inoculated  into  400ml  of  LB  and  100  pg/ml  ampicillin  and  25  pg/ml  kanamycin  and 
grown  until  they  reached  an  OD600mn  of  0.6-0.8.  The  culture  was  then  induced  with  2 
mM  and  0.2  mM  IPTG  respectively  and  grown  for  a  further  2.25  hours  before 
harvesting,  as  described  in  2.2.1.4.  The  E.  coll  were  resuspended  in  5mls  of  sonication 
buffer  (50  mM  Na-phosphate  pH  8.0,300  mM  NaCI)  and  pyridoxal  5'  phosphate  added 
to  a  final  concentration  of  20  gM. 
The  cells  were  lysed  by  10  rounds  of  sonication  (I  round  =  10  second  duration,  pulse 
on,  I  second,  pulse  off,  I  second)  (Jencons  sonicator)  and  the  soluble  fraction  was 
recovered  by  centrifugation  at  10,000  xg  for  30  min  at  4"C.  Soluble  fraction  was 
65 loaded  on  to  a  4ml  Ni2+-NTA  resin  column  (Qiagen)  which  had  been  pre-equilibrated 
with  sonication  buffer  overnight.  -  After  sample  application  the  column  was  washed  for 
60  minutes  with  30  ml  of  sonication  buffer  and  60  minutes  with  30  ml  of  wash  buffer 
(50  mM  Na-phosphate  pH  6.0,300  mM  NaCl,  10%  glycerol).  Recombinant  protein  was 
eluted  from  the  column  by  an  FPLC  generated  linear  gradient  of  0-5OOmM  imidazole  in 
wash  buffer  over  100  minutes  (Waters  LC  Chromatography  System). 
Fractions  containing  recombinant  rMGLI  or  rMGL2  were  identified  by  OD280  and  by 
Coomassie  Blue-R250  staining  of  the  fractions  following  SDS-PAGE  on  a  12%  gel  as 
described  in  2.3.1.  Recombinant  protein  eluted  from  the  Ni2+-NTA  resin  column  were 
combined  with  Laemmli  sample  buffer  but  only  heated  to  37"C,  due  to  the  presence  of 
imidazole.  Peak  fractions  were  pooled  and  dialysed.  against  I  litre  of  dialysis  buffer 
(100  mM  Na-phosphate  buffer  pH6.5,3  00  mM  NaCl,  20  [tM  pyridoxal  5'  phosphate 
and  15  pM  DTT)  for  18h  at  4"C.  Dialysed.  rMGL  I  or  rMGL2  was  combined  1:  1  with 
enzyme  stabilisation  solution  (80%  glycerol,  300  mM  NaCl,  20  pM  pyridoxal  5' 
phosphate,  15  ItM  DTT  in  100  mM  Na-phosphate  buffer  pH6.5)  and  stored  at  -20*C. 
2.3.12  Gel  filtration  chromatography  of  rMGL1  and  rMGL2. 
A  Superose  12  HR  10/30  column  (Pharmacia)  was  equilibrated  with  50mM  Na- 
phosphate  buffer  pH6.5,  I  OOmM  NaCI  and  0.05%  NaN3  overnight.  The  column  was 
calibrated  with  standards  of  known  molecular  mass  (ferritin,  450,000  Da;  catalase, 
240,000  Da;  aldolase,  158,000  Da;  bovine  serum  albumin,  68,000  Da;  ovalbumin, 
45,000  Da;  cytochrome  c,  12,400  Da,  Boeringher  Mannheim)  and  used  for  the 
estimation  of  the  native  molecular  mass  of  rMGLI  and  rMGL2. 
66 2.3.13  Immunisation  regime  for  polyclonal  antiscra  production. 
The  production  of  polyclonal  antisera  to  rMGLI  and  rMGL2  was  carried  out  as 
described  in  Harlow  and  Lane,  1988.  Briefly,  200  pg/mI  rMGLI  and  rMGL2  in 
Freund's  complete  adjuvant  was  injected  into  female  New  Zealand  White  rabbits.  A 
secondary  boost  of  100  Vg/ml  rMGL  I  and  rMGL2  in  Freund's  Incomplete  adjuvant  was 
injected  into  the  rabbits  one  month  later.  A  tertiary  boost  with  the  same  components  as 
the  secondary  boost  was  given  another  month  later.  Sera  was  taken  from  the  rabbits 
between  the  2*  and  3"  boosts  and  tested  against  the  antigen  and  T  vaginalis  lysates. 
Ten  days  after  the  P  boost,  the  rabbits  were  exsanguinated,  the  serum  separated  from 
the  blood  cells  and  aliquoted  and  stored  at  -700C. 
2.3.14  Commonly  used  buffers  and  reagents  in  biochemistry. 
Details  of  many  of  the  common  buffers  and  reagents  used  in  biochemistry  are  given  in 
the  reference  source,  Data  for  Biochemical  research,  P  edition,  Dawson  et  al.,  1989, 
Oxford  University  Press.  Unless  otherwise  stated  constituents  of  biochemical  buffers 
were  Analar  grade.  The  main  suppliers  of  chemicals  and  buffer  components  used  in  this 
study  were,  Sigma,  BDH  and  ICN  Flow. 
2.4  Immunofluorescence  of  intact  trichomonads  using  anti  rMGL1  and  rMGL2 
sera. 
T  vaginalis,  T  foetus  and  T  augusta  were  harvested  and  washed  as  described  2.1.1.4. 
Parasite  pellets  (-2.5  X  107)  were  fixed  in  2%  parafonnaldehyde  in  0.1  M  phosphate 
67 buffer  pH  7.2  and  were  smeared  onto  clean  glass  slides  and  air  dried..  The  smears 
incubated  in  phosphate  buffered  saline  (PBS)(pH  7.2)  with  0.2%  Tween  20  and  either 
3%  bovine  serum  albumen  (BSA)  or  10%  foetal  calf  serum  for  15  minutes.  Slides  were 
incubated  with  primary  anti-rMGL  1  or  anti-rMGL2  sera  diluted  to  1:  100  with 
PBS/BSA,  for  I  hour  at  room  temperature.  They  were  then  washed  with  3  changes  of 
PBS/O.  I%  BSA  for  10  min  [each]  and  incubated  with  secondary  donkey  anti-rabbit 
fluorescein  labelled  antibody  (Scottish  Antibody  Production  Unit)  at  a  dilution  of  1:  100 
with  PBS/BSA  plus  lOgg  ml-I  4',  -6-diamidino-2-phenylindole  (DAPI)  (Sigma)  as 
counter  stain,  for  one  hour.  Finally,  smears  were  washed  thoroughly  with  PB  S/O.  I% 
BSA.  Control  slides  were  exposed  to  PBS/BSA  containing  no  rabbit  immune  serum 
during  the  first  incubation,  or  were  incubated  in  pre-immune  rabbit  serum.  Slides  were 
mounted  in  10%  PBS  in  glycerol  with  25mg  ml-I  1'4-diazabicyclo-[2.2.2]  octane 
(DABCO)  antifadant  and  examined  using  a  Zeiss  Axioskop  compound  microscope  with 
phase  contrast  and  ultraviolet  (UV)  epifluorescence  through  fluorescein  and  DAPI  filter 
sets. 
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Figure  2.3.1  Standard  curve  for 
cc-ketobutyrate  using  MBTH  reagent. 
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0.0  5.0  10.0  15.0  20.0  25.0 Oligonucleotide  name  Oligonucleotide  sequence 
Cyst  51 
5'-GCAAGCTTGTITGGATTGAGACICCIACGAA-3' 
Cyst  31  5'-GCCTCGAGCCGTTIATGTACTTIGTAGC-3' 
AM9501 
5'-CGCCATGGCTCACGAGAGAATGAC-31 
AM9502 
5'-GCAGATCTTAAAAGAGCGTCAAGGCCC-3' 
AM9503 
5'-CGAGACACCAGCCAACCCAACACTC-31 
AM9504 
5'-ATCGGAGATTAAGTGATCTCCGGCC-3' 
AM9505 
5'-CTGGCATGGGTGCTATTGCTGCTTC-3' 
AM9506 
5'-GCAGCAATAGCACCCATGCCAGAAG-3' 
AM9507 
5'-GAAGCAGATGAAGATGTTCGGCTC-31 
AM9ý08 
5'-AACAACGTGGGAGGTGTCAAGGAC-3' 
AM9509 
5'-GCAATGGCACCCATGCCAGAAGATG-3' 
Table  2.1  Oligonucleotide  sequences  used  for  gene  specific  sequencing  and  cloning. 
70 CHAPTER  3.  EVALUATION  OFT.  VA  GINALIS  METHIONINE  -f- 
LYASE  POLYCLONAL  ANTIBODY  AND  PURIFICATION  OF 
NATIVE  METHIONINE  y-LYASE  FROM  T.  VAGINALIS. 
3.1  Introduction. 
The  work  described  in  this  chapter  is  considered  in  two  separate,  but  related  sections. 
As  has  already  been  outlined  in  the  aims  of  this  project,  it  was  a  priority  that  the  gene 
for  methionine  y-lyase  from  T  vaginalis  be  isolated  and  characterised.  The  results  of 
this  chapter  outline  the  various  problems  that  were  encountered  during  the  initial 
period  of  this  project  with  regards  to  polyclonal  antiserum  that  had  been  raised  against 
purified  methionine  y-lyase  and  the  purification  of  native  methionine  y-lyase  from  the 
parasite. 
3.2  Results. 
I  started  working  on  methionine  y-lyase  from  T  vaginalis  with  a  view  to  initiating  a 
molecular  characterisation  of  this  interesting  enzyme.  The  tools  available  to  me  to 
start  this  work  were:  aT  vaginalis  XZAPII  cDNA  expression  library,  some 
polyclonal  antiserum  which  had  been  raised  against  purified  methionine  y-lyase 
(Lockwood  and  Coombs,  199  1)  and  a  published  protocol  for  the  purification  of  the 
enzyme  from  T  vaginalis  (Lockwood  and  Coombs,  199  1).  A  starting  point  for  the 
isolation  of  the  gene  for  methionine  y-lyase  from  T  vaginalis  was  an  evaluation  of  the 
polyclonal  antiserum  that  had  been  raised  against  purified  enzyme  (Lockwood  and 
Coombs,  199  1).  1  felt  that  this  was  a  sensible  option  as  I  had  not  been  involved  in  the 
71 purification  of  the  enzyme  that  had  been  used  to  create  the  antiserum,  also  I  wanted  to 
familiarise  myself  with  techniques  that  I  would  be  using  throughout  the  course  of  my 
studies. 
3.2.1  Western  blot  analysis  of  T.  vaginalis  soluble  proteins  using  anti  serum 
raised  against  T.  vaginalis  methionine  y-lyase. 
Firstly,  I  used  the  polyclonal  antisera.  that  had  been  raised  to  methionine  y-lyase  from 
T  vaginalis  for  Western  blot  analysis  with  the  soluble  fraction  of  parasite  lysates. 
Figure  3.1  shows  the  results  of  Western  blot  analysis  of  T  vaginalis  soluble  proteins 
with  the  polyclonal  antiserum  raised  against  purified  methioniney-lyase. 
As  can  be  seen  from  Figure  3.1,  there  were  two  T  vaginalis  proteins  that  were 
predominately  recognised,  by  the  antiserum.  against  purified  methionine  y-lyase.  The 
major  protein  that  was  recognised  was  -66  kDa,  with  a  second  protein  of  -43  kDa 
also  being  recognised  by  the  antiserum.  It  must  be  mentioned  that  there  were  several 
other,  more  faintly  staining  bands,  being  recognised  by  the  antiserum.  that  could  not  be 
reproduced  in  this  figure  because  of  their  faintness.  The  pre-immune  serum  that  was 
available  from  the  rabbit  into  which  the  pure  methionine  y-lyase  was  injected,  was  of 
very  poor  quality,  (ie.  the  serum  had  been  freeze  dried  and  it  proved  difficult  to 
reconstitute  the  Iyophilised  serum)  but  at  I  in  50  dilution  for  Western  blots  the  pre- 
immune  serum  did  not  recognise  any  T  vaginalis  proteins. 
The  result  obtained  for  the  T  vaginalis  soluble  proteins  and  the  antiserum  raised 
against  methionine  y-lyase  gave  some  cause  for  concern.  The  subunit  size  of 
72 methionine  y-lyase  from  T  vaginalis  had  been  calculated  as  being  43  kDa,  so  it  was 
expected  that  a  band  of  43  kDa  would  be  recognised  by  the  methionine  y-lyase  in  T 
vaginalis  lysates.  As  for  the  band  at  66kDa  and  the  various  other  faintly  staining 
bands  recognised  by  the  antibody,  it  seemed  probable  that  they  were  contaminants  of 
the  supposedly  pure  methionine  y-lyase  that  was  injected  into  the  rabbits. 
3.2.2  Primary  screen  of  the  T.  vaginalis  cDNA  expression  library  with  the  T. 
vaginalis  methionine  y-lyase. 
Even  though  the  antiserum  against  methionine  y-lyase  was  recognising  several  T 
vaginalis  proteins  it  was  still  used  to  conduct  a  primary  screen  of  the  cDNA 
expression  library,  as  it  was  expected  that  one  of  the  proteins  that  the  antibody  was 
recognising  was  methionine  y-lyase  from  T  vaginalis.  However,  the  primary  screen 
of  the  library  with  the  antibody  failed  to  detect  any  reactive  bacteriophage  plaques. 
This  result  of  the  library  screen  was  disappointing  but  several  options  were  still 
available  to  enable  the  cloning  and  characterisation  of  the  methionine  y-lyase  gene 
from  T  vaginalis. 
The  first  option  was  to  evaluate  further  the  usefulness  of  the  polyclonal  antiserum  that 
had  been  raised  against  methionine  y-lyase  from  T  vaginalis.  It  was  decided  that 
immunoprecipitation  studies  would  be  carried  out  using  the  antiserum  that  had  been 
raised  against  the  trichomonal  enzyme.  Immunoprecipitation  is  a  sensitive  procedure 
which  allows  a  qualitative  analysis  of  proteins  that  are  recognised  by  the  antisera  in 
question.  The  aim  of  this  exPeriment  was  to  characterise  further  the  T  vaginalis 
proteins  that  were  being  recognised  by  the  methionine  y-lyase  antiserum.  To  perform 
73 Immunoprecipitations;  newly  synthesised  polypeptides  of  the  organism  in  question 
have  to  be  labelled  in  order  that  they  can  be  detected  after  the  immunoprecipitation 
has  taken  place.  Detection  of  the  T  vaginalis  proteins  after  inimunoprecipitation 
would  be  by  fluorography,  as  T  vaginalis  proteins  were  labelled  with  S35-methionine. 
3.2.4  Metabolic  labelling  of  T.  vaginalis  proteins. 
Metabolic  labelling  studies  were  therefore  undertaken  for  T  vaginalis  based  on  a 
system  used  for  Leishmania  mexicana  (see  Chapter  2  for  details  of  this  experiment). 
Figure  3.2  shows  the  result  of  a  metabolic  labelling  experiment  with  T  vaginalis.  As 
can  be  seen  from  Figure  3.2  the  labelling  of  newly  synthesised  proteins  in  T  vaginalis 
was  successful.  There  has  been  a  good  level  of  incorporation  of  the  radioactive 
methionine  in  to  all  proteins  present  in  the  supernatant  (lane  1)  and  pellet  fractions  of 
T  vaginalis  (lane  2). 
When  this  experiment  was  being  set  up,  the  high  rate  with  which  methionine  is 
metabolised  by  T  vaginalis  (Thong  and  Coombs,  1985a  and  b  and  Thong  et  aL,  1987) 
was  taken  into  consideration.  It  was  thought  that  it  may  have  been  possible  that  the 
radioactive  methionine  and  cysteine  may  have  been  lost  through  volatile  thiol 
production  as  a  result  of  their  catabolism  by  methionine  y-lyase  and  serine 
sulphydrase,  respectively.  Therefore,  metabolic  labelling  experiments  were  set  up  in 
the  presence  of  propargy1glycine,  a  known  inhibitor  of  the  enzymes  mentioned  above. 
Lanes  3  and  4  are  the  labelled  T  vaginalis  proteins  that  were  labelled  in  the  presence 
of  this  inhibitor.  As  can  be  seen  from  these  lanes  in  comparison  to  lanes  I  and  2  in 
which  the  inhibitor  was  absent,  there  appears  to  be  no  qualitative  difference  in  the  T 
vaginalis  proteins  that  have  been  labelled.  The  metabolic  labelling  experiment  did, 
74 however,  reveal  that  the  system  used  for  labelling  the  T  vaginalis  proteins  would  be 
suitable  for  detection  of  immunoprecipitated  proteins. 
3.2.5  Immunoprecipitation  of  T.  vaginalis  labelled  proteins  using  methionine  y- 
Iyase  antiserum. 
Immunoprecipitation  experiments  were  carried  out  using  the  metabolically  labelled 
proteins  of  T  vaginalis  and  three  different  sera.  The  results  of  this  experiment  are 
shown  in  Figure  3.2b.  Lane  I  shows  the  T  vaginalis  proteins  immunoprecipitated 
with  pre-immune  serum,  lane  2,  proteins  immunoprecipitated  with  immune  serum  and 
lane  3,  proteins  immunoprecipitated  with  Trypanosoma  bruce!  anti-VSG  sera.  As  can 
be  seen  from  lanes  I  and  2,  there  are  many  S35_labelled  T  vaginalis  proteins 
immunoprccipitatcd  by  both  the  prc-immune  and  immunc  scra.  Thcrc  appcars  to  bc 
no  difference  in  the  proteins  recognised  by  the  pre  immune  and  immune  sera.  This 
experiment,  I  feel,  confirms  quite  clearly  that  the  antibodies  raised  against  'purified' 
methionine  7-lyase  were  not  able  to  recognise  a  specific  protein  of  43  kDa,  which 
hopefully  would  have  been  the  methionine  y-lyase  of  T  vaginalis.  Instead  numerous 
proteins  are  immunoprecipitate  by  the  antibody,  which  confinns  earlier  fears  that  the 
methionine  y-lyase  used  as  antigen  in  the  immunisation  experiments  was  not  purified 
to  homogeneity,  as  was  thought.  There  was  no  recognition  of  T  vaginalis  proteins 
with  the  T  brucei  anti-VSG  serum. 
As  the  antibodies  raised  to  purified  T  vaginalis  methionine  y-lyase  were  in  no  way 
specific  for  the  protein  in  question,  it  was  decided  that  more  methionine  y-lyase  would 
be  purified  by  an  established  procedure  that  had  been  published  (Lockwood  and 
75 Coombs  1991).  Purified  methionine  y-lyase  would  provide  material  to  which  new 
pplyclonal.  antibodies  could  be  raised  and  it  would  also  allow  N  terminal  and/or 
internal  amino  acid  sequence  of  the  enzyme  to  be  determined,  which  would  provide 
the  basis  for  the  design  of  oligonucleotide  probes  that  could  be  used  alternatively  to 
screen  the  T  vaginalis  cDNA  library.  The  purification  of  methionine  y-lyase  from  T 
vaginalis  was  therefore  undertaken  according  to  the  procedures  of  Lockwood  and 
Coombs,  1991). 
3.2.6  Purification  of  native  methionine  y-lyase  from  T.  vaginalis. 
3.2.6.1  Anion  exchange  chromatography  of  T.  vaginalis  soluble  proteins,  the  first 
stage  of  the  native  methionine  y-lyase  purification  from  T.  vaginalis. 
Anion  exchange  chromatography  was  carried  out  exactly  as  described  in  Lockwood 
and  Coombs  (1991).  Figure  3.3  shows  a  representative  A280nm  profile  obtained  from 
a  Mono  Q  anion  exchange  chromatography  column  (Pharmacia),  when  soluble  T 
vaginalis  proteins  were  applied.  As  can  be  seen  from  Figure  3.3,  there  are  two  peaks 
of  homocysteine  desulphurase  activity  cluted  from  the  column  due  to  the  action  of  a 
linearly  increasing  gradient  of  NaCl  to  350  mM.  The  purification  of  methionine 
Iyase  was  monitored  by  homocysteine  breakdown  as  this  was  more  convenient  and  it 
had  been  shown  previously  that  methionine  y-lyase  was  responsible  for  the  breakdown 
of  homocysteine  in  T  vaginalis  (Lockwood  and  Coombs,  199  1).  The  major  peak  of 
homocysteine  desulphurase  activity  was  eluted  at  a  lower  salt  concentration  than  the 
second.  For  a  typical  purification  run  of  methionine  y-lyase,  the  Mono  Q  column  run 
was  repeated  four  times  with  I  ml  of  soluble  T  vaginalis  proteins  being  applied  to  the 
76 column.  The  fractions  of  the  major  peak  of  homocysteine  desulphurase  activity  from 
each  Mono  Q  run  were  pooled  (-12mls)  and  subsequently  concentrated  to  I  ml  using 
Centricon  30  concentrators  (Amicon).  The  anion  exchange  chromatography  step  of 
the  methionine  y-lyase  purification  was  very  consistent  in  the  A280  run  profiles  and 
separation  of  homocysteine  desulphurase  activities  that  it  produced  and  was  in 
agreement  with  the  results  of  this  column  step  as  outlined  in  Lockwood  and  Coombs 
(1991). 
3.2.6.2  Hydrophobic  interaction  chromatography  of  Mono  Q  eluant. 
Hydrophobic  interaction  chromatography  of  the  concentrated  post  Mono  Q  fractions 
was  carried  out  using  an  Alkyl  Superose  column  (Pharmacia)  according  to  the  method 
of  Lockwood  and  Coombs  (1991).  The  post  Mono  Q  fractions  were  cut  with  solid 
ammonium  sulphate  and  unprecipitated  proteins  applied  to  the  column.  Bound 
proteins  were  eluted  by  a  linearly  decreasing  gradient  of  ammonium  sulphate.  Figure 
3.4  shows  a  typical  A280  nm  trace  obtained  from  a  hydrophobic  interaction  column 
chromatography  run.  As  can  be  seen  from  Figure  3.4  there  was  hardly  any  protein 
eluted  from  the  column  and  there  were  three  main  peaks  of  homocysteine 
desulphurase  activity  and  not  one  as  reported  by  Lockwood  and  Coombs  (199  1). 
3.2.6.3  Gel  filtration  of  alkyl  superose  eluant. 
Peak  fractions  containing  homocysteine  desulphurase  activity  were  concentrated  using 
Centricon  30  concentrators  (Amicon)  prior  to  application  to  a  Superose  12  gel 
filtration  column,  protein  was  eluted  in  the  same  buffer  in  which  the  column  had  been 
equilibrated.  Figure  3.5  shows  a  typical  A280  nm  profile  obtained  from  the  gel 
filtration  column  stage  of  the  methionine  y-lyase  purification.  It  appears  from  Figure 
77 3.5  that  there  has  been  very  little  separation  of  the  post  alkyl  superose  fractions  on  the 
basis  of  native  molecular  weight.  There  are  still  several  peaks  of  homocysteine 
desulphurase  activity  detected  in  the  fractions  eluted  from  this  column.  As  this  was 
the  last  column  in  the  protein  purification  protocol,  one  may  expect  at  this  stage  only 
one  peak  of  activity  would  be  detected. 
3.2.6.4  SDS-PAGE  analysis  of  proteins  eluted  from  the  three  different  columns 
used  in  the  purification  of  methionine  y-lyase  from  T.  vaginalis. 
Figure  3.6  shows  the  polypeptide  constituents  of  the  homocysteine  desulphurase-, 
containing  fractions  that  were  eluted  from  the  three  columns  used  in  the  purification 
of  methionine  y-lyase  from  T  vaginalis.  The  most  important  feature  to  note  from  this 
Figure  is  that  homocysteine  desulphurase  containing  fractions  eluted  from  the 
Superose  12  column,  the  last  column  of  the  purification  scheme,  contain  numerous 
proteins  of  varying  molecular  weight.  There  appears  to  be  no  particular  enrichment  of 
a  protein  around  -43  kDa  which  would  be  the  subunit  size  of  the  purified  methionine 
y-lyase.  The  Mono  Q  column  procedure  resulted  in  the  removal  of  some  of  the  major 
T  vaginalis  proteins  between  64  and  36  kDa.  The  hydrophobic  interaction 
chromatography  step  resulted  in  many  T  vaginalis  proteins  being  removed  from  the 
post  Mono  Q  fraction,  but  many  faintly  silver  stained  proteins  remained  after  this  step, 
which  was  difficult  to  reproduce  in  Figure  3.6.  Qualitatively  there  was  no  difference 
between  proteins  eluted  from  the  hydrophobic  interaction  column  and  the  gel  filtration 
column. 
78 Table  3.1  shows  the  results  of  a  typical  purification  of  methionine  y-lyase  from  T 
vaginalis.  As  can  be  seen  the  recovery  of  enzyme  was  very  low,  only  1.5%  after  the 
gel  filtration  step.  The  recovery  of  the  enzyme  from  the  attempted  purifications  was 
approximately  5-fold  lower  than  the  purification  of  the  protein  as  reported  by 
Lockwood  and  Coombs  (1991). 
In  essence  the  purification  protocol  as  published  by  Lockwood  and  Coombs,  (199  1), 
failed  in  my  hands,  to  produce  methionine  y-lyase  that  was  homogeneous.  The 
purification  was  carried  out  many  times  with  changes  and  variations,  but  all  efforts 
were  in  vain,  I  simply  could  not  purify  methionine  y-lyase  from  T  vaginalis  based  on 
the  purification  scheme  of  Lockwood  and  Coombs,  1991. 
3.4  Discussion. 
A  considerable  period  of  time  was  spent  trying  to  purify  methionine  y-lyase  from  T 
vaginalis  according  to  Lockwood  and  Coombs,  199  1.  Unfortunately,  I  was  not  able  to 
purify  the  protein  to  homogeneity,  which  was  required  for  the  production  of  more 
polyclonal  antibodies  to  the  protein  and  for  amino  acid  sequence.  The  reasons  for  not 
being  able  to  purify  the  protein  are  still  a  mystery.  Every  possible  stage  of  the 
purification  protocol  was  checked. 
The  problems  that  were  experienced  with  the  purification  of  methionine  y-lyase  meant 
that  the  approach  of  the  project  had  to  be  re-thought.  The  results  of  the  project  rethink 
are  outlined  in  the  next  chapter  of  this  thesis. 
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Figure  3.1  Western  blot  analysis  of  Tvaginalk  soluble  fraction  proteins  with 
antiserum  raised  against  purified  methionine  7-1yase  from  T.  vaginaliv. 
Molecular  weight  markers  (Sigma,  SDS  7)  are  indicated  on  the  left  hand  side 
of  the  figure 
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Panel  B:  Immunoprecipitation  ofT  vagintdi.  v  IabcIIcd  protcins  ý%  ith 
various  antisera 
Lane  1:  7'  vaginalis  proteins  immunoprecipitated  %%  ith  pi-c-minimic  methionine  y- 
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Figure  3.3  A  representative  A280  nm  profile 
resulting  from  anion  exchange  chromatography  T. 
vaginalis  soluble  proteins  using  a  Mono  Q  column 
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Figure  3.4  A  representative  A280nm  profile  resulting  from 
hydrophobic  interaction  chromatography  of  Mono  Q  eluant 
using  an  Alkyl  Superose  column 
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Figure  3.5  A  representative  A280nm  profile 
resulting  from  gel  filtration  chromatography  of 
Alkyl  Superose  eluant  using  a  Superose  12  column. 
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05  10  15  20  25 Figure  3.6  A/B  SDS-PAGE  analysis  of  proteins  from  a  native  methionine  7-lyase 
purification. 
Proteins  eluted  from  the  columns  used  in  the  different  stages  of  the  purification  of 
methionine  7-lyase  from  were  combined  with  Laemmli  sample  buffer,  boiled, 
electrophoresed  and  stained  with  Coomassie  R250  or  silver  stained. 
PaneIA  Silver-stained-10%  acrylamide  gel 
Lane  1:  7'  vaginalis  non-sedimentable  fraction 
Lane  2:  Peak  homocysteine  desulphurase  fractions  eluted  from  the  Mono  Q  column 
Lane  3:  Peak  homocysteine  desulphurase  fractions  eluted  from  the  Alkyl  Superose 
COILImn 
Lane  4:  Peak  homocysteine  desulphurase  fractions  eluted  from  the  Superose  12 
column 
Lane  5:  Molecular  weight  markers 
Panel  13  Coornassie  Blue  R250-10%  stained  acrylamide  gel 
Lane  1:  T  vaginalis  non-sedimentable  fraction 
Lane  2:  Peak  honlocysteinc  desulphurase  fractions  eluted  from  the  Mono  Q  column 
Lane  3:  Peak  homocysteine  desulphurase  fractions  eluted  from  the  Superose  12 
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85 Total  activity  Recovery 
Non  sedimentable  fraction  2.12  100 
Mono  Q  cluate  0.45  21 
Alkyl  Superose  eluate  0.05  2.5 
Superose  12  eluate  0.03  1.5 
Table  3.1  Purification  of  methionine  y-lyase  from  T.  vaginalis. 
The  above  table  shows  the  results  of  a  typical  purification  of  the  several  that  were 
carried  out.  Activity  was  measured  with  homocysteine  as  the  substrate.  Total  activity  is 
in  ýLmol  PbS  produced  /min 
86 CHAPTER  4.  ISOLATION  AND  MOLECULAR 
CHARACTERISATION  OF  METHIONINE  y-LYASE  GENE 
HOMOLOGUES  FROM  T.  VAGINALIS. 
4.1  Introduction. 
The  aim  of  this  project  was  to  clone  the  gene  encoding  the  sulphur  amino  acid 
metabolising  enzyme,  methionine  -1-lyase,  from  T  vaginalis.  Three  different  approaches 
were  attempted  to  try  and  isolate  the  gene  which  encodes  this  interesting  enzyme.  The 
first  approach  was  to  screen  a  cDNA  T  vaginalis  expression  library  with  polyclonal 
antibodies  that  had  been  raised  previously  by  Dr.  B.  C.  Lockwood  against  purified 
methionine  7-1yase  from  T  vaginalis  (Lockwood  and  Coombs,  199  1).  However,  these 
polyclonal  antibodies  raised  against  methionine  y-lyase  from  T  vaginalis  were  found  to 
be  relatively  unspecific  and  therefore  unsuitable  for  isolating  the  gene  encoding  the 
protein  in  question  (see  Chapter  3.  ). 
A  second  approach  involved  the  purification  of  more  methionine  y-lyase  from  T 
vaginalis  according  to  the  published  methods  (Lockwood  and  Coombs.,  1991),  in  order 
that  N-terminal  amino  acid  sequence  and/or  proteolytic  cleavage  fragment  sequence  of 
the  enzyme  could  be  obtained.  This  sequence  information  would  subsequently  be  used 
to  design  oligonucleotides,  that  could  be  used  as  probes  to  screen  aT  vaginalis  AZAPll 
cDNA  library.  In  addition  it  was  hoped  that  more  specific  polyclonal  antibodies  would 
be  raised  against  the  purified  T  vaginalis  methionine  -y-lyase.  This  approach  was  also 
unsuccessful  as  purification  of  methionine  y-lyase  from  T  vaginalis  using  a 
87 combination  of  methods,  both  published  and  novel,  failed  to  yield  the  molecule  in  high 
enough  purity  or  quantity  (see  Chapter  3).  A  new  approach  was  therefore  sought  in 
order  to  advance  the  project. 
Methionine  y-lyase  as  well  as  being  present  in  T  vaginalis  is  also  found  in  various 
anaerobic  bacteria  narnely,  Pseudomonas  (Miwatani  et  aL,  1954;  Kallion  and  Larson, 
1955;  Ito  et  al.,  1975  and  Tanaka  et  al.,  1977),  Clostridium  (Wiesendanger  and  Nisman, 
1953  and  Kreis  and  Hession,  1977)  and  Aeromonas  (Nakayama  et  al.,  1984),  some 
rumen  bacteria  (Merricks  and  Salsbury,  1974)  and  the  anaerobic  parasitic  protist 
Entamoeba  histolytica  (Lockwood  and  Coombs,  1989).  There  was  at  the  time  of 
embarking  upon  this  project  no  nucleotide  sequence  available  for  methionine  y-lyase 
from  these  organisms.  There  was  a  small  amount  of  protein  sequence  available  for 
methionine,  y-lyase  from  P.  putida  derived  from  cyanogen  bromide  and  tryptic  fragment 
treatment  (Nakayama  et  al.,  1988a).  Mammals  do  not  possess  the  ability  to  breakdown 
methionine  in  a  single  catalytic  step  (Cooper,  1983).  Methionine  y-lyase  in  T  vaginalis 
may  represent  a  potential  new  target  for  chemotherapy. 
Cloning  the  methionine  y-lyase  gene  from  P.  putida  using  oligonucleotides  designed  to 
the  available  protein  sequence,  was  a  considered  option.  The  A  pulida  methionine 
lyase  gene  could  then  have  been  used  as  a  heterologous  probe  to  try  and  isolate  the  gene 
encoding  methionine  y-lyase  from  T  vaginalis.  However,  such  considerations  were 
soon  abandoned  as  the  available  protein  sequence  data  was  very  limited  and  little  was 
known  about  the  similarity  between  bacterial  and  trichornonal  methionine  y-lyases. 
88 The  third  option  taken  was  to  utilise  the  fact  that  the  sulphur  amino  acid  metabolising 
enzyme  cystathionine  y-lyase,  has  many  biochemical  features  in  common  with 
methionine  y-lyase.  Cystathionine  y-lyase  was  the  candidate  enzyme  to  study  for  the 
following  reasons.  Firstly,  T  vaginalls  has  been  shown  to  possess  both  methionine  y- 
Iyase  and  cystathionine  y-lyase  activities  (Thong  et  al.,  1987,  Thong  and  Coombs, 
1985a),  but  it  was  not  known  whether  the  methionine  y-lyase  and  cystathionine  y-lyase 
were  activities  due  to  distinct  enzymes  or  whether  one  protein  is  able  to  catalyse  the 
breakdown  of  both  methionine  and  cystathionine. 
Secondly,  both  methionine  y-lyase  and  cystathionine  y-lyase  catalyse  y-elimination 
reactions,  in  which  the  two  enzymes  catabolise  similar  substrates  by  identical  reaction 
mechanisms.,  Thus,  it  was  not  unreasonable  to  assume  that  these  two  enzymes  would  be 
structurally  similar  at  the  primary  amino  acid  level.  The  isolation  of  the  cystathionine  y- 
lyase  gene(s)  from  T  vaginalis  and  then  relating  the  gene(s)  and  the  encoded  enzyme 
activities  would  reveal  whether  or  not  the  methionine  y-lyase  and  cystathionine  y-lyase 
activities  in  T  vaginalis  could  be  attributed  to  the  same  or  two  different  molecules,  and 
thus  shed  more  light  on  what  may  or  may  not  be  exploitable  drug  targets  in  T  vaginalis. 
Thirdly,  nucleotide  sequence  data  (and  hence  encoded  protein  sequence)  was  available 
for  cystathionine  7-1yase  from  a  range  of  different  organisms,  thus  providing  the 
opportunity  to  clone  cystathionine  y-lyase  and  cystathionine  y-lyase  like  genes  from  T 
vaginalis.  The  following  approach  was  adopted: 
89 Firstly,  multiple  sequence  alignment  of  the  protein  sequences  for  cystathionine  y-lyase 
from  human,  rat  and  yeast  were  used  to  identify  regions  of  amino  acid  conservation 
within  the  sequence.  Degenerate  oligonucleotides  were  designed  to  the  best  regions  of 
homology  and  were  subsequently  used  in  polymerase  chain  reactions  (PCRs)  to  amplify 
the  equivalent  region  of  a  cystathionine  y-lyase  homologue  from  T  vaginalis  cDNA. 
Figure  4.1  a  shows  the  multiple  protein  sequence  alignment  for  cystathionine  y-lyase 
from  human,  rat  and  yeast.  Black  boxes  are  the  regions  of  homology  chosen  for  the 
design  of  degenerate  oligonucleotides  to  be  used  as  primers  in  PCRs.  The  first  region  of 
homology  chosen  for  the  design  of  the  5'  oligonucleotide  primer  was  a  region  in  which 
the  sequence  between  the  different  cystathionine  y-lyase  molecules  was  highly 
homologous,  V154-TI60,.  The  second  region  chosen  for  the  design  of  the  3'  primer  was 
the  pyridoxal  5'  phosphate  (PLP)  binding  domain,  A2  I  O-H217.  The  sequences  of  the 
degenerate  oligonucleotides  are  outlined  in  Figure  4.1b.  In  order  to  facilitate  cloning, 
restriction  sites  for  the  enzymes  HindIII  and  XhoI  were  tagged  onto  the  end  of  the  two 
degenerate  oligonucleotides,  respectively. 
When  the  positions  of  the  degenerate  primers  were  taken  into  consideration  and 
assuming  the  T  vaginalis  cystathionine  y-lyase  gene  would  have  the  same  basic  primary 
sequence  characteristics  as  the  cystathionine  y-lyase  genes  of  yeast,  rat  and  human  and 
not  have  any  insertions  or  deletions,  a  region  of  some  200bp  of  T  vaginalis  DNA  would 
be  expected  to  be  amplified. 
The  plan  was  if  the  PCRs  were  successful,  the  amplified  fragments  of  T  vaginalis  DNA 
would  be  cloned,  with  the  aid  of  the  restriction  sites  engineered  onto  the  ends  of  the 
90 fragment  by  the  amplification  process.  The  cloned  PCR  fragments  would  then  be 
sequenced  to  ascertain  their  identity  and  if  indeed  they  had  sequence  and  predicted 
peptide  homology  to  cystathionine  y-lyase  from  yeast,  rat  and  human.  If  aT  vaginalis 
cystathionine  y-lyase  homologue  was  isolated  then  the  PCR  fragment  would  be  used  as  a 
probe  to  screen  aT  vaginalis  XZAPII  cDNA  library,  with  a  view  to  isolating  full  length 
T  vaginalis  cystathionine  y-lyase  hornologues,  which  would  then  be  sequenced  and 
further  analysed. 
4.2  Results. 
4.2.1  RNA  Isolation. 
Total  RNA  was  successfully  isolated  from  T  vaginalis  in  a  single  step  using  the 
commercially  available  TRIZOLTm  reagent  (Gibco),  which  is  a  monophasic  solution  of 
phenol  and  guanidine  isothiocyanate.  The  total  RNA  produced  from  T  vaginalis  using 
this  reagent  was  analysed  both  spectrophotometrically  and  by  agarose  gel 
electrophoresis,  in  order  to  determine  quantity  and  purity  of  the  RNA. 
Spectrophotornetric  analysis  of  the  total  RNA  at  260  nm/280  nm  gave  ratios  between 
1.8  and  2.0.  A  ratio  of  >1.8  indicates  relatively  pure  RNA.  Poly  [A]+  RNA  was  isolated 
from  total  RNA,  as  this  type  of  RNA  was  deemed  to  be  more  suitable  for  cDNA 
synthesis.  Figure  4.2  shows  the  results  of  non-denaturing  gel  electrophoresis  of  total  T 
vaginalis  RNA  and  poly  [A]+  RNA.  Lanes  2  and  3  show  I  pg  and  4pg  of  T  vaginalis 
total  RNA  respectively.  The  electrophoretic  analysis  confirmed  the  purity  of  the  RNA 
as  there  appears  to  be  little  or  no  DNA  contwnination  of  the  RNA.  Also  the 
electrophoretic  process  has  separated  the  various  components  of  T  vaginalis  total  RNA. 
91 It  can  be  seen  that  there  are  two  distinct  bands  present  towards  the  top  of  the  gel  and 
these  correspond  to  the  large  subunit  rRNAs.  Towards  the  bottom  of  the  gel  there  are 
higher  mobility  RNAs  and  these  correspond  to  smaller  species  RNAs  such  as  tRNAs 
and  5S  rRNA.  The  T  vaginalis  poly  [A]+  upon  spectrophotornetric  analysis  had  a 
A260/280  nm  ratio  of  1.5. 
4.2.2  cDNA  Synthesis  and  PCR  using  degenerate  primers. 
I  gg  of  poly  [A]+  RNA  from  T  vaginalis  was  used  to  synthesise  first  strand  T  vaginalis 
cDNA.  The  cDNA  was  used  as  a  template  in  PCRs  with  the  degenerate 
oligonucleotides  (Figure  4.1  b).  A  control  cDNA  synthesis  was  performed  by  omitting 
reverse  transcriptase. 
Figure  4.3  shows  the  result  of  a  number  of  test  PCRs  using  the  degenerate 
oligonucleotides,  Cyst5'  and  Cyst3',  either  singly  or  in  combination,  and  T  vaginalis 
cDNA  synthesised  from  T  vaginalis  poly  [A]+  RNA,  plus  a  control  without  reverse 
transcriptase.  Conditions  of  the  PCRs  used  in  this  experiment  were  as  follows:  Initial 
denaturation  94*C  for  4  minutes  followed  by  30  amplification  cycles  consisting  of  940C 
for  I  minute,  42"C  for  I  minute  and  72*C  for  I  minute  and  a  final  extension  cycle  at 
72'C  for  5  minutes.  The  products  of  PCRs  when  only  the  Cyst  5'  primer  was  used 
along  with  T  vaginalis  cDNA  resulting  from  synthesis  with  reverse  transcriptase  and  a 
control  synthesis  without  enzyme  are  shown  in  Lanes  2  and  3,  respectively.  Lanes  4  and 
5  are  the  same  as  above  except  the  Cyst  31  primer  was  used  in  the  PCRs. 
No  amplified  DNA  was  detected  in  lanes  2,3,4  and  5  indicating  that  the  degenerate 
primers  on  their  own  and  coupled  with  the  control  reaction  does  not  give  spurious  DNA amplification.  The  diffusely  staining  regions  near  the  bottom  of  the  gel  are  monomer 
oligonucleotide  primers. 
No  DNA  was  amplified  when  PCR  was  performed  with  both  degenerate 
oligonucleotides  and  the  control  reaction,  in  which  the  reverse  transcriptase  was  omitted 
(lane  7).  The  PCR  under  these  conditions  confirmed  that  the  T  vaginalis  poly  [A]' 
RNA  was  free  from  any  contaminating  T  vaginalis  genomic  DNA.  PCR  performed 
with  both  degenerate  oligonucleotides  and  T  vaginalis  first  strand  cDNA,  amplified  two 
DNA  fragments  (lane  6).  The  first  fragment  was  approximately  200bp  in  size  (lower 
band  fragment),  and  the  second  fragment  was  approximately  250bp  in  size  (upper  band 
fragment).  The  200bp  amplified  fragment  of  approximately  was  about  the  size  of 
fragment  expected  to  be  amplified,  taking  into  consideration  the  location  of  the  regions 
used  in  the  design  of  the  degenerate  primers.  For  human  and  rat  cystathionine  y-lyase 
the  two  regions  are  64  amino  acid  residues  apart  and  a  208bp  fragment  would  be 
amplified.  For  yeast  cystathionine  y-lyase  the  two  regions  are  67  amino  acid  residues 
apart  (there  is  a  three  amino  acid  residue  insertion  in  the  yeast  cystathionine  y-lyase 
sequence  when  compared  to  the  amino  acid  sequence  of  the  cystathionine  y-lyase  of 
human  and  rat,  Figure  4.1b),  and  thus  a  217bp  fragment  would  be  amplified.  As  PCR 
using  the  two  degenerate  oligonucleotides  and  T  vaginalis  cDNA  amplified  the 
expected  size  fragment,  several  more  identical  PCRs  were  performed  in  order  to  obtain 
enough  material  for  cloning. 
A  positive  control  PCR  was  also  carried  out  after  the  original  degenerate  PCRs  to 
confirm  that  the  T  vaginalis  first  strand  cDNA  was  of  suitable  quality  and  integrity  to 
amplify  fragments  of  T  vaginalis  transcripts  and  that  the  conditions  of  the  PCR  being used  were  suitable  for  the  amplification  of  such  T  vaginalis  DNA  fragments. 
Degenerate  primers  previously  used  in  the  successful  isolation  of  cysteine  proteinase, 
genes  from  T  vaginalls  (Mallinson  et  al.,  1994),  were  used  in  PCRs  with  T  vaginalls 
first  strand  cDNA  under  the  same  conditions  as  outlined  previously,  the  results  are 
shown  in  Figure  4.4,  lane  3.  A  DNA  fragment  of  TvCPI  of  approximately  500  bp  was 
amplified,  which  was  in  complete  agreement  with  Mallinson  et  aL  1994.  The  result 
from  the  positive  control  PCR  appeared  to  confirm  that  the  template  T  vaginalis  first 
strand  cDNA  and  the  conditions  of  PCR  being  used,  should  successfully  amplify 
genuine  gene  fragments  of  T  vaginalis  cystathionine  y-lyase,  if  sufficient  homology 
exists  between  the  cystathionine  y-lyase  genes  of  different  species. 
The  results  of  PCRs  used  to  generate  enough  material  for  cloning  are  shown  in  Figure 
4.4.  Five  de  novo  PCR  reactions  were  set  up  under  the  exact  conditions  described 
previously.  The  products  of  the  five  identical  PCRs  were  combined  and  an  aliquot  run 
on  an  agarose  gel  (Figure  4.4,  lane  3).  Once  again  the  de  novo  PCRs  gave  both  an  upper 
band  and  lower  band  amplified  product  of  250bp  and  200bp  respectively. 
Figure  4.4  also  shows  that  when  previously  amplified  upper  band  (lane  4)  and  lower 
band  DNA  (lane  5)  which  were  gel  purified  and  subsequently  used  as  a  template,  in 
PCRs  with  less  amplification  cycles,  a  large  amount  of  product  was  observed  for  both 
sizes  of  template.  The  upper  band  DNA  template  (lane  4),  gave  a  mixture  of  amplified 
products,  consisting  mainly  of  4  bands,  between  200bp  and  250bp  in  size.  The  lower 
band  template  (lane  5)  gave  two  amplified  products  of  around  200bp  in  size. 
4.2.3  Cloning  of  PCR  fragments  amplified  using  degenerate  oligonucleotides  for 
methionine,  y-lyase. The  PCR  reaction  containing  amplified  DNA  was  precipitated  to  remove  contaminating 
nucleotides  and  subsequently  phenol  chlorofomi/chloroform  extracted  to  remove  the 
Taq  polymerase.  The  amplified  DNA  was  then  restricted  to  completion  with  Hind  III 
and  XhoI  restriction  enzymes.  These  enzymes  were  chosen  as  their  restriction  sites  had 
been  engineered  onto  the  ends  of  the  amplified  DNA  by  their  inclusion  at  the  termini  of 
the  Cyst  5'and  Cyst  Ydegenerate  oligonucleotides  respectively.  The  DNA  was  further 
purified  by  gel  electrophoresis.  DNA  was  run  on  a  2%  TAE  agarose  gel,  stained  with 
EtBr  to  allow  visualisation  of  the  amplified  DNA  under  a  UV  light  source,  the  amplified 
bands  of  interest  excised  from  the  gel  using  a  clean  scalpel  blade.  The  DNA  was  eluted 
from  the  agarose  gel  slice  using  commercially  available  Spin  X  columns  (Costar). 
The  restricted,  purified  DNA  (individual  upper  band  and  lower  band  products  and  a 
combination  of  the  two)  arising  from  the  PCRs  with  the  degenerate  primers,  was  then 
combined  with  pBluescript  (Stratagene)  which  also  had  been  restricted  with  Hind  III  and 
Xhol  and  gel  purified.  The  pBluescript  and  amplified  PCR  fragments  of  approximately 
200-250bp  were  ligated  in  quantities  of  200  ng  insert  plus  200  ng  vector  using  the 
Arnersharn  ligation  kit. 
The  ligations  were  then  transformed  into  Ultracompetent  XLI  Blue  (Stratagene). 
Approximately  30-50ng  of  ligated  DNA  was  used  to  transform  the  competent  bacterial 
cells.  Transformation  mixes  were  plated  out  onto  LB  plates  containing  ampicillin,  X- 
gal  and  IPTG  and  incubated  overnight  at  37'C.  Colonies  of  transformed  XLI  Blue 
bacteria,  when  plated  onto  LB-amp  X-gal,  IPTG  plates  take  on  either  a  white  or  deep 
blue  appearance,  after  growth.  The  presence  of  white  colonies  allowed  blue/white 
selection  of  plasmids  with  inserts  to  be  carried  out. After  transformation  mainly  white  bacterial  colonies  were  selected  from  LB  amp,  X-gal, 
IPTG  plates  for  further  analysis.  Plasmid  DNA  was  isolated  using  the  mini  prep 
procedure  and  subjected  to  selective  restriction  analysis  to  ascertain  whether  cloning  of 
the  amplified  DNA  into  pBluescript  had  been  successful. 
4.2.4  Restriction  based  screening  of  Cysta  clones  to  ascertain  successful  cloning  of 
the  200bp  amplified  fragment  into  pBluescript. 
PvulI  restriction  analysis  of  pBluescript  is  a  useful  procedure  to  adopt  when  screening 
this  vector  for  the  successful  insertion  of  small  DNA  fragments  into  the  multiple  cloning 
site  (MCS)  of  pBluescript.  pBluescript  possesses  two  PvulI  restriction  sites  that  flank 
the  MCS  and  about  400bp  apart.  If  pBluescript  is  restricted  with  PvuII,  a  fragment  of 
400bp  is  cleaved  from  the  plasmid.  However,  if  a  DNA  fragment  is  cloned  successfully 
into  the  MCS  of  pBluescript  and  then  cut  with  PvuIl,  the  size  of  the  PvuIl  fragment 
represents  a  sum  of  400bps  plus  the  size  of  the  fragment  that  was  cloned  into  the  vector. 
This  Pvull  screening  procedure  therefore  allows  a  more  accurate  sizing  of  smaller  DNA 
fragments  and  it  also  avoids  the  visualisation  of  small  DNA  fragments  on  high 
percentage  agarose  gels.  The  principles  of  this  PvulI  screening  process  are 
demonstrated  in  Figure  4.5.  When  pBluescript  was  restricted  with  Pvull,  two  fragments 
of  2.5  kb  and  400  bps  were  produced  (lane  2).  However,  when  plasmid  DNA  from 
different  single  white  transformants  (in  which  lower  band  PCR  amplified  material  was 
cloned  into  pBluescript)  was  restricted  with  PvuII,  two  fragments  of  2.4kb  and  -600bp 
were  produced  which  indicated  that  the  plasmid  had  an  insert  of  -200bp  in  the  multiple 
cloning  site  and  that  the  cloning  of  the  PCR  amplified  material  into  pBluescript  had 
been  successful  (lanes  3-7). Figure  4.6  illustrates  PvuIl  restriction  analysis  of  plasmid  from  individual  white 
transformants  in  which  PCR  amplified  material  from  all  bands  was  'shot-gun'  cloned 
into  pBluescript.  Two  clones  produced  a  650bp  fragment  (lanes  6  and  7),  probably 
corresponding  to  the  upper  band,  whereas  three  clones  gave  a  600bp  fragment  probably 
corresponding  to  the  lower  band  (lanes3,4  and  5). 
The  cloned  PCR  products  then  became  known  as  Tysta  clones'.  A  total  of  17  Cysta 
clones  were  obtained.  Sequencing  and  subsequent  analysis  of  the  Cysta  clones  would 
reveal  whether  a  genuine  fragment  of  a  cystathionine  y-lyase  homologue  had  been 
amplified  from  the  T  vaginalis  cDNA. 
4.2.5  Sequencing  and  analysis  of  the  Cysta  clones. 
All  of  the  Cysta  clones  were  sequenced  on  one  or  both  strands,  using  T7  and  -  21  mer 
primers  (Stratagene),  and  Sequenase  Quick  Denature  Plasmid  sequencing  Kit 
(Amersharn)  as  outlined  in  Chapter  2. 
Sequence  analysis  of  the  Cysta  clones  revealed  that  they  fell  into  three  groups.  Firstly 
one  group  consisted  of  Cystas  2,9,10  and  15  which  were  similar  to  each  other  and 
encoded  peptides  with  homology  to  yeast  cystathionine  y-lyase.  A  second  group 
consisted  of  Cystas  8,14  and  16,  which  were  similar  to  each  other  but  different  to  Cystas 
2,9,10  and  IS  also  had  peptide  homologies  to  yeast  cystathionine  y-1yase.  A  third 
group  of  Cystas  had  no  homology  to  yeast  cystathionine  y-lyase  and  were  thought  to  be 
non-specific  PCR  amplification  products.  A  correlation  was  found  between  the  Cysta 
clones  that  had  genuine  homology  to  cystathionine  7-lyase  and  the  lower  band  PCR 
97 products.  For  example  Cysta,  2,  a  representative  clone  from  one  of  the  groups  was  68% 
identical  and  84%  similar,  at  the  amino  acid  residue  level  to  cystathionine  y-lyase  from 
yeast.  Cysta  16,  a  Cysta  clone  from  the  other  group  was  58%  identical  and  74%  similar 
to  yeast  cystathionine  y-lyase  in  terms  of  amino  acid  residues. 
4.2.6  Southern  blot  analysis  of  T.  vaginalis  genomic  DNA  using  Cysta  based 
radioactive  probes. 
It  was  important  to  show  that  the  PCR  products  were  genuine  T  vaginalis  sequences 
and  not  PCR  artefacts  derived  other  organisms,  therefore  Southern  blot  analysis  was 
perfonned. 
An  electrophoretic  analysis  of  T  vaginalis  genomic  DNA  after  digestion  with  various 
restriction  enzymes  is  shown  in  Figure  4.7.  T  vaginalis  genomic  DNA  was  restricted 
with  EcoRI,  HincII,  HindIII  and  XbaI  for  5  hours  at  37'C  prior  to  being  electrophoresed 
on  a  0.7%  agarose  gel  (lanes  2-5  and  7-10)  A  distinct  banding  pattern  was  observed 
after  staining  with  EtBr.  The  distinct  fragments  are  thought  to  be  highly  repetitive 
nucleotide  sequences  that  occur  in  the  T  vaginalis  genome  (Wang  and  Wang,  1985). 
The  DNA  shown  in  these  gels  was  transferred  to  Hybond  N  filters  (Amersham)  using 
the  method  of  Southem  (1975)  and  subjected  to  hybridisation  with  the  200bp  amplified 
fragments  of  Cysta  8,9,14  and  16.  DNA  for  probes  specific  to  Cysta  8,9,14  and  16 
probes  was  generated  by  PCR,  using  the  appropriate  600bp  Pvull  fragment  from  each 
clone  as  template  and  the  degenerate  oligonucleotides  as  used  in  the  original  PCR.  The 
probes  were  labelled  using  a  random  priming  method. 
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hybridised  with  either  Cysta  9  (Panel  A)  or  Cysta  8  (Panel  B).  For  Cysta  9,  three 
hybridising  bands  of  different  sizes  were  detected.  Firstly,  a  EcoRI  fragment  of  7.5kb 
(lane  1),  secondly  a  6.5kb  Hind  III  fragment  (lane  3)  and  thirdly  a  >23kb  Xbal  fragment 
(lane  4).  There  was  no  hybridisation  of  the  Cysta  9  amplified  fragment  with  HincII 
restricted  T  vaginalis  genomic  DNA.  The  probable  explanation  for  the  lack  of 
hybridisation  with  the  Cysta  9  amplified  fragment  and  the  Hincll  digested  genomic 
DNA  is  that  there  was  a  Hincll  site  in  the  middle  of  the  probe  region  (See  Figure  4.17) 
and  therefore  it  was  likely  that  the  hybridising  fragments  were  too  small  to  be  detected. 
(Cysta  2-gave  same  size  bands  as  Cysta  9,  data  not  shown).  Cysta  8  hybridised  to  a 
7.5kb  EcoRI  fragment  (Panel  B,  lane  1),  a  2.5kb  fragment  with  HincIl  (Panel  B,  lane  2), 
a  15kb  fragment  with  Hind  III  (Panel  B,  lane3)  and  finally  a  18kb  fragment  with  XbaI 
(Panel  B,  lane  4). 
Figure  4.8  illustrates  the  hybridising  pattems  of  restricted  T  vaginalis  genomic  DNA 
with  the  Cysta  14  (Panel  C)  and  Cysta  16  (Panel  D)  amplified  DNA.  (The  filters  used  in 
these  hybridisation  experiments  were  duplicates  of  those  used  in  the  above  experiments, 
ie.,  two  gels  with  the  same  samples  were  run  and  subsequently  blotted).  Lanes  I  to  4 
represent  EcoRl,  HincII,  Hind  III  and  Xbal  restricted  T  vaginalls  genomic  DNA.  Cysta 
14  and  Cysta  16  gave  an  identical  hybridisation  pattern  as  those  obtained  with  Cysta  8 
and  restricted  T  vaginalis  genomic  DNA  (Figure  4.8,  Panel  B).  The  hybridisation. 
patterns  obtained  for  the  different  Cysta  clones,  together  with  nucleotide/peptide 
sequence  data  confirmed  that  they  fell  into  two  distinct  groups,  both  of  which  had 
sequence  homology  to  yeast  cystathionine  y-lyase.  Southern  blot  analysis  also 
confirmed  that  the  amplified  fragments  were  of  sufficient  size  to  detect  the  gene  from 
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length  genes  from  the  T  vaginalis  cDNA  library. 
4.2.7  Northern  blot  analysis  of  T.  vaginalis  total  and  poly  [A]+  RNA  using  a  600bp 
radioactive  fragment  from  Cysta  2. 
In  order  to  investigate  expression  of  the  putative  T  vaginalis  cystathionine  y-lyase 
homologue  Northern  blot  analysis  of  T  vaginalis  RNA  was  also  performed  with  the 
Cysta  2  clone  (Figure  4.9).  T  vaginalis  total  RNA  (lane  1)  and  poly  [A]+  RNA  (lane  2) 
was  probed  with  the  600bp  PvulI  restriction  fragment  from  the  Cysta,  2  plasmid.  A 
transcript  size  of  approximately  1.3kb  was  detected  in  both  total  and  poly  [A]+  RNA, 
which  has  the  coding  capacity  of  a  protein  of  approximately  43kDa.  This  corresponds 
to  the  subunit  size  of  cystathionine  y-lyase  from  a  yeast  (Ono  et  al.,  1992),  rat  (Erickson 
et  al.,  1990)  and  (Lu  et  al.,  1992). 
4.2.8  Isolation  of  full  length  T.  vaginalis  methionine  y-lyase  homologues. 
A  representative  clone  from  each  group  of  Cysta  clones,  Cysta  2  and  Cysta  16  were  used 
to  isolate  the  corresponding  full  length  cDNA  clones  from  aT  vaginalis  XZAP  H  cDNA 
library  (Mallinson  et  aL,  1994).  A  total  of  100,000  cDNA  clones  were  screened. 
Briefly,  100,000  bacteriophage  were  plated  in  L-top  agarose,  along  with  the  host  cells  E. 
coli  XLI  Blue  and  the  bacteriophage  plaques  were  allowed  to  propagate  at  371C  until 
they  were  just  touching  one  another  in  the  bacterial  lawn.  The  bacterioPhage  plaques 
were  then  transferred  to  a  Hybond  N  filter,  the  DNA  of  the  'phage  was  denatured  in  situ 
and  subsequently  hybridised  with  either  the  Cysta  2  or  Cysta.  16  200bp  cystathionine  y- 
lyase  cDNA  fragment.  The  Cysta  2  and  Cysta  16  probe  material  was  produced  by  PCR 
100 using  the  appropriate  600bp  PVUII  fragment  as  template,  along  with  the  degenerate 
oligonucleotides  used  in  the  original  PCRs. 
A  second  round  of  plaque  purification  was  carried  out  and  the  pure  clone  chosen  for 
further  analysis.  Positively  hybridising  X  clones  from  the  secondary  screens  with  Cysta 
2  and  Cysta  16  200bp  fragments  that  were  separate  from  other  plaques  were  selected  as 
these  could  be  isolated  as  pure  clones.  The  cDNA  present  in  the  XZAP  II  vector  was 
&rescued'  directly  into  the  plasmid  pBluescript  using  a  fl  helper  bacteriophage 
mechanism  (see  Short  et  al,  1987). 
4.2.9  Restriction  enzyme  analysis  of  Cysta  2  and  Cysta  16  clones. 
Two  lambda  clones  named  1100  and  4100,  which  hybridised  with  the  Cysta  2  probe  were 
rescued  into  pBluescript  using  the  fl  helper  bacteriophage  mechanism.  The  two 
pBluescript  phagemids  were  narned  pl.  loo  and  p4loo.  Restriction  analysis  of  the  DNA 
contained  in  pBluescript  was  then  undertaken  for  each  clone.  Figure  4.10  illustrates  the 
results  of  restriction  analysis  of  the  1100  and  4100  DNA,  which  hybridised  with  the  Cysta 
2,200bpprobe.  I  loo  and  4100  plasmids  were  restricted  with  EcoRl  and  Xhol  alone  and 
as  a  double  digest.  These  enzymes  were  chosen  as  the  original  T  vaginalis  cDNA  was 
cloned  into  these  sites  in  the  vector.  Also  I  100  DNA  was  restricted  with  both  SpeI  and 
KpnI.  1100  plasmid  DNA  restricted  with  EcoRI  and  AIoI  released  three  fragments  of 
-2.5kb,  -1.4kb  and  -lkb  (lane  2).  The  first  and  largest  fragment  was  the  pBluescript 
DNA,  the  1.4kb  fragment  was  thought  to  be  uncut  supercoiled  plasmid  and  the  I  kb 
fragment  was  thought  to  be  the  true  size  of  the  insert  contained  within  the  1100  plasmid. 
1100  plasmid  DNA  clcavcd  with  XhoI  alonc  (lanc  3)  or  EcoRl  alonc  (lanc  4)  rclcascd  no 
DNA  fragment  from  the  plasmid.  When  I  100  DNA  was  restricted  with  SpeI  and  Kpnl, 
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EcoRI  and  Xhol  sites  into  which  the  T  vaginalis  cDNA  was  originally  cloned,  four 
fragments  were  produced  of  -3  kb,  -2  kb,  -1.5  kb  and  -1  kb.  The  largest  fragments 
were  thought  restricted  pBluescript  and  uncut  supercoiled  plasmid  and  the  I  kb 
fragment  was  thought  to  be  the  true  size  of  fragment  contained  in  the  multiple  cloning 
site  of  pBluescript. 
A  series  of  restriction  digests  for  4100  plasmid  are  also  shown  in  Figure  4.10.  Adouble 
digest  of  4100plasmid  with  both  EcoRl  and  XhoI  produced  two  insert  DNA  fragments, 
one  of  Ikb  and  the  second  of  300bp.  This  result  indicates  that  one  of  the  restriction 
enzymes  used  was  cutting  within  the  insert.  A  300bp  fragment  was  cleaved  from  the 
4  100  plasmid  when  restricted  with  Xhol,  which  would  indicate  that  there  is  an  XhoI  site 
3  00bp  from  the  end  of  the  cDNA  which  was  cloned  into  the  XhoI  site  of  pBluescript. 
No  insert  was  released  from  the  4  100  plasmid  when  it  was  restricted  with  EcoRI  alone 
(lane  8).  As  a  result  of  the  restriction  analyses  of  1100  and  4100  plasmids,  clone  4100 
became  the  focus  of  further  study  as  it  had  the  larger  insert  totalling  about  1.3kb.  An 
insert  of  this  size  should  be  sufficient  to  encode  a  protein  of  43  kDa,  which  is  the 
subunit  size  of  cystathionine  y-lyase  from  a  variety  of  organisms. 
Five  lambda  clones  that  hybridised  with  Cysta  16  were  rescued  into  pBluescript  using 
the  fl  helper  bacteriophage.  The  rescued  plasmids  were  subsequently  analysed  by 
restriction  with  the  enzymes  EcoRI  and  Xhol.  Plasmid  clones  I  100a  (lane  2)  and  b  (lane 
3)  and  3  100  (lane  4)  were  digested  with  EcoRI  and  Xhol. 
Two  fragments  of  approximately  550bp  and  450bp  were  observed  together  with  Rb  of 
pBluescript  plasmid  showing  these  plasmids  had  an  internal  EcoRl  or  Xhol  site,  but 
making  an  insert  size  of  1000bp.  Plasmids  5100  (lane  6)  and  6100  (lane  7)  when  digested 
102 with  EcoRI  and  XhoI  gave  fragments  of  approximately  800bp  and  -470bp  in  size.  Thus 
the  'insert  was  nearly  1.3kb  in  total  and  contained  either  an  internal  EcoRI  or  XhoI  site. 
Figure  4.12  illustrates  the  results  of  restriction  analysis  undertaken  to  establish  which 
restriction  enzyme  sites  are  present  internally  within  the  inserts  Of  II  OOA  and 
510o.  plasmids.  When  1100A  plasmid  was  restricted  with  EcoRl  a  550bp  fragment  was 
released  (lanc  3),  indicating  that  the  internal  restriction  site  in  the  II  OOA  clone  DNA  is 
that  of  EcoRl.  No  fragment  was  released  after  digestion  with  XhoI  (lane  2)  A  800bp 
fragment  was  observed  when  the  5  100  plasmid  was  restricted  with  EcoRl  (lane  5), 
whereas  XhoI  did  not  cut  within  the  insert  (lane  4).  When  II  OOA  (lane  6)  and  51  oo  (lane7) 
plasmids  were  digested  with  Kpnl  and  SpeI,  restriction  enzymes  that  cut  out  with  the 
EcoRI  and  Xhol  sites  of  pBluescript,  the  intact  insert  was  released  This  restriction 
analysis  showed  that  the  II  OOA  plasmid  had  an  insert  size  of  was  I  000bp  (lane  6) 
whereas  the  insert  size  of  the  5,00  plasmid  was  1.3kb  (lane  7). 
As  a  result  of  restriction  analyses  of  the  plasmids  isolated  with  Cysta  2  or  Cysta  16 
200bp  probes,  a  Cysta  2  clone  (p4100)  and  a  Cysta  16  clone  (p5100),  a  Cysta  16 
hybridiser  were  selected  to  be  fully  sequenced.  These  two  clones  were  chosen  as  they 
had  the  largest  inserts  and  were  thought  to  be  of  sufficient  size  to  encode  a  full  length 
copy  of  the  cystathionine  y-lyase  gene  homologue  from  T  vaginalis. 
At  this  point  the  genes  encoding  the  mRNA  which  gave  the  cDNA  were  named  T 
vaginalis  mgII  for  the  41  oo  cDNA  clone  and  T  vaginalis  mgI2  for  the  5  100  cDNA  clone 
(to  be  referred  to  as  mgll  and  mgl2). 
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homologues. 
Restriction  analysis  of  p41oo  and  p5ioo  coupled  with  sequence  information  from  the  5' 
and  3'  ends  of  each  gene  allowed  the  construction  of  a  preliminary  restriction  map  of 
each  mgII  and  mgI2,  which  allowed  the  basis  of  a  subcloning  strategy  that  assisted  in 
obtaining  the  full  nucleotide  sequence  of  each  gene. 
The  results  of  the  digests  with  p4  100  and  p5  100  are  shown  in  Figures  4.13  and  4.14 
respectively.  It  is  important  to  note  at  this  point  that  the  cDNA  contained  in  p4loo  was 
reversed  ie.,  the  XhoI  site  was  present  at  the  5'  end  and  the  EcoRI  site  was  present  at  the 
3'end,  which  is  the  reverse  of  the  norm.  The  reversal  of  the  cDNA  insert  into 
pBluescript  may  have  partly  occurred  due  to  incomplete  digestion  of  vector/insert  by 
Xhol  during  the  synthesis  of  the  cDNA  library.  p4loo  restricted  with  EcoRl  and  Xhol 
and  Xhol  alone  (lanes  2  and  3,  respectively)  gave  fragments  of  I  kb  and  3  00bp  as 
previously  determined  (Figure  4.10,  lanes  6  and  7).  p4loo  digested  with  EcoRV  and 
Xhol  gave  three  fragments  500bp,  300bp  and  200bpin  size  (lane  4).  p4loo  digested  with 
EcoRV  alone  gave  a  fragment  of  200bp  (lane  5),  whereas  a  double  digest  of  the  plasmid 
with  both  EcoRI  and  EcoRV  gave  two  fragments  of  200bp  and  350bp  (lane  6). 
When  p5  100  was  digested  with  EcoRl  and  XhoI  two  fragments  of  800bp  and  450bp  were 
observed  (lanc  2),  whereas  the  same  plasmid  digested  with  EcoRI  alone  gave  a  fragment 
of  800bp  (lane  3)  which  suggests  an  internal  EcoRI  site,  as  seen  previously  (Figure  4.12, 
lane5).  With  respect  to  the  digestion  of  p5loo  with  EcoRV,  it  must  be  remembered  that 
there  is  an  EcoRV  site  in  the  polylinker  of  pBluescript  that  is  close  to  the  Xhol  site  used 
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therefore  all  of  the  other  EcoRV  sites  are  internal  in  the  cDNA  insert.  p5loodigested 
with  EcoRI  and  EcoRV  gave  four  fragments  which  were  approximately  550,350,120 
and  80  bp  in  size  (lane  4),  whereas  the  same  plasmid  digested  with  EcoRV  alone  gave 
three  fragments  of  450,120  and  80  bps  in  size  (lane  5).  Finally  when  p5loo  was  digested 
with  EcoRV  and  Xhol  (lane  6)  the  same  size  fragments  were  obtained  as  for  the  single 
digest  with  EcoRV. 
4.2.11  Restriction  mapping  and  subcloning  strategy  of  mgll  and  mgl2. 
The  information  generated  from  the  above  experiments  allowed  the  restriction  maps  to 
be  drawn  up  for  each  gene  (  Figures  4.15  and  Figure  4.16)  which  allowed  a  subcloning 
strategy  to  be  made  to  facilitate  the  full  sequencing  of  the  two  genes. 
The  subclones  of  p4  1  oo  and  p5  100  used  for  the  sequencing  of  mgll  and  mgI2  utilised 
restriction  sites  present  in  mgII  and  mgI2  that  were  present  at  intervals  of  reasonable 
base  pair  length.  The  restriction  sites  used  for  the  production  of  the  respective 
subclones  are  indicated  in  Figures  4.15  and  4.16.  The  restriction  sites  used  to  produce 
the  subclones  of  p4  1  oo  and  p5  100  can  be  correlated  to  Figures  4.17  and  4.18,  where  the 
sites  are  indicated  by  pink  text.  Where  it  was  not  possible  to  produce  a  subclone  for 
p4  I  oo  or  p5  1  oo  in  order  to  obtain  overlapping  sequence,  then  oligonucleotide  primers 
were  designed  to  fill  in  the  gaps  of  nucleotide  sequence  for  the  two  genes.  The 
oligonucleotides  used  to  complete  the  sequencing  of  mgII  and  mgI2  are  indicated  in 
blue  in  Figures  4.15  and  4.16  and  their  positions  are  able  to  be  seen  in  Figures  4.17  and 
4.18,  as  indicated  by  the  blue  text. 
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pBluescript)  was  achieved  using  Sequenase  Quick  Denature  Plasmid  sequencing  kit 
(Amersham)  with  T7  and  T3  primers  (Stratagene).  The  complete  nucleotide  sequence 
and  predicted  amino  acid  sequence  of  the  cDNA  clone  4100  is  shown  in  Figure  4.17, 
indicated  in  this  figure  are  the  relevant  restriction  sites  used  in  subdoning  and 
oligonucleotides  used  to  complete  the  sequencing  of  the  cDNA.  The  complete 
nucleotide  sequence  and  predicted  amino  acid  sequence  of  the  cDNA  5  100  is  shown  in 
Figure  4.18,  with  the  relevant  restriction  sites  and  oligonucleotide  sequences  indicated 
as  outlined  above. 
4.2.12  51  RACE  of  T.  vaginalis  mg11  and  mg12. 
In  order  to  obtain  the  sequence  covering  the  5'  untranslated  regions  (UTRs)  of  mg11  and 
mg12  and  to  determine  the  position  of  the  start  codons,  5'  Reverse  Transcriptase  Rapid 
Amplification  of  cDNA  Ends  (RT-RACE)  was  performed.  The  5'  ends  of  mg11  and 
mg12  were  obtained  using  a  commercially  available  5'  RACE  system  for  the  Rapid 
Amplification  of  cDNA  Ends  (Life  Technologies)  coupled  with  T  vaginalis  total  RNA 
that  had  been  isolated  from  the  parasites  using  the  commercially  available  reagent 
TRIzol  (Life  Technologies).  The  methodology  of  5'  RACE  is  summarised  in  Figure 
4.19.  Figure  4.20  summarises  the  5'  RACE  protocol  performed  for  mg11  and  mg12.  The 
location  of  the  gene  specific  primers  used  in  the  two  rounds  of  the  RACE-PCR  are 
shown  in  Figure  4.17  and  4.18.  Figure  4.21  shows  the  amplified  S'  RACE  products  for 
the  mgII  and  mgI2  and  genes  after  the  second  round  of  amplification  using  gene  specific 
primers  9  and  4  respectively.  Two  independent  amplifications  of  the  5'  ends  of  mgII  and 
mgI2  were  performed  (lanes  3  and  4,  lanes  6  and  7  respectively).  Control  amplifications 
using  the  appropriate  gene  specific  primers  for  each  gene  but  without  reverse 
106 transcriptase  were  perfonned  for  mgII  and  mgI2  (lanes  2  and  5,  respectively).  Both  of 
the  mgII  and  mgI2  5'-RACE  products  were  approximately  350bp  in  size,  the  size  of 
product  expected  when  the  location  of  each  gene  specific  primer  was  taken  into 
consideration  (see  Figures  4.17  and  4.18). 
The  350bp  5'-RACE  products  were  cloned  directly  into  pTAg  vector  of  the  ligATor  kit 
(Ingenius).  This  system  exploits  the  feature  that  PCRs  performed  in  the  presence  of  Taq 
polymerase  have  an  adenosine  residue  5'  overhang  on  the  ends  of  the  amplified 
fragment.  This  facilitates  the  cloning  of  PCR  products  into  a  vector  which  has  a 
complementary  thyrnidine  residue  overhang.  Restriction  analysis  of  transformants 
revealed  that  the  5'  RACE  products  had  been  cloned  into  pTAg-  Sequencing  of  the 
RACE  clones  was  carried  out  on  both  strands  using  the  -20  primer  and  the  M  13  reverse 
primer  (Perkin  Elmer).  The  sequence  of  the  5'  RACE  products  were  found  to  be 
identical  to  the  cDNA  clones  41  oo  and  5  100,  but  with  additional  5'  sequence  as  outlined 
in  Figure  4.17  and  4.18,  as  indicated  by  red  text. 
4loo  ATT=AGACAACATG 
5loo(l)  A=ATATAAAAGATG 
5100(2)  AAAGATG 
Sequence  analysis*of  the  mgII  and  mg12  RACE  clones  showed  that  the  5'  ends  of  each 
of  the  genes  had  been  amplified.  Only  one  RACE  clone  for  mgIlwas  obtained. 
However,  the  sequence  of  this  clone  was  identical  to  the  cDNA  sequence  isolated  from 
107 the  cDNA  library  and  showed  that  the  ATG  codon  present  at  the  beginning  of  this 
cDNA  probably  does  encode  the  start  methionine  of  this  gene.  The  S'  RACE  of  mgIJ 
also  revealed  that  the  5'  UTR  is  very  short,  being  only  some  13  nucleotides  long. 
For  mgI2  two  independent  5'  RACE  products  were  obtained.  Both  clones  possess  the 
methionine  start  codon,  which  was  absent  from  the  copy  of  the  gene  isolated  from  the 
cDNA  library.  The  5'  RACE  clones  for  mgI2  show  that  the  clone  isolated  from  the 
cDNA  library  was  only  12  base  pairs  short  of  the  nucleotides  encoding  methionine  start 
codon.  As  found  with  the  mgII  RACE  clone  there  was  a  very  short  5'  UTR  region 
which  was  only  14  nucleotides  in  length. 
4.2.13  Analysis  of  mgII  and  mgI2  sequence. 
Once  the  full  nucleotide  sequence  of  each  clone  was  obtained  a  number  of  analyses  were 
conducted  using  various  programmes  available  from  the  University  of  Wisconsin, 
Genetics  Computer  Group  (GCG).  The  nucleotide  sequences  of  the  open  reading 
frames  of  mgll  and  mgl2  were  converted  into  peptide  sequence  using  the  TRANSLATE 
program,  and  these  sequences  were  compared  to  two  available  sequences  of  methionine 
y-lyase  from  Pseudomonas  putida  and  to  cystathionine  y-lyase  from  yeast  and  human. 
Both  GAP  and  PILE-UP  applications  were  used  to  establish  the  percentage  identity  and 
the  percentage  similarity  between  the  different  sequences  of  interest  and  also  illustrate 
regions  of  homology  and  dissimilarity  in  peptide  sequence.  It  must  be  remembered  that 
the  methionine  y-lyase  sequences  of  P.  putida  was  not  available  when  this  project  was  - 
initiated  and  they  were  not  used  to  determine  the  sequence  of  the  degenerate 
oligonueleotides  used  in  PCRs.  Figure  4.22  shows  the  pile-up  comparison  of  the 
peptide  sequences  of  the  two  T  vaginalis  methionine  y-lyase  homologues,  TvMGLI  and 
108 TvMGL2  with  methionine  y-lyase  sequences  from  P.  putida  (PpMGLl  and  PpMGL2, 
Inoue  et  al.,  1995  and  Hori  et  aL,  1996  respectively)  and  cystathionine  y-lyase  from  yeast 
(ScCYS3)  (Ono  et  al.,  1992)  and  human  (HsCGL)  (Lu  et  al.,  1990).  Regions  of  amino 
acid  identity  found  in  all  sequences  are  indicated  by  black  boxes.  Amino  acid  residue 
identity  between  the  two  trichomonad  gene  products  and  the  two  methionine  y-lyases  of 
P.  putida  are  shown  by  a  #.  Points  of  interest  that  arise  from  the  peptide  sequence 
comparisons  are  as  follows: 
Firstly,  there  is  significant  amino  acid  identity  in  the  regions  to  which  the  degenerate 
oligonucleotides  were  designed  for  the  PCRs,  as  indicated  by  a  solid  black  line  in  Figure 
4.22.  This  feature  undoubtedly  contributed  to  the  success  of  cloning  T  vaginalis 
homologues  for  cystathionine  7-lyase.  Analysis  of  the  amino  acid  sequence  over  which 
the  3'Cyst  degenerate  oligonucleotide  was  designed  reveals  the  following  features. 
The  amino  acids  between  residues  A207  and  G213  (numbering  is  based  on  that  of  the 
TvMGLI  sequence)  are  identical  in  all  of  the  sequences  compared  except  for  the  amino 
acid  residues  at  positions  at  211  and  212.  Amino  acid  residue  identity  between  al  I  of  the 
sequences  also  extends  outside  region  to  where  the  Cyst  3'degenerate  was  designed, 
with  residues  being  identical  at  S206,  H214  and  D216.  There  is  such  a  high  degree  of 
conservation  in  sequence  between  species  within  this  region  because  it  represents  the 
pyridoxal  5'  phosphate  (PLP)  binding  domain  of  the  enzyme  (Nakayama  et  al.,  1988). 
The  region  between  residues  V151  and  N158  also  has  a  high  degree  of  amino  acid 
identity  between  the  different  species,  but  not  as  much  as  the  PLP  binding  region  of  the 
enzyme.  This  second  region  was  selected  for  the  design  of  the  Cyst  5'  degenerate 
oligonucleotides  for  PCR,  as  a  region  which  had  a  high  degree  of  peptide  sequence 
identity  between  the  relevant  sequences.  It  can  be  seen  that  there  is  identity  in  all 
109 residues  of  the  all  of  the  sequences  at  positions  E153,  P155  and  N158,  however,  there 
are  also  differences.  At  positions  Y152,  F153  and  A156  there  is  identity  in  all  of  the 
residues  between  the  four  known  methionine  y-lyase  sequences,  but  not  in  the 
cystathionine  y-lyases,  whereas  at  position  V  15  1  there  is  identity  between  the  two  T 
vaginalis  sequences  and  the  cystathionine  y-lyase  sequences  of  yeast  and  human. 
Secondly,  other  regions  of  identity  between  all  of  the  sequences  include  the  DNT  motif 
between  residues  184  and  186,  the  YPG  motif  between  residues  289  and  291,  the  SLG 
motif  beginning  at  residue  338,  the  ESL  motif  starting  at  residue  343  and  the  SVG  motif 
between  475  and  478.  As  such  regions  of  peptide  sequence  are  conserved  between  the 
methionine  y-lyases  of  P.  putida,  the  cystathionine,  -f-lyase  of  yeast  and  human  and  the  T 
vaginalis  homologues  this  would  intimate  that  such  residues  are  important  for  the 
function  of  the  enzyme.  They  could  for  example  be  important  in  maintaining  a  certain 
tertiary  structure  that  is  important  in  the  function  of  y-elimination  enzymes. 
Thirdly,  there  are  also  amino  acid  residues  that  are  exclusively  conserved  between  the 
methionine  y-lyases  of  T  vaginalis  and  P.  putida  (as  indicated  in  Figure  4.22).  There 
are  81  residues  that  are  identical  between  the  methionine  y-lyases  of  T  vaginalis  and  P. 
putida  in  addition  to  those  conserved  in  both  the  cystathionine  and  methionine  y-lyases, 
this  represents  a  20%  identity  of  the  residues  between  the  methionine  y-lyases  when 
expressed  as  a  percentage  of  the  total.  For  example,  there  is  a  three  amino  acid  motif 
beginning  at  Y30  along  with  a  region  between  G236  and  T241  in  which  four  of  the  six 
amino  acid  residues  located  in  this  region  are  identical  between  the  methionine  y-lyase 
sequences.  There  are  also  identical  single  amino  acid  residues  present  throughout  the 
110 methionine  y-lyase  sequences,  one  of  these  such  residues  is  that  of  C  113  (as  indicated  by 
a*  in  Figure  4.23),  which  has  been  implicated  in  being  catalytically  important,  but  not 
essential  (Nakayama  et  al.,  1988)  to  pyridoxal  5'  phosphate  binding  in  the  so  called 
class  of  PLP-linked  enzymes,  as  defined  by  Alexander  et  al.,  1994. 
Fourthly,  there  is  a  seven  amino  acid  insertion  between  residues  G49  and  155  in  all  of 
the  methionine  y-lyase  sequences  when  compared  to  cystathionine  y-lyase  from  yeast 
and  human. 
Table  4.1  shows  in  tabulated  form  the  %  identity  and  %  similarity  in  amino  acid 
residues  between  TvMGL  I  and  TvMGL2,  the  methionine  y-lyases  from  P.  putida  and 
cystathionine  7-lyase  from  yeast  and  human.  Also  included  in  this  table  are  the  % 
identities  and  similarities  between  the  former  amino  acid  sequences  and  sequences  from 
other  proteins  involved  in  sulphur  amino  acid  metabolism  in  yeast  and  E.  coli,  namely  S. 
cerevisiae  O-acetyl  homoserine  sulphydrylase  (Kerjan  et  aL,  1986)  and  E.  coli 
cystathionine  y-synthase  (Duchange  et  aL,  1983)  and  cystathionine  P-lyase  (Belfaiza  et 
aL,  1986).  TvMGLI  and  TvMGL2  have  more  sequence  identity  to  each  other  (69%) 
than  to  the  methionine  y-lyase  and  cystathionine  y-lyase  from  other  species  (42-44%).  It 
is  interesting  to  note  the  two  methionine  y-lyase  gene  homologues  from  T  vaginalis  are 
really  no  more  identical,  in  terms  of  amino  acid  residues  to  methionine  y-lyase  from  P. 
putida  than  to  cystathionine  7-1yase  from  yeast  or  human  The  percentage  identity 
between  TvMGLI  and  P.  putida  MGL1  and  yeast  cystathionine  y-lyase  (CTL)  is 
identical  at  44%  and  the  percentage  identity  between  TvMGL2  and  P.  putida  MGL  I  and 
yeast  CTL  is  45%  and  43%  respectively.  Amino  acid  sequence  comparison  of  the  two 
III T  vaginalis  methionine  y-lyase  homologues  with  the  sequences  of  related  sulphur 
amino  acid  metabolising  enzymes  from  yeast  and  E.  coli  reveals  that  they  have  lower 
overall  sequence  identities  and  similarities  than  with  the  methionine  y-lyase  of  P.  putida 
or  cystathionine  y-lyase,  of  K  coli.  MGLI  has  35%,  37%  and  30%  identity  to  yeast  0- 
acetyl  homoserine  sulPhydrylase  and  E.  coli  cystathionine  y-synthase  and  cystathionine 
P-lyase  respectively,  with  MGL2  having  38%  identity  to  both  yeast  O-acetyl  homoserine 
sulphydrylase  and  E.  coli  cystathionine  y-synthase  and  30%  identity  to  cystathionine  P- 
Iyase  of  E.  coli. 
4.2.14  Genomic  organisation  and  expression  of  mg1land  mg12  T.  vaginalis 
methionine  y-lyase  homologues. 
The  genomic  organisation  and  expression  of  mgII  and  mgI2  was  also  investigated. 
Genomic  DNA  from  T  vaginalis  was  digested  with  a  variety  of  restriction  enzymes  and 
resolved  by  agarose  gel  electrophoresis  prior  to  transfer  to  a  Hybond  N  filter 
(Amersham)  by  the  method  of  Southem  (1975).  The  immobilised  T  vaginalis  genomic 
DNA  was  then  subjected  to  analysis  by  hybridisation  with  specific  mg1land  mg12 
probes.  The  mgll  probe  was  made  by  digesting  the  4100  plasmid  with  EcoRl  and  Ahol, 
which  released  aI  kb  EcoRIIXhoI  fragment  along  with  a  300bp  XhoI  fragment.  It  was 
the  larger  I  kb  fragment  that  was  isolated  from  this  double  digest  which  was 
radioactively  labelled  using  a  random  priming  method  and  subsequently  used  for 
hybridisation  to  the  T  vaginalis  genomic  DNA.  Figure  4.23  illustrates  the  result  of 
Southern  blot  analysis  of  T  vaginalis  genomic  DNA  restricted  with  a  variety  of 
restriction  enzymes  and  the  mgII  specific  EcoRIIXhol  fragment.  Table  4.2  summarises 
112 the  sizes  of  the  hybridising  fragments  after  Southern  analysis.  Single  hybridising  bands 
for  BamHI,  EcoRI,  EcoRV,  Pstl,  Smal  and  SphI  indicate  that  mgII  is  at  single  copy  in 
the  T  vaginalis  genome.  Restriction  of  T  vaginalis  genomic  DNA  with  HincII  and 
HindIII  results  in  more  than  one  hybridising  band,  which  is  due  to  the  presence  of  that 
particular  restriction  enzyme  site  in  the  gene  fragment  used  as  the  probe  for  the  Southern 
hybridisation.  However,  there  is  more  than  one  hybridising  band  present  for  the  T 
vaginalis  DNA  which  was  restricted  withAhol,  this  most  probably  arises  as  the  result  of 
a  partial  restriction  digest  of  the  T  vaginalis  DNA  with  this  particular  enzyme. 
Figure  4.24  illustrates  the  result  of  Southern  blot  hybridisation  after  differently  restricted 
T  vaginalis  genomic  DNA  was  hybridised  with  a  800bp  fragment  of  mgI2.  The  mgI2 
probe  was  made  by  digesting  the  5  100  plasmid  with  EcoRl  and  Xhol  which  released  two 
fragments  of  800bp  and  400bp  in  size.  The  larger  800bp  fragment  was  gel  purified  and 
radioactively  labelled  using  a  random  priming  method  and  used  in  hybridisation 
experiments  with  T  vaginalis  genomic  DNA.  Hybridisation  of  the  radioactively 
labelled  mgI2  probe  to  the  T  vaginalis  genomic  DNA  and  the  subsequent  washing  of 
the  filters  were  performed  at  high  stringency.  As  can  be  seen  from  Figure  4.24  single 
hybridising  bands  are  obtained  with  the  restriction  enzymes  BamHl,  EcoRI,  HinclI, 
HindIll,  SmaI  and  Sphl,  the  sizes  of  which  are  summarised  in  Table  4.3.  Such  a  result 
indicates  that  mgI2  is  also  at  single  copy  in  the  T  vaginalis  genome,  with  the  presence 
of  more  than  one  band  with  the  restriction  enzymes  EcoRV  and  Sall  and  being  due  to 
the  presence  of  that  particular  restriction  enzyme  site  within  the  800bp  mgI2  probe. 
When  the  EcoRV  restriction  sites  are  considered  for  the  800bp  mgI2  probe  one  would 
expect  hybridising  fragments  of  >570bp,  70bp,  120bp  and  421bp  (See  Figure  4.18).  The 
113 Southern  blot  data  agrees  well  with  the  sizes  of  hybridising  fragments  expected,  as  two 
bands  of  7kb  and  -500bp  were  obtained,  the  smallest  EcoRV  bands  are  probably  not 
detected  on  the  Southern  blot  due  to  their  small  size.  Once  again  there  is  more  than  one 
hybridising  band  present  when  T  vaginalis  genomic  DNA  is  restricted  with  Xhol  which 
is  probably  explained  by  a  partial  restriction  digest  of  the  DNA  with  this  particular 
enzyme. 
It  is  also  interesting  to  note  from  the  Southern  blots  that  EcoRI  restricted  T  vaginalis 
genomic  DNA  gives  a  7.5kb  hybridising  fragment  when  probed  with  both  the  mgll  and 
mgI2  gene  fragments.  This  may  indicate  that  both  mgll  and  mgl2  genes  fragment  are 
linked.  If  indeed  this  is  the  case  then  this  would  suggest  that  mg11  and  mg12  may  have 
arisen  via  a  gene  duplication  event.  The  genomic  copies  of  mgII  and  mgI2  have 
subsequently  been  cloned  by  an  inverse  PCR  approach  by  T.  D  Edlind,  whilst  on 
sabbatical  to  Dr.  Mottram's  laboratory.  Genomic  cloning  and  sequencing  was  achieved 
by  Cal  digestion  of  T  vaginalis  genomic  DNA,  which  resulted  in  a  3.5  kb  Cal 
fragment  being  cloned  for  mgII  and  a  2.6  kb  CIaI  fragment  being  cloned  for  mgI2. 
Sequencing  of  the  two  Clal  fragments  for  mgll  and  mgI2  has  shown  that  the  two  genes 
are  not  tandemly  arranged.  (T.  D.  Edlind,  personal  communication). 
4.2.15  Northern  blot  analysis  of  T.  vaginalis  total  and  polyJAI+  RNA  with  mgII  and 
mgI2  specific  probes. 
Expression  of  mgI1  and  mgI2  was  also  investigated.  Figure  4.25  shows  Northern  blot 
analysis  of  T  vaginalis  total  and  poly[A]+  RNA  probed  with  the  mgII  and  mgI2  gene 
fragments,  in  which  the  probe  material  was  prepared  in  the  same  way  as  for  the 
Southems  (see  above).  The  two  genes  are  transcribed  to  give  identical  size  mRNAs  of 
114 1.3kb.  The  size  of  the  transcripts  agrees  well  with  the  size  of  the  cDNAs  isolated  from 
the  library  and  shows  that  the  clones  isolated  were  almost  full  length. 
4.3  Discussion 
The  use  of  degenerate  oligonucleotides  designed  against  conserved  regions  of  protein 
sequence,  in  PCRs,  is  a  strategy  that  has  successfully  used  for  the  isolation  of 
homologous  genes  in  parasitic  protozoa  and  nematodes  (Sakanari  et  al.,  1989).  More 
specifically,  cyclin  dependent  kinases  have  been  isolated  from  Trypanosoma  bruce! 
using  this  approach  (Mottram.  and  Smith,  1995),  as  has  a  rho  family  gene  from  E. 
histolytica  (Lohia  and  Samuelson,  1993).  Several  genes  from  T  vaginalis  have  also 
been  isolated  using  this  approach,  some  of  these  include  P-glycoprotein,  a  70  kDa 
cytosolic  heat  shock  protein,  P  tubulin  and  the  a  subunit  of  succinyl  CoA  synthetase  (all 
these  proteins  are  referenced  in  Quon  et  aL,  1994)  cysteine  proteinase  genes  (Mallinson 
et  aL,  1994)  and  adenosylhornocysteinase  genes  (Bagnara  et  aL,  1996). 
Due  to  the  success  of  the  cloning  of  many  genes  from  various  parasitic  protozoa 
including  T  vaginalis,  by  the  degenerate  oligonucleotide/  PCR  strategy,  it  was  thought 
that  such  an  approach  may  also  be  successful  in  obtaining  T  vaginalis  methionine  y- 
Iyase  gene  homologues. 
The  sequence  of  the  degenerate  oligonucleotides  used  in  this  study  were  based  on  the 
sequences  of  human,  rat  and  yeast  cystathioniney-lyase.  This  approach  allowed  the 
isolation  of  two  genes,  both  of  which  have  high  sequence  homology  to  cystathionine  g- 
lyase  from  a  variety  of  sources  and  to  methionine  y-lyase  which  was  isolated  from 
115 Pseudomonas  putida  in  1995  (Inoue  et  al.,  1995  and  was  sequence  information  that  was 
not  available  when  this  project  was  initiated). 
The  reason  for  the  success  in  isolating  the  T  vaginalis  methionine  y-lyase  homologues 
became  clear  when  a  comparison  of  the  regions  of  homology  used  initially  for  the 
design  of  the  degenerate  oligonucleotides  was  performed  using  the  actual  protein 
sequences  derived  from  the  two  isolated  methionine  y-lyase  gene  homologues. 
The  region  chosen  for  the  design  of  the  5'  degenerate  oligonucleotide,  a  region  that  had 
a  high  degree  of  sequence  homology  between  all  of  the  different  sequences  for 
cystathionine  7-1yase  has  five  out  of  the  eight  amino  acid  residues  chosen  for  the  design 
of  the  Cyst  5'  oligonucleotide  that  are  identical  between  the  designed  oligonucleotide 
and  the  actual  amino  acid  sequence  of  the  two  genes  that  were  isolated.  The  other  three 
residues  W151  and  1152  and  T156  encoded  in  the  Cyst  5'  oligonucleotide  are 
conservative  substitutions  in  mgll  and  mgI2  (See  Figures  4.1  a  and  4.1  b  for  reference). 
Secondly,  the  pyridoxal  5  phosphate  binding  region  which  was  chosen  for  the  design  of 
the  3'  degenerate  oligonucleotide,  has  five  out  of  seven  identical  mnino  acid  residues  in 
the  sequences  that  are  compared  in  Figures  4.1  a  and  4.1  b. 
There  are  a  number  of  other  points  that  raise  themselves  for  discussion,  when  the 
predicted  protein  sequences  of  the  two  T  vaginalis  methionine  y-lyase  homologues  are 
compared  to  the  protein  sequences  of  methionine  y-lyase  from  P.  putida, 
to  cystathionine  y-lyase  from  both  yeast  and  human  and  also  to  other  related  pyridoxal 
5'-phosphate  linked  enzymes  from  E.  coli  and  yeast. 
116 Firstly,  the  two  T  vaginalis  genes  are  only  69%  identical  to  one  another  (Table  4.1)an 
inference  that  can  be  made  from  this  comparison  is  that  the  two  methionine  y-lyase 
cDNAs  isolated  from  T  vaginalis  are  unlikely  to  be  allelic,  as  they  have  a  low  degree  of 
identity  to  one  another. 
Secondly,  MGL  I  has  the  same  %  identity  to  both  methionine  y-lyase  from  P.  putida  and 
cystathionine  y-lyase  from  yeast  (44%),  whereas  MGL2  has  a  slightly  higher  identity  to 
methionine  y-lyase  I  from  P.  putida  (45%)  and  a  slightly  lower  identity  to  yeast 
cystathionine  y-lyase  (43%).  The  two  T  vaginalis  methioniney-lyase  homologues  also 
have  significant  percentage  identities  to  other  related  pyridoxal  5'-phosphate  linked 
enzymes  involved  in  sulphur  amino  acid  metabolism  in  yeast  and  E.  coli  (see  Table  4.1). 
Thus,  it  is  difficult  to  deduce,  based  on  sequence  comparison  data  what  enzyme  is 
encoded  by  the  two  T  vaginalis.  The  fundamental  question  that  needs  to  be  addressed 
is  as  follows:  -Do  the  genes  in  T  vaginalis  encode  a  methionine  y-lyase  or  do  they 
encode  a  cystathionine  y-lyase  or  do  they  encode  both  enzyme  activities? 
In  their  1995  paper  Inoue  et  al.,  report  the  primary  structure  of  methionine  y-lyase  from 
P.  putida,  as  deduced  from  its  nucleotide  sequence.  They  show  that  methionine  y-lyase 
from  P.  putida  has  extensive  homology  with  other  known  y  elimination  and  y- 
replacement  PLP  dependent  enzymes,  such  as  cystathionine  y-lyase  (Ono  el  al.,  1992), 
cystathionine  y  synthase  (Duchange  et  al.,  1983)  and  0-acetylhomoserine  0-acetylserine 
sulphydrylase  (Kedan  et  al.,  1986)  The  percentage  similarity  of  amino  acid  residues 
between  the  enzymes  outlined  above,  P.  putida  methionine  y-lyase  and  the  T  vaginalis 
homologues  are  at  the  same  order  of  magnitude  (38%-27%,  see  Table  4.1  fordetails)as 
117 reported  by  Inoue  et  al.,  1995.  Figure  4.26  shows  an  amino  acid  residue  comparison 
between  all  of  the  PLP-linked  enzymes  mentioned  above  and  cystathionine  P-lyase  from 
E.  coli  (Belfaiza  et  al,  1986)  This  figure  illustrates  the  amino  acid  residues  that  are 
conserved  between  all  of  the  sequences.  The  conservation  of  certain  residues  in  all  of 
the  PLP-linked  enzyme  sequences  intimate  that  these  residues  are  important  for 
maintaining  the  general  structural  or  catalytic  characteristics  of  y-elimination  enzymes. 
Recently,  this  has  been  confirmed  by  an  analysis  of  the  3D  structure  of  cystathionine  P- 
lyase  of  E.  coli  which  has  recently  been  crystallised  (Clausen  et  aL,  1996). 
Cystathionine  P-lyase,  even  though  it  catalyses  P-climination  and  replacement  reactions 
has  been  attributed  to  the  so  called  g  class  of  PLP-linked  enzymes  as  described  by 
Alexander  et  al.,  1994.  Points  of  interest  that  arise  from  the  3D  structure  of 
cystathionine  P-lyase,  which  may  be  relevant  to  future  determinations  of  the  crystal 
structure  of  methionine  y-lyase  from  T  vaginalis  are  as  follows:  Firstly,  the  N-terminal 
domain  of  cystathionine  P-lyase  is  composed  of  three  (x-helices  and  I  P-strand,  this 
domain  contributes  to  the  tetramer  formation  of  the  protein  and  a  part  of  its  active  site. 
The  second  domain  of  the  protein  harbours  the  cofactor,  pyridoxal  5'-phosphate  and  the 
C-terminal  domain  is  connected  by  a  long  a-helix  to  the  PLP-binding  domain  and 
consists  of  four  helices  packed  on  a  solvent  accessible  site  of  an  anti  parallel  four 
stranded  P-sheet.  Specific  residues  that  have  been  implicated  in  the  catalytic  function  of 
cystathionine  P-lyase  are  as  follows:  Arginine  59  anchors  the  distal  carboxylate  group 
of  the  cystathionine  substrate,  Alanine  87  forms  a  hydrogen  bond  with  the  second 
phosphate  group  of  the  PLP  cofactor  and  finally  Tyrosine  338  is  one  of  three  aromatic 
residues  which  may  be  involved  in  active  site  screening.  The  3D  structure  of 
118 cystathionine  P-lyase  will  provide  a  useful  base  for  any  ftiture  molecular  modelling  with 
T  vaginalis  methionine  y-lyase. 
As  can  be  seen  the  regions  of  homology  are  distributed  throughout  all  the  amino  acid 
sequences,  which  suggests  that  the  genes  encoding  the  above  proteins  may  have  evolved 
from  a  common  ancestor.  This  is  a  theory  that  has  already  been  proposed  by  Belfaiza  et 
al.,  1986  to  explain  similarities  between  the  methionine  biosynthetic  enzymes  of  E.  coli. 
It  is  interesting  to  note  that  the  O-acetylhomoserine  sulphydrylase  from  yeast  has  two 
distinct  insertions  in  its  sequence  starting  at  positions  D224  and  D356,  it  is  probable  that 
these  insertions  contribute  highly  to  the  enzymatic  specificity  of  this  particular 
molecule,  which  involves  the  synthesis  of  homocysteine  from  OAH  and  a  sulphur 
donor,  such  as  hydrogen  sulphide,  this  enzyme  function  may  have  arisen  by  an 
additional  gene  duplication  event  when  compared  to  the  other  enzymes  involved  in 
transulphuration  pathways. 
Figure  4.26  also  illustrates  differences  in  amino  acid  residues  between  the  different 
proteins,  which  one  could  imagine,  arose  through  mutations  in  the  common  ancestral 
gene  and  therefore  lead  to  the  specialisation  of  the  encoded  proteins.  When  one  looks 
more  specifically  at  the  amino  acid  sequences  of  the  T  vaginalis  methionine  y-lyase 
hornologues,  the  P.  putida  methionine  y-lyase  sequences  and  the  sequences  of 
cystathionine  y-lyase  from  yeast  and  human  there  are  a  number  of  points  that  raise 
themselves  for  discussion. 
119 Firstly,  as  can  be  seen  from  Figure  4.22  and  as  outlined  in  the  results  section  of  this 
chapter  there  are  residues  in  the  sequences  of  the  methionine  y-lyases  from  T  vaginalis 
and  P.  putida  that  are  identical,  for  example  Y29,  Q3  0  and  T3  1,  the  residues  at  the  same 
positions  in  the  yeast  and  human  cystathionine  y-lyase  are  S29,  L30  and  S3  1.  This 
comparison  of  the  amino  acid  residues  at  this  particular  region  in  the  molecules  shows 
immediately  that  the  hydrophobic  tyrosine  residue  at  position  29  in  the  methionine  y- 
Iyases  has  changed  to  a  hydrophilic  serine  residue  in  the  cystathionine  y-lyases.  The 
differences  between  the  other  residues  in  the  two  enzymes  are  more  conservative 
substitutions  with  the  glutarnine  at  position  30  and  the  threonine  at  position  31  being 
substituted  for  leucine  and  serine  residues  respectively.  These  particular  differences 
between  the  methionine  y-lyases  of  T  vaginalis  and  P.  putida  support  the  view  that 
mutations  in  an  ancestral  gene  could  account  for  enzyme  specialisation,  with  for 
example,  the  hydrophobic  for  hydrophilic  residue  substitution  at  position  30,  being 
important  for  the  catalytic  breakdown  of  methionine  or  for  maintaining  a  hydrophobic 
region  in  the  tertiary  structure  of  the  protein.  Such  a  view  may  be  similarly  applied  to 
other  differences  or  similarities  in  amino  acid  residues  between  the  methionine  y-lyases 
of  T  vaginalis  and  P.  putida  and  the  cystathionine  y-lyases  of  yeast  and  human. 
Secondly,  earlier  studies  by  Nakayama  et  aL,  1988a  and  b  show  that  methionine  y-lyase 
from  P.  putida  contains  a  four  cysteine  residues  in  each  subunit  of  which  Cys  116  is 
catalytically  important  but  not  essential  and  is  located  close  the  PLP  binding  site  of  the 
enzyme.  Cyanylation  of  Cys  116  resulted  in  substantial  inactivation  of  methionine  g- 
Iyase  with  respect  to  both  the  ay  and  ap  elimination  reactions.  The  authors'  sequence 
comparison  with  other  various  y  elimination  and  y  replacement  pyridoxal  5'  phosphate 
120 dependent  enzymes  (mentioned  above,  Inoue  et  aL,  1995)  show  that  this  important 
cysteine  residue  is  not  conserved  in  these  enzymes.  The  authors  infer  that  it  this  unique 
cysteine  residue  in  methionine  y-lyase  of  P.  putida  that  makes  it  different  from  the  other 
pyridoxal  5'  phosphate  sulphur  amino  acid  metabolising  enzymes  to  which  it  is 
compared.  What  is  really  interesting  is  that  both  of  the  T  vaginalis  methionine  7-lyase 
homologues  contain  a  cysteine  residue  at  the  same  position  (C  113)  and  this  cysteine 
residue  is  not  conserved  in  the  cystathionine  7-1yase  genes  of  yeast  or  human.  An 
inference  from  this  is  that  the  two  genes  isolated  from  T  vaginalis  may  well  encode 
methionine  y-lyase  and  it  is  this  essential  cysteine  residue  that  makes  the  molecule  a 
methionine  y-lyase  rather  than  a  cystathionine  -y-lyase.  However,  such  a  suggestion 
should  be  considered  with  caution  as  it  is  unlikely  that  a  single  amino  acid  residue 
difference  at  the  active  site/PLP  binding  region  of  the  enzyme  could  wholly  contribute 
to  different  substrate  specificities  between  methionine  y-lyase  and  cystathionine  y-lyase, 
especially  as  there  are  several  other  amino  acid  residues  that  are  unique  to  the 
methionine  7-1yases  of  T  vaginalis  and  P.  putida. 
Methionine  y-lyase  in  anaerobic  bacteria  such  as  P.  pulida  and  in  anaerobic  protists  such 
as  T  vaginalis  may  have  evolved  before  cystathionine  y-lyase  and  indeed  there  is  no 
cystathionine  y-lyase  present  in  bacteria.  Certainly,  it  has  been  shown  that  T  vaginalis 
is  an  ancient  eukaryote,  based  on  a  number  of  phylogenetic  studies  (Sogin,  1993  and 
Doolittle  et  aL,  1996  )  and  that  they  branched  early  during  eukaryote  evolution.  The 
phylogenetic  position  of  T  vaginalis  may  explain  why  this  ancient  organism  possesses 
methionine  catabolising  capabilities  that  are  identical  to  anaerobic  prokaryotes  and  why 
121 more  recently  evolved  organisms  such  as  yeast  and  humans  possess  cystathionine  y- 
Iyase  rather  than  methionine  y-lyase. 
Presence  of  a  string  of  A  residues  at  the  3'  end  of  the  cDNAs  indicated  that  the  cDNA 
was  derived  from  a  polyadenylated  mRNA  and  was  not  a  genomic  DNA  fragment. 
Tbe4loo  cDNA  had  an  insert  of  1235bp,  had  a  methionine  start  codon  at  its  5'  end  but 
had  no  sequence  upstream  of  this  start  codon.  The  5,00  cDNA  gene  isolated,  in  contrast, 
was  1287bp  in  length  but  was  missing  a  methionine  start  codon  and  therefore  any 
upstream  5'  sequence.  The  initial  isolation  and  preliminary  sequencing  of  the  two 
cDNAs  lead  to  the  thought  that  4,00  possessed  its  true  methionine  start  and  that  it  was 
missing  only  a  few  nucleotides  that  would  make  up  the  5'untranslated  region  (5'UTR) 
of  the  gene.  Also,  it  was  thought  that  5  100  was  only  missing  the  nucleotides  that  would 
comprise  the  methionine  start  site  of  the  gene  along  with  the  5'UTR.  The  belief  that  the 
two  genes  were  probably  almost  full  length  was  supported  by  the  Northern  blot  data 
generated  for  the  two  genes.  Northern  blots  showed  that  both  mgII  and  mgJ2  were 
being  actively  transcribed  to  transcript  sizes  of  1.3kb,  a  size  that  is  only  slightly  larger 
than  the  insert  sizes  of  the  4100  and  5loo  cDNAs. 
5'  RACE-PCR  was  performed  to  confirm  the  methionine  start  site  for  the  mgll 
transcript  and  to  detennine  the  methionine  codon  for  mgI2  and  to  obtain  the  S'UTR  for 
transcripts  for  both  genes,  the  5'  ends  of  the  mgll  and  mgI2  transcripts  were  obtained  by 
5'  RACE  confinned  that  the  start  codon  present  in  the  copy  of  mgII  cDNA  isolated 
from  the  T  vaginalis  library  was  indeed  genuine.  5'  RACE  also  revealed  the 
methionine  start  codon  of  the  mg12  transcript  and  confirmed  that  the'clone  isolated  from 
the  cDNA  library  was  only  twelve  nucleotides  of  being  full  length  (see  Figure  4.18). 
122 The  S'  UTRs  of  mgll  and  mg12  transcripts  are  thirteen  and  fourteen  nucleotides 
respectively.  The  short  5'  ends  of  mgII  and  mgI2  agrees  with  the  short  51UTR  data  that 
have  been  characteristically  obtained  for  other  T  vaginalis  genes.  Quon  et  aL,  (1994) 
have  characterised  seven  protein  coding  genes  from  T  vaginalis  and  have  revealed  the 
presence  of  a  highly  conserved  DNA  sequence  motif  immediately  upstream  of  the 
coding  region  of  these  genes.  They  also  found  no  typical  TATA  box  was  present  at  a 
position  of  25-30  nucleotides  upstream  of  the  transcription  start  sites  of  these  genes,  as 
found  in  many  other  eukaryotic  genes.  Quon  et  aL,  (1994)  propose  that  the  conserved 
motif  in  their  seven  protein  coding  genes  acts  as  an  initiator  (Inr)  element  that  is  able  to 
recruit  RNA  polymerase  and  associated  transcription  factors  necessary  for  accurate  , 
transcription  initiation.  Such  initiator  elements  are  also  found  in  mammalian  genes  that 
lack  a  traditional  TATA  motif  and  in  such  TATA-less  promoters,  the  Inr  element  is 
critical  in  positioning  RNA  polymerase  11  (for  review  see  Weis  and  Reinberg,  1992). 
Outlined  in  Figure  4.27  are  the  conserved  nucleotide  sequences  surrounding  the 
transcription  initiation  site  of  the  seven  protein  coding  genes  as  characterised  by  Quon  et 
al,  1994  and  these  are  compared  to  the  5'  UTRs  of  mg1land  mgI2  transcripts  as 
characterised  by  5'  RACE  (see  Figures  4.21  and  4.22). 
As  can  be  seen  from  Figure  4.27  the  5'  UTRs  characterised  from  transcripts  derived 
from  the  genes  mgII  and  mgI2,  even  though  characteristically  short,  appear  to  share  only 
part  of  the  consensus  as  drawn  up  by  Quon  et  aL,  1994.  The  explanation  for  this  may  be 
that  the  genes  isolated  by  Quon  et  al.,  1994  represent  a  bias  in  the  type  of  proteins  for 
which  they  are  encoding.  For  example  three  of  the  seven  proteins  are  derived  from  the 
hydrogenosome  of  the  parasite  and  it  may  be  that  proteins  present  in  this  unusual 
123 organelle  possess  a  characteristic  5'UTR  that  are  not  found  in  other  protein  coding 
genes.  Indeed  support  for  this  view  is  provided  by  the  same  group  of  workers  in  some 
of  their  later  work.  Quon  et  al,  1996  have  characterised  the  5'  end  of  an  RNA 
polymerase  11  gene  from  T  vaginalis  and  found  that  only  5  out  of  13  bp  match  the 
consensus  motif  outlined  above,  also  Bagnara  et  al.,  1996  comments  on  the  breakdown 
of  the  consensus  of  the  initiator  region  of  T  vaginalis  genes  as  more  T  vaginalis  genes 
are  characterised. 
The  isolation  and  sequencing  of  DNA  surrounding  genomic  copies  of  the  two  genes 
would  confirm  the  site  of  initiation  for  mgII  and  mgI2  and  would  confirm  the  sequence 
obtained  by  5'RACE.  It  would  also  allow  characterisation  of  the  upstream  flanking 
sequence  of  the  two  genes  and  indeed  confirm  whether  a  typical  TATA  motif  is  present 
in  these  two  methionine  y-lyase  gene  homologues  from  T  vaginalis.  It  is  also 
interesting  to  note  that  short  5'UTRs  are  characteristic  of  other  ancient  parasitic 
anaerobic  protists,  namely  Entamoeba  histolytica  (Edman  et  aL,  1987  and  1990  and 
Huber  et  aL,  1987  and  1988)  and  Giardia  lamblia  (Kirk-Mason  et  aL,  1989,  Alonso  and 
Peattie,  1992  and  Ey  et  aL,  1993).  Thus  T  vaginalis  and  these  other  organisms  can  be 
used  to  study  the  molecular  properties  underlying  transcription  initiation  in  early 
diverging  eukaryotes. 
In  conclusion,  the  data  presented  in  this  chapter  indicate  that  two  T  vaginalls 
methionine  y-lyase  gene  homologues  have  been  isolated,  they  have  extremely  short  S' 
untranslated  regions,  are  at  single  copy  in  the  T  vaginalis  genome  and  have  a  high 
degree  of  sequence  identity  and  similarity  to  genes  from  a  range  of  other  organisms  that 
are  involved  in  transulphuration  pAways. 
124 Figure  4.1a  Multiple  protein  sequcnce  alignment  of  cystathionine  y-lyase 
from  human,  HsCGL  (Lu  et  al.,  1992),  rat,  RnCGL  (Erickson  et  al.,  1990)  and 
yeast,  CYS3  (Ono  et  aL,  1992).  Regions  of  peptide  sequence  chosen  for  the 
design  of  degenerate  oligonucleotides  are  indicated  by  the  black  boxes.  Amino 
acid  residue  number  for  each  sequence  are  indicated  on  the  left  and  right-hand 
sides  of  the  sequences.  *  indicate  stop  codons  and  (.  )  show  gaps  introduced  to 
maximise  the  sequence  alignment.  The  multiple  sequence  alignment  was  obtained 
by  using  the  PILE-UP  program  of  the  University  of  Wisconsin  Genetics  Computer 
Group  (GCG). HsCGL  1  MQEKDASSQG  FLPHFQHFAT  QAIHVGQDPE  QWTSRAVVPP  ISLSTTFKQG  50 
RnCGL  1  CCGAA  HLLATTFKQD  15 
ScCYS3  1M  TLQESDKFAT  KAIHAGEHVD  VHGS..  VIEP  ISLSTTFKQS  39 
HsCGL  51  APGQHSG.  FE  YSRSGNPTRN  CLEKAVAALD  GAKYCLAFAS  GLAATVTITH  99 
RnCGL  16  SPGQSSG.  FV  YSRSGNPTRN  CLEKAVAALD  GAKHCLTFAR  GLAATTTITH  64 
ScCYS3  40  SPANPIGTYE  YSRSQNPNRE  NLERAVAALE  NAQYGLAFSS  GSATTATILQ  89 
HsCGL  100  LLKAGDQIIC  MDDVYGGTNR  YFRQVASEFG  LKISFVDCSK  IKLLEAAITP  149 
RnCGL  65  LLKAGDEVIC  MDEVYGGTNR  YFRRVASEFG  LKISFVDCSK  TKLLEAAITP  114 
ScCYS3  90  SLPQGSHAVS  IGDVYGGTHR  YFTKVANAHG  VETSFTN.  DL  LNDLPQLIKE  140 
HsCGL  150  ETKL  NPTQKVIDI  EGCAHIVHKH  G  ...  DIILVV  DNTFMSPYFQ  196 
KnCGL  115  QTKLOA"MRM  NPTLKLADI  KACAQIVHKH  K  ...  DIILVV  DNTFMSAYFQ  161 
ScCYS3  141  NTKLMMFM 
INPTLKVTDI 
QKVADLIKKH  AAGQDVILVV  DNTFLSPYIS  190 
HSCGL  197  RPLALGADIS.  MYS  SDVVMGLVS  VNCESLHNRL  RFLQNSLGAV  246 
RnCGL  162  RPLALGADIC  MCSý  M  SDVVMGLVS  VNSDDLNERL  RFLQNSLGAV  211 
ScCYS3  191  NPLNFGAbIV  VHSýll 
IIISDVVLGVLA 
TNNKPLYERL  QFLQNAIGAI  240 
HsCGL  247  PSPIDCYLCN  RGLKTLHVRM  EKHFKNGMAV  AQFLESN.  PW  VEKVIYPGLP  296 
RnCGL  212  PSPFDCYLCC  RGLKHCRSGW  RNTFQDGMAV  ARFLESN.  PR  VEKVIYPGLP  261 
ScCYS3  241  PSPFDAWLTH  RGLKTLHLRV  RQAALSANKI  AEFLAADKEN  VVAVNYPGLK  290 
HSCGL  297  SHPQHELVKR  QCTGC..  TGM  VTFYIKGTLQ  HAEIFLKNLK  LFTLAESLGG  344 
RnCGL  262  SHPQHELAKR  SARAC..  PGM  VSFYIKGTLQ  HAQVFLKNIK  LFALAESLGG  309 
ScCYS3  291  THPNYDVVLK  QHRDAIGGGM  ISFRIKGGAE  AASKFASSTR  LFTLAESLGG  340 
HsCGL  345  FESLAELPAI  MTHASVLKND  RDVLGISDTL  IRLSVGLEDE  EDLLEDLDQA  394 
RnCGL  310  YESLAELPAI  MTHASVPEKD  RATLGISDTL  IRLSVGLEDE  KDLLEDLGQA  359 
ScCYS3  341  IESLLEVPAV  MTHGGIPKEA  REASGVFDDL  VRISVGIEDT  DDLLEDIKQA  390 
HsCGL  395  LKAAHPPSGI  HS*  406 
RnCGL  360  LKAAHP*  365 
ScCYS3  391  LKQATN*  396 
125 Cyst  S'  degenerate  oligonucleotide.  31  nucleotides,  3  inosines. 
Amino  acid  residue  VWIETPTN 
Sense  nucleotide  sequence  51  GCAAGCTTGTITGGATTGAGACICCIACGAA  Y 
HindIII  CA 
AT 
C 
Cyst  3'  degenerate  oligonucleotide.  28  nucleotides,  2  inosines. 
M 
Amino  acid  residue  ATKYING 
Sense  nucleotide  sequence  5t  GCTACIAAGTACATIAACGG  31 
CAT 
G 
A 
antisense  nucleotide  51  GCCTCGAGCCGTTIATGTACTTIGTAGC  31 
sequence  XhoI  ATG 
C 
T 
Figure  4.1b  Degenerate  oligonucleotides  designed  to  conserved  regions  of 
cystathionine  y-lyase  from  yeast,  rat  and  human  (see  Figure  4.1  a).  The 
complementary  nucleotide  sequence  and  encoded  amino  acid  residues  of  the  Cyst  3' 
degenerate  oligonucleotide  are  shown  below  the  antisense  nucleotide  sequence  of  this 
oligonucleotide.  Inosine  residues  (I)  were  introduced  at  some  positions  of  4  fold 
degeneracy. 
126 Figure  4.2  Northern  analysis  of  T  vaginalis  total  and  poly  JAI'  RNA. 
1.5%  non-denaturing  agarose  gel  showing  T  vaginalis  total  and  poly  IA  I' 
RNA,  stained  with  ethidiurn  bromide  and  photographed  under  UV 
illumination. 
Lane  1:  1  ýig  T  vaginalis  poly  [A]'  RNA 
Lane  2:  1  ýtg  T  vaginalis  total  RNA 
Lane  3:  4pg  T  vaginalis  total  RNA 
No  markers  were  run  on  this  gel 
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1 Figure  4.3  PCR  of  T.  vaginalis  cDNA  with  degenerate  primers  designed  to 
cystathionine  y-lyase. 
PCRs  of  T  vaginalis  first  strand  cDNA  or  a  control  first  strand  cl)NA  Lising  the 
degenerate  oligonucleotides  Cyst  5and/or  Cyst  3'were  eicctroplioresed  in  a  2% 
TBE  agarose  gel,  stained  with  ethidium  bromide  and  photographed  under  I  IV 
illumination. 
Lanes  I  and  8:  1  kb  ladder  (Life  Technologies) 
Lane  2:  Cyst  5'  degenerate  oligonucleotide  and  T  vaginalis  first  strand  cl)NA 
Lane  3:  Cyst  5'  degenerate  oligonucleotide  and  control  reaction  cl)NA  synthesis 
Lane  4:  Cyst  3'  degenerate  oligonucleotide  and  7'  vaginalis  first  strand  cl)NA 
Lane  5:  Cyst  3'  degenerate  oligonucleotide  and  control  reaction  cl)NA  synthesis 
Lane  6:  Cyst  5'  and  Cyst  3'  degenerate  oligonucleotides  and  7'  vaginalis  first 
strand  cDNA 
Lane  7:  Cyst  5'  and  Cyst  3'  degenerate  oligonucleotides  and  control  reaction 
cDNA  synthesis kb 
1.6- 
1.0- 
0.5- 
0.34- 
0.22- 
0.15- 
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12345678 Figure  4.4  PCR  of  T.  vaginalis  cDNA. 
PCRs  were  electrophoresed  in  a  2%  TBF  agarosc  gel.  stained  mth  cthidiurn 
bromide  and  photographed  under  UV  illumination. 
Lanes  I  and  6:  1  kb  ladder  (Life  Technologies) 
Lane  2:  Positive  control  PCR  using  T  vaginalis  first  strand  cl)NA  and  primers 
used  for  the  isolation  of  TvCP  I,  a  cysteine  proteinasc  gene  (Mallinson  et 
al.,  1994). 
Lane  3:  De  novo  PCR  using  T  vaginalis  first  strand  cl)NA  and  Cyst  5'  and  Cyst 
3'  degenerate  oligonucleotides 
Lane  4:  PCR  using  Cyst  5'  and  Cyst  3'  degenerate  oligonucleoticles  and  gel 
purified  upper  band  DNA  from  Figure  4.3,  lane  4 
Lane  5:  PCR  using  Cyst  5'  and  Cyst  3'  degenerate  oligonucleotides  and  gel 
purified  lower  band  DNA  from  Figure  4.3,  lane  5 kb 
1.6- 
1.0- 
0.5- 
0.34- 
0.22- 
0.15- 
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Figure  4.5  Pvull  restriction  analysis  of  Cysta  clones  . 
Plasmid  DNA  isolated  frorn  white  XL  I  -Blue  transformants  was 
restricted  with  Pvull  and  electrophoresed  on  a  2%TBE  agarose  gel, 
stained  with  EtBr  and  visualised  under  UV  illumination. 
Lanes  I  and  8:  1  kb  ladder  (Life  Technologies) 
Lane  2:  pBluescript  (SK-)  digested  with  Pvull 
Lane  3:  Cysta  3  restricted  with  I'vid  I 
Lane  4:  Cysta  4  restricted  with  Pvul  [ 
Lane  5:  Cysta  5  restricted  with  Null 
Lane  6:  Cysta  6  restricted  with  I'vul  I 
Lane  7:  Cysta  7  restricted  with  Pvull 
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Figure  4.6  Pvull  restriction  analysis  of  Cysta  clones. 
Plasmid  DNA  isolated  from  white  XI,  I  -Blue  transformants  was  restricted 
and  electrophoresed  on  a  1.5%  TBE  agarose  gel,  stained  with  EtBr  and 
visualised  under  UV  illurnination. 
Lane  1:  1  kb  ladder  (Life  Technologies) 
Lane  2:  pBluescript  (SK-)  digested  with  Pvull 
Lane  3:  Cysta  9  restricted  with  Pvull 
Lane  4:  Cysta  10  restricted  with  Ivul  I 
Lane  5:  Cysta  II  restricted  with  Pvull 
Lane  6:  Cysta  12  restricted  with  Pvull 
Lane  7:  Cysta  13  restricted  with  Pvull 
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Figure  4.7  T.  vaginalis  genomic  DNA  restrictions. 
Restricted  T  vaginalis  genomic  DNA  was  electrophorescd  on  a  0.7%TBE  agarose 
gel,  stained  with  F.  tl3r  and  visualised  under  IN  illumination. 
Lanes  I  and  12:  1  kb  ladder  (Litle  Technologies) 
Lane  6:  ý.  Hindlll  marker  (Lite'rechriologies) 
Lanes  2  and  7:  7'  vaginalis  genomic  DNA  (2pg)  digested  with  Fc.  ()RI 
Lanes  3  and  8:  7'  vaginalis  genomic  DNA  (2pg)  digested  with  Ifincil 
Lanes  4  and  9:  T  vaginalis  genomic  DNA  (2pg)  digested  with  Ifindill 
Lanes  5  and  10:  7.  vaginalis  gcnomic  DNA  (2ptg)  digested  withXhal 
Size  of  markers  to  the  left  are  ý,  Ifindl  II  (Lane  6) 
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Figure  4.8A/B  Southern  blot  analysis  of  Tvaginalis  genomic  DNA 
with  200bp  PCR  generated  fragment  from  Cysta  9  (Panel  A)  and  Cysta  8 
(Panel  B). 
Digested  T  vaginalis  genomic  DNA  (2ýtg)  was  electrophoresed  through 
a  0.7%  TBEI  agarose  gel,  blotted  to  Hybond  N  (Amersham  International  p1c), 
hybridised  with  the  radiolabelled  200bp  fragment  from  Cysta  9  or  Cysta  8  and 
washed  at  high  stringency  prior  to  exposure  to  medical  X-ray  film. 
Lane  1:  7'  vaginalis  DNA  digested  with  EcoRl 
Lane  2:  T  vaginalis  DNA  digested  with  Ifincl  I 
Lane  3:  T  vaginalis  DNA  digested  with  Ilindl  II 
Lane  4:  T  vaginalis  DNA  digested  with  Xhal 
Markers  indicated  on  the  left  are  Windill  (LitleTechnologics) 
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Figure  4.8  C/D  Southern  blot  analysis  of  Tvaginalis  genomic  DNA 
with  200bp  PCR  generated  fragments  from  Cysta  14  (Panel  C)  or  a  200bp 
fragment  fromCysta  16  (Panel  D). 
The  digested  Tvaginalis  genomic  DNA  (2pg)  was  electrophoresed  through 
a  0.7%  TBE  agarose  gel,  blotted  to  I  lybond  N  (Amersham  International  p1c), 
hybridised  with  the  radiolabelled  200bp  fragment  from  Cysta  14  or  Cysta  16  and 
washed  at  high  stringency  prior  to  exposure  to  medical  X-ray  film. 
Lane  1:  T  vaginalis  DNA  digested  with  EcoRl 
Lane  2:  7'  vaginalis  DNA  digested  with  Hincl  I 
Lane  3:  T  vaginalis  DNA  digested  with  Ifindl  II 
Lane  4:  T  vaginalis  DNA  digested  with  Xhal 
Markers  indicated  on  the  left  hand  side  are  ;  Windill  (Life  Tcc  lino  logics) 
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Figure  4.9  Northern  blot  analysis  of  T.  vaginalis  total  RNA  and 
polylAl'  RNA  hybridised  with  a  600bp  Pvull  fragment  of  the 
Cysta  2  clone. 
T  vaginalis  total  and  poly[A]'  RNA  were  electrophoresed  through 
a  1.5%  agarose/MOPS/fonnaidehyde  gel,  blotted  to  I  lybond  N 
(Amersham  International  p1c),  hybridised  with  the  600bp  NO  fragment 
from  the  Cysta  2  clone  and  washed  at  high  stringency  prior  to  exposure  to 
medical  X-ray  film. 
Lane  1:  1  0[tg  T  vaginalis  total  RNA 
Lane  2:  1  pg  T  vaginalis  poly[Al'  RNA 
9.5  kb-  0.24  kbRNA  ladder  (Life  Technologies)  are  indicated  on  the  left. 
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Figure  4.10  Restriction  enzyme  analysis  of  pI  and  p4joil,  Cysta  2  hybridising 
plasmids. 
pl  ,,,,  and  p4,  (,  ()  DNA  was  restricted  with  various  restriction  enzymes  as  outlined 
below  and  clectrophoresed  in  a  1.5%TBEagarose  gel,  stained  with  Ftlir  and 
visualised  under  LJV  illumination. 
Lane  1:  1  kb  ladder  (LifieTechnologies) 
Lane  2:  pl  ()o  digested  with  EcoRl  and  Xhol 
Lane  3:  pl  ()()  digested  with  Ahol 
Lane  4:  pl  ()o  digested  with  EcoRl 
Lane  5:  pl  ()()  digested  withSpel  and  Kpnl 
Lane6:  p  41()o  digested  with  EcoRl  and  Xhol 
Lane7:  p4l()o  digested  with  Xhol 
Lane8:  p4lo()digested  with  EcoRl 
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Figure  4.11  Restriction  enzyme  analysis  of  a  variety  of  Cysta  16  hybridising 
plasmids. 
Various  plasmids  were  restricted  with  the  enzymes  outlined  below  and 
electrophoresed  on  a  1%  TBE  agarose  gel,  stained  with  FtBr  and  visualised 
under  LJV  illumination. 
Lanes  I  and  7:  1  kb  ladder  (Life  Technologies) 
Lane2:  I  I()(),,  plasmid  digested  with  EcoR  I  and  Xhol 
Lane  3:  1  ()Ob  plasmid  digested  with  EcoRl  and  Xhol 
Lane  4:  3  100  plasmid  digested  with  EcoRl  and  Xhol 
Lane  5:  5  10()  plasmid  digested  with  EcoRl  and  Xhol 
Lane  6:  610()plasmid  digested  with  EcoRl  and  Xhol 
Lane  8:  k  HindIll  marker  (LifieTechnologies) 
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Figure  4.12  Further  restriction  enzyme  analysis  of  pI  and  p5,,,,,, 
two  Cysta  16  hybridising  plasmids. 
pl.  100,,  and  p5l()()  were  restricted  with  the  enzymes  outlined  below  and 
electrophoresed  on  a  I%  TBE  agarose  gel,  stained  with  FtBr  and  visualised  under 
UV  illumination. 
Lanes  I  and  8:  1  kb  ladder  (Life  Technologies) 
Lane  2:  pl  digested  with.  Vhol 
Lane  3:  p]  ý)O,,  digested  with  EcoRl 
Lane  4:  p5  loo  digested  with  Xhol 
Lane  5:  p5  loo  digested  with  EcoRl 
Lane6:  pl  10j),,  digested  with  Spel  and  Kpnl 
Lane  7:  p5loo  digested  withSpel  and  Kpnl 
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Figure  4.13  Restriction  enzyme  digests  of  p4,  (,,,  cDNA. 
p4jo(ý  was  restricted  with  a  variety  of  enzymes  as  outlined  below  and 
electrophoresed  in  a  2%  TBE  agarose  gel,  staincd  with  FtBr  and  v1sualised  under 
UV  illumination.  The  double  and  single  restriction  enzyme  digests  oi'p4,  ()()  were 
used  to  ascertain  fragment  sizes  suitable  for  cloning  and  to  draw  up  a  preliminary 
restriction  map  of  the  cDNA  contained  in  p4l()() 
Lanes  I  and  7:  1  kb  ladder  (Life  Technologies) 
Lane  2:  p4loo  restricted  with  EcoRl  and  Xhol 
Lane  3:  p4  100  restricted  with  Xhol  only 
Lane  4:  p4  100  restricted  with  EcoRV  and  Xhol 
Lane  5:  p4j()(I  restricted  with  EcoRV  alone 
Lane  6:  p410()  restricted  with  EcoRl  and  EcoRV 
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Figure  4.14  Restriction  enzyme  digests  of  p5,  (,,,  cDNA. 
p5loo  was  restricted  with  a  variety  of  enzymes  as  outlined  below  and 
electrophoresed  on  a  2%  TBE  agarose  gel,  stained  with  l,  'tllr  and  visualised 
under  UV  illumination.  The  double  and  single  restriction  enzyme  digests  of 
p510()  were  used  to  ascertain  fragment  sizes  suitable  Ior  cloning  and  to  draw 
up  a  preliminary  restriction  map  ofthe  cl)NA  contained  in  p5,  (,  (, 
Lanes  I  and  7:  1  kb  ladder  (Life  Technologies) 
Lane  2:  p5  I  j)o  restricted  with  EcoR  I  and  Xhol 
Lane  3:  p5,  ()()  restricted  with  EcoRl  only 
Lane  4:  p51()()  restricted  with  EcoRl  and  EcoRV 
Lane  5:  p5,  ()()  restricted  with  EcoRV  only 
Lane  6:  p51()()  restricted  with  E-coRV  and  Ahol 
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1 Figure  4.15  Map  and  sequencing  strategy  for  the  Tvmgll  gene. 
The  black  box  indicates  the  open  reading  frame  and  the  black  line  the  polylinker 
used  in  cloning  the  cDNA.  The  arrows  indicate  the  extent  and  direction  of 
sequencing.  Relevant  restriction  sites  used  in  creating  subclones  for  sequencing 
are  indicated.  Sequence  derived  from  subclones  is  indicated  by  black  arrows. 
Sequence  derived  from  internal  oligonucleotides  is  indicated  by  dotted  arrows. illotZ7 
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141 Figure  4.16  Map  and  sequencing  strategy  for  the  Tvmgl2  gene. 
The  black  box  indicates  the  open  reading  frame  and  the  black  line  the  polylinker 
used  in  cloning  the  cDNA.  The  arrows  indicate  the  extent  and  direction  of 
sequencing.  Relevant  restriction  sites  used  in  creating  subclones  for  sequencing 
are  indicated.  Sequence  derived  from  subclones  is  indicated  by  black  arrows. 
Sequence  derived  from  internal  oligonucleotides  is  indicated  by  dotted  arrows. IOYX 
H 
A 
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142 Figure  4.17  Nucleotide  and  deduced  amino  acid  sequence of  mgll. 
Key  restriction  sites  used  in  subcloning  experiments  are  indicated  by  pink  text. 
The  sequence  and  position  of  oligonucleotides  used  in  sequencing  and  5'-RACE 
are  indicated  by  blue  text.  The  sequence  determined  by  the  5-RACE  experiments 
is  indicated  by  red  text. ATTTTTAGACA;  ý.  ATGTCTCACGAGAGA 
--------------------------  28 
ý'AAAAA'I'-I'TrýT'I'GTACAGAGTGCTCTCT 
MSHER 
ATGACCCCAGCAACAGCATGCATCCATGCTAATCCACAGAAGGATCAGTTTGGAGCAGCC 
29  ------------------------------------------------------------  88 
TACTGGGGTCGTTGTCGTACGTAGGTACGATTAGGTGTCTTCCTAGTCAAACCTCGTCGG 
MTPATACIHANPQKDQFGAA 
ATCCCACCAATCTACCAAACATCAACATTCGTTTTCGATAACTGCCAACAGGGTGGAAAC 
89  ------------------------------------------------------------  148 
TAGGGTGGTTAGATGGTTTGTAGTTGTAAGCAAAAGCTATTGACGGTTGTCCCACCTTTG 
IPPIYQTSTFVFDNCQQGGN 
AGATTCGCTGGTCAGGAATCCGGCTACATCTACACACGTCTCGGCAACCCAACAGTTTCA 
149  ------------------------------------------------------------ 
TCTAAGCGACCAGTCCTTAGGCCGATGTAGATGTGTGCAGAGCCGTTGGGTTGTCAAAGT  208 
RFAGQESGYIYTRLGNPTVS 
:ý  r-ý  oT  sp,  ý  IT 
AACCTCGAAGGCAAGATCGCCTTCý-"1'(--'(ý'A(,  -AAAACAGAA(ýCATC,  ('GTTGCCACATCTTCT 
209  ---------------------------------------------------------  268 
TTGGAGCTTCCGTTCTAGCGGAAGGA(;  CTCTTTTGTCTT(.  'GTAC:  (-;  CAACGGTGTAGAAGA 
AM9509 
NLEGKIAFLEKTEACVATSS 
GGCATGGGTGCCATTGCTGCTACAGTTTTGACAATCCTCAAGGCCGGAGATCACTTAATC 
269  ----------------------------------------------------------  328 
CCGTACCCACGGTAACGACGATGTCAAAACTGTTAGGAGTTCCGGCCTCTAGTGAATTAG 
AM9504 
GMGAIAATVLTILKAGDHLI 
TCCGATGAGTGCCTTTATGGCTGCACACATGCTCTCTTTGAGCACGCATTGACAAAGTTC 
329  ------------------------------------------------------------  388 
AGGCTACTCACGGAAATACCGACGTGTGTACGAGAGAAACTCGTGCGTAACTGTTTCAAG 
SDECLYGCTHALFEHALTKF 
GGCATCCAGG"ICGACTTCATCAACACAGCCATCCCAGGCGAGGTCAAGAAGCACATGAAG 
389  ------------------------------------------------------------  448 
CCGTAGGTCCAGCTGAAGTAGTTGTGTCGGTAGGGTCCGCTCCAGTTCTTCGTGTACTTC 
GIQVDFINTAIPGEVKKHMK 
AM9503 
CCAAACACAAAGATTGTCTATTTCGAGACACCAGCCAACCCAACACTCAAGATCATCGAC 
449  ------------------------------------------------------------  508 
GGTTTGTGTTTCTAACAGATAAAGCTCTGTGGTCGGTTGGGTTGTGAGTTCTAGTAGCTG 
PNTKIVYFETPANPTLKIID 
ATGGAGCGCGTCTGCAAGGACGCCCACAGCCAGGAGGGCGTCTTAGTTATCGCCGATAAC 
509  ------------------------------------------------------------  568 
TACCTCGCGCAGACGTTCCTGCGGGTGTCGGTCCTCCCGCAGAATCAATAGCGGCTATTG 
MERVCKDAHSQEGVLVIADN 
!Iý  ric7  TI  /ý',  aiI 
ACATTCTGCTCACCAATGATCACAAACCCA(',  '!  '(*.  GA(ýTTTGGCGTCGATGTTGTTGTCCAC 
569  ------------------------------------------------------------  628 
TGTAAGACGAGTGGTTACTAGTGTTTGGGT('AGC,  'T(-,  AAACCGCAGCTACAACAACAGGTG 
TFCSPMITNPVDFGVDVVVH 
TCTGCAACAAAGTACATCAACGGCCACACAGATGTCGTCGCTGGCCTTATCTGTGGCAAG 
629  ------------------------------------------------------------  688 
AGACGTTGTTTCATGTAGTTGCCGGTGTGTCTACAGCAGCGACCGGAATAGACACCGTTC 
SATKYINGHTDVVAGLICGK 
143 Ecc)-R'ý, 
GCTGACCTCCTTCAACAGATTCGTATGGTTGGTATCAAGGAI'ATCACAGGATCTGTTATC 
689  ------------------------------------------------------------  748 
CGACTGGAGGAAGTTGTCTAAGCATACCAACCATAGTTCý.  "I'A'1'1\(ýTGTCCTAGACAATAG 
ADLLQQIRMVGIKDITGSVI 
AGCCCACACGACGCTTGGCTCATCACACGTGGCCTCTCAACACTCAACATCAGAATGAAG 
749  ------------------------------------------------------------  808 
TCGGGTGTGCTGCGAACCGAGTAGTGTGCACCGGAGAGTTGTGAGTTGTAGTCTTACTTC 
SPHDAWLITRGLSTLNIRMK 
GCTGAGAGCGAGAACGCCATGAAGGTCGCTGAGTACCTCAAATCTCACCCAGCCGTTGAG 
809  ------------------------------------------------------------  868 
CGACTCTCGCTCTTGCGGTACTTCCAGCGACTCATGGAGTTTAGAGTGGGTCGGCAACTC 
AESENAMKVAEYLKSHPAVE 
Fcop',  / 
AAGGTTTACTACCCAGGCTTCGAGGACCACGAGGGCCAC(;  Aý',  Zýýý'GCTAAGAAGCAGATG 
869  ------------------------------------------------------------  928 
TTCCAAATGATGGGTCCGAAGCTCCTGGTGCTCCCGGTGCTA'Fiý(ýCGATTCTTCGTCTAC 
KVYYPGFEDHEGHDIAKKQM 
AGAATGTCGGGTTCAATGATCACATTCATCCTCAAGTCCGGCTTCGAAGGCGCTAAGAAG 
929  ------------------------------------------------------------  988 
TCTTACAGCCCAAGTTACTAGTGTAAGTAGGAGTTCAGGCCGAAGCTTCCGCGATTCTTC 
RMSGSMITFILKSGFEGAKK 
HindI  II 
CTCCTCGACAACCTCAAGCT'I'ATCACACTTGCAGTTTCCCTTGGTGGCTGCGAGTCCCTC 
989  ------------------------------------------------------------  1048 
GAGGAGCTGTTGGAGTTCGAATAGTGTGAACGTCAAAGGGAACCACCGACGCTCAGGGAG 
LLDNLKLITLAVSLGGCESL 
ATCCAGCACCCAGCTTCAATGACTCACGCTGTCGTTCCAAAGGAGGAGCGTGAGGCCGCT 
1049  ------------------------------------------------------------  1108 
TAGGTCGTGGGTCGAAGTTACTGAGTGCGACAGCAAGGTTTCCTCCTCGCACTCCGGCGA 
IQHPASMTHAVVPKEEREAA 
GGTATTACAGATGGCATGATCCGCCTTTCTGTCGGTATTGAAGATGCCGACGAACTCATC 
1109  ------------------------------------------------------------  1168 
CCATAATGTCTACCGTACTAGGCGGAAAGACAGCCATAACTTCTACGGCTGCTTGAGTAG 
GITDGMIRLSVGIEDADELI 
GCTGATTTCAAACAGGGCCTTGACGCTCTTTTATAA 
1169  ------------------------------------  1202 
CGACTAAAGTTTGTCCCGGAACTGCGAGAAAATATT 
ADFKQGLDALT 
144 Figure  4.18  Nucleotide  and  deduced  amino  acid  sequence  of  mgl2. 
Key  restriction  sites  used  in  subcloning  experiments  are  indicated  by  pink  text. 
The  sequence  and  position  of  oligonucleotides  used  in  sequencing  and  5'-RACE 
are  indicated  by  blue  text.  The  sequence  determined  by  the  5'-RACE  experiments 
is  indicated  by  red  text. ACTTTATATAAAAGATGAGTGGCCAG 
-------------------------  27 
TGA,  kn,  TATATTTTCTACTC'ACCGGTC 
MSGH 
GCTATCGACCCAACACATACAGACACACTTTCCATCCACGCCAACCCACAGAAGGATCAG 
28  ------------------------------------------------------------  87 
CGATAGCTGGGTTGTGTATGTCTGTGTGAAAGGTAGGTGCGGTTGGGTGTCTTCCTAGTC 
AIDPTHTDTLSIHANPQKDQ 
TTCGGTGCTATTGTTGCTCCAATCTACCAAACATCCACCTTCCTCTTCGACAACTGCGAC 
88  ------------------------------------------------------------  147 
AAGCCACGATAACAACGAGGTTAGATGGTTTGTAGGTGGAAGGAGAAGCTGTTGACGCTG 
FGAIVAPIYQTSTFLFDNCD 
CAGGGTGGTGCTCGTTTCGGTGGCAAGGAAGCCGGTTACATGTACACACGTATCGGTAAC 
148  -------------------------------------------------------------  207 
GTCCCACCACGAGCAAAGCCACCGTTCCTTCGGCCAATGTACATGTGTGCATAGCCATTG 
QGGARFGGKEAGYMYTRIGN 
SPI'l 
CCAACAAACTCCGCACTCGAAGGCAAGATCGCCAAGCTCGAACACGCTGAG(jCAq'GCGCT 
208  -------------------------------------------------------------  267 
GGTTGTTTGAGGCGTGAGCTTCCGTTCTAGCGGTTCGAGCTTGTGCGACTCCGTAC*GCGA 
PTNSALEGKIAKLEHAEACA 
AM9505 
GCCACAGCTTCTGGCATGGGTGCTATTGCTGCTTCTGTCTGGACATTCCTCAAGGCCGGT 
268  -------------------------------------------------------------  327 
CGGTGTCGAA(3ACCGTACCCACGATAACGACGAAGACAGACCTGTAAGGAGTTCCGGCCA 
AM9506 
ATASGMGAIAASVWTFLKAG 
GATCACCTTATCTCCGACGATTGCCTTTATGGCTGCACACACGCCCTCTTCGAGCATCAG 
328  -------------------------------------------------------------  387 
CTAGTGGAATAGAGGCTGCTAACGGAAATACCGACGTGTGTGCGGGAGAAGCTCGTAGTC 
DHLISDDCLYGCTHALFEHQ 
CTCCGCAAGTTCGGCGTTGAAGTTGATTTCATCGACATGGCTGTCCCAGGAAACATTGAG 
388  -------------------------------------------------------------  447 
GAGGCGTTCAAGCCGCAACTTCAACTAAAGTAGCTGTACCGACAGGGTCCTTTGTAACTC 
LRKFGVEVDFIDMAVPGNIE 
AAGCACTTGAAGCCAAACACAAGAATCGTCTACTTCGAAACACCAGCTAACCCAACATTA 
448  -------------------------------------------------------------  507 
TTCGTGAACTTCGGTTTGTGTTCTTAGCAGATGAAGCTTTGTGGTCGATTGGGTTGTAAT 
KHLKPNTRIVYFETPANPTL 
ý,  c  ")  1-1,  V 
AAGGTTATCGACATCGAAGACGCCGTCAAGCAGGCCAGAAAGCAGAAG(;,  '\'I'A'I'(:  CTCGTT 
508  -------------------------------------------------------------  567 
TTCCAATAGCTGTAGCTTCTGCGGCAGTTCGTCCGGTCTTTCGTCTTCý"I'A'I'i\C,  GAGCAA 
KVIDIEDAVKQARKQKDILV 
P-*(-Opv 
ATCGTTGATAACACCTTCGCTTCACCAATTCTTACAAACCCACTCGACCTCGGTGTT(',  A'I' 
568  -------------------------------------------------------------  627 
TAGCAACTATTGTGGAAGCGAAGTGGTTAAGAATGTTTGGGTGAGCTGGAGCCACAA(:  '['A 
IVDNTFASPILTNPLDLGVD 
ATCGTCGTTCACTCCGCTACTAAGTACATCAATGGCCACACCGATGTTGTCGCCGGCCTT 
628  -------------------------------------------------------------  687 
TA(ýCAGCAAGTGAGGCGATGATTCATGTAGTTACCGGTGTGGCTACAACAGCGGCCGGAA 
IVVHSATKYINGHTDVVAGL 
E(-oRV 
GTCTGCTCAAGAGCTGACATCATCGCTAAGGTCAAGTCCCAGGGTATCAAG(-'A7'1ý'I,  C'ACA 
688  -------------------------------------------------------------  747 
CAGACGAGTTCTCGACTGTAGTAGCGATTCCAGTTCAGGGTCCCATAGTTCCTATA(,  TGT 
VCSRADIIAKVKSQGIKDIT 
145 GGCGCCATCATTTCCCCACACGACGCTTGGCTCATCACAAGAGGCACACTTACACTCGAT 
748  -------------------------------------------------------------  807 
CCGCGGTAGTAAAGGGGTGTGCTGCGAACCGAGTAGTGTTCTCCGTGTGAATGTGAGCTA 
GAIISPHDAWLITRGTLTLD 
E  cc-,  P.  1 
ATGCGTGTCAAGCGCGCTGCCGAGAACGCTCAGAAGGTCGCT(ýAATTC*CTCCATGAGCAC 
808  -------------------------------------------------------------  867 
TACGCACAGTTCGCGCGACGGCTCTTGCGAGTCTTCCAGCGA('TTA,,  '-,  ';  GAGGTACTCGTG 
MRVKRAAENAQKVAEFLHEH 
AAGGCCGTCAAGAAGGTCTACTACCCAGGCCTTCCAGACCATCCAGGCCACGAAATCGCC 
868  -------------------------------------------------------------  927 
TTCCGGCAGTTCTTCCAGATGATGGGTCCGGAAGGTCTGGTAGGTCCGGTGCTTTAGCGG 
KAVKKVYYPGLPDHPGHEIA 
AM9507  ýjncll/ý,;,  il  I 
AAGAAGCAC,  ATGAAGATGTTCGGCTCTATGATCGCATTCGATGTC(7,  Aý:  GGATTAGAGAAG 
928  -------------------------------------------------------------  987 
TTCTTCGTCTACTTCTACAAGCCGAGATACTAGCGTAAGCTACAGCTGCCTAATCTCTTC 
KKQMKMFGSMIAFDVDGLEK 
GCCAAGAAAGTCCTTGACAACTGCCACGTTGTTTCTCTCGCCGTTTCCCTCGGTGGTCCA 
988  -------------------------------------------------------------  1047 
CGGTTCTTTCAGGAACTGTTGACGGTGCAACAAAGAGAGCGGCAAAGGGAGCCACCAGGT 
AM9508 
AKKVLDNCHVVSLAVSLGGP 
GAATCCCTCATCCAGCACCCAGCTTCAATGACACACGCTGGTGTTCCAAAGGAGGAACGC 
1048  -------------------------------------------------------------  1107 
CTTAGGGAGTAGGTCGTGGGTCGAAGTTACTGTGTGCGACCACAAGGTTTCCTCCTTGCG 
ESLIQHPASMTHAGVPKEER 
GAGGCTGCTGGCCTAACAGATAACCTCATCCGCCTCTCTGTTGGCTGTGAGAACGTTCAG 
1108  -------------------------------------------------------------  1167 
CTCCGACGACCGGATTGTCTATTGGAGTAGGCGGAGAGACAACCGACACTCTTGCAAGTC 
EAAGLTDNLIRLSVGCENVQ 
E(:.  (-"P"V, 
GATATCATCGACGACCTCAAGCAGGCTCTCGACTTAGTCCTC 
1168  -------------------------------------------  1209 
CTATAGTAGCTGCTGGAGTTCGTCCGAGAGCTGAATCAGGAG 
DIIDDLKQALDLVL 
146 3' 
AAAAA 
TTTTT 
1.  Anneal  oligo  dT  to  total  RNA  from  Tvaginalis  Oligo  dT 
3' 
AAAAA 
TTTTT 
59 
2.  Synthesise  I  st  strand  cDNA  using  Superscript  11  reverse  transcriptase 
5'  3' 
......................................  AAAAA 
3'  5' 
3.  Degrade  RNA  using  RNase  H 
ccccc 
3' 
4.  Generate  dC-tailed  I  st  strand  cDNA  using  dCTP  and  tenninal  deoxynucleotide 
transferase 
Anchor  primer 
0 
ccccc 
3' 
GSPI  5' 
5.1  st  round  PCR:  PCR  amplify  the  dC-tailed  I  st  strand  cDNA  using  the  anchor  primer 
and  a  gene  specific  primer  for  each  gene  (GSP  I) 
Anchor  primer 
0 
14 
GSP2 
6.2nd  round  PCR:  PCR  amplify  the  products  from  the  I  st  round  PCR  reaction  using  the 
anchor  primer  and  a  nested  gene  specific  primer  for  each  gene  (GSP2) 
Figure  4.19  Summary  of  the  5'  RACE  methodology. 
147 T  vaginalis  total  RNA 
T  vaginalis  cDNA 
I  st  strand  cDNA  using  Oligo  dT  followed  by  dC  tailing 
5'RACE-PCR  for  mg1I  5'RACE-PCR  for  mg12 
I  st  round  PCR  amplification 
using  the  anchor  primer 
and  gene  specific  primer  4 
2nd  PCR  amplification 
using  the  anchor  primer 
and  gene  specific  primer  9 
in  two  independent  PCR 
reactions 
Agarose  gel  electrophoresis, 
purification  and  cloning  of  RACE 
products  into  pTAg 
I  st  round  PCR  amplification 
using  the  anchor  primer 
and  gene  specific  primer  8 
2nd  PCR  amplification 
using  the  anchor  primer 
and  gene  specific  primer  6 
in  two  independent  PCR 
reactions 
Agarose  gel  electrophoresis, 
purification  and  cloning  of  RACE 
products  into  pTAg 
Figure  4.20  A  summary  of  the  51RACE-PCR  protocol 
carried  out  for  the  amplification  of  the  5'  ends  of  mgIJ  and  mgI2. 
148 kb 
1.0- 
0.5- 
0.34- 
0.22- 
Figure  4.21  5'  RACE  products  for  mgll  and  mgl2. 
5'  RACE  products  for  mgll  and  mg12  qfier  two  rounds  of  amplification  were 
electrophoresed  on  a  1.5%  TBE  agarose  gel  and  stained  with  E.  tl3r  and  visualised 
under  IN  illurnination. 
Lanes  I  and  8:  1  kb  ladder  (Life  Technologies) 
Lane  2:  Control  5'  RACE  reaction  of  mg1I  carried  out  in  the  absence  of  reverse 
transcriptase 
Lane  3:  5'  RACE  ofmgII  using  T  vaginalis  first  strand 
cDNA  and  gene  specific  primers  4  and  9  in  the  two  rounds  ofPCIZ 
amplification 
Lane  4:  As  lane  3  but  an  independent  PCR  reaction 
Lane  5:  Control  5'  RACE  of  nigI2  carried  out  in  the  absence  of  reverse 
transcriptase 
Lane  6:  5'  RACE  of  ingI2  using  T  vaginalis  first  strand 
cDNA  and  gene  specific  primers  8  and  6  in  the  two  rounds  of  PCR 
amplification 
Lane  7:  As  lane  6  but  an  independent  PCR  reaction 
149 
12345678 Figure  4.22  Amino  acid  sequence  alignment  of  methionine  y-lyases  from  T. 
vaginalis  and  P.  putida  and  cystathionine  y-lyase  from  a  variety  of  sources. 
Amino  acid  sequence  alignment  of  T  vaginalis  methionine  7-lyases,  MG1,  I  and 
MGL2,  this  study,  with  two  dilTerent  methionine  y-lyases  from  Neudonionas 
pulida  (PpMGL  1,  Inoue  et  al.,  1995  and  PpMG1.2,  I  Ion  et  al.,  1996)  and 
cystathioninc  7-1yase  From  yeast  (CYS3,  Ono  el  al.,  1992)  and  human  (I  IsCGI.,  Lu 
ef  a/.,  1992).  Each  individual  sequence  is  numbered  accordingly.  Residues  that 
are  conserved  in  all  sequences  are  indicated  by  black  boxes.  Residues  that  are 
conserved  in  all  four  methionine  y-lyase  sequences  but  are  absent  from  the 
cystathionine  y-lyase  sequences  are  indicated  by  a  #.  The  proposed  essential 
cysteine  residue  for  the  methionine  y-lyase  is  indicated  by  a*(.  )  indicate  gaps 
introduced  to  maximise  the  sequence  alignment.  The  multiple  sequence 
alignment  was  obtained  by  using  the  PILE-UP  program  of  the  University  of 
Wisconsin  Genetics  Computer  Group  (GCG). TvMGL1  1  MS  HERMTPA...  TACIHANPQK  DQFG.  AAlp  TYOTS  FVFD  38 
TvMGL2  I  MS  GHAIDPTHTD  TLSIHANPQK  DQFG.  AIV  JYQTS  FLFD  41 
PpMGL1  I  MH  GSNKLPGFAT  RAIHHGYDPQ  DHGG.  AINP  VYQT  FTFP  41 
p  PpMGL2  1  MR  DSHNNTGFST  RAIHHGYDPL  SHGG.  A]ýV  VYQT  YAFP  41 
E  ScCYS3  1M  TLQESDKFAT  KAIHAGEHVD  VHGS..  VIE  1ýýLST  FKQ,  39 
p 
HsCGL  1  MQEKDASSQG  FLPHFQHFAT  OAIHVGQDPE  QWTSRI\VVrP) 
]p 
ý  ýýLST  50 
### 
TvMGLI  39  NCQQGGNRFA  GQESGY1  T  Dý  T.  'ý',  N  (;  I,  I  EKIFII'l  A  C',  VIT  88 
TvMGL2  42  NCDQGGARFG  GKEAGY:,  TF  iýý  I  IT"'I'l  AC  91 
PpMGLI  42  TVEYGAACFA  GEQAGli:  -  T,  As  Eý;  C,  E  A(,  L  Lt  91 
PpMGL2  42  TVEYGAACFA  GEEAGH!  Ti,  Alý 
1)1%  S  AGL  L  1ý  91 
ScCYS3  40  SPANPIGTYE 
.......  INI-  !  -ýN  Fýý  82 
HsCGL  51  APGQHSG.  FE 
....... 
YCL  F  92 
TvMGL1  89  AIAATV1,  Tý 
TvMGL2  92  AIAASVWTF 
PpMGL1  92  AITSTLWTIý 
PpMGL2  92  AITSTLWTIý 
ScCYS3  83  T.  TAT  I  D.  )ý! 
HsCGL  93  A.  TVT  I'l'i  11, 
TvMGL1  139  EVKKHMFI'N 
TvMGL2  142  NIEKHLFi'N 
PpMGLI  142  ALEAAMTPA 
PpMGL2  142  ALKAAINýýK 
ScCYS3  131  DLPQLIKFN 
HsCGI,  142  LLEAATTPE 
TvMGLI  186  FICS  [':  'N 
TvMGL2  189  VAS  II  'ýTl 
PpMGL1  188  Yý 
PpMGL2  188  yý  'T  P, 
ScCYS3  181  VI";  ýýN 
Y  HsCGL  189 
IFMSIý'ý_)R 
# 
EHAL'ITE  IQ  VDFINTAIPG  138 
IS[)  EHQLRFF-  E  VDFIDMAVPG  141 
Pl,  Pf,  ýVLLGN  I'k  I  ýO`L,  HHGTGE1,  K  LRHVDMADLQ  141 
Pý  Pl,  ýLIWP  I'L  HHGDIFIý  F  IHHVDLNDAK  141 
11I.  Av  SI  TKVANAl  I  'E  'FSFTN.  DLLN  130 
F]D(ý,  EICMD  RQVA,  ",  f-',  [,  LK  ISFVDCSKIK  , 
JL 
141 
F  IV  I*  ý  TLF  IT  IER  VCKDAHSQ.. 
. 
EGVLV  1,18ý 
Vy  1,  TI  FV  li  IE  1)  AVKQARKQ..  KDILVI\  lHa 
RV  I  Yjý  IMHM  IA  (-'ý  VAKIARKH..  GATI.,  VV  I  R-1 
PM  ý:  1.  T"  Mý)Iýý  I  AA  VVEAVRGS..  DVL',  'Vl',  l  IH  -7 
FI  VW  i  TLKVT  I  ý-)F,  VADLTKKHAA  GQ  DV  I  IHO 
FI  Vw  TQKV1  TEG  CAHIVHKHG. 
..  DTJIN  lH8  FI 
lp 
4 
V  1,  [ý  JJVJJ  J,  v,.  -I,  MT  1V  I,  t0-;  K  ADLLQQIRMV  235  I 
1,  I)k  IV  T  7vi  I,  V(:  SR  ADTIAKVKSQ  238 
ilEl  J,  V  I  Tý  IVV(-S  QALVDRIRLQ  237 
1.  ilýl  LA",  I  I"  VV(;  R  KALVDRIRLE  237 
LNfý  IVVH  IN  VL  '11"UN  NKPLYE.  RLQ  229 
VM  Vý;  VN  CESLHN.  RLR  237  I  MY 
INIý;  [ 
1111, 
If  ##  It  tl 
TvMGL1  236  GIKE)II  "A'  lIIw  IT  1111ý  N 
IIIIM  K  AESENAMKI  1.  ý  IIA.  284 
TvMGL2  239  GIKPIT  I\  III  Vý,  T  T!,  PH  F  RAAENAQK  111ý  2  87 
PpMGL1  238  GLKDMri 
', 
I'll  ;:  ;  ýý"  ,1  287  it,  'I.  ý  RHCANAý-)Vl  1ýý  i. 
PpMGL2  238  GLKD  M'l 
I"/A\ 
IiLIf 
. 
1ý  ýil  RHCANA1,  E  f.  287 
ScCYS3  230  FLQNA  II1  11  M  TH  iJ,  ill,  'P  (JAALSANKI  F  i,  Ai  IF'f-ýN  2.79 
-V,  HsCGL  238  FLQNSI  CN  I 
1ý1  I 
11-ý  Fli  FKN(;  MA  I)WI 
TvMGL1  285  1-ý 
E:  1i  IND.  (;  LEK  AKKVL1)NCHV  334  TvMGL2  28  8 
ýiýU'H 
I 
PpMGL1  288  F:  Tý  I  i!  I  FPQYTLARý  M:  ',.  I  EI,  F,  (;  (,;  IGA  GRRFMNALQL  334 
PpMGL2  288  E  FAQYELAQP  MP.  1,;  1  EJX(;  GTEA  GRGFMNALQL  334 
ScCYS3  280  V:  %  L!  "I  HPNYDVVI,  F  I  P,  I  K(,  (,  AEA  ASKFASSTRL  329 
HsCGL  287  EF",  i  l'i  ýý  IIPQHELVi,:  i,  YI  KG,  'FLQH  AEIFLKNLKL  334 
TvMGL1  333  VIF,  EEE  ZVI  IT  I1  382 
TvMGL2  335  Vý  I  Vl,  ý=,  I':  IT  MI  1,1  1  ti'llo  384 
PpMGL1  335  F:  ýIEF,  Ally  I  i,  ý(:  IVI1  1)  384 
PpMGL2  335  ý'OE  Alill  IV  384 
ScCYS3  330  ý'E  FAS)  FMILV  379 
HSCGL  335  Jý"  1'  1.  j  ,  'IXND  [,  Vl  Tsf)Tlýl  II  id'ýE  384 
I 
TVMGL1  383  EL  I  ý146 
TvMGL2  385  IITID  LFI)ý  DI,  VL  398 
PpMGL1  385  FAýýA  398 
PpMGL2  385  Dl,  ý"  J  ý,  i  EN'ýA  398 
ScCYS3  380  D  1,1,1:  1  Ký),  '\TN  394 
HsCGL  385  D  1,  t,  Iýi  I  (.  V  FAAHPPSGTHS  405 
150 Figure  4.23  Southern  blot  analysis  of  T.  vaginalis  genomic  DNA  digested 
with  various  restriction  endonucleases  and  hybridised  with  a  mgll  gene 
specific  fragment. 
The  digested  T  vaginalis  genomic  DNA  (2ýtg)  was  electrophoresed  through  a 
0.7%  TBE  agarose  gel,  blotted  to  Hybond  N  (Amersharn  International  p1c), 
hybridised  with  the  I  kb  EcoRIIXhoI  mgII  gene  fragment  and  washed  at  high 
stringency  prior  to  exposure  to  medical  X-ray  film. 
Lane  1:  T  vaginalis  genomic  DNA  digested  with  BamHl 
Lane  2:  T  vaginalis  genomic  DNA  digested  with  EcoRI 
Lane  3:  T  vaginalis  genomic  DNA  digested  with  EcoRV 
Lane  4:  T  vaginalis  genomic  DNA  digested  with  HincIl 
Lane  5:  T  vaginalis  genomic  DNA  digested  with  Hindlll 
Lane  6:  T  vaginalis  genomic  DNA  digested  with  PstI 
Lane  7:  T  vaginalis  genomic  DNA  digested  with  Sall 
Lane  8:  T  vaginalis  genomic  DNA  digested  with  Smal 
Lane  9:  T  vaginalis  genomic  DNA  digested  with  Sphl 
Lane  10:  T  vaginalis  genomic  DNA  digested  with  XhoI 
),  HindIII  markers  are  indicated  on  the  left. kb 
123456789  10 
23.1- 
9.6- 
6.6- 
4.4- 
2.3- 
1.6- 
151 Figure  4.24  Southern  blot  analysis  of  T.  vaginalis  genomic  DNA  digested 
with  various  restriction  endonucleases  and  hybridised  with  a  mgI2  gene 
specific  fragment. 
The  digested  T  vaginalis  genomic  DNA  (2ptg)  was  electrophoresed  through  a 
0.7%  TBE  agarose  gel,  blotted  to  Hybond  N  (Amersham  Intemational  p1c), 
hybridised  with  the  800bp  EcoRI  mgI2  gene  fragment  and  washed  at  high 
stringency  prior  to  exposure  to  medical  X-ray  film. 
Lane  1:  T  vaginalis  genomic  DNA  digested  with  BamHI 
Lane  2:  T  vaginalis  genomic  DNA  digested  with  EcoRI 
Lane  3:  T  vaginalis  genomic  DNA  digested  with  EcoRV 
Lane  4:  T  vaginalis  genomic  DNA  digested  with  HincIl 
Lane  5:  T  vaginalis  genomic  DNA  digested  with  Hindlll 
Lane  6:  T  vaginalis  genomic  DNA  digested  with  PsII 
Lane  7:  T  vaginalis  genomic  DNA  digested  with  Sall 
Lane  8:  T  vaginalis  genomic  DNA  digested  with  SmaI 
Lane  9:  T  vaginalis  genomic  DNA  digested  with  SphI 
Lane  10:  T  vaginalis  genomic  DNA  digested  with  Xhol 
WindIll  markers  are  indicated  on  the  left. 123456789  10 
kb 
23.1- 
am 
9.6- 
mm 
6.6- 
4.4- 
400 
2.3- 
40W 
1.6- 
152 Figure  4.25  A/B  Northern  blot  analysis  of  T.  vaginalis  total  and  poly  [All 
RNA  hybridised  with  the  mgll  gene  fragment  (A)  or  the  mgl2  gene  fragment 
(B). 
The  T  vaginalis  total  and  poly  [A]'  RNA  were  electrophoresed  through  a  1.5% 
agarose/MOPS/formaldehyde  gel,  blotted  to  Hybond  N  (Amersham  Intemational 
p1c),  hybridised  with  the  lkb  EcoRllXhoI  mgllgene  fragment  (A)  or  the  800bp 
EcoRl  mgI2  gene  fragment  (B)  and  washed  at  high  stringency  prior  to  exposure  to 
medical  X-ray  film. 
Lane  1:  1  Oýtg  T  vaginalis  total  RNA 
Lane  2:  1  gg  T  vaginalis  poly[A]+  RNA 
9.5  kb-0.24  kb  RNA  ladder  (Life  Technologies)  are  indicated  on  the  left. 2.4- 
AB 
1 
153 Figure  4.26  Amino  acid  sequence  alignment  of  various  enzymes  involved  in 
transu  lph  u  ration  pathways  from  a  variety  of  organisms. 
Amino  acid  sequence  alignment  of  T  vaginalis  methionine  7-1yases,  MGL  I  and 
MGL2  (this  study)  with  methionine  y-lyase  from  Pseudomonaspulida  (PpMGL, 
Inoue  el  al.,  1995)  and  cystathionine  y-1yase  from  yeast  (ScCYS3,  Ono  ef  al., 
1992)  and  human  (I  IsCGL,  Lu  el  al.,  1992),  plus  cystathionine  7  synthase  and 
cystathionine  P-1yase  from  E.  coli  (EcMETB,  Duchange  el  al.,  1983  and 
FcMl,  ']'C,  Belfaiza  et  al.,  1986.  respectively)  and  0-acetylhomoserine 
sulphydrylase  from  yeast  (ScMET25,  Kerjan  et  al.,  1986)  Lach  individual 
sequence  is  numbered  accordingly.  Residues  that  are  conserved  in  all  sequences 
are  indicated  by  black  boxes.  ()  indicate  gaps  introduced  to  maximise  the 
sequence  alignment.  The  multiple  sequence  alignment  was  obtained  by  using  the 
PILE-UP  program  of  the  University  of  Wisconsin  Genetics  Computer  Group 
(GCG). TvMGL1  1  MSHERMTPAT  ACIHAN.  PQK  DQF..  GAAIP  PIYQTSTFVF  37 
TvMGL2  1  MSG  HAIDPTHTDT  LSIHAN.  PQK  DQF..  GAIVA  PIYQTSTFLF  40 
PpMGL1  1  MHG  SNKLPGFATR  AIHHGY.  DPQ  DHG..  GALVP  PVYQTATFTF  40 
ScCYS3  1M  TLQESDKFAT  KAIHAG.  EHV  D..  VHGSVIE  PISLSTTF..  36 
HsCGL  1  MQEKDASSQG  FLPHFQHFAT  QAIHVG.  QDP  EQWTSRAVVP  PISLSTTF..  47 
EcMETB  1  MTRKQAT  IAVRSG.  LND  DE.  QYGCVVP  PIHLSSTYNF  35 
EcMETC  1  MADKKLDT  QLVNAG.  RSK  KYTLGAVNS  VIQRASSLVF  36 
ScMET25  1  MPSHFDT  VQI,  HAGQENP  GDNAHRSRAV  PIYATTSYVF  37 
TvMGL1  38  DNCQQGGNRF  AGQESG.  YI  TRLGNPTVSN  LEGKIAIý  FF  TEACVAT.  'ýý',  86 
TvMGL2  41  DNCDQGGARF  GGKEAG.  Y  TPIGNPTNSA  LEGK  1  t',  "  , 'ýEACAýTý  l'i,:;  ýi  9 
PpMGLI  41  PTVEYGAACF  AGEQAG.  H  SRTSNPTLNL  LEARM,  Tý.  ý  ;  EAGLIý.  LA'ý  H9 
ScCYS3  37 
... 
KQSSP..  ANPIGT.  YVF  SRýýQNPNREN  LERAV,,  '  l%QYGL,  ',.;  -,  '::  80 
HsCGL  48 
... 
KQGAP..  GQHSG..  FE  SP'ýGNPTRNC  LEKAV,,  90 
EcMETB  36  TGF 
.......  . 
NEPRA  HI)  SP.  RGNPTRDV  VQRA  I  'AGAVI.  TTIT  '7  6 
EcMETC  37  DSVEAKKHAT  RNRANGEIAý  GPR(,  -TLTHFS  LQQAV,: 
-'iý, 
;  AGCV!  A-T('  86 
ScMET25  'I  SP  Fý  ",  )  N  PT  38  ENSKHGSQLF  GLEVPG.  i"  NV  LEERIJEG  'jAAAI,.,  -.  *,  ' 
186 
TvMGL1  87  MGAIAATVLT  IK  DHL  IS  DECI  (-,  (-THA  LFEHAL'iKFG  IQVDF!  tý',  'ii  136 
TvMGL2  90  MGAIAASVWT  FLK  DIILIS  D  D,  ý  1,  (ý(:  THA  LFEHQLRKFG  VEVDFIDMAV  139 
PpMGL1  90  MGAITSTLWT  LLP  P  GN':  ':  'TFA  FLHHGIGEFG  VKLRHVDMAD  139 
ScCYS3  81  S.  ATTATILQ  SLP,  )  :  ýfi,  ',  Vs  I  iip,  YFTKVANAHG  VETSFTN.  DL  128 
HsCGL  91  L.  AATVTITH  LIF  Dý-)  IIC  Ký  R  YFRQVASEFG  LKISFVDCSK  139 
EcMETB  77  MSAIHLVTTV  FLKP  DLLVA  pii,  ý'R  LFDSLAKRGC  YRVLFVDQGD  126 
EcMETC  87  AAAVANSILA  FIE  DHVLM  TNTi  Elý:  ý?  D  FCSKILSKLG  VTTSWFDPLI  136 
ScMET25  87  QAAQTLAIQG  LAHITDNIVS  TL3YL  '(:  TYN  QFKISFKRFG  IEARFVEGDN  136 
TvMGL1  137  PGEVKKHMKP  NTKIVYIý 
.N 
PýL  ý  FRVCKDAHSQ 
... 
EGVLVIA  183 
TvMGL2  140  PGNIEKHLKP  NTRIVYi-  Týý  ANPrl, 
ý 
ýý'ITJII 
I  1,:  DAVKQARKQ 
... 
KDILVIV  186 
PpMGL1  140  LQALEAAMTP  ATRVý:;  -  I 
ANPNMý1ý1.  -'  "  AGVAKIARKH 
.... 
GATVVV  185 
ScCYS3  129  LNDLPQLIKE  NTKLVý,:  TNPTIZ.  ý':  '  I  ý)KVADLIKKH  AAGQDVILVV  178 
HsCGL  140  IKLLEAAITP  ETKI,  ',  4  TNPTI,,,  -ý':  1-:  GCAHIVHKH  G 
... 
DIILVV  186 
ECMETB  127  EQALRAALAE  KPKL,  ',.,  l,  '  SNPL',:,  i  AFICHLARE. 
... 
VGAVSVV  172 
EcMETC  137  GADIVKHLQP  NTK  ]'.  '!  !,  .  'I  Gs  I  Tr,:  1. 
.! 
i  ",  PAIVAAVRS.  VVPDAIIMI  184 
ScMET25  137  PEEFEKVFDE  RTKI,  '-. 
jff:: 
i-]KIVAIAHKH 
.... 
GIPVVV  182 
Fv  TvMGL1  184  F.  ('SPMI  TNPVL)ý  V  'AGLI  (  ..........  223 
TvMGL2  18-/  F.  A.  SPIL  TNPI,  I)f  I  v"!  11:  1Y  ilý  IAGLV  C 
......... 
226 
PpMGL1  180  Y.  (:  'FPYL  QRPLE'  1,  V,.,  ii:  ý.  ý%  "AGIV  V 
.........  225 
ScCYS3  17  li  F.  LSPYI  SNPIJýIý  I  F  'I,  GVI,  A 
.........  218 
HsCGL  18  F.  ME  PYF  QR 
ý'MGLV  "; 
.........  226 
EcMETB  17  F.  I,  -`,  PAL  QN  Pil,  A;  I,  V.,  ýAGVV  I 
......... 
212 
EcMETC  18'  AACVL  FKA  1.  '  1.  '4  1  GTA  V 
......... 
224 
F(;  AGGYF  CQP  ScMET25  18 
11 
ii(,  GI  I  VI),;  (',  KFPWKD  232 
TvMGL1  224 
..........  ..........  ....  il,  ',!  V(ý  IK  I)  IT  ý;  V  PH  D  249 
TvMGL2  227 
..........  ..........  .... 
SRADII  AKVKSQGIK[)  I'l,  A!  lf3PHD  252 
PpMGLI  226 
..........  ..........  .... 
GSQALV  DRIRLQGLI<,  l  :;  PHD  251 
ScCYS3  219 
..........  ..........  .... 
TNNKPL  YE.  RLQF1,  Ql)  /.  I  %li,:;  PFD  243 
HsCGL  227 
..........  ..........  .... 
VNCESL  HN.  RLRFLQt: 
-`:; 
PI  D  251 
EcMETB  213 
..........  ..........  .... 
AKDPDV  V.  TELAWWNý  týi  ',  '!  ',;  (;  AFD  237 
EcMETC  225 
..........  ..........  .... 
CNARCW  EQLRENAY..  :  ý. 
.  )ýI'!  I)ADT  248 
SCMET25  233  YPEFFI%)Fý'U  j'Al,  ý(,  YHGTIY  NEAYGNLAYI  VHVRTELLPI 
.11,  JýMNPFA  281 
TvMGL1  250  AWL  JTk  1_ý  t.  -IFAESE  NAMKVAEYLK  SHP.  AVEKV'i  i  ,  IIEGH  298 
TvMGL2  253  AWL  ITIý  'I  I  NAQKVAEFLH  EHK.  AVKKVY  1  jliPGH  301 
PpMGLI  252  AALI,  ý11"  iF  lik  ýl  ý  :  ý('A  NAQVLAEFLA  RQP.  QVELIH  /%ýýI-,  PQY  300 
ScCYS3  244  AWM  lil-'  IFf;:  '.  'I 
.,! 
%,  AL  SANKIAEFLA  ADKENVVAVN  i'  ý'i  I  PN  Y  293 
HSCGL  252  CYL(  .1  FK  NGMAVAQFLE  SNPW.  VEKV!  iI  PQH  300 
EcMETB  238  SY1,1  1,1  ý  :,  I  'I,  1!  -l  ý  ý.  QR  NAQAIVKYLQ  TQPL.  VKKLY  i  I-,  NQGH  286 
EcMETC  249  AYITýýI'  1,  iý 
., 
ýiflE  SSLKVAEWLA  EHP.  QVARVtj  297 
SCMET25  282  SFLLIý]Vfýýj 
1: 
i, 
l, 
ý 
NALKLAKWLE  QSPY.  VSW  330 
TvMGL1  299  DIAKKý)Mll,.  Mý(;:;  M  ITFI  L  KSGFEG 
....  ...... 
AKKIý  J,  1,  i,  I-'!,  IT  LA  336 
TvMGL2  302  EIAKI<,  QMK.  MF6ZMlAFDV  DGLEK 
.....  ...... 
AKKV  1,  I)N('IIVVSLA  338 
PpMGL1  301  TLARQQMS. 
- 
QPGGMIAFEL  KGGIGA 
....  ......  GRRF  MNAI,  QLFSRA  338 
ScCYS3  294  DVVLKQHRDA  LGGGMISFRI  KGGAEA 
....  ...... 
ASKF  ASSTRLFTLA  333 
HsCGL  301  ELVKRQCTGC  T..  GMVTFYI  KGTLQH 
....  ...... 
AEIF  LKNLKLFTLA  338 
ECMETB  287  EIAARQQKG.  FGAMLSFEL  DGDEQT 
....  ...... 
LRRF  LGGLSLFTLA  324 
EcMETC  298  EFWKRDFTGS  SGLFSFVLKK  KLNNEE 
....  ...... 
LANY  LDNFSLFSMA  337 
ScMET25  331  ENAKKYLSNG  FGGVLSFGV  KDLPNADKET  DPFKLSGAQV  VDNLKLASNL  379 
154 T  vm(ý  1,1  Q'  VýýI,  G  'F  ý'  ,I  T  ý)(  :,  11  !.  ýýV  i  T)i%i  F;  "A  llýý, 
TvMGL2  339  Gill'S  I  UHPASMTHAG  VPKEEREAAG  LTi)lll,  l  1,.:  V  1,7  ý.  )  1)  11  D  388 
PpMGLI  339  VSL  DAES  UliPASMTHSS  YTPEERAHYG  ISE(;  I,  v  1- 
ý  . 
DDLLA  388 
ScCYS3  334  ESL  GIFS  L  EVPAVMTHGG  IPKEAREASG  VFD  L)',  'Y  1'',  i'!  )DLLE  383 
HsCGL  339  ESL  G  FES 
[  I 
ELPAIMTHAS  VLKNDRDVLG  IS  DTi,  1  1,:  !  -ýEDLLE 
l  l 
388 
EcMETB  325  ES  L  ('VE's  I  SHAATMTHAG  MAPEAPAAAG  ISE':  I  T,  ý  ý,:  '.:  ],:  DLIA  374 
EcMETC  338  Ysw  ('Y  F,  ý,  I  1,  ANQPEHTAA  TPPQGE..  TD  F'S'C",  1.  "  L;  1  '.  '!  )DLIA  385 
ScMET25  380  DAKT  ANV  TAPYFTTHKQ  LNl)KFK1,  A`C;  i  l F:  DD  I  IA  429 
TvMGL1  38ý  FKQGLDALL  396 
TvMGL2  389  LKQALDLVL  398 
PpMGL1  389  C)OALKASA  398 
ScCYS3  384  IKQALKQAT  N  394 
HsCGL  381)  LDQALKAAH 
[ 
PPSGIHS  405 
EcMETB  3ý5  1,  ENGFRAAN  KG  386 
EcMETC  386  LDAGFARIV  395 
ScMET25  430  QQSFETVF  AGQKP  444 
155 fd  TCACTTCT=AGCGAATG 
P-Scs  TCACTTCACATTACAATG 
a-scs  TCACTTCACATTAATG 
chsp70  TCA"I"I"=AATAATG 
Pgpl  CCATTAATCATTAGTGATG 
a-tub  TCACTCTTCATCATCAATG 
P-tub  TCATTATTCACATG 
mgll  ATTTTTAGACAACATG 
mq.  12  AC=ATATAAAAGATG 
Consensus  TCAYTWYTCATTA 
Figure  4.27  Conserved  nucleotide  sequence  surrounding  the  transcription 
initiation  sites  of  seven  T.  vaginalis  protein  coding  genes,  compared  to  the 
nucleotide  sequence  of  mgII  and  mgI2  as  determined  by  51RACE.  The  5'  sequences 
immediately  flanking  the  ATG  translational  start  codon  of  the  genes  encoding  the 
following  proteins  are  shown:  Ferredoxin  (Fd),  Johnson  et  aL,  (1990),  P-subunit 
succcinyl  CoA  synthetase  (P-SCS),  Lahti  et  aL,  (1992),  a-subunit  succcinyl  CoA 
synthetase  (aSCS),  cytosolic  heat  shock  protein  (cHSP70),  P-glycoprotein,  (PGP  I), 
Tubulin,  (PTUB),  Quon  et  aL,  (1994)  and  a-tubulin,  (aTUB)  Johnson  et  al.,  (1990). 
156 Table  4.1  Percentage  identities  and  percentage  similarites  (in  brackets)  of 
amino  acid  residues  between  various  enzymes  invloved  in  sulphur  amino  acid 
metabofism  from  a  variety  of  different  organisms. 
The  percentage  identities  and  similarities  were  determined  using  the  GAP  program 
of  the  University  of  Wisconsin  Genetics  Computer  Group  (GCG).  The  references 
of  the  sequences  used  are  as  follows:  T  vaginalis  methionine,  y-lyases,  MGLI  and 
MGL2  (this  study),  methionine  y-lyase  from  Pseudomonasputida  (PpMGL,  Inoue 
et  aL,  1995)  and  cystathionine  y-lyase  from  yeast  (ScCYS3,  Ono  et  aL,  1992)  and 
human  (HsCGL,  Lu  et  aL,  1992),  plus  cystathionine  y  synthase  and  cystathionine 
P-lyase  from  E.  coli  (EcMETB,  Duchange  et  aL,  1983  and  EcMETC,  Belfaiza  et 
aL,  1986,  respectively)  plus  0-acetylhomoserine  sulphydrylase  from  yeast 
(ScMET'25,  Kerjan  et  al.,  1986) Q0  laý  tj  :a 
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157 Restriction  enzyme  Size  of  hybridising  fragment  (kb) 
BamHl  >23.1 
EcoRl  7.5 
EcoRV  2.4 
Hincll  2.5,1.3 
HindIll  15,6.5 
PStI  20 
Sall  >23.1,20 
SmaI  >23.1 
Sphl  6.5 
Xhol  >23.1,14,9  (very  faint) 
Table  4.2  A  summary  of  the  sizes  of  hybridising  fragments  obtained  by  Southern  blot 
analysis  after  T  vaginalis  genomic  DNA  was  digested  with  various  restriction  enzymes 
and  subsequently  probed  with  a  mgII  -specific  probe,  I  kb  EcoRllXhol  fragment  of  p4  1  oo. 
158 Restriction  enzyme  Size  of  hybridising  fragment  (kb) 
BamHI  >23.1 
EcoRI  7.5 
EcoRV  6.8,0.5 
Hincll  2.5 
HindIll  15 
Psti  >23.1 
Sall  >23.1  (faint)  3.5 
SmaI  >23.1 
Sphl  14 
Xhol  19,13,9 
Table  4.3  A  summary  of  the  sizes  of  hybridising  fragments  obtained  by  Southern  blot 
analysis  after  T  vaginalis  genomic  DNA  was  digested  with  various  restriction  enzymes 
and  subsequently  probed  with  a  mg12-specific  probe,  800bp  EcoRI  fragment  of  p5  1  oo. 
159 CHAPTER  5:  EXPRESSION,  PURIFICATION  AND 
BIOCHEMICAL  CHARACTERISATION  OF  RECOMBINANT 
T.  VAGINALIS  METHIONINE  y-LYASE  HOMOLOGUES. 
5.1  Introduction. 
Two  gene  homologues  for  methionine  y-lyase  have  been  isolated  from  T  vaginalis 
which  have  a  high  level  of  identity  to  methionine  y-lyase  from  P.  putida  and  to 
cystathionine  7-1yases  from  yeast  and  human.  (Chapter  4).  Amino  acid  residue 
comparisons  of  methionine  y-lyase  from  P.  putida  and  cystathionine  y-lyase  from  yeast 
and  human  with  the  T  vaginalis  mgII  and  mg12  were  unable  to  convincingly  assign  the 
T  vaginalis  genes  an  identity.  In  order  to  address  this  problem  the  two  genes  were 
cloned  into  E.  coli  expression  vectors  in  order  to  obtain  recombinant  proteins.  These 
were  biochemically  characterised  and  lead  to  an  enzyme  activity  being  attributed  to  the 
products  of  the  T  vaginalis  mgll  and  mgI2  genes. 
The  QIAexpressionist  system  (Qiagen)  was  chosen  for  the  expression  and  purification 
of  mgII  and  mgI2.  They  were  cloned  in  to  a  QlAexpress  pQE  expression  vector  which 
encode  a  6xHistidine  tag  at  the  N  or  C  terminus  of  the  expressed  protein.  The 
6xHistidine  tagged  recombinant  protein  was  then  affinity  purified  using  M2ý-NTA 
(nitrilo-tri-acetic  acid)  resin. 
5.2  Results. 
5.2.1  Cloning  of  mgII  into  pQE60. 
160 The  mgII  cDNA  p4loo  contained  the  complete  open  reading  frame  of  the  mgII  gene  but 
was  missing  13  nucleotides  that  made  up  the  5'UTR  of  the  gene  (See  Chapter  4  for 
details).  As  the  p4loo  cDNA  of  mgI1  included  the  methionine  start  site  it  was  decided  to 
use  a  Type  ATG  (pQE60)  vector  to  clone  the  complete  open  reading  frame  for  mgII. 
This  would  produce  a  recombinant  protein  with  a  6xHistidine  tag  located  at  the  C- 
terminus  and  utilises  its  authentic  ATG  codon.  Cloning  of  the  cDNA  of  p4,00  into  a 
Type  ATG  construct  also  removes  the  authentic  mgII  stop  codon  by  mutating  it  and 
therefore  expression  the  recombinant  protein  from  the  vector  becomes  dependent  on  the 
vector  derived  stop  codon.  Sequence  analysis  revealed  that  no  restriction  sites  were 
available  within  p4loo  that  would  enable  the  direct  cloning  of  mg11  into  pQE60.  In  order 
to  overcome  these  cloning  problems,  a  PCR  based  cloning  strategy  was  adopted  to 
enable  mgI1  to  be  cloned  into  pQE60.  Oligonucleotide  primers  were  designed  to  the 
5'and  3'ends  of  mgII  and  included  the  restriction  endonucleases  Ncol  and  BgIlI 
respectively.  The  NcoI  site  at  the  5'  end  of  the  construct  serves  to  regenerate  the  AUG 
start  codon.  Through  the  PCR  amplification  process  these  two  restriction  sites, 
engineered  onto  the  ends  of  the  mgII  DNA,  would  facilitate  cloning  into  Ncol  and  BgIlI 
restricted  pQE  vector.  The  nucleotide  sequence  of  the  two  Primers  used  in  the  PCR  are 
outlined  below:  - 
5'  NcoI  primer  for  mgI1  PCR,  for  cloning  into  pQE60  (24nucleotides) 
5'  3' 
CGCCATGGCTCACGAGAGAATGAC 
NcoI 
3'  BgRI  primer  for  mgII  PCR,  for  cloning  into  pQE60  (27nucleotides) 
5'  3' 
GCAGATCTTAAAAGAGCGTCAAGGCCC 
BglII 
161 p4  100  was  linearised  using  Bamfll,  which  served  as  the  template  for  the  PCR  with  the 
two  oligonucleotides  and  Pfu  polymerase,  which  has  proof-reading  activity  . 
The 
following  amplification  protocol  was  employed.  An  initial  denaturation  step  of  4 
minutes  at  94'C  was  followed  by  30  cycles  at  94*C  for  1  minute,  421C  for  I  minute  and 
72"C  for  I  minute.  A  final  step  of  5  minutes  at  72T  was  used  to  complete  the 
extension.  After  PCR,  contaminating  nucleotides  and  polymerase  were  removed  from 
the  PCR  product  using  Magic  PCR  Wizard  preps.  The  cleaned  up  DNA  was  restricted 
with  NcoI  and  Bg1Il  and  ligated  with  NcollBgIII  restricted  pQE60  and  subsequently 
transformed  into  XLI  -Blue  cells.  XLI  -Blue  were  chosen  in  order  to  make  the  screening 
process  easier.  The  cells  into  which  the  pQE  plasmid  are  transformed  for  efficient 
protein  expression,  MI  5pREP4,  contain  an  additional  plasmid  pREP4,  which  encodes 
the  lac  repressor  and  is  required  for  the  prevention  of  expression  of  the  recombinant 
protein  until  IPTG  is  added  to  the  cells. 
In  order  to  ascertain  whether  the  cloning  of  the  mg11  PCR  product  into  pQE60  had  been 
successful,  restriction  enzyme  analysis  of  plasmid  from  transformed  cells  was 
performed.  pQE60  plasmid  was  isolated  from  transformed  XLI-Blue  clones  and 
restricted  with  NcoI  and  BgIII,  and  electrophoresed  in  a  I%  agarose  gel  (Figure  5.1, 
lanes  3-6).  Lanes  3  and  5  contain  a  single  band  of  3.5kb  which  represents  the  plasmid 
pQE60  alone.  Lanes  4  and  6,  however,  both  contain  two  fragments  of  3.5kb  and  1.3kb 
and  this  indicated  the  cloning  of  the  amplified  1.3kb  fragment  of  mgII  into  the  pQE60 
expression  vector  had  been  successful. 
After  the  cloning  of  mgII  into  pQE60,  the  intact  plasmid  was  then  transformed  into 
M15pREP4.  The  protein  expression  clone  for  mgII  was  named  pQMGLIa  (lane  4). 
162 The  nucleotide  and  predicted  amino  acid  sequence  of  pQMGLI  is  shown  in  Figure  5.2. 
Differences  between  pQMGL1  and  mill  are  outlined  by  red  and  green  text,  which 
highlights  the  change  in  the  second  amino,  acid  residue  of  pQMGLI  compared  to  mgII 
and  also  shows  the  6x  Histidine  tag  that  is  present  at  the  C-terminus  of  the  recombinant 
protein. 
5.2.2  Test  induction  and  expression  rMGL1  from  pQMGL1. 
Test  expressions  of  E.  coli  containing  pQMGL  Ia  were  carried  out.  Firstly,  I  00mls 
Ml5pREP4  cells  containing  pMGLI  were  grown  in  LB  amp/kan  (100  pg  and  25  pg/ml, 
respectively)  at  371C  until  the  OD60o.,,,,  reached  0.7-0.9  (-1.75  hours),  the  cells  were 
induced  with  2  mM  IPTG  and  grown  for  a  further  3  hours  at  37"C.  An  experiment  was 
then  carried  out  to  check  the  location  and  the  solubility  of  the  expressed  protein,  by 
following  a  protocol  in  the  QlAexpressionist  handbook  (See  QlAexpress  handbook  for 
details).  The  experiment  was  designed  to  find  out  whether  the  expressed  protein  was 
located  in  the  pellet,  periplasm  or  soluble  fraction  of  the  induced  cells.  SDS-PAGE 
analysis  of  the  pellet,  periplasmic  and  cytosolic  fractions  of  the  induced  E.  coli  revealed 
the  cellular  location  and  solubility  status  of  the  expressed  protein  (Figure  5.3).  A 
predominant  protein  was  detected  in  the  soluble  fraction  of  the  induced  cells  of  43  kDa 
(Figure  5.3,  lane  4).  The  recombinant  protein  was  the  expected  size  to  be  produced 
when  the  insert  of  size  of  the  plasmid  is  taken  into  consideration.  There  is  a  protein  of 
the  same  size  present  in  the  pellet  fraction  of  the  induced  cells  along  with  some  larger 
proteins  (lane  5),  but  not  in  the  same  quantities  as  in  the  soluble  fraction.  There  was  no 
protein  of  the  expected  size  present  in  the  periplasmic  fraction  of  the  induced  cells  (lane 
6). 
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The  expression  and  purification  of  recombinant  MGLI  (rMGLI)  was  based  on  the 
results  of  the  experiments  outlined  above,  using  2  mM  IPTG  and  isolating  the  protein 
from  the  soluble  fraction  of  the  induced  cells.  A  50  ml  overnight  culture  of  E.  coli 
containing  pQMGLI  was  inoculated  into  400  ml  of  LB  broth  containing  100ý1g/ml 
ampicillin  and  25[tg/ml  kanamycin,  which  was  grown  for  1.75  hours  at  37*C  prior  to 
induction  with  2  mM  IPTG,  the  cells  grown  for  a  further  2.25  hours  before  harvesting. 
The  recombinant  protein  was  released  from  the  cells  by  sonication  and  separated  from 
the  bacterial  cell  debris  by  a  subsequent  centrifugation  step  prior  to  purification.  The 
soluble  fraction  of  the  cells  was  filtered  through  a  0.22gM  filter  and  loaded  onto  a  4ml 
Ni2+-NTA  column.  The  non-histidine  tagged  E.  coli  proteins  were  washed  off  I using 
successive  washes  of  sonication  and  wash  buffer.  The  6xHistidine  tagged  recombinant 
protein  eluted  from  the  column  using  a  FPLC  generated  linear  gradient  of  O-5OOmM 
imidazole.  Figure  5.4  shows  a  typical  A280nm  trace  obtained  from  the  purification  of 
rMGLl  and  summarises  the  FPLC  protocol  used  to  purify  the  6xHistidine  tagged 
protein.  A  large  peak  of  absorbance  was  seen  for  the  first  50  minutes  of  the  purification 
of  rMGL  I,  this  was  the  large  amount  of  E.  coli  proteins  that  do  not  bind  to  the  Ni2+_ 
NTA  column  and  are  washed  from  the  column  by  sonication  buffer.  There  was  also  a 
second  smaller  peak  observed  at  100  minutes  and  this  too  represents  E.  coli  proteins  that 
are  more  hydrophobic,  as  they  were  eluted  from  the  column  by  wash  buffer  that 
contained  glycerol.  Two  peaks  were  eluted  during  the  imidazole  gradient.  The  first  at 
170-180  minutes  and  the  second  starting  at  190  minutes.  The  large  single  peak  that  is 
eluted  between  194  and  210  minutes  had  a  maximum  A280  run  absorption  of  2AU  and 
shows  the  rMGLI  being  eluted  specifically  from  the  Ni2+-NTA  between  220  mM  and 
164 300  mM  imidazole.  Fractions  shown  to  contain  rMGLI,  based  on  the  A280  run  trace 
run  were  selected  for  analysis  by  SDS  PAGE  (Figure  5.5) 
The  insoluble  fraction  of  the  induced  pQMGL  IMI  5pREP4  cells,  that  was  obtained 
after  the  sonication  and  centrifugation  step  is  shown  in  Panel  A,  lane  1.  The  protein 
profile  of  the  soluble  induced  fraction  of  MI  5pREP4  cells  that  was  loaded  onto  the 
Ni2'-NTA  (Panel  A,  lane  2)  shows  a  predominant  band  of  -43  kDa,  which  was  the 
induced  6xHistidine  tagged  rMGLI.  The  immediate  flow  through  fraction  from  the 
purification  is  shown  in  Panel  A,  lane  3  and  SDS-PAGE  analysis  reveals  that  essentially 
all  of  the  induced  6xHistidine  tagged  rMGLI  has  bound  to  the  Ni2+-NTA  column,  with 
other  E.  coli  proteins  being  eluted  from  the  column  in  sonication  buffer.  Lanes  5  and  6 
show  a  number  of  faintly  wash  buffer  fractions  that  were  eluted  from  the  column,  there 
are  staining  bands  of  molecular  weights  ranging  between  45  and  66  kDa  were  detected 
in  Panel  A,  lanes  5  and  6.  Proteins  eluted  from  the  Ni2+-NTA  column  between  174  and 
180  minutes  of  the  purification  run  are  shown  in  Panel  A,  lanes  8-10.  The  proteins 
present  in  these  fractions  have  various  molecular  weights  and  are  different  from  the 
proteins  previously  eluted  from  the  column  using  sonication  and  wash  buffer.  The 
fractions  that  were  collected  at  194-210  minutes  into  the  protein  purification,  Figure 
5.513,  lanes  2-10.  These  fractions  contain  the  6xHistidine  tagged  rMGLI  protein  that 
was  eluted  from  the  column  between  220  mM  and  300  mM  imidazole  and  which  made 
up  the  main  peak  that  was  eluted  from  the  column  during  the  running  of  the  imidazole 
gradient.  Two  main  proteins  were  eluted  from  the  column,  one  -43kDa,  which  is  the 
size  of  recombinant  protein  expected  to  be  produced  when  the  size  of  the  mgll  open 
reading  frame  is  taken  into  consideration,  the  second  protein  was  of  higher  molecular 
weight,  greater  than  66  kDa.  (Panel  B,  lanes  2-10).  The  rMGLI  samples  were  only 
165 heated  to  37*C  in  the  presence  of  Laemmli  sample  buffer  so  as  to  prevent  the  hydrolysis 
of  acid  labile  bonds  that  exist  between  the  recombinant  protein  and  the  imidazole  buffer. 
To  investigate  whether  the  higher  molecular  weight  protein  present  in  the  fractions 
eluted  from  the  column  was  a  multimeric  complex  being  formed  by  the  rMGLI 
molecules,  the  imidazole  used  to  elute  the  recombinant  protein  from  the  column  was 
dialysed  away  and  the  sample  subjected  to  SDS-PAGE  analysis  after  being  boiled  with 
Laemmli  sample  buffer  (Figure  5.6).  rMGLl  was  heated  to  37"C  in  the  presence  of 
imidazole  buffer.  Two  main  bands  of  protein,  one  of  greater  than  66  kDa  in  size  and  the 
other  of  -43  kDa  were  detected  and  this  was  the  same  as  outlined  in  Figure  5.5,  Panel  B, 
lanes  2-10.  When  rMGL  I  was  boiled  in  the  presence  of  Laemmli  sample  buffer  in  the 
absence  of  imidazole  buffer,  one  main  protein  of  -43  kDa  was  detected.  (Figure  5.6,  lane 
2).  There  was  no  evidence  of  higher  molecular  bands.  Thus  rMGL  I  forms  multimeric 
complexes  under  certain  conditions. 
A  typical  purification  of  rMGLI  from  450  ml  of  E  coli  containing  pQMGLI  yielded 
5  mg  of  the  recombinant  protein. 
5.2.4  Cloning  of  the  mgI2  into  pQE30. 
The  p5  I  oo  cDNA  was  missing  26  nucleotides  which  made  up  the  S'  end  of  the  gene, 
including  the  AUG  start  codon.  The  presence  of  suitable  restriction  sites  present  in  the 
p5  100  cDNA  allowed  the  cloning  of  mg12  directly  into  a  Type  IV  pQE  expression 
construct.  The  Type  IV  construct  places  the  6xHistidine  tag  at  the  N-ten-ninus  of  the 
protein.  p5  1  oo  was  restricted  with  BamHl  and  XhoI  and  the  1.3  kb  insert  was  gel  purif  ied 
and  ligated  with  BamHl  and  SaR  restricted  pQE30  and  transfonned  into  XLI-Bluc  cells. 
Mini-prep  DNA  from  individual  transformants  was  tested  for  the'presence  of  insert  by 
166 of  restriction  enzyme  analysis.  pQE30  alone  was  restricted  with  PstI  (Figure  5.7,  lane  2) 
and  BamHl  and  HindlIl  (Figure  5.7,  lane  3),  showed  a  single  band  of  -3.5  kb,  which  is 
the  size  of  the  vector.  Restriction  analysis  of  plasmid  isolated  from  two  individual 
transformants  that  was  restricted  with  BamHl  and  HindIII  revealed  two  different  size 
fragments  (Figure  5.7,  lanes  5  and  6).  The  3.5kb  band  is  the  vector  and  the  1.3kb  band, 
which  was  the  expected  size  of  the  insert  of  p5  100  ligated  into  the  expression  vector. 
The  expression  vector  construct  for  mgI2  was  named  pQMGL2  and  the  nucleotide  and 
predicted  amino  acid  sequence  of  the  insert  of  mg12  contained  in  this  plasmid  is  shown 
in  Figure  5.8.  As  can  be  seen  the  6xHistidine  is  located  at  the  N  terminus  of  the  protein 
but  due  to  nature  in  which  the  mgI2  insert  from  p5loo  was  cloned  into  pQE30  there  are 
an  additional  8  amino  acid  residues  derived  from  pBluescript  located  at  the  N  terminus 
of  the  protein,  this'Vector  derived  sequence  is  shown  by  blue  text  in  Figure  5.8. 
5.2.5  Test  induction  and  expression  of  rMGL2  from  pQMGL2. 
Test  expressions  were  also  carried  out  for  pQMGL2  in  the  same  way  as  for  pQMGL  I. 
SDS-PAGE  analysis  of  the  various  fractions  obtained  for  the  induced  E.  coll  cells 
containing  pQMGL2  is  shown  in  Figure  5.9.  The  protein  profile  of  uninduced  and 
induced  bacterial  cells  are  shown  in  Figure  5.9,  lanes  I  and  2  respectively.  The  protein 
constituents  of  the  soluble  fraction  of  the  induced  cells  are  shown  in  Figure  5.9,  lane  4, 
there  are  a  number  of  proteins  of  different  molecular  weights,  with  a  predominant  band 
at  -43  kDa,  the  expected  size  of  rMGL2.  The  insoluble  fraction  of  the  induced  cells 
(Figure  5.9,  lane5),  shows  a  predominant  band  of  43  kDa  along  with  other  proteins  of 
different  molecular  weights.  No  protein  bands  are  visible  in  the  periplasmic  fraction  of 
the  induced  cells  (Figure  5.9,  lane  6).  It  would  appear  results  that  the  6xHistidine 
167 tagged  rMGL2  is  present  both  in  the  soluble  and  insoluble  fractions  of  the  induced  E. 
coli  cells.  Based  on  the  results  of  the  above  experiment  it  was  decided  to  reduce  the 
concentration  of  IPTG  that  was  being  used  to  initiate  rMGL2  expression  ten  fold,  this 
change  was  decided  as  it  was  most  likely  that  the  expression  of  rMGL2  was  too  great 
initially  and  that  expressed  protein  was  being  produced  in  very  large  quantities  that  was 
causing  probably  two  thirds  of  the  protein  to  become  insoluble.  A  lower  concentration 
of  IPTG  would  encourage  a  more  steady  production  of  the  recombinant  protein  over 
time  and  allow  a  larger  quantity  of  the  protein  to  remain  in  the  soluble  fraction  of  the 
induced  cells,  which  could  be  purified  more  easily  than  if  the  protein  was  to  become 
insoluble. 
5.2.6  Routine  expression  and  purification  of  rMGL2. 
Based  on  the  experiment  outlined  above  it  was  decided  that  the  expression  of  rMGL2 
would  identical  to  the  protocol  used  for  the  expression  of  rMGL  I,  with  the  exception 
that  the  cells  would  be  induced  with  0.2  mM  IPTG. 
Figure  5.10  shows  the  A280  rim  profile  obtained  from  a  typical  purification  of  rMGL2. 
The  profile  is  very  similar  to  the  one  obtained  for  the  purification  of  rMGLI.  There  is  a 
large  flow  through  and  wash  peak  (>2AU)  that  is  obtained  when  the  W+ýNTA  is 
washed  with  sonication  buffer  during  the  first  50  minutes  of  the  protein  purification. 
There  is  another  small  peak  at  100  minutes  into  the  purification,  which  were  E  coli 
proteins  that  are  eluted  from  the  column  in  the  presence  of  wash  buffer,  that  contains 
glycerol.  Between  180  and  195  minutes  of  the  purification  there  is  a  large  peak  (>2AU) 
that  is  eluted  from  the  column,  this  is  the  6xHistidine  tagged  protein  that  is  displaced 
from  the  column  by  imidazole. 
168 Figure  5.11  A/B  shows  SDS-PAGE  analysis  of  certain  fractions  that  were  collected 
during  the  purification  of  rMGL2  for  which  the  A280  run  profile  is  shown  in  Figure 
5.10.  Figure  5.11,  Panel  A,  lane  I  shows  the  protein  constituents  of  the  insoluble 
fraction  of  the  induced  E.  coli  cells  obtained  after  the  sonication  and  centrifugation  step 
of  the  purification  of  rMGL2.  There  are  many  proteins  that  make  up  the  insoluble 
fraction  of  the  cells  but  there  is  no  induced  protein  of  -43  kDa  present  in  this  fraction 
of  the  cells,  which  indicates  that  the  reduction  in  the  concentration  of  IPTG  used  to 
induce  the  cells  was  successful  in  preventing  the  rMGL2  going  into  the  insoluble 
fraction  of  the  bacteria.  The  protein  profile  of  the  soluble  fraction  of  the  induced  E.  coli 
(Figure  5.1  IA,  lane  2),  shows  a  predominant  band  of  -43  kDa,  which  is  the  6xHistidine 
tagged  rMGL2,  along  with  other  soluble  bacterial  proteins  of  various  molecular  weights. 
The  immediate  flow  through  fraction  from  the  column  (Figure  5.11  A,  lane  3),  shows  that 
the  6xHistidine  tagged  rMGL2  has  bound  to  the  Ni2+-NTA,  with  other  non  tagged  E.  , 
coli  proteins  being  eluted  from  the  column  with  sonication  buffer.  The  E.  coli  proteins 
eluted  from  the  Ni2+-NTA  column  when  washed  with  sonication  buffer  (Figure  5.11  A, 
lane  5),  show  a  few  faintly  staining  bands  of  various  molecular  weights.  The  bacterial 
proteins  that  were  eluted  from  the  column  with  wash  buffer  (Figure  5.11  A,  lane  7),  due 
to  the  faintness  of  the  staining  of  the  bands  in  this  fraction  they  are  not  visible  in  Figure 
5.11,  but  there  were  several  bands  of  different  molecular  weights  present  in  this  fraction. 
rMGL2  that  was  eluted  from  the  Ni2+-NTA  column  by  imidazole  between  178  and  194 
minutes  of  the  purification  run  is  shown  in  Figure  5.1  IB,  lanes  1-4,6-10  As  can  be  seen 
from  all  lanes,  especially  lanes  2-4  and  6-8  (which  are  fractions  taken  from  the  middle 
of  the  peak  eluted  by  imidazole),  there  is  a  predominant  protein  band  of  -43  kDa  with  a 
small  amount  of  a  another  band  of  >66  kDa  in  size.  As  with  rMGL  I  the  higher 
169 molecular  weight  band  is  a  multimeric  complex  of  rMGL2,  which  in  the  absence  of 
imidazole  and  boiled  in  the  presence  of  Laemmli  sample  buffer  is  reduced  to  the  43  kDa 
monomer.  The  amount  of  multimeric  complex  formed  by  rMGL2  is  not  nearly  as  great 
as  that  formed  by  rMGL  I. 
A  typical  purification  of  rMGL2  from  450  ml  of  induced  E.  coli  culture  typically  yielded 
-20mg  of  protein. 
Preliminary  enzyme  assays  investigated  the  catabolism  of  homocysteine,  one  of  the 
substrates  broken  down  by  methionine  7-1yase  from  both  T  vaginalis  and  P.  pulida  and 
they  revealed  that  both  of  the  recombinant  proteins  produced  from  the  two  T  vaginalis 
methionine  y-lyase  gene  homologues  were  able  to  break  down  this  substrate.  This  was  a 
very  exciting  finding  as  enzymatically  active  recombinant  T  vaginalis  methionine  y- 
lyase  provided  the  material  with  which  to  fully  biochemically  characterise,  the  two 
methionine  y-lyase  gene  homologues  and  therefore  assign  an  enzyme  activity  to  the  two 
genes  that  had  been  isolated. 
5.2.7  Stabilisation  studies  of  rMGL1  and  rMGL2. 
Good  quantities  of  both  rMGLI  and  rMGL2  (-15-20mg/  purification  run)  could  be 
obtained  from  a  single  protein  purification,  which  would  enable  extensive  biochemical 
characterisation  of  the  two  recombinant  proteins.  A  study  was  undertaken  to  determine 
the  conditions  under  which  optimum  enzyme  activity  could  be  maintained  over  a 
number  of  weeks.  Based  on  stabilisation  conditions  that  had  been  used  for  native 
methionine  y-lyase  (Lockwood  and  Coombs,  1991)  and  for  enzyme  stabilisation  in  ý 
general,  a  number  of  different  conditions  were  investigated,  for  their  ability  to  stabilise 
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stabilisation  experiments  for  rMGL  I  and  rMGL2,  respectively. 
Before  the  two  purified  recombinant  proteins  were  combined  with  the  different  enzyme 
stabilisation  solutions  (A-F)  they  were  treated  in  one  of  three  ways.  1.  Recombinant 
protein  that  was  eluted  from  the  Ni2'-NTA  column  was  combined  immediately  with  the 
different  enzyme  stabilisation  solutions  (rMGLI  or  rMGL2  +  Imidazole).  2. 
Recombinant  proteins  eluted  from  the  column  were  dialysed  overnight  against  0.1  M 
sodium  phosphate  buffer  pH  7.5  and  20%  (v/v)  glycerol,  15  VM  DTT  and  20  VM  PLP, 
in  order  to  remove  the  imidazole  that  was  present  (rMGLI  or  rMGL2  -Salt).  3.  Purified 
proteins  were  dialysed  overnight  against  0.1  M  sodium  phosphate  buffer  pH  7.5  with  the 
same  additions  as  in  2.  but  which  also  contained  300mM  sodium  chloride  (rMGLI  or 
rMGL2  +Salt).  The  results  presented  in  Tables  5.1  and  5.2  basically  show  the  same 
overall  trends  with  regards  to  the  stability  of  the  recombinant  proteins  under  the  variety 
of  conditions.  Firstly  it  appears  that  the  replacement  of  the  imidazole,  in  which  the 
proteins  are  eluted,  with  the  dialysis  buffer  containing  sodium  chloride,  glycerol,  DTT 
and  PLP  increases  the  stability  of  the  enzyme.  Thus,  whereas  rMGLI  retained  47%  of 
its  homocysteine  desulphurase  activity  after  storage  in  buffer  that  contained  imidazole 
for  14  days,  96%  of  the  original  activity  was  retained  over  the  same  time  when  the 
enzyme  was  in  the  stabilisation  buffer  containing  300mM  sodium  chloride.  For  rMGL2 
the  same  trend  is  observed:  47%  homocysteine  desulphurase  activity  was  retained  in  the 
presence  of  the  buffer  with  imidazole  whereas  91%  activity  was  retained  under  the  same 
storage  condition  but  after  dialysis  overnight  with  buffer  containing  sodium  chloride. 
For  nearly  all  stabilisation  conditions  used,  the  trend  was  similar  for  both  rMGLI  and 
rMGL2.  As  for  the  addition  of  reducing  agents  and  PLP  on  the  maintenance  of 
homocysteine  desulphurasc  activity  of  the  two  recombinant  proteins,  it  can  be  seen  from 
171 Tables  5.1  and  5.2  that  100%  activity  was  retained  by  both  of  the  proteins  over  14  days 
subsequent  to  being  dialysed  against  buffer  containing  sodium  chloride  then  being 
combined  with  stabilisation  buffer  F  and  stored  at  -20*C.  Thus,  due  to  the  excellent 
stabilisation  of  enzymatic  activity  of  the  two  recombinant  proteins  under  these 
conditions  outlined  above,  it  was  decided  they  would  be  adopted  as  the  standard 
stabilisation  conditions  for  rMGL  I  and  rMGL2.  These  enzyme  stabilisation 
experiments  were  also  useful  in  that  they  revealed  the  time  period  over  which  the 
enzyme  activity  was  retained.  It  was  important  to  know  this  before  the  onset  of  detailed 
biochemical  characterisations.  Further  analyses  were  carried  out  on  the  stored  enzyme  in 
stabilisation  buffer  F  at  -20*C,  no  loss  in  homocysteine  desulphurase  activity  was  found, 
after  the  two  recombinant  proteins  were  stored  over  a  period  of  three  months. 
5.2.8  Determination  of  pH  optima  for  homocysteine  breakdown  by  rMGL1  and 
rMGL2. 
The  pH  optima  were  also  determined  for  the  breakdown  of  homocysteine  by  rMGL  I  and 
rMGL2.  Such  experiments  were  carried  out  so  that  the  pH  at  which  the  enzymatic 
activities  were  conducted  could  be  standardised.  As  can  be  seen  from  Figures  5.12  and 
5.13,  the  pH  optimum  for  both  rMGLI  and  rMGL2  appears  to  be  pH  6.5.  Imidazole 
buffer  was  used  as  it  covered  the  expected  pH  range  of  the  two  recombinant  proteins 
and  preliminary  pH  optimum  experiments  had  indicated  that  homocysteine  breakdown 
by  the  two  recombinants  was  elevated  in  the  presence  of  imidazole  buffer.  Thus,  all 
future  enzyme  assays  were  conducted  at  pH6.5  in  imidazole  buffer,  also  the  pH  of  the 
dialysis  buffer  and  enzyme  stabilisation  buffer  used  at  the  end  of  the  purification  of  the 
two  recombinant  proteins  were  changed  to  pH  6.5.  The  pH  optimum  was  not 
determined  for  the  other  substrates  used  by  the  two  recombinant  proteins. 
172 5.2.9  Biochemical  characterisation  of  rMGL1  and  rMGL2. 
5.2.9.1  Substrate  speciricities  of  rMGLI  and  rMGL2. 
A  number  of  biochemical  characterisations  were  carried  out  for  the  two  recombinant 
proteins  in  order  to  determine  the  likely  physiological  roles  of  the  two  enzymes.  Firstly, 
the  6reakdown  of  a  number  of  key  substrates  by  rMGL  I  and  rMGL2  was  investigated. 
The  substrates  selected  were  from  those  that  had  been  used  to  characterise  native 
methionine  y-lyase  from  T  vaginalis.  Table  5.3  summarises  the  specific  activities 
obtained  for  rMGL  I  and  rMGL2  with  a  range  of  substrates.  The  specific  activities  were 
calculated  using  values  obtained  for  the  production  of  the  cc-keto  acid  from  each 
substrate.  As  can  be  seen  from  Table  5.3,  the  two  recombinant  proteins  had  a  very  high 
specific  activity  for  homocysteine-64  pmol/min/mg  and  54  pmol/min/mg  for  rMGLI 
and  rMGL2  respectively.  The  two  recombinant  proteins  were  also  able  to  break  down 
methionine,  with  the  value  of  8.4  pmol/min/mg  being  obtained  for  rMGLI  and  1.8 
pmol/min/mg  being  obtained  for  rMGL2.  rMGLl  and  rMGL2  also  have  activity 
towards  O-acetyl-L-serine  and  cysteine,  with  the  specific  activities  calculated  for  0- 
acetyl-L-serine  being  very  similar  for  the  two  proteins  and  the  activity  for  the 
breakdown  of  cysteine  being  nearly  two-fold  higher  for  rMGLI  than  for  rMGL2.  The 
activity  toward  S-adenosyl-methionine  of  the  two  proteins  is  also  very  low.  Neither 
recombinant  protein  showed  activity  towards  cystathionine.  This  suggests  that  mgll  and 
mg12  are  truly  methionine  y-lyases  and  probably  not  cystathionine  y-lyases.  The 
substrate  specificity  data  presented  in  Table  5.3  would  support  this  view,  as  the 
substrates  broken  down  by  rMGLI  and  rMGL2  are  also  characteristically  broken  down 
173 by  methionine,  y-lyase  from  anaerobic  bacteria  such  as  P.  pulida  and  Aeromonas  species 
(Esaki  and  Soda,  1987). 
5.2.9.2  Determination  of  kinetic  parameters  for  rMGLI  and  rMGL2. 
Kinetic  parameters  for  rMGLI  and  rMGL2  were  also  determined  when  homocysteine, 
methionine  and  cysteine,  were  substrates  for  the  two  proteins.  Figures  5.14  to  5.19  show 
typical  saturation  curves  obtained  for  hornocysteine,  methionine  and  cysteine  for  the  two 
recombinant  proteins.  The  saturation  curves  determined  for  homocysteine  and  cysteine 
used  the  hydrogen  sulphide  trapping  assay,  whereas  the  methionine  saturation  curves 
were  determined  using  the  colourimetric  reagent,  MBTH.  As  can  be  seen  from  Figures 
5.14  and  5.15  rMGLI  displayed  hyperbolic  kinetics  with  respect  to  homocysteine  and 
methionine.  However,  the  saturation  curve  for  cysteine  with  rMGLI  is  sigmoidal 
(Figure  5.16),  which  suggests  that  co-operativity  may  exist  between  the  subunits  of 
rMGLI  when  cysteine  is  used  as  a  substrate  and  that  regulatory  modulators  may  be  able 
to  act  on  rMGLI.  For  rMGL2  it  is  interesting  to  note  that  Michaelis-Menten  kinetics 
are  presented  for  methionine  as  a  substrate  (Figure  5.18).  Sigmoidal  kinetics,  however, 
are  presented  for  both  homocysteine  and  cysteine  (Figures  5.17  and  S.  19  respectively), 
which  may  suggest  the  possibility  of  allosteric  regulation  of  rMGL2  by  some  unknown 
effector.  Table  5.4  surnmarises  the  Km  and  Vmax  data  obtained  for  rMGL  I  and 
rMGL2  from  a  number  of  experiments  with  the  three  substrates  outlined  above.  As  can 
be  seen  from  Table  5.4,  the  Krn  value  obtained  when  methionine  is  the  substrate  for 
rMGLI  is  low  when  compared  to  the  values  obtained  for  hornocysteine  and  cysteine, 
0.65mM  for  methionine  compared  to  4.7  mM  for  hornocysteine  and  6.1  rnM  for 
cysteine.  Comparison  of  the  Km  values  obtained  for  rMGL  I  for  the  three  substrates  to 
the  values  obtained  for  methionine  with  rMGL2  reveal  that  the  MGL2  Km  values  are 
174 higher  in  all  cases.  There  is  a  significant  difference  in  the  Km  value  obtained  for 
methionine  when  rMGL2  is  compared  to  rMGLI,  10.6  mM  compared  to  0.65  mM.  The 
Km  values  for  homocysteine  and  cysteine  with  rMGL2  are  approximately  four-fold 
greater  than  the  values  obtained  for  the  same  substrates  with  rMGLI.  Comparison  of 
the  Vmax  values  for  both  proteins  with  the  three  different  substrates  reveal  that  for  both 
homocysteine  and  cysteine  the  Vmax  values  for  the  two  proteins  are  very  similar. 
However,  the  Vmax  value  calculated  for  methionine  with  rMGLI  is  two  fold  higher 
than  the  equivalent  value  calculated  for  rMGL2. 
5.2.9.3  The  effect  of  exogenous  thiol  on  homocysteine  breakdown  by  rMGL1  and 
rMGL2. 
The  breakdown  of  homocysteine  by  rMGLI  and  rMGL2  was  assayed  in  two  ways. 
Firstly,  by  monitoring  the  production  of  hydrogen  sulphide  in  a  continuous  assay,  in 
which  the  trapping  agent  lead  acetate  was  used.  This  was  converted  to  lead  sulphide, 
the  production  of  which  can  be  monitored  at  360  nm  (Thong  and  Coombs,  1985) 
Secondly,  the  production  of  cc-ketobutyrate  which  used  the  reagent  3-methyl-2- 
bcnzothiazolone  hydrazonc  hydrochloride  (MBTH)  which  reacts  with  a-keto  acids  to 
form  azines  which  absorb  maximally  at  320nm  (Soda,  1968)  It  was  found  that  the 
calculated  specific  activities  for  the  breakdown  of  homocysteine  by  rMGLI  and  rMGL2 
differed  depending  on  which  assay  system  was  used.  As  can  be  seen  from  Table  5.5,  the 
specific  activity  calculated  for  the  breakdown  of  homocysteine  by  rMGL  I  using  the 
H2S-trapping  system  was  246  pmol/min/mg  protein  compared  with  49  ýLmol/min/mg 
protein  when  the  production  of  (x-ketobutyrate  was  investigated.  Similarly,  the  specific 
activities  calculated  for  rMGL2  were  323  pmol/min/mg  protein  for  the  H2S  detection 
175 compared  to  50g  mol/min/mg  protein  for  the  cc-keto,  acid  detection.  This  was 
surprising  as  the  y-elimination  of  honlocysteine  catalysed  by  methionine  y-lyase  gives 
equirnolar  quantities  of  the  three  products,  cc-ketobutyrate,  hydrogen  sulphide  and 
ammonia  (see  Figure  5.20).  As  elevated  levels  of  hydrogen  sulphide  were  produced  by 
both  recombinant  proteins  compared  with  cc-keto  acid  production  it  was  thought  that  an 
exchange/replacement  reaction  could  be  occurring.  As  is  detailed  in  Figure  5.20  this 
type  of  reaction  is  able  to  occur  when  exogenous  thiol  (eg.  P-mercaptoethanol)  is  added 
along  with  homocysteine  and  other  sulphur-containing  amino  acids.  The 
elimination/exchange  reaction  results  in  more  thiol  being  liberated  from  the  substrate 
and  a  decrease  in  the  amount  of  cc-keto  acid  formed.  However,  it  was  not  likely  that 
rMGLI  and  rMGL2  with  regards  to  homocysteine  breakdown,  as  there  was  no 
exogenous  thiol  added  to  the  assays.  However,  to  investigate  this  further  assays  were 
carried  out  in  the  presence  P-mercaptoethanol.  The  results  of  this  experiment  are  also 
given  in  Table  5.5.  For  both  proteins,  there  was  a  decrease  in  the  amount  of  ct- 
ketobutyrate  produced  by  the  two  proteins  compared  with  the  equivalent  assay  without 
exogenous  thiol  (2.6  and  13.3  limol/min/mg  protein  for  rMGLI  and  rMGL2, 
respectively),  but  there  is  also  a  decrease  in  the  amount  of  thiol  produced  from 
homocysteine  by  rMGL  I  (152  pmol/min/mg  protein)  and  the  amount  of  hydrogen 
sulphide  produced  from  the  breakdown  of  homocysteine  by  rMGL2  is  basically  the 
same  as  for  the  control  experiment  (326  pmol/min/mg  protein).  These  results  appear  to 
indicate  that  some  sort  of  exchange  reaction  was  taking  place  as  judged  by  the  decrease 
in  the  amount  of  oc-keto  acid,  but  an  increase  in  the  amount  of  thiol  liberated  was  not 
occurring.  Indeed  it  appeared  for  rMGLl  that  the  exogenous  thiol  may  be  inhibiting  the 
176 exchange  reaction.  It  could  be  that  some  thiol  other  than  hydrogen  sulphide  is  being 
produced,  that  is  not  able  to  be  detected  by  the  lead  acetate  of  the  trapping  assay. 
5.2.9.4  SDS-PAGE  analysis  of  rMGL1  and  rMGL2. 
Further  biochemical  analyses  of  the  two  recombinant  proteins  included  SDS-PAGE. 
PAGE  analysis  of  the  two  recombinant  proteins  on  large  acrylamide  gels  revealed 
differences  in  size  between  rMGLI  and  rMGL2.  As  can  be  seen  from  Figure  5.21  the 
rMGLI  protein  is  44  kDa  in  size,  whereas  the  rMGL2  protein  is  of  slightly  higher 
molecular  mass  at  47  kDa.  It  must  be  remembered  that  the  6xHistidine  tagged  rMGL2 
protein  is  expected  to  be  of  higher  molecular  weight  when  compared  to  rMGL  I,  due  to 
the  way  in  which  mgI2  was  cloned  into  pQE30.  rMGL2  has  eight  additional  amino  acid 
residues  that  are  derived  from  pBluescript  (see  Figure  5.8). 
5.2.9.5  Gel  filtration.  chromatography  of  rMGLI  and  rMGL2. 
The  native  molecular  weights  of  the  two  recombinant  proteins  were  investigated  by  gel 
filtration  chromatography.  A  Superose  12  column  was  used  for  the  native  molecular 
weight  determinations.  The  calibrated  gel  filtration  column  revealed  that  the  native 
molecular  mass  of  rMGLI  was  >  440  kDa  in  size.  The  protein  was  eluted  from  the  gel 
filtration  column  after  23  minutes  compared  to  the  27  minutes  that  it  took  for  ferritin  to 
be  eluted,  which  is  440  kDa,  thus  one  is  able  to  conclude  that  rMGLI  is  larger  than 
ferritin.  This  result  was  really  not  that  surprising  when  the  characteristics  of  rMGLI  in 
not  fully  reduced  conditions  on  Laemmli  gels  are  taken  into  consideration.  It  has 
already  been  shown  earlier  in  this  chapter  that  rMGLI  has  a  tendency  to  form  high 
molecular  weight  complexes  which  can  be  dissociated  by  boiling  in  the  presence  of 
Laenunli  sample  buffer,  after  the  removal  of  imidazole  (Figure  5.6).  The  result  from  the 
177 gel  filtration  experiment  appear  to  indicate  that  high  molecular  weight  complexes  are 
formed  by  rMGL  I,  which  do  not  to  affect  enzyme  activity.  The  native  molecular  of 
rMGL2  as  determined  by  gel  filtration  chromatography  was  -158  kDa.  The  protein  was 
eluted  from  the  column  at  exactly  the  same  time  as  a1dolase,  which  has  a  molecular 
mass  of  158  kDa.  The  size  of  rMGL2  would  appear  to  indicate  that  this  protein  is 
fortning  a  tetrameric  structure,  which  is  characteristic  of  other  methionine  y-lyases 
isolated  to  date. 
5.2.9.10  Native  gel  electrophoresis  of  rMGL1  and  rMGL2. 
Native  gel  electrophoresis  was  also  carried  out  for  the  two  recombinant  proteins,  Figure 
5.22  shows  the  result  of  this  experiment.  Lanes  I  and  2  show  Coomassie  Blue  R250 
staining  of  rMGLI  and  rMGL2,  respectively.  The  mobility  of  rMGL2  was  slower  than 
that  of  rMGLl,  consistent  with  the  difference  in  molecular  weight  of  the  two  proteins. 
Figure  5.22,  Lanes  3  and  4  show  the  homocysteine  desulphurase  activity  of  the  two 
proteins  and  as  can  be  seen  the  homocysteine  catabolising  capabilities  of  the  two 
proteins  are  coincident  with  the  Coomassie  stained  proteins.  Finally  lanes  5  and  6  show 
the  effect  of  the  inhibitor  propargy1glycine  on  the  homocysteine  desulphurase  activity  of 
the  two  recombinant  proteins.  The  activity  of  the  two  proteins  was  completely  inhibited 
by  a  10  mM  concentration  of  this  inhibitor. 
5.2.9.11  Western  blot  analysis  of  T.  vaginalis  homogenates  using  antibodies  raised 
against  rMGLI  and  rMGL2. 
Polyclonal  antibodies  were  raised  against  the  two  recombinant  proteins  and  they  were 
subsequently  used  in  Western  blot  analyses  with  T  vaginalis  homogenates,  pellet  and 
supernatant  fractions.  Figure  5.23  shows  the  result  of  the  Western  blots  using  antisera 
178 against  rMGLI  and  rMGL2.  Figure  5.23,  Panel  A,  lanes  6  and  7  show  the  reactivity  of 
the  anti  rMGL  I  antisenun  with  rMGL  I  and  rMGL2,  respectively.  A  single  band  of  -43 
kDa  is  detected  with  the  anti  rMGLI  and  the  rMGLI  protein,  a  slightly  larger  size  band 
is  detected  with  the  same  antibody  and  rMGL2.  A  single  band  of  -43  kDa  was  detected 
in  aT  vaginalis  homogenate  (panel  A,  lane  8)  and  soluble  fraction  (Panel  A,  lane  10), 
there  is  no  reactivity  of  the  anti-rMGLI  serum  and  a  pellet  fraction  from  T  vaginalis 
(panel  A,  lane  9).  Figure  5.23  Panel  A  lanes  1-5  show  the  result  of  Western  blot 
analysis  when  the  same  samples  as  described  above  were  reacted  with  the  appropriate 
serum.  There  was  no  reactivity  of  the  samples  with  the  pre-immune  serum.  Figure 
5.23,  Panel  B,  lanes  6  and  7  show  the  reactivity  of  the  anti  rMGL2  antiserum  with 
purified  rMGLI  and  rMGL2  respectively.  There  was  no  reactivity  of  the  anti  rMGL2 
antibody  and  purified  rMGLI  (Lane  6),  whereas  the  same  antiserum  recognises  a  protein 
of  -43  kDa  when  reacted  with  rMGL2.  A  single  band  of  -43  kDa  is  detected  in  aT 
vaginalis  homogenate  (Panel  B,  lane  8)  and  soluble  fraction  (Panel  B,  lane  10),  there  is 
no  reactivity  of  the  anti-rMGLI  antiserum  and  a  pellet  fraction  from  T  vaginalis  (panel 
B  lane  9).  Panel  B  lanes  1-5  show  the  result  of  Western  blot  analysis  in  which  the  same 
samples  as  described  above  are  reacted  with  pre-immune  anti-rMGL2  antiserum,  as  can 
be  seen  there  was  no  reactivity  of  the  samples  with  the  pre-immune  serum. 
Western  blot  analysis  with  lysates  of  Ml5pREP4  cells  with  the  antisera  raised  against 
rMGLI  and  rMGL2  revealed  that  no  proteins  in  the  bacterial  cell  lysate  were  recognised 
by  the  two  antisera. 
5.3  Discussion. 
179 The  cloning  of  the  two  T  vaginalis  methionine  -1-lyase  hornologues,  mgII  and  mgI2  into 
protein  expression  vectors  for  the  production  of  recombinant  proteins  was  successful. 
The  production  and  subsequent  purification  of  recombinant  proteins  using  the  pQE 
vector  and  W+ýNTA  system  has  been  used  widely  in  a  number  of  biological  disciplines, 
for  example  in  characterisation  of  HIV  proteins  (Certa  et  al.,  1986),  the  characterisation 
of  an  IFN-y  receptor  (Fountoulakis,  1989)  and  for  the  production  of  large  mammalian 
proteins  (Traunecker,  199  1).  Also,  in  parasitology  research,  the  system  has  been  used 
for  the  production  and  subsequent  characterisation  of  a  number  of  proteins  including, 
Leishmania  mexicana  cell  cycle  regulatory  protein  homologues  (Mottram  and  Grant, 
1996).  The  system  has  also  been  used  for  the  characterisation  of  hydrogenosomal 
proteins  from  the  anaerobic  fungus  Neocallimasfixfrontalis  (Brondijk  et  al.,  1996). 
Fortuitously,  both  of  the  recombinant  proteins  produced  from  the  T  vaginalis  genes 
were  enzymatically  active  and  this  property  of  the  recombinants  opened  up  a  vista  of 
biochemical  characterisations  that  could  be  performed  on  the  two  proteins. 
The  various  biochemical  characterisations  performed  for  the  two  recombinant  proteins 
raise  a  number  of  points  for  discussion. 
An  important  feature  to  note  from  this  table  is  that  neither  protein  possesses  the  ability 
to  metabolise  cystathionine  (Table  5.3).  This  finding  provides  important  information  on 
the  possible  identities  of  the  two  T  vaginalis  genes.  It  would  appear,  from  the  inability 
of  rMGLI  and  rMGL2  to  breakdown  cystathionine,  as  well  as  the  ability  by  the  two 
proteins  to  catabolise  a  number  of  key  substrates,  that  have  been  associated  with 
methionine  y-lyases  especially  from  bacterial  sources  such  as  P.  pulida  (Esaki  and  Soda, 
1987),  that  the  two  genes  isolated  from  T  vaginalis  are  indeed  methionine  7-lyase 
180 homologues.  The  breakdown  of  hornocysteine,  cysteine,  O-acetyl  L-serine  and  S- 
adenosylmethionine  are  at  very  similar  levels  for  rMGLI  and  rMGL2.  However,  the 
breakdown  of  methionine  by  rMGL1  is  approximately  4  fold  higher  than  for  rMGL2.  In 
tenns  of  substrate  specificity  there  are  no  striking  differences  between  the  two  proteins, 
even  though  at  the  amino  acid  level  the  proteins  are  only  69%  identical.  However,  the 
kinetic  parameters  calculated  for  certain  substrates  with  the  two  proteins  may  intimate 
more  subtle  differences  in  enzyme  function. 
Comparison  of  the  substrate  specificities  of  the  two  recombinant  proteins  are  compared 
to  purified  native  methionine  7-1yase  from  T  vaginalis  provides  further  data  for  the 
identity  of  the  two  isolated  T  vaginalis  genes.  The  substrate  specificities  of  rMGLI, 
rMGL2  and  native  MGL  from  T  vaginalis  are  shown  in  Table  5.6,  the  activities  are 
expressed  relative  to  methionine  breakdown  by  each  protein.  The  breakdown  of  all 
substrates  relative  to  methionine  by  rMGL2  are  greater  than  the  equivalent  values  for 
rMGLl.  The  relative  value  for  the  breakdown  of  homocysteine  by  native  MGL  is  most 
similar  to  the  relative  breakdown  of  this  substrate  by  rMGLI  (903  and  764  relative 
activities,  respectively),  whereas  the  breakdown  of  cysteine  by  native  MGL  is  most 
similar  to  the  relative  value  obtained  for  the  breakdown  of  this  substrate  by  rMGL2  (99 
and  77  relative  activities  respectively).  This  result  may  possibly  be  explained  by  the  fact 
that  the  native  MGL  purified  from  T  vaginalis  may  have  been  a  mixture  of  proteins 
encoded  by  mgII  and  mgI2.  Table  5.6  also  reveals  distinct  differences  between  the 
relative  activities  of  rMGLI  and  2  and  the  native  MGL,  notably  native  MGL  has  huge 
relative  activities  for  0-acetyl  L-serine  (945)  and  S-adenosylmethionine  (830).  In  the 
case  of  0-acetyl  L-serine  the  relative  activity  is  greater  than  that  obtained  for 
homocysteine.  The  explanation  I  propose  for  this  result  is  that  the  native  MGL  from  T 
181 vaginalis  was  not  purified  to  homogeneity.  Support  for  this  explanation  comes  from 
attempted  purifications  of  the  native  enzyme  by  the  published  method  of  Lockwood  and 
Coombs,  (1991)  as  presented  in  Chapter  3  of  this  thesis.  Purifications  of  the  native 
enzyme  by  the  published  methods  failed  to  produce  the  molecule  in  a  homogeneous 
state,  there  were  numerous  contaminating  proteins  still  present  in  the  native  MGL 
preparation  even  after  three  chromatographic  column  steps.  Evidence  also  comes  from 
immunoprecipitation  data  presented  in  Chapter  3  of  this  thesis,  in  that  antibodies  raised 
to  supposedly  pure  MGL  from  T  vaginalis  immunoprecipitated  many  proteins  from 
metabolically  labelled  T  vaginalis  proteins.  I  suggest,  therefore,  that  the  high  activities 
toward  0-acetyl-L-serine  and  S-adenosyl-methionine  that  are  seen  with  native  MGL  are 
due  to  contaminating  proteins  that  were  'copurified'  with  the  native  MGL.  Further 
support  for  this  view  is  provided  by  the  fact  that  during  the  purification  of  cystathionine 
y-lyase  from  yeast  it  was  found  that  0-acetyl-L-serine/0-acetyl  L-homoserine 
sulphydrylase  (OAS/OAH  sulphydrylase)  was  a  contaminating  activity  of  the  y- 
elimination  enzyme  (Ono  et  al.,  1993). 
The  substrate  specificities  obtained  for  the  two  T  vaginalis  recombinant  proteins  also 
agree  well  with  published  data  for  methionine  y-lyases  characterised  from  other,  mainly 
anaerobic  bacteria,  sources,  thus,  providing  further  evidence  that  they  are  methionine 
lyase  homologues  Methionine  y-lyase  isolated  from  P.  putida  and  Aeromonas 
breakdown  methionine,  homocysteine  and  cysteine  at  very  similar  relative  activities  to 
the  two  T  vaginalis  recombinant  proteins  (Nakayama  et  al.,  1984,  Tanaka  et  al.,  1985 
and  Esaki  and  Soda,  1987).  Similar  specific  activities  were  also  obtained  for  purified 
182 methionine  y-lyase  from  Clostridium  sporogenes  (Kreis  and  Hession,  1973)  when 
compared  to  rMGL  I  and  rMGL2. 
Secondly,  it  appears  that  both  rMGLI  and  rMGL2  display  Michaelis-Menten  kinetics 
with  methionine  as  the  substrate.  The  Krn  determined  for  rMGL  I  with  methionine  as 
the  substrate  was  16-fold  lower  than  the  equivalent  Km  calculated  for  rMGL2,  this 
result  intimates  that  rMGL  I  has  a  greater  affinity  for  methionine  than  rMGL2  and  that 
rMGLI  may  be  responsible  for  the  authentic  methionine  catabolising  activity  in  the 
parasite.  Also  the  ratio  of  specific  activities  for  MGLI  (Table  5.6)  are  most  similar  to 
the  native  enzyme  from  T  vaginalis. 
Native  methionine  y-lyase  from  P.  putida  had  a  calculated  Km  value  for  methionine  of  1 
mM  (Esaki  and  Soda,  1987)  and  recombinant  methionine  y-lyase  from  A  pulida  also 
had  a  Km  of  I  mM  for  methionine  (Hori  et  aL,  1996),  so  the  Km  value  calculated  for 
methionine  for  rMGLI  is,  therefore,  in  the  same  range  as  the  Km  values  calculated  for 
the  bacterial  enzyme.  It  is  interesting  to  note  that  sigmoidal  saturation  curves  were 
obtained  with  cysteine  as  the  substrate  for  both  rMGLI  and  rMGL2  and  for 
homocysteine  with  rMGL2.  As  mentioned  in  the  results  such  results  indicate  that  there 
may  be  co-operativity  between  the  subunits  of  these  enzymes  when  cysteine  or 
homocysteine,  in  the  case  of  rMGL2,  is  used  as  the  substrate.  There  may  be  some 
activator  that  is  able  to  bind  to  these  enzymes  and  exert  some  type  of  metabolic 
regulation.  It  would  be  interesting  to  see  what  effect  an  exogenous  thiol  had  on  the 
saturation  curves  of  cysteine  for  both  of  the  proteins  and  on  the  homocysteine  saturation 
curve  of  rMGL2.  It  may  be  that  thiol  concentrations  in  the  cell  are  able  to  regulate  the 
cysteine  and  homocysteine-catabolising  capabilities  of  the  native  enzymes.  This  idea 
183 arises  from  thoughts  about  the  functional  significance  of  the  homocysteine,  methionine 
and  cysteine  breakdown  in  T  vaginalis.  One  idea  is  that  methionine  y-lyase  is 
functioning  to  maintain  the  redox  balance  of  the  cell.  As  thiols  are  produced  from  the 
breakdown  of  homocysteine,  methionine  and  cysteine,  it  may  be  that  the  enzymes  that 
produce  these  compounds  are  able  to  regulate  their  activity  by  binding  thiols.  The 
functional  significance  of  methionine,  -y-lyase  in  trichomonads  will  be  further  addressed 
in  Chapter  6  of  this  thesis. 
Another  point  that  must  be  mentioned  in  this  discussion  is  the  discrepancy  that  appears 
to  exist  between  the  specific  activities  calculated  for  the  breakdown  of  homocysteine  by 
rMGL  I  and  rMGL2,  when  the  assays  for  hydrogen  sulphide  and  cc-ketobutyrate  were 
used.  It  was  thought  that  the  y-exchange/replacement  reaction  that  is  known  to  occur 
with  sulphur  amino  acids  and  exogenous  thiol  may  have  been  responsible  for  this 
discrepancy,  however,  this  was  thought  not  to  be  the  case  (see  Table  5.5).  The 
explanation,  therefore,  that  I  give  for  this  discrepancy  is  simply  the  difference  in 
sensitivity  of  the  two  assay  methods  that  were  used.  Indeed  the  unequal  production  of 
thiol  and  a-ketobutyrate  from  homocysteine  by  T  vaginalis  lysates  has  been  reported  by 
Thong,  1987,  but  without  comment. 
Thirdly,  mgII  and  mgI2  genes  encode  proteins  with  predicted  molecular  mass  of  42.9 
kDa  and  43.1  kDa  respectively  and  SDS-PAGE  analysis  showed  that  rMGLI  is 
approximately  43kDa,  whereas,  rMGL2  is  slightly  larger  than  predicted  because  of  extra 
amino  acids  that  are  derived  from  pBluescript.  The  sizes  of  rMGLI  and  rMGL2  agree 
well  with  molecular  size  data  published  for  the  methionine  y-lyases  from  bacterial 
184 sources.  Methionine  y-lyase  from  P.  putida  has  a  subunit  size  of  43  kDa  whereas 
Aeromonas  sp  methionine  y-lyase  has  a  subunit  size  of  41  kDa  (Tanaka  et  al.,  1985  and 
Esaki  and  Soda,  1987). 
The  native  molecular  masses  of  rMGLI  and  rMGL2  were  determined  as  >440  kDa  and 
158  kDa,  respectively.  The  native  molecular  mass  calculated  for  rMGL2  is  indicative  of 
a  homotetrameric  structure,  in  which  the  active  enzyme  is  composed  of  four  identical 
monomer  subunits  each  of  43  kDa.  The  calculation  of  the  molecular  weight  of  rMGL2 
is  in  good  agreement  with  the  native  molecular  weights  of  the  P.  putida  and  Aeromonas 
sp  enzyme.  The  P.  putida  enzyme  has  a  molecular  mass  of  165  kDa  and  the  Aeromonas 
enzyme  a  native  molecular  weight  of  149  kDa.  (Tanaka  et  d,  1985).  The  rMGLI 
native  molecular  mass  is  considerably  larger  than  the  expected  size  when  the  subunit 
molecular  mass  is  taken  into  consideration.  It  is  thought  that  this  protein  aggregates  to 
form  higher  molecular  weight  complexes  which  are  still  enzymatically  active.  It  is 
probable  that  that  the  high  molecular  weight  complex  is  composed  of  hornotetramers 
that  have  aggregated  together.  One  could  imagine  that  the  tertiary  structure  of  rMGLI  is 
such  that  surface  located  amino  acid  residues  encourage  subunit  aggregation  above  the 
normal  tetrameric  structure.  Further  experiments  that  would  favour  the  dissociation  of 
the  multimeric  complexes  of  rMGLI  may  reveal  the  true  native  molecular  weight  of  this 
protein. 
Fourthly,  antibodies  raised  against  rMGLl  and  rMGL2  were  used  to  investigate  the 
expression  of  the  two  proteins  in  T  vaginalls  homogenates,  soluble  and  pellet  fractions. 
Western  blot  analysis  using  the  two  antibodies  revealed  that  a  -43  kDa  protein,  in  both 
cases,  expressed  in  hornogenates  and  more  specifically  in  the  soluble  fraction  of  T 
185 vaginalis  lysates.  This  result  ties  up  with  Northem  blot  data  from  Chapter  4  and  shows 
that  the  mgII  and  mgI2  genes  are  being  actively  transcribed  and  translated  in  T 
vaginalis. 
It  should  be  remembered  that  rMGL2  was  missing  four  N  terminal  amino  acids  of  the 
open  reading  frame  (these  were  characterised,  by  5'-RACE  as  outlined  in  Chapter  4  of 
this  thesis).  Also  the  protein  had  an  additional  eight  amino  acids  that  were  derived  from 
pBluescript  as  a  result  of  the  cloning  of  mgI2  into  the  pQE30  vector.  As  rMGL2  is 
enzymatically  active  and  has  many  biochemical  characteristics  that  are  similar  to  the 
same  enzyme  from  bacterial  sources,  it  is  unlikely  that  the  absence  and  presence  of 
certain  amino  acid  residues  as  outlined  above  is  having  a  great  effect  on  the  biochemical 
characteristics  of  this  recombinant  protein.  However,  one  could  never  be  completely 
confident  that  the  missing/additional  residues  were  not  important  for  enzyme  function 
without  cloning  and  expressing  the  full  length  mg12.  If  time  had  permitted,  this  would 
have  been  carried  out. 
To  end  this  discussion  there  are  several  ideas  that  I  want  to  propose  based  on  the  results 
presented  in  this  Chapter.  It  appears  that  the  two  methionine  y-lyase  homologues 
isolated  from  T  vaginalis,  which  are  68%  identical  at  the  amino  acid  residue  level,  are 
in  terms  of  a  number  of  biochemical  characteristics,  quite  similar.  The  exceptions  to 
this  appear  to  be  the  kinetic  parameters  calculated  for  methionine  and  that  saturation 
curves  for  homocysteine  and  cysteine  for  rMGL2  and  cysteine  for  rMGLI  exhibit 
allosteric  kinetics.  Also  the  native  molecular  mass  of  rMGLI  is  considerably  larger  than 
that  for  rMGL2. 
186 One  may  ask  the  question:  Why  have  two  genes  that  are  only  69%  identical  but  whose 
products  are  biochemically  very  similar?  I  feel  that  there  are  a  number  of  possible 
answers  to  this  question.  Firstly,  it  may  be  that  the  possession  of  two  genes  by  T 
vaginalis  that  give  products  with  very  similar  biochemical  characteristics  may  be  an 
insurance  policy  adopted  by  the  organism.  If  the  gene  product  has  an  essential  function 
in  the  parasite,  then  the  organism  may  have  safeguarded  against  damage  to  one  of  the 
genes  by  having  a  back-up  copy.  Certainly,  T  vaginalis  has  several  copies  of  P-tubulin 
genes  (Katiyar  and  Edlind,  1994).  Secondly,  it  may  be  that  I  haven't  discovered  the 
crucial  substrate  that  would  be  able  to  distinguish  the  two  gene  products.  I  tend  to 
believe,  however,  that  this  is  not  the  case,  as  a  fairly  rigorous  biochemical 
characterisation  of  the  two  recombinant  proteins  has  taken  place,  in  which  the  majority 
of  the  classic  substrates  used  by  methioniney-lyases  have  been  tested  with  rMGL  I  and 
rMGL2.  Thirdly,  it  may  be  possible  that  the  two  gene  products  may  combine  in  the 
parasite  to  give  a  heterotetramer  that  possesses  different  substrate  specificities  to  the 
homotetramers  of  rMGLI  and  rMGL2.  Finally,  it  may  be  that  the  two  recombinant 
proteins  have  different  locations  in  the  parasite,  where  they  perform  slightly  different 
functions,  indeed  this  theory  may  be  supported  to  some  extent  by  immunolocalisation 
data  using  intact  T  vaginalis  and  the  MGLI  and  MGL2  antisem  presented  in  the  next 
chapter  of  this  thesis. 
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Figure  5.1  Restriction  analysis  of  pQMClA  clones. 
Plasi-nid  DNA  isolated  from  individual  XI.  I  -Blue  trans  formants  was 
restricted  with  Acol  and  Bgll  I  and  clectrophorcsed  on  a1  %TBF  agarose 
gel,  stained  with  FtBr  and  visualised  under  (  IV  illumination. 
Lanes  I  and  8:  1  kb  ladder  (I.  i  fle  Technoiogics) 
Lane  3:  pQMGLla  restricted  with  Nc-ol  and  BgIll 
Lane4:  pQMGl,  lb  restricted  with  Ncol  and  Bglll 
Lane  5:  pQMG1.1c  restricted  with  Ncol  and  BgIll 
Lane  6:  pQMG1,1a  restricted  with  Neol  and  BgIll 
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12345678 Figure  5.2  Nucleotide  and  deduced  amino  acid  sequence  of  Histidine-tagged  MGLI. 
The  clone  used  in  this  study  was  pQMGL  I  b.  Changes  in  mg1I  sequence  in  pQE60 
compared  to  mgll  in  pBluescript  at  the  5'  end  are  indicated  in  red  text.  The  6-Hlstidine  tag 
is  indicated  in  green  text  and  other  sequence  encoded  by  pQE60  is  shown  in  blue  text. 1  CCATGG(-'TCACGAGAGAATGACCCCAGCAACAGCATGCATCCATGCTAATCCACAGAAGG  60 
1MP,  HERMTPATACIHANPQKD  20 
61  ATCAGTTTGGAGCAGCCATCCCACCAATCTACCAAACATCAACATTCGTTTTCGATAACT  120 
21  QFGAAIPPIYQTSTFVFDNC  40 
121  GCCAACAGGGTGGAAACAGATTCGCTGGTCAGGAATCCGGCTACATCTACACACGTCTCG  180 
41  QQGGNRFAGQESGYIYTRLG  60 
181  GCAACCCAACAGTTTCAAACCTCGAAGGCAAGATCGCCTTCCTCGAGAAAACAGAAGCAT  240 
61  NPTVSNLEGKIAFLEKTEAC  80 
241  GCGTTGCCACATCTTCTGGCATGGGTGCCATTGCTGCTACAGTTTTGACAATCCTCAAGG  300 
81  VATSSGMGAIAATVLTILKA  100 
301  CCGGAGATCACTTAATCTCCGATGAGTGCCTTTATGGCTGCACACATGCTCTCTTTGAGC  360 
101  GDHLISDECLYGCTHALFEH  120 
361  ACGCATTGACAAAGTTCGGCATCCAGGTCGACTTCATCAACACAGCCATCCCAGGCGAGG  420 
121  ALTKFGIQVDFINTAIPGEV  140 
421  TCAAGAAGCACATGAAGCCAAACACAAAGATTGTCTATTTCGAGACACCAGCCAACCCAA  480 
141  KKHMKPNTKIVYFETPANPT  160 
481  CACTCAAGATCATCGACATGGAGCGCGTCTGCAAGGACGCCCACAGCCAGGAGGGCGTCT  540 
161  LKIIDMERVCKDAHSQEGVL  180 
541  TAGTTATCGCCGATAACACATTCTGCTCACCAATGATCACAAACCCAGTCGACTTTGGCG  600 
181  VIADNTFCSPMITNPVDFGV  200 
601  TCGATGTTGTTGTCCACTCTGCAACAAAGTACATCAACGGCCACACAGATGTCGTCGCTG  660 
201  DVVVHSATKYINGHTDVVAG  220 
661  GCCTTATCTGTGGCAAGGCTGACCTCCTTCAACAGATTCGTATGGTTGGTATCAAGGATA  720 
221  LICGKADLLQQIRMVGIKD1  240 
721  TCACAGGATCTGTTATCAGCCCACACGACGCTTGGCTCATCACACGTGGCCTCTCAACAC  780 
241  TGSVISPHDAWLITRGLSTL  260 
781  TCAACATCAGAATGAAGGCTGAGAGCGAGAACGCCATGAAGGTCGCTGAGTACCTCAAAT  840 
261  NIRMKAESENAMKVAEYLKS  280 
841  CTCACCCAGCCGTTGAGAAGGTTTACTACCCAGGCTTCGAGGACCACGAGGGCCACGATA  900 
281  HPAVEKVYYPGFEDHEGHD1  300 
901  TCGCTAAGAAGCAGATGAGAATGTCGGGTTCAATGATCACATTCATCCTCAAGTCCGGCT  960 
301  AKKQMRMSGSMITFILKSGF  320 
961  TCGAAGGCGCTAAGAAGCTCCTCGACAACCTCAAGCTTATCACACTTGCAGTTTCCCTTG  1020 
321  EGAKKLLDNLKLITLAVSLG  340 
1021  GTGGCTGCGAGTCCCTCATCCAGCACCCAGCTTCAATGACTCACGCTGTCGTTCCAAAGG  1080 
341  GCESLIQHPASMTHAVVPKE  360 
1081  AGGAGCGTGAGGCCGCTGGTATTACAGATGGCATGATCCGCCTTTCTGTCGGTATTGAAG  1140 
361  EREAAGITDGMIRLSVGIED  380 
1141  ATGCCGACGAACTCATCGCTGATTTCAAACAGGGCCTTGACGCTCTTTTAA(;  ýA'I'ý""ý-'.  )'ý'I'C  1200 
381  ADELIADFKQGLDALLP';  HH  400 
1201  ACCATCACCATý-ýACTAAGCTTAATTAGCTGAG  1232 
401  HHHH  410 
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Figure  5.3  SDS-PAGE  showing  the  location  and  solubility  of  the 
6xHistidine  tagged  rMGL1  in  M15pREP4  cells. 
Different  fractions  of  the  bacterial  cells  were  electrophoresed  on  a  10% 
acrylamide  gel  and  stained  with  Coomassie  Blue  R250. 
Lane  1:  Molecular  weight  markers  (Biorad) 
Lane  2:  Uninduced  whole  cell  hornogenate  of  Ml5pREP4 
Lane  3:  Induced  whole  cell  hornogenate  of  MI  5pREP4 
Lane  4:  Soluble  fraction  of  induced  Ml5pREP4  cells 
Lane5:  Insoluble  fraction  of  induced  Ml5pREP4  cells 
Lane  6:  Periplasmic  fraction  of  induced  MI  5pREP4  cells 
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Figure  5.4  A280nm  trace  obtained  from  the  purification  of  rMGLI. 
The  FPI,  C  generated  programme  for  the  purification  of'rMGl,  I  is  outlined 
below. 
0-30  minutes:  Sample  application  at  0.2ml/min  in  sonication  buffer 
(50mM  Sodium  phosphate  buffer  pl  18.0,300mM  NaCI) 
30-90  minutes:  Column  wash  with  sonication  bufter(as  above)  at  0.5ml/min 
90-150  minutes:  Column  wash  with  wash  buffer  (50mM  Sodium  phosphate  butler  pi  16.0 
300mM  NaCl,  10%  glycerol)  at  0.5ml/min 
150-250  minutes:  Linear  imidazole  gradient  0-500mM  in  wash  butler  (as  above) 
at  0.5  ml/min 
2  minute  fractions  (I  ml)  were  collected  over  the  imidazole  gradient 
191 
Minutes Figure  5S.  'SA/B  SDS-PA(,  F  of,  ýarious  fractlon%  from  a  purification  of 
rNICL  1. 
Samples  were  hollcd  in  Lacninill  buffer  for  Ike  minuics  prior  to  application  to  a 
12%  acrylamidc  gel,  samples  containing  inildazole  .  %ere  onlý  IlejItcd  to  3TIC  prior 
to  application  to  the  acrylamide  gel,  after  the  electrophorelic  run  the  gels  %%ere 
stained  with  Coomassic  Bluc  R250. 
Panel  A 
Lane  1:  1  nsoluble  pcl  let  fi'actIon  ofinduccd  \1  I  ý,  pRI  P-1  m,  I  1,  Q%  I(  iII 
Lane  2:  1  nduced  soluble  fraction  ot'M15pR  I  '114and  pQ%  I(  III  %klilcli  ý%as  loaded 
onto  the  Ni2*-N'I'A  column 
Lane  3:  Flow  through  fraction  ofinduced  MI  5pR  F.  P4  from  thc  Nr`-N  1A  column 
Lane  4:  Molecular  weight  markers,  SDS  7  (Signia) 
Lane  5:  Wash  buffer  fraction  at  100  minutes 
Lane  6:  Wash  buffer  fraction  at  I  10  minutes 
Lane  7:  Imidazole  gradient  fraction  at  174  minutes 
Lane  9:  Imidazole  gradient  fraction  at  176  minutes 
Lane  9:  Imidazole  gradient  fraction  at  179  minutes 
Lane  10:  Imidazole  gradient  fraction  at  180  minutes 
Panel  B 
Lane  1:  Molecular  veight  markers,  SDS  7  (Sigma) 
Lanes  2-10:  Protein  eluted  from  the  Ni2*-N'I'A  column  by  inudazole  lvt,.  %eell  194 
and  2  10  minutes  of  the  purification A 
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Figure  5.6  SDS-PAGE  analysis  of  rMGLI  showing  the  effects  of 
imidazole  removal  and  boiling  on  multimer  formation. 
rMGLI  protein  was  heated  to  370C  with  Laemmli  sample  buffer  and  applied 
directly  to  a  12%  acrylamide  gel  or,  dialysed  overnight  against  sodium 
phophate  buffer  pH  6.5  and  300mM  sodium  chloride  and  boiled  in  the 
presence  of  Laemmli  buffer  prior  to  application.  After  the  electrophoretic  run 
the  gel  was  stained  with  Coomassie  Blue  R250. 
Lane  1:  rMGL  I  in  the  presence  of  imidazole  buffer 
and  heated  to  only  370C  with  Laenimli  reducing  swnple  buffer 
Lane  2:  rMGLI  in  the  absence  of  imidazole  buffer  and  boiled  in  Laemmli 
reducing  sample  buffer 
SDS  7  (Sigma)  molecular  weight  markers  are  shown  on  the  left 
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Figure  5.7  Restriction  analysis  of  pQM(.  1,2  clones. 
pQE30  and  plasmid  DNA  isolated  From  individual  XIA-Blue  transformants  was 
restricted  with  Baml-11  and  HindIll  and  electrophoresed  in  a  MT111`1  agarosc  gel, 
stained  with  FtBr 
and  visuallsed  under  IN  illumination. 
Lanes  I  and  8:  1  kb  ladder  (1,1  fe  Tec  hno  logics) 
Lane  2:  pQE30  restricted  with  Psil 
Lane3:  pQE30  restricted  with  Bamill  and  HindIll 
Lane  5:  pQMGL2a  restricted  with  Bumill  and  HindIll 
Lane  6:  pQMG1,2b  rcstricted  with  Bamill  and  Hindill 
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12145678 Figure  5.8  Nucleotide  sequence  and  deduced  amino  acid  sequence  of  Histidine-tagged 
pQMGL2. 
The  clone  used  in  this  study  was  pQMGL2b.  The  6-Histidine  tag  is  indicated  in  green  text 
and  other  pBluescfipt  derived  sequence  is  shown  in  blue  text. 1  ATGAGAGGATCGCATCACCATCACCATCACGGATCCCCCGGGCTGCAGGAATTCGGCACG  60 
1MRGSHHHHHHGSPGLQEFGT  20 
61  AGCGCTATCGACCCAACACATACAGACACACTTTCCATCCACGCCAACCCACAGAAGGAT  120 
21  SAIDPTHTDTLSIHANPQKD  40 
121  CAGTTCGGTGCTATTGTTGCTCCAATCTACCAAACATCCACCTTCCTCTTCGACAACTGC  180 
41  QFGAIVAPIYQTSTFLFDNC  60 
181  GACCAGGGTGGTGCTCGTTTCGGTGGCAAGGAAGCCGGTTACATGTACACACGTATCGGT  240 
61  DQGGARFGGKEAGYMYTRIG  80 
241  AACCCAACAAACTCCGCACTCGAAGGCAAGATCGCCAAGCTCGAACACGCTGAGGCATGC  300 
81  NPTNSALEGKIAKLEHAEAC  100 
301  GCTGCCACAGCTTCTGGCATGGGTGCTATTGCTGCTTCTGTCTGGACATTCCTCAAGGCC  360 
101  AATASGMGAIAASVWTFLKA  120 
361  GGTGATCACCTTATCTCCGACGATTGCCTTTATGGCTGCACACACGCCCTCTTCGAGCAT  420 
121  GDHLISDDCLYGCTHALFEH  140 
421  CAGCTCCGCAAGTTCGGCGTTGAAGTTGATTTCATCGACATGGCTGTCCCAGGAAACATT  480 
141  QLRKFGVEVDFIDMAVPGN1  160 
481  GAGAAGCACTTGAAGCCAAACACAAGAATCGTCTACTTCGAAACACCAGCTAACCCAACA  540 
161  EKHLKPNTRIVYFETPANPT  180 
541  TTAAAGGTTATCGACATCGAAGACGCCGTCAAGCAGGCCAGAAAGCAGAAGGATATCCTC  600 
181  LKVIDIEDAVKQARKQKDIL  200 
601  GTTATCGTTGATAACACCTTCGCTTCACCAATTCTTACAAACCCACTCGACCTCGGTGTT  660 
201  VIVDNTFASPILTNPLDLGV  220 
661  GATATCGTCGTTCACTCCGCTACTAAGTACATCAATGGCCACACCGATGTTGTCGCCGGC  720 
221  DIVVHSATKYINGHTDVVAG  240 
721  CTTGTCTGCTCAAGAGCTGACATCATCGCTAAGGTCAAGTCCCAGGGTATCAAGGATATC  780 
241  LVCSRADIIAKVKSQGIKD1  260 
781  ACAGGCGCCATCATTTCCCCACACGACGCTTGGCTCATCACAAGAGGCACACTTACACTC  840 
261  TGAIISPHDAWLITRGTLTL  280 
841  GATATGCGTGTCAAGCGCGCTGCCGAGAACGCTCAGAAGGTCGCTGAATTCCTCCATGAG  900 
281  DMRVKRAAENAQKVAEFLHE  300 
901  CACAAGGCCGTCAAGAAGGTCTACTACCCAGGCCTTCCAGACCATCCAGGCCACGAAATC  960 
301  HKAVKKVYYPGLPDHPGHE1  320 
961  GCCAAGAAGCAGATGAAGATGTTCGGCTcTATgATCGCATTCGATGTCGACGGATTAGAG  1020 
321  AKKQMKMFGSMIAFDVDGLE  340 
1021  AAGGCCAAGAAAGTCCTTGACaACTGCCACGTTGTTTCTCTCGCCGTTTCCCTCGGTGGT  1080 
341  KAKKVLDNCHVVSLAVSLGG  360 
1081  CCAGAATCCCTCATCCAGCACCCAGCTTCAATGACACACGCTGGTGTTCCAAAGGAGGAA  1140 
361  PESLIQHPASMTHAGVPKEE  380 
1141  CGCGAGGCTGCTGGCCTAACAGATAACCTCATCCGCCTCTCTGTTGGCTGTGAGAACGTT  1200 
381  REAAGLTDNLIRLSVGCENV  400 
1201  CAGGATATCATCGACGACCTCAAGCAGGCTCTCGACTTAGTCCTCTAAATTTAACTTTCG  1260 
401  QDIIDDLKQALDLVL  420 
1261  AATTTCAGTAATAAAATCCTAGATATCTTCCCCCCC  1320 
1321  1341 
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Figure  5.9  SDS-PAGE  showing  the  location  and  solubility  the  6xHistidine  tagged 
rMGL2  in  Ml5pREP4  cells. 
Different  fractions  of  the  bacterial  cells  were  electrophoresed  on  a  10%  acrylamide  gel 
and  stained  with  Coomassie  Blue  R250. 
Lanes  I  and  7:  Molecular  weight  markers  (Biorad) 
Lane  2:  Uninduced  whole  cell  homogenate  of  MI  5pREP4  and  pQMGL2a, 
Lane  3:  Induced  whole  cell  homogenate  of  Ml5pREP4  and  pQMGL2a. 
Lane  4:  Soluble  fraction  of  induced  MI  5pREP4  cells 
Lane  5:  Insoluble  fraction  of  induced  Ml5pREP4  cells 
Lane  6:  Periplasmic  fraction  of  induced  MI  5PREP4  cells 
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Figure  5.10  A280nni  trace  obtained  from  the  purification  of  rMCL2. 
The  FPLC  generated  programme  for  the  purification  of  rMGL,  2  is  outlined  below 
0-30  minutes:  Sample  application  at  0.21nl/inin  in  sonication  buffer 
(50mM  Sodium  phosphate  buffer  pt-18.0,300rnM  NaCI) 
30-90  minutes:  Column  wash  with  sonication  buffier(as  above)  at  0.5ml/min 
90-150  minutes:  Column  wash  with  wash  butTer  (50inM  sodium  phosphate  buffer 
plJ6.0,300mM  NaCI,  10%  glycerol)  at  0.5ml/rnin 
150-250  minutes:  Linear  imidazole,  gradient  0-500mM  in  wash  buffer  (as  above) 
at  0.5  ml/min 
2  minute  fractions  (I  ml)  were  collected  over  the  imidazole  gradient 
197 
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Minutes Figure  5.11  A/B  SDS-PAGE  of  various  fractions  from  a  purification  of 
rMGL2. 
Samples  were  boiled  in  Laemmli  buffer  for  five  minutes  prior  to  application  to  a 
12%  acrylamide  gel,  samples  containing  imidazole  were  only  heated  to  37'C  prior 
to  application  to  the  acrylamide  gel.  After  electrophoresis  the  gels  were  stained 
with  Coomassie  Blue  R250. 
Panel  A 
Lane  1:  Insoluble  pellet  fraction  of  induced  MI  5pREP4  and  pQMGL2 
Lane  2:  Induced  soluble  fraction  of  Ml5pREP4  and  pQMGL2  loaded  onto  the 
Nj2+-NTA  column 
Lane  3:  Flow  through  fraction  of  induced  MI  5pREP4  from  the  Ni2-'-NTA  column 
Lane  4:  Molecular  weight  markers,  SDS  7  (Sigma) 
Lane  5:  Sonication  buffer  wash  fraction  at  40  minutes 
Lane  6:  Sonication  buffer  wash  fraction  at  80  minutes 
Lane  7:  Wash  buffer  fraction  at  100  minutes 
Lane  8:  Wash  buffer  fraction  at  140  minutes 
Lane  9:  Imidazole  gradient  fraction  at  196  minutes 
Lane  10:  Imidazole  gradient  fraction  at  198  minutes 
Panel  B 
Lanes  1-4:  Protein  eluted  from  the  Ni2'-NTA  column  by  imidazole  between  178- 
186  minutes  of  the  purification 
Lane  5:  Molecular  weight  markers,  SDS  7  (Sigma) 
Lanes  6-10:  Protein  eluted  from  the  Ni21-NTA  column  by  imidazole  between 
188-194  minutes  of  the  purification A 
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Figure  5.12  ptl  optimum  for  homocysteine 
breakdown  by  rMCLI  using  imidazole  buffer.  Data 
points  are  means  with  the  ei-roi-  bat-s  rcpt-cscnfing  the 
S.  D.  (n=3). 
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Figure  5.13  pH  optimum  for  homocysteine 
breakdown  by  rMGL2  using  imidazole  buffer.  Data 
points  are  means  with  the  error  bars  representing  the  S.  D. 
(n=3) 
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Figure  5.14  A  representative  homocysteine  saturation  curve  of 
rMGLI  and  Hanes  plot  of  data  (insert).  The  activity  associated 
with  a  fixed  quantity  ot'recombinant  protein  was  assayed  at 
different  concentrations  of  homocystemc.  The  kinetic  parameters 
for  this  experiment  were:  Km,  5.4  mM  and  the  Vmax,  35 
nmol/min/ml. 
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Figure  5.15  A  representative  methionine  saturation  curve 
of  rMG'Ll  and  Hanes  plot  of  data  (insert).  The  activity  of 
a  fixed  quantity  ot'rccombinant  protein  was  assayed  at 
different  concentrations  of  methionine.  The  kinetic 
parameters  for  this  experiment  were:  Kin,  0.66rnM  and  the 
Vmax,  20.8  nmoI/min/mI 
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Figure  5.16  A  representative  cysteine  saturation  curve  of  rMGIA 
and  Hanes  plot  (insert).  The  activity  ol'a  I  Ned  quantity  of' 
recombinant  protein  was  assayed  at  different  concentrations  of* 
cysteine.  The  kinetic  parameters  for  this  experiment  were:  Kin 
7.2mM,  Vniax.  13.1  nmol/min/ml  and  I  fill  Coell  icient  2.4 
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Figure  5.17  A  representative  homocysteine  saturation  curve  of 
rMGL2  and  Hanes  plot  of  data  (insert).  The  activity  ofa  fixed 
quantity  ofrecombinant  protein  was  assayed  at  different 
concentrations  of  hornocysteine.  The  kinetic  parameters  ofthis 
experiment  were:  Km27.1  mM,  Vmax,  45.3  nniolhnin/ml  and  I  fill 
coefficient  1.9 
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Figure  5.18  A  representative  methionine  saturation  curve 
of  rMGL2  and  Hanes  plot  of  data  (insert).  The  activity  ofa 
fixed  quantity  ot'recombinant  protein  was  assayed  at  different 
concentrations  ot'i-nethionine.  The  kinetic  parameters  for  this 
experiment  were:  Km,  7.0rnM  and  the  Vmax,  9.7 
nmoI/min/mI 
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Figure  5.19  A  representative  eysteine  saturation  curve  of  rMCL2 
and  Hanes  plot  of  the  data  (insert).  The  activity  ol'a  fixed  quantity  of 
recombinant  protein  was  assayed  at  different  concentrations  ol'cysteine. 
The  kinetic  parameters  lor  this  experiment  were:  Krn,  44.6mM,  Vrnax, 
7.1  nmol/min/rnl  and  Ifill  coefficient  2.9 
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0.0  2.0  4.0  6.0  8.0  10.0 Methionine  catabolism  by  methionine  y-lyase 
CH3SCH2CH2CHNH2COOH  +  H20  -)CH3SH  +  CH3CH2COCOOH  +  NH3 
Methionine  +  Water  Methanethiol  +  (x-ketobutý,  rate  +  Ammonia 
ct-y  elimination  reaction 
CH3SCH2CH2CHNH2COOH  +  SHOCH2-CH3->  CH3-CH2-0-SCH2CH2CHNH2COOH 
Methionine  +  P-mercaptoethanol  S-hydroxyethylhomocysteine 
+  CH3SH 
Methanethiol 
y-replacement/exchange  reaction 
Homocysteine  catabolism  by  methionine  y-lyase 
HS-CH2-CH2CHNH2COOH  +  H20  -),  H2S  +  CH3CH2COCOOH  +  NH3 
Homocysteine  +.  Water  Hydrogen  sulphide  +  a-ketobutyrate  +  Ammonia 
ct-y  elimination  reaction 
HS-CH2-CH2CHNH2COOH  +  SHOCH2-CH3  ->  CH3-CH2-0-SCH2CH2CHNH2COOH 
Homocysteine  +  P-mercaptoethanol  S-hydroxyethylhomocysteine 
+  H2S 
Hydrogen  Sulphide 
y-replacement/exchange  reaction 
Cysteine  catabolism  by  methionine  y-lyase 
SH-CH2CHNH2COOH  +  H20 
-* 
H2S  +  CH3COCOOH  +  NH3 
Cysteine  +  Water  Hydrogen  sulphide  +  Pyruvate  +  Ammonia 
cc-P  elimination 
SH-CH2CHNH2COOH  +  SHOCH2-CH3  -ý  CH3-CH2-0-SCH2CHNH2COOH  +  H2S 
Cysteine  +  P-mercaptoethanol  S-hydroxymethylhomocysteine  +  Hydrogen  Sulphide 
P-replacement/exchange  reaction 
Figure  5.20  The  reactions  catalysed  by  methionine  y-lyase  with  the  substrates 
methionine,  homocysteine  and  cysteine. 
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Figure  5.21  SDS-PAGE  analysis  of  purified  rMGLI  and  rMGL2. 
Purified  rMGL  I  and  rMGL2  was  dialysed  overnight  against  0.1  M  sodium 
phosphate  buffer  pH6.5  and  300  mM  soditun  chloride,  boiled  with  Laemmli 
reducing  sample  buffer  prior  to  application  on  a  12%  acrylamide  gel. 
Lane  1:  Purified  rMGLI 
Lane  2:  Purified  rMGL2 
Molecular  weight  size  markers  (Sigma  SDS  7)  are  indicated  on  the  left 
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Figure  5.21  SDS-PAGE  analysis  of  purified  rMG'LI  and  rMGL2. 
Purified  rMGL  I  and  rMGL2  was  dialysed  overnight  against  0.1  M  sodium 
phosphate  buffer  pH6.5  and  300  mM  sodium  chloride,  boiled  with  Laemmli 
reducing  sample  buffer  prior  to  application  on  a  12%  acrylamide  gel. 
Lane  1:  Purified  rMGI,  l 
Lane  2:  Purified  rMGI-,  2 
Molecular  weight  size  markers  (Sigma  SDS  7)  are  indicated  on  the  left 
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Figure  5.22  Native  PAGE  of  rMGL1  and  rMGL2. 
rMGL  I  and  rMGL2  combined  with  non  reducing  Laemmli  sample  buffer  was 
applied  to  a  non-denaturing  12%  acrylamide  gel  and  after  electrophoresis 
placed  in  hornocysteine  desulphurase  activity  stain. 
Lane  1:  Coomassie  Blue  R250  stained  rMGLI 
Lane  2:  Coomassie  Blue  R250  stained  rMGL2 
Lane  3:  Homocysteine  desulphurase  staining  of  rMGL  I 
Lane  4:  Homocysteine  desulphurase  staining  of  rMGL2 
Lane  5:  Homocysteine  desulphurase  staining  of  rMGLI  after  incubation 
of  the  gel  slice  in  10  mM  propargy1glycine 
Lane  6:  Homocysteine  desulphurase  staining  of  rMGL2  after  incubation 
of  the  gel  slice  in  10  mM  propargy1glycine 
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Figure  5.23  Western  blot  analysis  of  rMGLl  and  rMGL2  and  T.  vaginalis 
homogenates,  pellet  and  supernatant  fractions. 
Panel  A 
Lane  1:  rMGL  I  probed  with  preimmune  serum 
Lane  2:  rMGL2  probed  with  preimmune  serum 
Lane  3:  T  vaginalis  homogenate  probed  with  preimmune  antiserum 
Lane  4:  T  vaginalis  pellet  fraction  probed  with  preimmune  antiserum 
Lane  5:  T  vaginalis  soluble  fraction  probed  with  preimmune  antiserum 
Lanes  6-10:  Loaded  with  the  same  samples  as  above  but  probed  with  immune 
serum  raised  against  rMGL  I 
Panel  B 
Lanes  1-5:  Loaded  with  the  sarne  samples  as  in  Panel  A,  lanes  1-5  but  probed  with 
preimmune  serurn 
Lanes  6-10:  Loaded  with  the  same  samples  as  in  Panel  A,  lanes  1-5  but  probed  with 
serurn  raised  against  rMGL2 
210 f 
.  20C  -70C  -20C  -70C  -20C  -70C  -20C  -70C  -20C  -70C  -20C  -70C 
rMGLI  47  44  59  54  54  66  58  64  76  58  65  43 
I 
+Imidazole 
rMGLI  63  39  64  1  65  72  1  27  89  1  27  94  1  45  74  29 
-Salt  I  I 
rMGLI  96  43  98  46  72  70  94  65  82  100  100  93 
+S,:  dt 
- 
1  1 1  1  1 
Table  5.1  Stabilisation  studies  of  enzymatic  activity  of  rMGL1. 
Homocysteine  desulphurase  activities  of  rMGL  after  14  days,  expressed  as  a  percentage 
of  the  homocysteine  desulphurase  activity  of  freshly  purified  recombinant  protein. 
rMGLl  +  Imidazole,  rMGL1  combined  with  stabilisation  buffers  A-F  immediately  after 
elution  from  the  Ni2+-NTA  column. 
rMGLI  -Salt,  rMGLI  combined  with  stabilisation  buffers  A-F  after  dialysis  against 
sodium  phosphate  buffer  without  sodium  chloride 
rMGLI  +Salt,  rMGLI  combined  with  stabilisation  buffers  A-F  after  dialysis  against 
sodium  phosphate  buffer  with  sodium  chloride 
The  different  conditions  and  final  concentration  of  enzyme  stabilisation  buffer 
components  used  were: 
A:  40%  glycerol  in  0.1  M  sodium  phosphate  buffer  pH7.5 
B:  40%  glycerol  in  0.1  M  sodium  phosphate  buffer  pH7.5  and  15  pM 
Pmercaptoethanol 
C:  40%  glycerol  in  0.1  M  sodium  phosphate  buffer  pH7.5  and  IS  gM  DTT 
D:  40%  glycerol  in  0.1  M  sodium  phosphate  buffer  pH7.5  and  20  [tM  PLP 
E:  40%  glycerol  in  0.1  M  sodium  phosphate  buffer  pH7.5,15  ýM  P-mercaptoethanol 
and  20  gM  PLP 
F:  40%  glycerol  in  0.1  M  sodium  phosphate  buffer  pH7.5,15  ýM  DTT  and  20  ýM  PLP 
211 I  I 
-20C  -70C  -20C  -70C  -20C  -70C  ,  -20C  -70C  -20C  -70C  -20C  -70C 
rMGL2  47  60  38  73  34  87  34  88  50 
151 
67  59 
+Imidazole 
rMGL2  88  1  68  60  50  85  74  50  72  72  44  72  59 
-Salt 
I  I  I 
rMGL2  91  81  85  89  58  96 
L77 
89  71  85  100  91 
+Salt  I  I 
___JI 
Table  5.2  Stabilisation  studies  of  enzymatic  activity  of  rMGL2. 
Homocysteine  desulphurase  activities  of  rMGL2  after  14  days,  expressed  as  a 
percentage  of  the  homocysteine,  desulphurase  activity  of  freshly  purified  recombinant 
protein.  rMGL2  +  Imidazole,  rMGL2  combined  with  stabilisation  buffers  A-F 
immediately  after  elution  from  the  Ni2+-NTA  column. 
rMGLI  -Salt,  rMGL2  combined  with  stabilisation  buffers  A-F  after  dialysis  against 
sodium  phosphate  buffer  without  sodium  chloride 
rMGLI  +Salt,  rMGL2  combined  with  stabilisation  buffers  A-F  after  dialysis  against 
sodium  phosphate  buffer  with  sodium  chloride 
The  different  conditions  and  final  concentration  of  enzyme  stabilisation  buffer 
components  used  were: 
A:  40%  glycerol  in  0.1  M  sodium  phosphate  buffer  pH7.5 
B:  40%  glycerol  in  0.1  M  sodium  phosphate  buffer  pH7.5  and  15  ýLM 
Pmercaptoethanol 
C:  40%  glycerol  in  0.1  M  sodium  phosphate  buffer  pH7.5  and  15  gM  DTT 
D:  40%  glycerol  in  0.1  M  sodium  phosphate  buffer  pH7.5  and  20  [tM  PLP 
E:  40%  glycerol  in  0.1  M  sodium  phosphate  buffer  pH7.5,15  gM  P-mercaptoethanol 
and  20  jiM  PLP 
F:  40%  glycerol  in  0.1  M  sodium  phosphate  buffer  pH7.5,15  gM  DTT  and  20  pM  PLP 
212 Substrate  rMGLI  rMGL2 
Hornocysteine  64.2±16.0  (12)  53.9±0.11  (12) 
Methionine  8.4±1.1  (7)  1.8±0.09  (8) 
Cysteine  2.5±0.54  (5)  1.4±0.76  (6) 
0-acetyl-L-serine  2.7±0.11  (11)  2.5±0.43  (11) 
S-adenosyl-L-methionine  0.14±0.01  (8)  0.04±0.01  (8) 
Cystathionine  ND<0.001  (12)  ND<0.001  (12) 
Table  5.3  Summary  of  the  specific  activities  obtained  for  the  T.  vaginalis 
recombinant  proteins  rMGL1  and  rMGL2  with  various  substrates. 
The  data  are  the  enzyme  activities  in  gmol/min/mg  protein  and  are  Means  ±  S.  D.,  n  in 
parentheses.  N.  D.,  not  detectable 
213 rMGLI  rMGL2 
Km  Vmax  Km  Vmax 
Homocysteine  4.7±0.8  mM  28.6±7.4  23.7±3.0  mM  31.3±12.3 
(3)  nmols/min/ml  (3)  nmols/min/ml 
(3)  (3) 
Methionine  0.65±0.02  mM  17.0±3.4  10.6±4.0  mM  8.7±1.3 
(3)  muols/min/ml  (4)  runols/min/ml 
(3)  (4) 
Cysteine  6.1±1.1  mM  11.8±1.1  25.7±16.5  mM  7.4±0.2 
(3)  nmols/min/ml  (3)  nmols/min/ml 
1 11 
(3) 
1 
(3) 
Table  5.4  Summary  table  of  K.  s  and  V...  obtained  for  the  T.  vaginalis 
recombinant  proteins  rMGLI  and  rMGL2. 
The  substrates  homocysteine,  methionine  and  cysteine  were  used  in  the  kinetic 
determinations. 
The  data  are  means  ±  S.  D.,  n  in  parentheses 
214 rMGLI  rMGL2 
Hornocysteine  246±3.2  (8)  323±19.8  (8) 
H2S  detection 
Hornocysteine 
and  I  OmM  152±15.0  (8)  326±24.0  (8) 
P-mercaptoethanol 
H2S  detection 
Hornocysteine  49.2±3.6  (8)  50.6±2.0  (8) 
a-keto-acid  detection 
Hornocysteine 
and  I  OmM  2.6±1.2  (8)  13.3±2.4  (8) 
P-mercaptoethano 
oc-keto  acid  detection 
Table  5.5  Effect  of  P-mercaptoethanol  on  homocysteine  desulphurase  activity  of 
rMGL1  and  rMGL2. 
Summary  table  of  specific  activites  for  rMGLI  and  rMGL2  when  homocysteine  is  used 
as  a  substrate  with  and  without  P-mercaptoethanol  in  the  assay.  Two  different  assay 
methods  were  used  to  determine  the  breakdown  of  homocysteine.  Enzyme  activities 
pmol  min/mg  are  means  ±  S.  D.,  n  in  parentheses 
215 Substrate  rMGLI  rMGL2  native  MGL 
Methionine  100  100  100 
Homocysteine  764  2994  903 
Cysteine  30  77  99 
O-acetyl  L-serine  32  139  945 
S-adenosylmethionine  1.7  2.2  830 
Cystathionine  ND  ND  ND 
Table  5.6  Substrate  specificity  of  recombinant  MGLs  compared  to  native  MGL 
from  T.  vaginalis. 
Results  are  expressed  as  the  activity  relative  to  that  towards  methionine,  when  assaying 
for  the  production  of  a-keto  acids.  Data  for  native  MGL  are  taken  from  Lockwood  and 
Coombs,  (199  1) 
N.  D.,  not  detectable. 
216 CHAPTER  6:  INVESTIGATIONS  INTO  THE  FUNCTIONS  OF 
METHIONINE  y-LYASE  AND  OTHER  SULPHUR  AMINO  ACID- 
METABOLISING  ENZYMES  IN  T.  VA  GINALIS  AND  OTHER 
TRICHOMONADS. 
6.1  Introduction. 
The  results  from  molecular  and  biochemical  characterisation  of  methionine  y-lyase  from 
T  vaginalis  has  been  presented  in  the  previous  two  chapters  of  this  thesis.  Questions, 
however,  remain  unanswered  with  regards  to  the  function  of  this  unusual  enzyme  in  the 
T  vaginalis.  Two  main  ideas  have  been  proposed  for  the  purpose  of  an  enzyme  that  is 
able  to  catabolise  hornocysteine  and  methionine  at  a  high  rate  (Thong  el  al.,  1987) 
The  first  is  that  the  a-keto  acids  produced  from  the  breakdown  of  several  sulphur- 
containing  amino  acids  by  T  vaginalis  are  catabolised  via  energy  generating  pathways 
similar  to  the  breakdown  of  pyruvate.  Support  for  this  proposal  comes  from  the  finding 
that  pyruvate:  ferredoxin  oxidoreductase,  the  enzyme  that  catalyses  the  conversion  of 
pyruvate  to  acetyl  CoA,  will  also  catalyse  the  conversion  of  cc-ketobutyrate  to  propionyl 
CoA  (Williams  et  aL,  1987). 
The  second  idea  is  that  methionine  y-lyase  along  with  serine  sulphydrase,  another 
sulphur  amino  acid-catabolising  enzyme  of  T  vaginalis  (Thong  and  Coombs,  1985),  are 
involved  in  maintaining  a  reducing  environment  in  the  cell.  Indeed,  it  has  been 
suggested  that  Entamoeba  histolytica  and  Giardia  lamblia,  as  well  as  T  vaginalis, 
require  thiols  (particularly  cysteine)  to  counter  the  toxic  effects  of  oxygen  (Gillin  et  aL, 
217 1984  and  Fairlamb,  1989).  It  may  be  that  in  T  vaginalis,  methionine  y-lyase  and  serine 
sulphydrase  are  themselves  involved  in  countering  the  toxic  effects  of  oxygen. 
The  work  presented  in  this  chapter  details  some  experiments  carried  out  to  investigate 
the  possibility  of  methionine  y-lyase  and  serine  sulphydrase,  being  involved  in 
maintaining  the  redox  balance  of  the  cell.  The  hornocysteine-catabolising  capabilities  of 
T  vaginalis,  Tritrichomonasfoetus  and  Trichomilus  augusta  were  investigated.  As  has 
been  outlined  in  previous  chapters,  it  appears  that  methionine  y-lyase  is  also  responsible 
for  the  breakdown  of  homocysteine,  particularly  in  T  vaginalis.  Therefore,  in  this 
chapter  the  enzyme  names  homocysteine  desulphurase,  and  methionine  y-lyase,  are 
interchanged.  Homocysteine  desulphurase  activity  reflects  the  ability  by  methionine  y- 
Iyase  to  breakdown  homocysteine. 
This  chapter  also  describes  some  work  carried  out  using  the  polyclonal  antibodies  that 
were  raised  against  recombinant  MGLI  and  MGL2,  in  localisation  studies  of 
methionine  y-lyase  in  T  vaginalis,  T  foetus  and  T  augusta. 
6.1  Results. 
6.2.1  Effects  of  propargy1glycine  on  methionine  y-lyase  and  serine  sulphydrase 
activities  of  T.  vaginalis. 
Firstly,  T  vaginalis  was  grown  in  the  presence  of  a  range  of  propargy1glycine 
concentrations,  a  known  inhibitor  of  y-elimination  enzymes  (Abeles  and  Walsh,  1973). 
See  2.1.1.2  for  details  of  T  vaginalis  cultivation.  The  addition  of  propargylglycine  to 
cultures  of  T  vaginalis  did  not  affect  parasite  growth.  As  can  be  seen  from  Table  6.1, 
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concentration  of  propargy1glycine  whilst  serine  sulphydrase  activity  was  elevated  in  - 
comparison  to  the  control.  When  the  concentration  of  propargy1glycine  was  increased 
there  was  an  accompanying  increase  in  the  specific  activity  of  serine  sulphydrase.  It 
must  be  noted,  however,  that  the  activity  of  serine  sulphydrase  when  T  vaginalis  was 
grown  in  I  mM  propargy1glycine  was  lower  than  when  grown  with  100  pM  of  the 
inhibitor.  Homocysteine  desulphurase  activity  remained  inhibited. 
These  results  were  in  agreement  with  those  presented  by  Thong  and  Coombs,  1987. 
This  experiment  was  only  conducted  once,  which  may  raise  questions  as  to  the 
reliability  of  the  data.  The  same  experiment,  however,  has  been  repeated  by  two  ' 
parasitology  students  in  their  honours  projects  and  the  same  general  trend  observed, 
which  gives  me  confidence  that  the  results  obtained  are  real. 
6.2.2  Effects  of  exogenous  cysteine,  serine  and  propargy1glycine  on  the  methionine 
y-lyase  and  serine  sulphydrase  activities  of  T.  vaginalis. 
Table  6.2  shows  the  result  of  an  experiment  when  T  vaginalis  was  grown  in  the 
presence  of  various  concentrations  of  propargylglycine  in  the  medium  and  supplemented 
with  10  mM  cysteine  or  10  mM  serine.  When  T  vaginalls  was  grown  in  medium 
supplemented  with  cysteine  alone  and  in  the  presence  of  the  inhibitor  plus  cysteine,  the 
elevation  of  serine  sulphydrase  did  not  occur.  Also  homocysteine  desulphurase  activity 
was  not  completely  abolished.  However,  when  the  cells  were  grown  in  additional 
serine,  the  parasites  responded  as  they  did  when  grown  in  the  presence  of 
propargy1glycine  alone. 
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augusta. 
The  activity  of  methionine  7-lyase  was  also  investigated  in  two  other  species  of 
trichomonad,  T  foelus  and  T  augusta.  Table  6.3  shows  the  results  obtained  when 
homocysteine  catabolism  was  investigated  in  the  two  different  species  of  trichomonad. 
As  can  be  seen  from  Table  6.3,  no  hornocysteine  catabolising  activity  could  be  detected 
in  homogenates  of  T  foetus  or  T  augusta. 
6.2.4  Western  blot  analysis  of  Tfoetus  and  T.  augusta  homogenates,  soluble  and 
pellet  fractions  with  the  anti-rMGL1  and  anti-rMGL2  sera. 
Enzymatic  activity  was  not  detected  for  the  breakdown  of  homocysteine  by  T  foetus  or 
T  augusla.  It  was  decided  to  investigate  the  of  enzyme  homologues  in  lysates  of  the 
two  parasites  by  using  the  two  antibodies  that  had  been  raised  to  recombinant  proteins 
encoded  by  the  two  methionine  y-lyase  homologues  that  had  been  isolated  from  T 
vaginalis.  Figure  6.1  shows  Western  blot  analysis  of  homogenates,  pellet  and  soluble 
fractions  of  the  two  parasites  with  the  anti-rMGLI  and  anti-rMGL2  sera. 
As  can  be  seen  from  Panel  A,  lanes  I  and  3  there  was  a  tiny  amount  of  reactivity  of  the 
T  foetus  soluble  fraction  and  homogenate  with  the  pre-immune  rMGL  I  serum,  with  a 
protein  of  -68  kDa  being  recognised.  Panel  A,  lanes  4-6,  also  show  some  reactivity 
with  the  T  augusta  samples  and  the  rMGL  I  pre-immune  serum.  There  were  a  number 
of  proteins  recognised  by  the  pre-immune  serum  in  the  T  augusta  hornogenate  that 
range  in  size  from  -96-35  kDa,  two  proteins  of  -68  kDa  and  -35  kDa  were  recognised 
by  the  same  serum  in  the  T  augusta  soluble  fraction. 
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using  the  immune  rMGLI  serum.  As  can  be  seen  from  Panel  B,  lanes  I  and  3,  there  was 
a  small  amount  of  reactivity  in  the  T  foetus  soluble  and  homogenate  fractions,  with  a 
protein  of  >96  kDa  being  recognised  in  the  soluble  fraction  (Panel  B,  lane  1)  and  several 
proteins  of  between  68->96  kDa  being  recognised  in  the  T  foetus  homogenate  (Panel  B, 
lane  3).  No  proteins  were  recognised  in  the  T  foetus  pellet  fraction  (Panel  B,  lane  2)  by 
the  immune  rMGLI  sera.  Panel  B,  lanes  4-6  show  the  reactivity  of  T  augusta  proteins 
with  the  immune  rMGLI  sera.  As  can  be  seen  from  Panel  B,  lane  4,  there  are  some  high 
molecular  weight  bands  of  >96  kDa  that  were  recognised  with  the  immune  rMGL  I 
serum,  that  were  not  recognised  with  the  pre-immune  serum.  Panel  B,  lane  6  shows  that 
several  proteins  of  the  T  augusta  homogenate  are  recognised  by  the  immune  rMGLI 
serum  that  are  not  recognised  by  the  pre-immune  serum.  For  example,  the  protein  of 
-35  kDa  recognised  with  the  pre-immune  rMGLI  serum  is  more  strongly  recognised 
with  the  immune  rMGLI  serum.  Proteins  >43  kDa->96  kDa  were  also  recognised  by 
the  immune  rMGLI  serum  but  not  the  pre-immune  serum. 
Panel  C,  lanes  1-3  show  the  reactivity  of  the  pre-immune  rMGL2  serum  with  T  foetus 
soluble  and  pellet  fractions  and  homogenates,  respectively.  There  was  only  a  slight 
reactivity  of  two  proteins  of  >96  kDa  and  -68  kDa  in  the  T  foelus  homogenate  (Panel 
C,  lane  3).  Panel  B,  lanes  4-6  show  the  reactivity  of  the  same  fractions  but  from  T 
augusta.  There  was  only  a  small  amount  of  reactivity  of  proteins  of  -68  kDa  and  -75 
kDa  and  T  augusta  soluble  fraction  with  the  pre-immune  rMGL2  serum  (Panel  C,  lane 
4). 
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with  the  immune  rMGL2  serum.  As  can  be  seen  from  lanes  I  and  3,  there  were  many 
bands  of  >43kDa  recognised  by  the  rMGL2  immune  serum.  There  were  no  proteins 
recognised  in  the  pellet  fraction  of  T  foetus  with  the  immune  rMGL2  antibody  (Panel 
D,  lane  2).  Panel  D,  lanes  4  and  6,  show  the  reactivity  of  T  auguista  soluble  fraction 
and  homogenates  with  the  immune  rMGL2  serum,  as  can  be  seen  from  lanes  4  and  6 
there  were  several  proteins  ranging  from  -5OkDa  to  >96kDa  recognised  be  the  immune 
rMGL2  serum.  There  was  a  single  protein  of  >96kDa  recognised  by  the  immune 
rMGL2  serum  in  the  pellet  fraction  of  T  augusta  (Panel  D,  lane  5). 
6.2.5  Immunolocalisation  of  methionine  y-lyase  homologues  in  intact  T.  vaginalis, 
T.  foetus  and  T.  augusta. 
The  results  of  the  Western  blots  for  T  vaginalis  (Chapter  5),  T  foetus  and  T  augusta 
homogenates,  pellet  and  supernatant  fractions  with  the  two  antisera  that  had  been  raised 
against  rMGLI  and  rMGL2  prompted  immunolocalisation  experiments  in  the  intact 
parasites. 
Figure  6.2  shows  the  results  of  immunofluorescence  with  intact  T  vaginalis  and  the 
polyclonal  antibodie's  raised  against  rMGLl  and  rMGL2.  Figure  6.2,  Panel  A,  shows 
DAPI  nuclear  counter  staining  of  fixed  T  vaginalis  under  UV  epifluorescence.  Panel  B 
shows  immunolabelling  of  T  vaginalis  with  the  polyclonal  anti-rMGLI  serum  under 
UV  epifluorescence.  As  can  be  seen  from  Panel  B  there  appears  to  be  a  very  specific 
labelling  of  the  nucleus  of  T  vaginalis  with  the  rMGLI  antibody.  There  also  appears  to  0 
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intense  as  the  immunostaining  of  the  nucleus  of  the  parasite. 
Figure  6.2,  Panel  C  shows  DAPI  nuclear  counter  staining  of  fixed  T  vaginalis  under 
UV  epifluorescence.  Panel  D  shows  immunolabelling  of  T  vaginalis  with  the 
polyclonal  anti-rMGL2  serum  under  UV  epifluorescence.  As  can  be  seen  from  Panel  D 
there  appears  to  be  a  very  specific  labelling  of  the  nucleus  of  T  yaginalis  with  the 
rMGL2  antibody.  There  also  appears  to  be  a  general  less  intense  labelling  of  the 
cytoplasm  of  the  cell  with  the  a*ntibody. 
Figure  6.3  shows  the  results  of  immunofluorescence  with  intact  T  fbefus  and  the 
polyclonal  antibodies  raised  against  rMGL  and  rMGL2.  Figure  6.3,  panel  A  shows 
DAPI  nuclear  counter  staining  of  fixed  T  foetus  under  UV  epifluorescence.  Panel  B 
shows  immunolabelling  of  T  fbelus  with  the  polyclonal  anti  rMGLI  serum  under  UV 
epifluorescence.  As  can  be  seen  from  Panel  B,  there  appears  to  be  a  very  specific 
labelling  of  a  structure  anterior  to  the  nucleus  in  this  parasite,  as  well  as  a  more  general 
staining  of  the  cytoplasm  of  these  cells. 
Figure  6.3,  Panel  C  shows  DAPI  nuclear  counter  staining  of  fixed  T  fbelus  under  UV 
epifluorescence.  Panel  D  shows  immunolabelling  of  T  fbefus  with  the  polyclonal  anti- 
rMGL2  serum  under  UV  epifluorescence.  As  with  the  rMGLI  serum  and  T  foelus  there 
was  specific  staining  of  a  structure  anterior  to  the  nucleus  and  general  staining  of  the 
cytoplasm  of  the  parasites  with  the  rMGL2  antiserum. 
223 Figure  6.4,  Panel  A,  shows  DAPI  nuclear  counter  staining  of  fixed  T  augusta  under  UV 
epifluorescence.  There  is  no  figure  showing  the  immunostaining  of  these  parasites  with 
the  rMGLI  antiserum,  but  it  can  be  seen  from  Panel  A  that  there  is  a  structure  anterior 
of  the  nucleus  that  is  visible  on  the  DAPI  filter  and  this  structure  was  recognised  by  the 
rMGLI  antibody. 
Figure  6.4,  Panel  B,  shows  DAPI  nuclear  counter  staining  of  fixed  T  augusta  under  UV 
epifluorescence.  Panel  C  shows  immunostaining  with  the  rMGL2  antiserum  can  be 
seen  there  is  a  structure  anterior  to  the  nucleus  that  is  specifically  labelled  with  the 
antibody,  as  was  the  result  with  T  foetus. 
6.3  Discussion. 
The  work  presented  in  this  chapter  indicates  that  methionine  y-lyase  and  serine 
sulphydrase  of  T  vaginalis  may  have  complementary  functions,  as  has  been  previously 
suggested  by  Thong  et  al.,  1987.  It  was  found  that  methionine  y-lyase  was  inhibited  by 
I  [tM  propargy1glycine  whilst,  serine  sulphydrase  activity  was  increasingly  elevated  up 
to  100  pM  of  inhibitor.  The  ffirther  increase  in  serine  sulphydrase  activity  that  is 
observed  even  when  methionine  y-lyase  activity  is  inhibited  can  probably  be  explained 
by  other  pyridoxal  5'-phosphate  enzymes  present  in  T  vaginalis  being  inhibited.  For 
example,  cystathionine  y-lyase  which  is  reported  to  exist  in  T  vaginalis  (Thong  and 
Coombs,  1985)  is  a  pyridoxal  5'-phosphate  linked  enzyme.  The  enzyme  in  other 
systems  is  reported  to  be  inhibited  by  propargy1glycine  (Abeles  and  Walsh,  1973).  The 
products  of  cystathionine  breakdown  by  cystathionine  y-lyase  are  cysteine,  cc- 
ketobutyrate  and  ammonia.  It  may  be  that  other  enzymes  present  in  T  vaginalis  have  a 
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proteins  of  the  parasite  reduced,  and  that  these  enzymes  have  a  similar  sensitivity  to 
propargy1glycine  (ie.  cystathionine  y-lyase).  Thus  the  effects  of  propargy1glycine  on 
methionine  y-lyase  and  serine  sulphydrase  may  be  a  cumulative  effect  of  the  inhibitor  on 
several  enzymes  in  T  vaginalis  that  are  involved  in  redox  balance  of  the  cell.  It  would 
be  interesting  therefore  to  assay,  for  example,  cystathionine  y-lyase  of  T  vaginalis  when 
the  parasites  were  grown  in  different  concentrations  of  propargy1glycine. 
Results  obtained  for  the  experiment  in  which  T  vaginalis  was  grown  in  the  presence  of 
10  mM  cysteine  are  indicative  of  senine  sulphydrase  of  T  vaginalis  operating  in  the 
direction  of  cysteine  synthesis.  The  elevation  of  serine  sulphydrase  activity  brought 
about  by  the  inhibition  of  methionine  y-lyase  by  propargy1glycine  does  not  need  to  be 
balanced  as  there  is  already  sufficient  cysteine  in  the  environment  of  the  cell  to  keep 
conditions  reduced.  It  is  interesting  to  note  that  in  the  presence  of  cysteine  and  various 
concentrations  of  propargy1glycine  the  activity  of  hornocysteine  desulphurase  was  not 
completely  abolished.  It  is  probable  that  cysteine  is  present  in  the  active  site  of 
methionine  y-lyase,  and  this  is  why  a  residual  activity  is  seen.  '  It  should  also  be  noted 
that  at  high  concentrations  of  propargy1glycine  (I  mM),  the  activity  of  serine 
sulphydrase  also  decreases.  The  likely  reason  for  this  is  that  at  high  concentrations  of 
propargy1glycine,  the  activity  of  serine  sulphydrase  the  activity  of  this  enzyme  is  also 
being  inhibited.  I  feel  this  result  probably  reflects  the  different  sensitivities  of 
methionine  y-lyase  and  serine  sulphydrase  to  propargy1glycine.  The  determination  of 
Kis  for  methionine  y-lyase  and  serine  sulphydrase  of  T  vaginalis  with  propargy1glycine 
is  an  experiment  that  would  need  to  be  carried  out  to  support  this  hypothesis. 
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may  be  important  in  protecting  the  parasite  from  the  toxic  effects  of  oxygen  is  provided 
by  Lloyd  et  al.,  199  1,  who  has  shown  that  methanethiol,  a  reaction  product  from  the 
catabolism  of  methionine,  can  be  auto-oxidised  to  dimethy1disulphide  in  T  vaginalis. 
The  importance  of  cysteine,  and  other  reducing  agents  in  the  biology  of  T  vaginalis  was 
questioned  by  the  findings  presented  by  Paget  and  Lloyd,  1989.  Their  data  indicated 
that  oxygen  was  less  toxic  to  T  vaginalis  in  the  absence  of  reducing  agents.  However, 
cysteine  in  particular  may  have  role  in  the  generation,  maintenance  and/  or  protection  of 
thiol  groups  on  the  surface  of  the  parasite  (Gillin  et  al.,  1984).  Indeed  Paget  and  Lloyd, 
(1989)  showed  that  T  vaginalis  grown  in  6  mM  cysteine  and  I  mM  ascorbate  had  a 
rough  surface  and  a  shape  varying  from  pyriform  to  spherical,  whereas,  T  vaginalis 
grown  without  an  excess  of  reducing  agents  had  smooth  surfaces  and  uniform  shapes. 
Paget  and  Lloyd  stated  that  such  structural  changes  in  T  vaginalis  in  the  presence  of 
reducing  agents  could  be  explained  if  cysteine  was  a  major  component  of  a  structural 
surface  protein  of  T  vaginalis.  Gillin  et  al.,  1984  had  previously  showed  that  T 
vaginalis  was  killed  by  incubation  with  non-penetrative  thiol  blocking  reagents,  which 
is  indicative  of  thiols  being  present  at  the  surface  of  the  parasite.  Indeed,  it  may  be  that 
the  production  of  cysteine  in  T  vaginalis  is  important  in  adherence  of  the  parasite  to  the 
vaginal  epithelial  cells  and  their  binding  of  host  macromolecules  (Graves  and  Gardner, 
1993),  both  of  which  would  aid  the  survival  of  T  vaginalis  in  its  human  host. 
The  results  presented  on  the  immunofluorescence  of  intact  T  vaginalis,  T  foelus  and  T 
augusta  with  the  two  polyclonal  antibodies  raised  to  rMGLI  and  rMGL2  are  very 
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vaginalis  and  a  general  localisation  in  the  cytoplasm  of  the  cells.  Western  blot  analysis 
of  T  vaginalis  homogenates  and  pellet  and  soluble  fractions  (Chapter  5)  indicated  that 
both  rMGL  I  and  rMGL2  were  expressed  as  a  43  kDa  protein  in  the  soluble  fraction  of 
the  cells.  Also  subcellular  localisation  studies  of  methionine  y-lyase  showed  that  the 
majority  of  the  protein  was  found  in  the  non-sedimentable  fraction  of  the  parasite 
(Lockwood  and  Coombs,  199  1).  The  explanation  that  I  give  for  the  strong  reactivity  of 
both  polyclonal  antibodies  with  intact  T  vaginalis  is  simply  a  cross  reactivity  with  an 
epitope  in  the  nucleus  of  these  parasites,  which  is  very  similar  to  the  methionine  y-lyase 
homologues  to  which  the  antibodies  were  raised. 
Similarly,  the  results  of  immunolocalisation  with  the  rMGLI  and  rMGL2  antisera  and  T 
foetus  and  T  augusta  are  very  interesting.  Both  parasites  with  both  antisera  show  a 
specific  immunolocalisation  to  a  structure  which  is  anterior  to  the  nucleus.  The  results 
of  the  Western  blots  of  T  foetus  and  T  augusta  homogenates,  pellet  and  supernatant 
fractions  showed  that  there  was  no  specific  recognition  of  a  single  protein,  as  there  was 
for  T  vaginalis.  The  reactivity  of  the  two  antisera  with  intact  T  foelus  and  T  augusla, 
as  with  T  vaginalis  is  thought  to  be  a  cross  reactivity  of  the  antibodies  with  similar 
epitopes  to  the  protein  to  which  the  antibodies  were  originally  raised.  It  is  thought  that 
the  structure  being  recognised  by  the  anti-rMGL  I  and  anti-rMGL2  sera  was  the  Golgi 
apparatus.  Recently  Diaz  et  al.,  (1996)  have  isolated  the  Golgi  complex  from  T  foetus 
and  have  carried  out  ultrastructural  studies  for  this  parasite  which  revealed  the  position 
of  this  organelle  in  the  parasite. 
227 Confirmation  of  the  structure  of  T  f0elus  and  T  augusta  being  recognised  by  the  two 
anti-sera  raised  against  the  two  recombinant  methionine  y-lyases  of  T  vaginalis,  as  the 
Golgi  apparatus,  could  be  achieved  through  by  using  a  variety  of  approaches.  Firstly, 
subcellular  fractionation  of  T  foetus  and  T  augusta  could  be  carried  out  to  enrich  for 
Golgi  apparatus  of  these  parasites,  followed  by  immunostaining  with  the  two  anti-sem 
raised  against  the  recombinant  methionine  y-lyase.  Immuno-electron  microscopy  of  the. 
two  parasites  and  the  two  anti-sera,  could  be  carried  out.  Thirdly,  a  molecular  probe 
specific  to  Golgi  apparatus  could  be  used  in  an  attempt  to  counterstain  the  organelle 
along  with  immunostaining  using  the  two  antisera. 
228 Figure  6.1  A/B/C/D  Western  blot  analysis  of  Tfoetus  and  T.  augusta 
supernatant,  pellet  and  soluble  fractions  with  anti-rMGL1  and 
-rMGL2  sera. 
Panel  A 
Lane  1:  T  foetus  soluble  fraction 
Lane  2:  T  foetus  pellet  fraction 
Lane  3:  T  foetus  homogenate 
Lane  4:  T  augusta  soluble  fraction 
Lane  5:  T  augusta  pellet  fraction 
Lane  6:  T  augusta  homogenate 
Probed  with  pre-immune  rMGL  I  sera 
Panel  B 
Lanes  as  above,  probed  with  immune  rMGLI 
Panel  C 
Lanes  as  above,  probed  with  pre-immune  rMGL2 
Panel  D 
Lanes  as  above,  probed  with  immune  rMGL2 kDa 
96- 
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229 Figure  6.2  A/B/C/D  Light  micrographs  showing  specificity  of 
immunolabelling  of  T.  vaginalis  with  polyclonal  antisera  raised  against 
rMGLI  and  rMGL2. 
Panel  A:  T  vaginalis  under  UV  epifluorescence  showing  DAPI  nuclear 
counterstain  (x63  magnification). 
Panel  B:  T  vaginalis  under  UV  epifluorescence  showing  fluorescent  labelling 
with  anti-rMGL  I  serum. 
Panel  C:  As  Panel  A. 
Panel  D:  As  Panel  B  but  with  anti-rMGL2  serum. 
Scale  bar:  10  ýtrn. A  B 
C  1) 
230 Figure  6.3  A/B/C/D  Light  micrographs  showing  specificiql  of 
immunolabelling  of  T  foelus  with  polyclonal  antiscra  raised  against  rMGL  I 
and  rMGL2. 
Panel  A:  T  foetus  under  UV  epifluorescence  showing  DAPI  nuclear  counterstain 
(x63  magnification). 
Panel  B:  Tfoelus  under  UV  epifluorescence  showing  fluorescent  labelling  with 
anti-rMGLI  serum. 
Panel  C:  As  Panel  A. 
Panel  D:  As  Panel  B  but  with  anti-rMGL2  serum. 
Scale  bar:  10  pm. A 
C 
B 
D 
231 Figure  6.4  A/B/C/D  Light  micrographs  sho%  ing  specif  icitN  of 
immunolabelling  of  T.  augusla  with  pol.,  clonal  antiscra  raised  against 
rMGLI  and  rMCL2. 
Panel  A:  T  augusta  under  I  IV  epilluorescence  showing  DAIII  nuclear 
counterstain  (x63  magnification) 
Panel  B:  As  Panel  A 
Panel  C:  T  augusla  under  I  JV  epilluorescence  shw%ing  fluorescent  label  I  ing  with 
anti-rMG1,2  serum 
Scale  bar:  10  pm A 
B  C 
232 T.  vaginalis 
[Propargylglycinel  Homocysteine 
desulphurase 
Serine 
sulphydrase 
Control  139  217 
1  gm  ND<3  468 
IOPM  ND<3  1390 
100ýtm  ND<3  2580 
Imm  ND<3  1790 
Table  6.1:  Homocysteine  desulphurase  and  serine  sulphydrase  activities  in 
supernatant  fractions  of  T.  vaginalis  grown  in  the  presence  of  various 
concentrations  of  propargy1glycine. 
This  experiment  was  only  carried  out  once. 
Units:  nmol/min/mg  protein). 
ND:  not  detectable. 
233 10  mM  cysteine  10  mM  serine 
[Propargylglycinel 
Homocysteine 
desulphurase 
Serine 
sulphydrase 
Homocysteine 
desulphurase 
Serine 
sulphydrase 
Control 
No  inhibitor 
No  amino  acid 
230  506  112  200 
Amino  acid  only  212  8.2  83  206 
1  ptM  21  4.1  -  - 
lopm  4.1  5.3  ND<3  1420 
100ýtm  3.8  3.7  ND<3  1620 
IMM  5.1  3.4  ND<3  1440 
Table  6.2:  Homocysteine  desulphurase  and  serine  sulphydrase  activities  in 
supernatant  fractions  of  T.  vaginalis  when  incubated  with  various 
concentrations  of  propargy1glycine  and  supplemented  with  either  cysteine  or 
serine. 
This  experiment  was  only  carried  out  once. 
Units:  mnol/min  /protein- 
ND:  not  detectable 
234 T  foetus  T  augusta 
Homocysteine 
desulphurase 
ND<l  (3)  ND<2  (3)  I 
Table  6.3  Homocysteine  desulphurase  activity  in  T.  foetus  and  T.  augusta 
supernatant  fractions. 
ND:  not  detectable 
Units:  nmol/min/mg  protein- 
n  in  parentheses 
235 CHAPTER  7:  GENERAL  DISCUSSION. 
Two  methionine  y-lyase  gene  homologues  have  been  isolated  and  biochemically 
characterised  from  T  vaginalis  .  Molecular  characterisation  of  the  two  genes  have 
revealed  that  they  have  extremely  short  5'  untranslated  regions,  are  at  single  copy  in  the 
T  vaginalis  genome,  are  transcribed  to  give  1.3  kb  poly  [A]+  RNAs  and  have  a  high 
degree  of  sequence  identity  and  similarity  to  genes  from  a  range  of  other  organisms  that 
are  involved  in  transulphuration  pathways.  The  two  methionine  y-lyase  gene 
homologues  were  cloned  into  expression  vectors  and  recombinant  protein  produced. 
Biochemical  characterisation  of  the  two  recombinant  proteins  revealed  that  both  of  the 
gene  products  were  able  to  catabolise  methionine  and  a  range  of  other  sulphur- 
containing  amino  acids.  Interestingly,  the  two  T  vaginalis  methionine  y-lyase 
homologues  were  not  able  to  breakdown  cystathionine. 
The  essentiality  of  the  two  gene  products  to  the  parasite  is  currently  only  an  area  for 
speculation.  However,  this  is  a  question  that  could  be  realistically  addressed  in  future 
research.  The  isolation  of  the  genomic  copies  of  the  two  genes  for  mgII  and  mgI2  by  T. 
D.  Edlind  (personal  communication)  now  provides  the  opportunity  for  knock-out 
vectors  to  be  constructed,  which  would  allow  the  targeted  gene  disruption  of  the  mgII 
and  mgI2  loci  by  integration  of  an  antibiotic  resistance  marker.  This  is  an  approach  that 
has  been  used  to  test  the  essentiality  of  cysteine  proteinase  genes  in  Leishmania 
mexicana  (Mottram  et  al.,  1996).  Discovery  of  the  essentiality  of  the  two  T.  vaginalis 
methionine  y-lyase  gene  homologues  is,  of  course,  dependent  on  a  stable  transfection 
system  being  developed  for  T  vaginalis.  Such  a  transfection  system  would  probably  be 
based  on  that  used  for  L.  mexicana  gene  disruption  as  described  above. 
236 Another  question  that  should  be  addressed  is,  does  T  vaginalis  really  possess  a 
cystathionine  y-lyase?  There  has  been  only  one  report  of  the  breakdown  of 
cystathionine  by  T  vaginalis  (Thong  and  Coombs,  1985a)  and  this  particular  enzyme 
has  received  no  further  attention  until  this  study.  As  has  been  presented  in  Chapter  4, 
the  degenerate  oligonucleotides  designed  for  the  isolation  of  methionine  y-lyase  gene 
homologues  from  T  vaginalis  were  based  on  cystathionine  y-lyase  from  a  number  of 
sources.  Initially,  when  the  two  gene  homologues  were  isolated  from  T  vaginalis,  both 
of  which  had  a  similar  level  of  amino  acid  sequence  identity  to  methionine  y-lyase  from 
P.  putida  and  to  cystathionine  y-lyase  from  S.  cerevisiae,  it  was  thought  that  maybe  one 
of  the  genes  would  encode  the  methionine  catabolising  capability  of  the  parasite  and  the 
other  the  cystathionine  catabolising  capability.  However,  the  production  and 
biochemical  characterisation  of  the  two  recombinant  proteins  for  the  methionine  y-lyase 
gene  homologues  revealed  that  this  was  not  the  case.  There  needs  to  be  confirmation  of 
cystathionine  catabolising  capability  in  T  vaginalis. 
The  production  of  recombinant  proteins  for  the  two  T  vaginalls  methionine  y-lyase  gene 
homologues  opens  a  vista  of  future  research  in  this  area  of  sulphur-amino  acid 
metabolism  in  this  parasite.  The  natural  progression  of  research  in  this  area,  in  my 
view,  would  be  the  crystallographic  characterisation  of  these  two  methionine  y-lyase 
gene  homologues.  Such  an  approach  would  allow  the  characterisation  of  the  3D 
structure  of  the  enzymes,  this  could  also  include  the  molecular  modelling  specific  of 
inhibitors  to  the  active  site  of  the  enzymes. 
237 Site  directed  mutagenesis  of  key  amino  acid  residues  in  the  two  recombinant  proteins  is 
another  option  for  future  research.  This  is  a  study  that  has  already  been  initiated  by  Dr. 
John  Walker,  using  a  PCR  based  site  directed  mutagenesis  system.  Dr.  Walker  has 
mutated  the  Cysteine  113  residue  in  mgII  and  mgI2,  the  residue  that  has  been  implicated 
in  the  active  site/pyridoxal  5-phosphate  binding-region  of  the  P.  putida  methionine  y- 
lyase.  The  data  obtained  for  mutant  rMGLI  correlate  well  with  the  results  of  the 
chemical  modification  of  the  P.  putida  methionine  y-lyase  (Nakayama  et  al.,  1988),  with 
the  a  y-elimination  activity  being  reduced  to  -8%  of  the  original  and  the  cc  P- 
elimination  being  reduced  to  -40%.  The  data  obtained  for  mutant  rMGL2  shows  a 
reduction  in  the  (x  y-elimination  activity  to  22%  of  the  original,  whilst  the  a  P- 
elimination  activity  is  elevated  to  180%  of  the  original  (personal  communication,  Dr  J 
Walker).  Interestingly,  the  mutation  of  Cysteine  113  to  a  glycine  residue  does  not 
confer  the  ability,  by  the  two  proteins,  to  break  down  cystathionine. 
Sulphur-amino  acid  metabolism  in  T  vaginalis  is  an  area  which  has  great  research 
potential.  There  are  many  more  avenues  that  can  be  opened  to  investigation.  In 
particular,  it  would  be  interesting  to  confirm  whether  there  is  a  functional 
transulphuration  pathway  in  T  vaginalis.  Cystathionine  P-synthase,  the  first  enzyme  of 
the  transulphuration  sequence,  has  not  been  looked  at  in  T  vaginalis.  However,  the 
presence  of  activated  serine  sulphydrase  activity  in  T  vaginalis  indicates  that  the 
capacity  to  produce  cystathionine  from  homocysteine  and  serine  probably  does  exist  in 
the  parasite.  Also,  as  mentioned  above,  there  needs  to  be  confirmation  of  a 
cystathionine  catabolising  capability  in  the  parasite.  The  presence  of  other  enzymes 
involved  in  sulphur  amino  acid  metabolism  could  be  confirmed  by  future  research,  for 
238 example,  does  cystathionine  y-synthase,  cystathionine  P-lyase  and/or  O-acetyl 
homoserine/0-acetyl  serine  sulphydrylase  exist  in  T  vaginalis?  Also  the  function,  as 
significance  to  the  parasite  of  enzymes  involved  in  sulphur  amino  acid  metabolism  in  T 
vaginalis  could  be  addressed  further. 
Finally,  one  should  remember  that  all  of  the  work  conducted  in  this  study  was  based  on 
T  vaginalis  that  was  obtained  via  in  vitro  cultivation.  Whilst  methionine  y-lyase  is  at 
high  activity  in  in  vitro  cultivated  parasite  material,  the  role  of  the  enzyme  in  vivo  may 
become  all  the  more  important.  One  must  consider  that  the  conditions  in  the 
urinogenital  tract  are  considerably  different  from  those  found  a  bottle  of  MDM.  It  is 
probable  that  the  availability  of  carbohydrate  sources  in  the  host  are  limited  and  that 
proteinaceous  substrates,  available  for  proteolytic  degradation  by  T  vaginalis 
proteinases,  are  much  more  abundant.  Amino  acids,  in  particular  sulphur  amino  acids, 
which  may  result  from  the  breakdown  of  keratin  containing  proteins  in  the  urinogenital 
tract  of  the  host,  may  become  more  important  with  regards  to  the  provision  of  energy  to 
the  parasite.  As  well  as  the  provision  of  energy  resulting  from  the  breakdown  of  sulphur 
containing  and  other  amino  acids,  the  thiols  that  are  also  generated  from  sulphur  amino 
acid  catabolism  may  be  important  for  the  maintenance  of  aT  vaginalis  infection  in  the 
host. 
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